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Summary
Bacterial contamination of the female genital tract after parturition is 
common and subsequent infections are associated with infertility. Infections of the 
uterus or mammary gland in cattle perturb ovarian function, with decreased 
dominant follicle growth rate and delayed ovulation. Granulosa cells that line 
ovarian follicles express the molecular machinery necessary to respond to common 
bacterial pathogen-associated molecular patterns (PAMPs), suggesting that granulosa 
cells may play a role in ovarian innate immunity.
In the present thesis, the effect of bacterial PAMPs on ovarian follicle cells 
was examined during follicular growth, from emergence through dominance, and the 
early stages of embryogenesis. Granulosa cells from emerged or dominant bovine 
follicles increased production of inflammatory mediators, such as IL-6 and IL-8, 
through Toll-like receptor (TLR)-dependent pathways in response to the PAMPs 
lipopolysaccharide and the synthetic triacylated lipopeptide Pam3CSK4. The 
requirement for TLR2 and TLR4 was confirmed by using siRNA, showing 
activation of MAPK intracellular pathways and inhibiting key signals (p38, MEK or 
NFkB) in TLR pathways. The endocrine function of granulosa cells was perturbed 
by PAMPs, with decreased oestradiol and progesterone output. In addition, the 
endocrine environment affected granulosa cellular responses, with high EGF 
increasing the cellular response to PAMPs. Bacterial PAMPs also perturbed the 
oocyte, with increased cumulus expansion and parthenote cleavage rate, as well as 
changes in key genes involved in oocyte maturation. Finally, a human granulosa cell 
line was used to examine if PAMPs perturb human as well as bovine ovarian health. 
Indeed, human cells also expressed TLRs and mounted a cellular response to PAMPs 
at the mRNA level.
This thesis provides a molecular mechanism for the perturbation of ovarian 
function by an infection at a site distal to the ovary.
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1.1 General introduction
Ovarian health is central to successful reproduction. Microbial infections of 
the reproductive tract can cause uterine disease, which causes sub-fertility. Uterine 
disease is common in cattle and humans and, in addition to causing pain and 
suffering to the individual, the disease is also an economic burden for society. Early 
research into uterine disease focussed on visible symptoms and epidemiology, with 
more recent investigations beginning to address the underlying mechanisms leading 
to infertility. Studies have tended to examine the effect of bacterial infections on the 
uterus, but the disease also impacts the ovaries in vivo. This thesis will focus on how 
bacterial infections distant to the ovaries impact the function of cells within ovarian 
follicles.
As uterine disease and the associated ovarian dysfunction have principally 
been identified in dairy cattle, much of the research uses bovine ovaries. Ovarian 
cells and oocytes are readily available from healthy animals after slaughter. The first 
three research chapters address mechanisms of inflammation and immunity in the 
bovine ovary. The bovine ovary is also a good model for the human ovary, as it is 
similar in size and function. Obtaining healthy human ovaries is near impossible as 
most people having an oophorectomy will either have pre-existing ovarian problems 
or will be post-menopausal. Thus, in the penultimate chapter of the thesis, results are 
presented from investigations using a human ovarian cell line.
In the present chapter, the background literature to the thesis will be 
discussed. It will start by concentrating on the reproductive system, describing 
bovine ovarian structure and function, before reviewing follicular growth, ovulation 
and early embryogenesis. The focus of the literature review will then shift to centre 
on uterine disease, the associated bacterium Escherichia coli and how the body 
responds to pathogen invasion. The two sides of the story will then be linked by 
describing the interactions between endocrine and innate immune pathways. Lastly, 
the culture techniques previously used will be reviewed and the aims and objectives 
of this thesis identified.
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1.2 Ovarian structure and function
Ovaries are gonads of female mammals, which have two main functions: to 
produce oocytes with the capacity for fertilisation and development, and to act as 
endocrine glands, secreting steroid hormones necessary for establishment of 
pregnancy. Each healthy ovary is around 3.5 cm x 2.5 cm x 1.5 cm and is covered in 
a monolayer of flat-to-cuboidal epithelium, except at the hilum where mesentery 
attaches to suspend the ovary from the back of the broad ligament of the uterus, as 
shown in Fig 1.1 (Auersperg et al., 2001). The inside of the ovary is divided into 
cortex and medulla, with the outer part of the cortex forming the tunica albuginea, a 
thin connective tissue layer. The remaining cortex contains stromal cells, capillaries, 
follicles and corpus lutea. Of main interest to this thesis are the granulosa cells (GCs) 
contained within the basement membrane of ovarian follicles.
Bovine ovaries develop from gonadal primordia as a paired thickening of the 
coelomic epithelium on the ventral-medial surface of the urogenital ridge on around 
day thirty of embryo development (Wrobel and Suss, 1998). Primordial germ cells, 
the embryonic pre-cursors of adult gametes, are necessary for formation of the 
ovary: in their absence, the gonad degenerates into a seminiferous cord-like structure 
(Whitworth, 1998). These germ cells originate from the hindgut and migrate through 
the dorsal mesentery to the gonad, where they rapidly proliferate. From this point, 
mitosis, meiosis and atresia of primordial oocytes (oogonia) occur, with the rate of 
mitosis decreasing and the rate of atresia increasing at a similar rate, until mitosis 
ends at 150 days (Erickson, 1966). Oogenesis is the development of meiotic oocytes 
from mitotic oogonia. Bovine oogonia initiate meiosis 75-80 days post conception, 
occurring in a wave from the anterior to the posterior side of the ovary. After the first 
round of cell division, premeiotic DNA is synthesised, maternal and paternal 
chromatids exchange genetic information and the oogonium develops into an oocyte. 
The oocyte is arrested at the final stage of prophase when somatic pregranulosa cells 
enclose the oocyte, forming primordial follicles and the oocyte secretes coat proteins 
to form the zona pellucida. The first meiotic division is completed at ovulation and 
the oocyte proceeds to the second meiotic division but is arrested at metaphase until 
fertilisation.
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Figure 1.1 Structure and location of ovaries in the cow. (A) Bovine ovaries are 
suspended near the end of the oviducts and are located near the end of the uterine 
horn. (B) Structure of the ovary showing a developing follicle. CL -  corpus luteum; 
GC -  granulosa cell; COC -  cumulus-oocyte complex
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1.3 Reproductive hormones
Female reproduction is controlled by the timely release of gonadotrophins 
and steroid hormones. The pattern of release will be described below, but first it is 
important to have an understanding of how these chemicals are formed and their 
basic function. Steroids are terpenoid lipids, synthesised via the HMG-CoAR 
(3-hydroxy-3-methyl-glutaryl coenzyme A reductase) pathway (Davidson and 
Sittman, 1999). Steroidogenesis is the process by which steroids are formed by 
transformations of other steroids, leading to a pathway of steroid synthesis (Fig 1.2). 
The major female steroid hormones are oestrogens and progesterones and are mainly 
produced by the ovaries. The gonadotrophins (glycoprotein hormones) 
follicle-stimulating hormone (FSH) and luteinising hormone (LH) are secreted by the 
anterior pituitary gland in response to gonadotrophin-releasing hormone (GnRH) and 
act on the ovaries after transport through the circulatory system. High-frequency 
pulses of GnRH result in release of LH, with low-frequency pulses resulting in FSH 
release (Wildt et al., 1981, Kaiser et al., 1997). Prostaglandins (PG) are produced by 
cyclooxygenase degradation of arachidonic acid, and are secreted by the uterus to 
influence the corpus luteum, either promoting (PGF2a) or protecting from (PGE2) 
luteolysis.
Steroids are synthesised from cholesterol, which is imported into theca cells 
mainly through the low-density lipoprotein (LDL) receptor, where it is maintained 
within lipid droplets. A hydrolase enzyme converts this cholesterol into free 
cholesterol, which is internalised into mitochondria through the rate-limiting action 
of steroidogenic acute regulatory protein (StAR). Here, the cholesterol is converted 
into pregnenolone, which diffuses out of the mitochondria. Through a chain of 
enzymatic events, pregnenolone is converted into progesterone, androstenedione and 
testosterone. Androstenedione and, to a lesser extent, testosterone are utilised by 
GCs to produce 17p-oestradiol, the main oestrogen produced by bovine ovaries. 
Progesterone is produced mainly by the corpus luteum after ovulation, with low 
plasma concentrations prior to ovulation at around 0.25 ng/ml, rising to 7 ng/ml 
whilst a corpus luteum is present (Malhi et al., 2005).
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Figure 1.2 Steroid hormones are produced through an enzyme cascade which 
begins with cholesterol. In the ovaries, oestradiol is produced by GCs, through 
aromatase oxidation and elimination of a methyl group of androstenedione, released 
from the theca cells. LDL-R: low density lipoprotein receptor, StAR: steroidogenic 
acute regulatory protein, P450scc: cholesterol side-chain cleavage enzyme, P450i7_oh: 
17a-hydroxylase, 3(3-HSD: 3P-hydroxysteroid dehydrogenase, P450arom: aromatase
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1.4 Oestrous cycle
The oestrous cycle consists of cyclic release of steroids (Fig 1.3), mainly 
17P-oestradiol prior to ovulation and progesterone after ovulation, corresponding to 
physical changes in the body and in female behaviour. The bovine oestrous cycle 
lasts for 21 days (Stabenfeldt et al., 1969) and can be divided into four phases: 
oestrus, proestrus, metoestrus and dioestrus (Ball and Peters, 2004). Oestrus is 
designated as the first day of a new cycle and is characterised by the dominant 
follicle reaching its maximal size and ovulation occurring. Ovulation is induced by a 
preovulatory peak in concentrations of LH and occurs approximately thirty hours 
after the onset of oestrus (Kaim et al., 2003, Fortune et al., 2009). In the absence of 
gonadotrophins, oestrus does not occur (Crowe et al., 2001). During this time, 
circulating concentrations of FSH and oestrogen decline, and concentrations of 
progesterone begin to increase.
At the end of oestrus, metoestrus occurs and lasts for around 3 days. A 
corpus luteum is formed which secretes progesterone. During metoestrus, bleeding 
may occur with streaks of blood present in the vaginal mucus. This bleeding is not 
indicative of a failure to conceive or of conception and is not menstruation (Ball and 
Peters, 2004). Dioestrus occurs after metoestrus and persists for twelve days, during 
which time, the corpus luteum is at maximum size coinciding with high 
concentrations of progesterone. During dioestrus, follicles continue to grow, but until 
luteolysis, ovulation is unable to occur, due to the inhibitory effect of high 
progesterone on the release of LH.
If pregnancy has not occurred, the uterus releases PGF2a which causes 
luteolysis. During proestrus, the corpus luteum recedes and plasma progesterone 
concentrations decline to basal concentrations. A new dominant follicle is selected, 
which leads to a high circulatory concentration of oestradiol (Allrich, 1994). The low 
concentration of progesterone combined with the high concentration of oestradiol 
triggers the peak of LH that precedes ovulation. Oestrus is induced by the action of 
oestradiol on the hypothalamus, occurring with a lack of progesterone due to 
luteolysis of the CL. Alternatively, if pregnancy has occurred, the embryo releases 
interferon tau, preventing the release of PGF2Q and thus maintaining high 
concentrations of progesterone.
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Figure 1.3 Hormone dynamics of the oestrous cycle. The graph starts with 
ovulation of the dominant follicle, after which there is a rise in FSH concentrations, 
triggering growth of the next wave of follicles. Whilst a corpus luteum is present, 
progesterone concentrations remain high, preventing a further ovulation. If 
pregnancy has not occurred, the uterus releases PGF2a, which causes luteolysis, thus 
progesterone concentrations drop and ovulation is triggered.
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1.5 Follicle development
Follicles are the functional units of the ovary, with each follicle consisting of 
an oocyte surrounded by layers of somatic GCs. The cells within the follicle are 
separated from interstitial tissue by a basal lamina, thus neither the oocyte nor GCs 
have a vascular supply. Gap junctions connect the cytoplasm of adjacent cells, 
allowing exchange of second messengers, metabolites and electrical communication 
between cells. As the follicle grows, a layer of theca cells outside the basal lamina is 
formed and becomes vascularised. Increasing layers of mural GCs are formed within 
the follicle, around a fluid-filled antrum. Cumulus GCs surround and nurture the 
oocyte.
Follicular development is a complex process (Fig 1.4) that starts before birth 
and takes around 180 days, from 30 pM at the primordial stage (Wandji et al., 1996) 
to 12-18 mm at ovulation (Perry et al., 2007, Giordano et al., 2013). Each ovary has 
around 133,000 primordial follicles at birth (Erickson, 1966), each consisting of an 
oocyte surrounded by a single layer of flattened pregranulosa cells. Recruitment of 
primordial follicles into primary follicles is thought to be triggered by signalling 
between the oocyte and the surrounding GCs, and between granulosa and theca cells 
(Braw-Tal, 2002). At this stage, the pregranulosa cells of the primordial follicle 
transform their shape, becoming cuboidal, and the oocyte grows and acquires a zona 
pellucida (Smitz and Cortvrindt, 2002).
The next stage in follicle development is the transition from primary follicle 
to preantral or secondary follicle. This stage is marked by the growth of a second 
layer of GCs around the oocyte, which develop into further layers through this 
preantral development due to high mitotic activity of the GCs (van den Hurk and 
Zhao, 2005). The oocyte grows further and theca cells are recruited to surround the 
basal lamina. These theca cells undergo differentiation to become the theca interna 
and theca externa and capillaries form between the two layers to provide a blood 
supply. At the end of the preantral stage, there are up to nine layers of GCs (Bullock 
et al., 2001) and the follicle attains 200 pm in diameter (Gutierrez et al., 2000). 
Granulosa cells start to express the receptor for follicle stimulating hormone (FSH) 
during the preantral stage, although preantral and early antral growth seem to be 
gonadotrophin-independent as follicles continue to grow to 4 mm when
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gonadotrophins are inhibited (Gong et al., 1996). Follicle growth above 4 mm is 
gonadotrophin-dependent and involves recruitment, selection and dominance. An 
interesting study investigated the effects of blocking gonadotrophin-releasing 
hormone, and reported that even when exogenous LH was given, follicles were 
unable to emerge, demonstrating the need for FSH (Crowe et al., 2001).
During recruitment, GCs within early antral follicles begin to express 
CYP19A1 mRNA in response to FSH, allowing oestrogen to be produced by utilising 
androgens produced by theca cells. The GCs also develop the ability to metabolise 
cholesterol to pregnenolone, but are unable to produce progesterone. Antral follicles 
are characterised by the development of a fluid-filled space (the antrum) adjacent to 
the oocyte, and the presence of a vascular supply through a mature theca cell layer 
(Matsuda et al., 2012). Although the process is not completely understood, fluid 
from the theca capillary system is thought to cross into the ovary to form the 
follicular fluid through a blood-follicle barrier of around 100 kDa (Clarke et al., 
2006). This provides the potential for the secretion of large products within the 
follicle to form an osmotic gradient, drawing fluid into the follicle. Granulosa cells 
produce hyaluronic acid, which is hydrophilic and has been measured at a molecular 
weight of 2xl06, thus could create osmotic potential to pull fluid into the follicle 
(Rodgers and Irving-Rodgers, 2010). During pre-antral follicle growth, multiple 
small fluid-filled cavities develop, expand and combine to form a central antrum.
It is at the early antral stage that dominant follicle selection occurs from 
among a number of small antral follicles with differential FSH sensitivity. Atresia of 
small follicles occurs through apoptosis of all cells in the follicle and the oocyte. 
However, remaining follicles secrete oestradiol and inhibin, which negatively 
feedback on FSH (Kaneko et al., 1991), starving smaller follicles with fewer FSH 
receptors of their gonadotrophin drive. During selection of the dominant follicle, 
GCs within the follicle begin to express mRNA encoding the LH receptor and 
develop the capability to synthesise progesterone from pregnenolone. The FSH and 
LH receptors are 7-transmembrane G-protein coupled receptors which share similar 
post-receptor mechanisms, activating cyclic AMP and inducing genes downstream of 
PKA (Simoni et al., 1997), p38 MAPK (Gonzalez-Robayna et al., 2000) and AP-1 
(Sharma and Richards, 2000) pathways.
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Figure 1.4 Follicles grow from 30 juM to around 16 mm over a period of 180 
days. Cows are born with thousands of primordial follicles, which develop into 
primary and secondary follicles. Antral follicles are characterised by the formation of 
a fluid filled space (or antrum). Each wave, 6-24 follicles emerge as selected and 
usually one will become dominant, potentially ovulating a cumulus-oocyte complex.
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1.6 Follicle waves
In cattle, follicles develop in follicular waves, with most oestrous cycles 
consisting of 2 or 3 waves, each lasting 6 to 9 days (Evans et al., 1994) (Fig 1.5). A 
cohort of 6 to 24 ovarian follicles synchronously emerge in response to increased 
concentrations of follicle stimulating hormone in peripheral plasma (Fortune et al.,
2001). The concentration of FSH begins to decline after a further 2 days and only 
larger follicles with more FSH receptors are able to survive, whilst remaining 
follicles undergo atresia. As FSH concentrations continue to fall, one follicle is 
selected as the dominant follicle, becoming responsive to luteinising hormone. In 
cows actively immunised against GnRH, FSH treatment alone only stimulates 
development of a low number of medium-sized follicles which are oestradiol 
inactive, and no follicles reach dominance (Crowe et al., 2001). Interestingly, any 
viable follicle is capable of becoming dominant, as cows can be super-ovulated with 
FSH (Adams et al., 1993, Ireland et al., 2007); one randomly selected 5 mm follicle 
can be directed to become dominant if all other follicles of a similar size are 
destroyed (Gibbons et al., 1997), and the subordinate follicle will become dominant 
if the dominant follicle is ablated prior to day 15 of the oestrous cycle (Dean and 
Dailey, 2011). However, it seems the follicle selected is not random, rather that the 
follicle has a developmental advantage over the other follicles, such as being closer 
to the ovarian vasculature (Fraser, 2006, Acosta, 2007).
The future dominant follicle emerges 7 h earlier than the largest subordinate 
follicle (Kulick et al., 1999). Prior to deviation, all follicles grow at the same rate 
(Ginther et al., 1997). However, because the future dominant follicle emerges first, it 
is larger and thus maintains its advantage over the other follicles in the cohort. Thus, 
the larger follicle increases its surface area at a greater rate, reflected by more GCs 
within the follicle and more FSH receptors. As FSH concentrations decline, the 
larger follicle is still able to grow, not only due to its greater number of FSH 
receptors, but also the presence of LH receptors on GCs within dominant follicles. 
Activation of the LH receptor leads to production of androstenedione, which GCs 
convert to oestradiol. Higher concentrations of oestradiol within the follicle increase 
granulosa responsiveness to FSH, further protecting the dominant follicle from 
atresia. The greater response to FSH in the larger follicle also increases the 
production of insulin-like growth factor (IGF) binding protein proteases (Rivera and
12
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Fortune, 2001), which increase the concentration of bio-available IGF-1 within the 
follicle (Rivera and Fortune, 2003). The bio-available IGF-1 acts synergistically with 
FSH to increase the production of oestradiol by the dominant follicle (Adashi, 1998), 
which then suppresses FSH thus starving the smaller follicles of their gonadotrophin 
drive (Burke et al., 1996, Ginther et al., 2000). It has also been hypothesised that 
other substances produced by the dominant follicle may suppress FSH including 
inhibin (Lussier et al., 1993, Kaneko et al., 1997), which may be synthesised by the 
dominant follicle in response to falling concentrations of FSH, thus further 
suppressing the subordinate follicles (Mihm et al., 1997).
The fate of the dominant follicle depends on whether the corpus luteum from 
the previous oestrus cycle has luteolysed. When a corpus luteum is present, the 
circulating concentration of progesterone is high and LH pulsatile frequency is low. 
In this situation, the dominant follicle undergoes atresia, FSH is no longer 
suppressed and a new wave of follicle growth begins (Roche, 1996). If luteolysis has 
occurred, LH pulse frequency increases, circulating concentrations of progesterone 
are low and the dominant follicle persists. The stimulatory effect of LH on GCs also 
induces expression of epidermal growth factor (EGF)-like factors in GCs that 
propagate the LH signals through the follicle to the cumulus cells and oocyte 
(Portela et al., 2011), which do not express the LH-receptor (Peng et al., 1991, Park 
et al., 2004, Ashkenazi et al., 2005, Jamnongjit et al., 2005). These factors cause 
resumption of meiosis in the oocyte and formation of a hyaluron-rich extracellular 
matrix (Lorenzo et al., 1994, Lonergan et al., 1996, Hosoda and Terada, 2007). This 
matrix leads to cumulus expansion, which causes a concurrent increase in antrum 
volume, forming a blister on the follicle (Fulop et al., 2003). Cyclic AMP stimulates 
plasminogen activator, which catalyses the breakdown of plasminogen to plasmin 
(LeMaire, 1989). Activation of LH also increases latent collagenase, which seems to 
be activated by plasmin (Woessner Jr et al., 1989). Active collagenase digests the 
follicular tissue at the blister site creating a hole, known as a stigma, through which 
the cumulus-oocyte complex exits. The retained mural GCs within the follicle 
become luteinised, producing progesterone and the remaining follicle forms a highly 
vascularised corpus luteum. The oocyte is wafted by cilia towards the fallopian tube, 
at which point, the oocyte has finished meiosis I, yielding a large secondary oocyte 
which contains all cytoplasmic material, and a smaller polar body.
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Figure 1.5 Bovine ovarian follicles develop in waves (3-wave model). After 
ovulation, an increase in FSH (shown in blue) triggers recruitment of a cohort of 
small antral follicles (orange circles). Most of these undergo atresia until there is one 
dominant follicle remaining. The previously ovulated follicle forms a corpus luteum 
(CL), releasing progesterone which prevents the necessary rises in LH (green) for 
ovulation, thus the dominant follicle undergoes atresia (cream circles) and a second 
rise in FSH triggers a new wave of follicles to emerge. Concentrations of 
progesterone remain high through this second wave of growth thus all follicles 
undergo atresia, triggering a third rise in FSH and a new wave of follicular growth. 
When a cow is not pregnant, the uterus releases PGF^a, causing luteolysis and thus 
progesterone concentrations fall. This enables a sufficient peak in LH to trigger 
ovulation of the dominant follicle.
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1.7 Oocyte maturation
The oocyte is the female gamete, containing a rich cytoplasm and a nucleus. 
During early embryo development, primordial germ cells that develop into oogonia 
are surrounded by somatic cells and form primordial follicles. The oogonia enter 
meiosis I during foetal development, arresting at the end of prophase I. The egg 
produces cAMP, which inactivates cyclin B, maintaining the meiotic arrest until the 
pre-ovulatory surge in LH triggers an increase in maturation promoting factor (MPF) 
(Aktas et al., 1995). Oocyte maturation, when MPF releases the oocyte from meiotic 
release, consists of nuclear and cytoplasmic maturation and begins at the end of 
prophase I, continuing until the egg is once again arrested at metaphase II. During 
nuclear maturation, the nuclear membrane begins to fold, the nuclear pores disappear 
and the nuclear membrane fragments. These events are collectively termed as 
germinal vesicle breakdown (GVBD). Following GVBD, the chromosomes 
condense, separate, migrate to the poles (anaphase I), become surrounded by a 
nuclear membrane (telophase I) and the first polar body is extruded. Cytoplasmic 
maturation refers to the redistribution of cytoplasmic organelles, reorganisation of 
the cytoskeleton and storage of oocyte-derived mRNAs, which will support 
fertilisation and early embryo development of the fertilised mature oocyte (Ferreira 
et al., 2009).
At the end of anaphase I, levels of MPF rapidly drop and the oocyte is once 
again arrested at metaphase II, during which a second meiotic division takes place 
without chromosome replication (Wu et al., 1997). This decrease in chromosome 
number is essential to ensure that the fertilised embryo is restored to a diploid cell. 
At fertilisation, binding of the sperm to the egg triggers a rise in the intra-oocyte 
calcium concentration (Fissore et al., 1995, Ross et al., 2008). This leads to egg 
activation, when an oocyte becomes competent to begin embryo development. 
Oocyte activation is characterised by resumption of meiosis n, cortical granule 
exocytosis to prevent polyspermy and extrusion of the second polar body (Liu et al.,
2009).
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Figure 1.6 The oocyte divides by meiosis. Prior to birth, the oocytes grow through 
interphase I, when chromosomes duplicate, and arrest at the end of prophase I, when 
the nuclear membrane has begun to break down and homologous recombination 
takes place. In response to the preovulatory surge in LH, the oocyte continues to 
mature, with the nuclear membrane breaking down during prophase I, microtubule 
spindles attaching to the chromosomes (metaphase I) and homologous chromosomes 
being separated (anaphase I). During telophase I, the nuclear membrane reforms 
around pairs of chromosomes and a secondary oocyte and a polar body are formed 
through cytokinesis. The polar body disintegrates and the secondary oocyte arrests at 
metaphase II until fertilisation, when sister chromatids separate, the oocyte matures 
and a second polar body is formed.
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1.8 Communication between cumulus cells and the oocyte
At the start of follicular development, GCs form contact sites with the 
oolemma, consisting of cytoplasmic projections extending from a single granulosa 
cell, which traverse the zona pellucida and form gap junctions at the oolemma. 
Called transzonal projections (TZPs), these specialised membrane structures, which 
connect the cytoplasm of adjacent GCs, are formed at the primordial stage of follicle 
development by the docking of two hemi-channels around an aqueous pore to form 
intercellular channels. These allow the transfer of small metabolites, nucleotides and 
second messengers up to 1 kDa in size between cells (Gershon et al., 2008). It has 
also been postulated that gap junctions are involved in cytoplasmic maturation of the 
oocyte (Eppig et al., 1996) and in maintaining meiotic arrest of oocytes. Transfer of 
inhibitory cAMP from somatic cells to the oocyte maintains meiotic arrest, with 
reinitiation of meiosis occurring if communication between cells is disrupted, as 
occurs during the pre-ovulatory surge in LH (Larsen et al., 1981).
Transzonal projections are formed from cytoskeletal components, including 
F-actin and microtubules, which provide tracks for translocation of organelles of the 
secretory pathway, such as lysosomes (Albertini et al., 2001). Use of Mitotracker, a 
fluorescent dye which stains mitochondria, has demonstrated the bidirectional 
movement of mitochondria and translocation of endosomes and lysosomes across the 
zona pellucida (Albertini et al., 2001). The TZPs have been shown to deliver factors 
derived from the follicle cells, such as leptin and STAT3 to the oocyte (Antczak and 
Van Blerkom, 1997), which may influence oocyte metabolism. Albertini et al (2001) 
proposed a model for delivery of paracrine factors to and from the oocyte, which is 
summarised in Fig 1.7. During in vitro bovine oocyte maturation, the density of 
TZPs increases in response to hormonal changes in the media (Allworth and 
Albertini, 1993). During periods of oocyte growth, TZPs extend as deep 
invaginations, invading the germinal vesicle. Preantral follicles contain the most 
TZPs with retraction of TZPs during antrum formation, decreasing the number of 
connections between oocyte and somatic cells (Makabe et al., 2006). GDF-9 has 
been shown to be an important protein in the development of TZPs; healthy mice 
develop TZPs anchored by F-actin but GDF-9'7' knockout mice develop TZPs that 
are not anchored but envelop the surface of the oocyte (Carabatsos et al., 1998).
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Figure 1.7 A potential model for the delivery of paracrine factors between GCs 
and the oocyte. (1) Secretory vesicles transport granulosa cell-derived factors to the 
oocyte, where they are endocytosed. (2) Oocyte factors are endocytosed at attached 
sites of TZPs to the oolemma. Endocytic vesicles traffic along microtubules to the 
body of the granulosa cell, where intracellular processing may take place. (3) Gap 
junctions allow for direct communication between granulosa cell and oocyte or 
between GCs. (4) Anchoring between the granulosa cell and the zona pellucida (ZP) 
is necessary for correct orientation of TZPs. Black circles represent granulosa cell- 
derived factors and purple circles represent oocyte-derived factors. Figure adapted 
from (Albertini et al., 2001).
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1.9 Early embryogenesis
Meiosis II starts straight after meiosis I has finished, but the oocyte is 
arrested at metaphase II until fertilisation, when the cell membrane of the oocyte and 
sperm fuse. Then, the oocyte resumes its second round of meiosis, producing a 
haploid ovum and releasing a second polar body. The sperm forms a pronucleus and 
its tail and mitochondria degrade, before fusing with the ovum (Okamura and 
Nishiyama, 1978). The first stage to occur after fertilisation is holoblastic cleavage, 
where mitotic divisions occur every twelve to twenty-four hours without the zygote 
growing, resulting in blastomere cells (Gilbert, 2000). The first division occurs 
across the meridional axis of the egg with second division perpendicular to this, thus 
producing four cells (Gilbert, 2000). Rotational cleavage then takes place until 
midblastular transition when maternal-zygotic transition occurs with degradation of 
maternal RNAs and synthesis of embryonic RNAs and embryonic transcription 
begins (Schier, 2007). Prior to the initiation of embryonic transcription, maternal 
effect genes play a key role. The products of these genes from the maternal genome 
are required for key steps in embryonic development, such as establishment of 
meiosis and determination of the body patterning (Tadros and Lipshitz, 2009). In the 
cow, maternal effect genes include ZAR1, GDF9 and NLRP5 (also known as 
MATER). These genes are expressed by bovine oocytes and zygotes, up until the 8 
cell stage (Pennetier et al., 2004). Although the role of these genes is yet to be fully 
elucidated, especially in domestic animals, fertilised oocytes from Nlrp5~'' knockout 
mice fail to progress beyond the 2 cell stage (Tong et al., 2000) and embryos from 
Zarl'1' knockout mice mostly arrest prior to cleavage (Wu et al., 2003).
When the zygote reaches eight blastomeres, the cells compact, become 
polarised and form tight junctions between cells on the outside of the cellular ball. 
This leads to the development of two populations: trophoblast cells on the outside 
and apolar blastomeres which form the inner cell mass. The trophoblast cells act as a 
sodium pump, and later produce the chorion, the embryonic part of the placenta 
(Gilbert, 2000). The water which enters the cell through osmosis forms a blastocoel 
cavity thus the zygote is now known as an early blastocyst. The inner cell mass is 
pushed to one side of the blastocoel cavity and later gives rise to the embryo and 
some extraembryonic membranes.
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It is essential for the development of the embryo and uterus to synchronise 
for successful implantation to occur (Rowson et al., 1972). In the cow, attachment to 
the uterus occurs between 30 and 55 days after ovulation with chorionic villi making 
contacts with maternal tissues in the crypts of caruncles, eventually forming the 
functional unit of the placentome (Brinster, 1974). This protracted pre-implantation 
period allows the bovine blastocyst to hatch from inside the zona pellucida and 
change in shape, becoming first tubular and then filamentous, filling the entire 
uterine horn (Bazer et al., 2009). This filamentous blastocyst consists mainly of 
extra-embryonic trophectoderm lined with entoderm (Spencer et al., 2008). 
Progesterone stimulates blastocyst growth and when elongated, the trophoblast 
produces interferon x, which acts on the endometrium to inhibit release of 
prostaglandin F2a ensuring continued production of progesterone by the corpus 
luteum (Bazer et al., 1991).
1.10 Uterine disease
Uterine disease, pelvic inflammatory disease (PID), endometritis and metritis 
are generic terms used to describe the disease following protozoal, fungal, viral or 
bacterial infection of the upper female genital tract and are most common in humans 
and cattle. Infection leads to activation of the innate immune system and 
inflammation. Uterine disease can cause infertility through disruption of endocrine 
function in the reproductive tract, direct damage caused to the reproductive organs 
and through the effect of infection on ovarian and uterine function.
In humans, most cases of PID are associated with sexually transmitted 
infections, for example chlamydia, caused by the obligate intracellular gram negative 
bacterium Chlamydia trachomatis. Up to forty per cent of untreated chlamydia cases 
will develop symptomatic PID with post-infection damage to fallopian tubes causing 
a third of all cases of female infertility (W.H.O, 2011). In the United States of 
America, it is estimated that over one million women seek treatment for PID every 
year. However, as uterine infection can be symptomless, the true number of people 
affected could be greater. Each year, one hundred thousand American women 
become infertile and one hundred and fifty die from PID or further complications 
(N.I.A.I.D, 2009).
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Bacterial contamination of the bovine uterus is ubiquitous after parturition 
with 40% of cows developing clinical disease within 10 days of calving (metritis), 
20% suffering from a prolonged clinical disease for at least 3 weeks post-partum 
(endometritis) and 30% having subclinical endometritis (Sheldon et al., 2009). These 
infections impact on fertility and milk yield, as well as causing pain and suffering to 
the animal. The economic cost of this is estimated at €290 per case when reduced 
milk production, delayed conception and treatment costs are taken into account 
(Drillich et al., 2001). This results in an estimated annual cost of around €1.4 billion 
for the European Union alone (Sheldon et al., 2009). Post partum infection leads to 
activation of the innate immune system, influx of neutrophils into the endometrium 
and inflammation. In subclinical endometritis, inflammation of the endometrium 
leads to a significant decrease in reproductive performance, but occurs without signs 
of clinical endometritis (Sheldon et al., 2009). Subclinical endometritis is defined by 
the presence of neutrophils exceeding five-and-a-half per cent of all cells in uterine 
flushes taken more than five weeks post partum and affects up to three quarters of all 
dairy cows. Animals with subclinical disease take longer to conceive and have 
reduced conception rates (Salasel et al., 2010, Moges and Jebar, 2012). There are 
three grades of clinical metritis: animals with grade one metritis have an enlarged 
uterus and purulent discharge; grade two cows have symptoms as stage one but also 
with signs of a systemic illness, for example, hyperthermia, and grade three cattle 
have signs of toxaemia, such as decreased appetite (Sheldon et al., 2009). The 
grading of metritis is directly related to prognosis.
During pregnancy, the bovine uterus is sterile, but contamination of the post­
partum uterus is ubiquitous. The most prevalent bacteria isolated from the 
postpartum bovine uterus are Escherichia coli and Truepurella pyogenes (Sheldon et 
al., 2002). A number of anaerobic bacteria are also present, although other bacteria 
can be isolated from the uterus of cows with or without uterine disease. Escherichia 
coli appears to prime the uterus for infection by bacteria, such as T. pyogenes, thus 
both Gram negative and Gram positive bacteria are isolated from the uteri of animals 
with metritis (Sheldon et al., 2009). Bacteria are expelled through uterine contraction 
and regeneration of the endometrium; often the host immune system is able to 
overcome any infection and clinical disease may not occur. Risk factors for 
developing uterine disease include placental retention and dystocia (Dubuc et al.,
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2010). Birth of twins is also a risk factor because it causes stretching of the uterus, 
resulting in ineffectual uterine contraction, increased risk of retained foetal 
membranes and reduced expulsion of contaminating bacteria (Potter et al., 2010).
Most cows will clear bacterial contamination within three weeks of 
parturition without need for treatment. However, treatment is needed for clinical 
endometritis after three weeks post partum, as the chance of the cow spontaneously 
clearing the infection within a 2 week period is only thirty-three per cent, compared 
to double that for pharmaceutical treatment (Sheldon, 2007). Oestrus is one of the 
most effective ways of clearing uterine infection, achieved by administering 
intramuscular PGF2a, which is luteolytic, thus decreasing progesterone if a corpus 
luteum is present. Progesterone suppresses uterine immune defences by decreasing 
lymphocyte proliferation: ovariectomised ewes show increased lymphocyte 
proliferation and exogenous progesterone causes decreased lymphocyte proliferation 
(Lewis, 2004). Thus by decreasing production of progesterone, the immune response 
of the cow can be enhanced. Administration of prostaglandins also causes release of 
leukotriene B4, which promotes uterine involution, thus enhancing clearance of 
uterine infection and contamination (Lewis, 2004). In cows without a functional 
corpus luteum, exogenous PGF2a may enhance uterine involution and contractility 
(Hirsbrunner et al., 2003). An alternative treatment for endometritis is intra-uterine 
infusion of antimicrobials, such as cephalosporin, with non-steroidal anti­
inflammatory co-therapy when systemic signs are present (Drillich et al., 2007).
Escherichia coli is a gram negative, anaerobic bacterium and part of the 
normal flora of the gastrointestinal tract. The bacterium is rod-shaped and up to 2 pm 
long, with some strains using flagella for motion. The lipopolysaccharide (LPS) 
outer layer consists of lipid A, which is responsible for the E. coli’s toxicity, and an 
O-antigen, which is highly variable and consists of repeated oligosaccharide units 
(Beutin et al., 2007). A protective capsule surrounds the bacterium, which consists of 
K-antigen proteins (Whitfield and Roberts, 1999). Until recently, it was presumed 
that the bacteria that colonise the postpartum uterus are a random collection of 
E. coli strains from the gastrointestinal tract, urinary tract and environment. 
Interestingly, it now seems that in bovine uterine disease, specific strains of E. coli 
are pathogenic in the endometrium, especially strains in phylogenetic groups A and 
B1 (Sheldon et al., 2010).
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Uterine infections not only impact on endometrial health, but also on the 
function of the hypothalamus, pituitary and ovary. Although uterine disease does not 
perturb the secretion of FSH by the pituitary, intra-uterine LPS infusion prevents the 
pre-ovulatory surge of LH, thus preventing ovulation (Peter et al., 1989). This 
perturbation of LH signalling has been observed in other species, including pigs 
(Jana et al., 2004) and sheep (Battaglia et al., 1999), in which peripheral infusion of 
LPS suppresses pulsatile LH secretion from the pituitary and GnRH secretion from 
the hypothalamus. Interestingly, LPS infusion blocks the pre-ovulatory rise in 
oestradiol concentrations even in animals with normal LH pulsatility, suggesting 
direct effects of LPS on the ovary (Battaglia et al., 2000). Animals with metritis have 
an increased risk of a prolonged luteal phase and cows with abnormal vaginal 
discharge are more likely to have delayed ovulation, decreasing fertility (Opsomer et 
al., 2000). Post-partum cows with a high bacteria growth from transcervical swabs 
had a smaller first dominant follicle and lower plasma oestradiol concentrations than 
those with low bacterial growth (Sheldon et al., 2002) and also had lower serum 
progesterone concentration, a smaller corpus luteum, an increased risk of a persistent 
dominant follicle and a decreased chance of ovulation (Williams et al., 2007). 
Interestingly, it seems that E. coli is the main organism to cause ovarian dysfunction 
as uterine infusion of T. pyo had no effect on FSH, LH, oestradiol or progesterone 
concentrations, nor did this effect follicle wave emergence, dominant follicle 
diameter or corpus luteum diameter (Miller et al., 2007), whereas LPS treated 
animals were less likely to ovulate (Williams et al., 2008). Although many of these 
studies have examined the effects of clinical endometritis on ovarian health, a recent 
study found that animals with subclinical endometritis were less likely to have a 
corpus luteum (19% vs 55%) and fewer had returned to cyclicity after parturition 
than healthy cows (Green et al., 2011). These animals with subclinical endometritis 
also had altered hormone concentrations in follicular fluid, with increased cortisol 
and decreased testosterone, oestradiol, androstenedione and DHEA.
In a long-term study in Germany, infertility was the reason for almost a third 
of all bovine culling (Frerking, 1999). This high incidence of culling due to 
infertility, a major cause of which is uterine disease, leads to farms having to 
maintain a larger herd size to allow for the wastage within the system. This has an 
environmental impact, increasing the greenhouse effect and using valuable land.
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Although livestock farming could be argued to be highly energy inefficient, there is 
little chance of consumer appetite for meat and dairy products reducing, thus 
methods to minimise the environmental impact are likely to become more important 
as the global population and wealth increases.
Escherichia coli paves the way for further infection by other bacteria and 
LPS is the part of E. coli recognised by the immune system, triggering a response 
characterised by release of pro-inflammatory cytokines (Dohmen et al., 2000). Thus, 
in vitro experiments focussed on the response of uterine cells to LPS, finding that 
endometrial cells express the molecular machinery necessary to detect LPS (Herath 
et al., 2006) and that LPS treatment switches endometrial prostaglandin production 
to favour PGE, thus providing a mechanism to explain the prolonged luteal phase 
often observed in vivo (Herath et al., 2009a). In vivo, endometrial expression of pro- 
inflammatory cytokines is higher in cows with uterine disease (Chapwanya et al., 
2009, Herath et al., 2009b), and in vitro, endometrial cells increase expression of 
mRNA and protein accumulation of pro-inflammatory cytokines in response to LPS 
(Cronin et al., 2012). An interesting and relevant paper found that LPS collects in the 
ovarian follicular fluid of infected cows, with the concentration of LPS correlating to 
the clinical diagnosis (highest in cows with endometritis, lower in cows with 
subclinical endometritis, undetectable in healthy cows) and, although the 
concentrations found in follicular fluid are lower than those found in the uterus 
(Williams et al., 2007), the concentration is higher than found in the plasma of 
diseased animals (Dohmen et al., 2000), thus the GCs of infected cows are bathed in 
LPS. It was further found that in vitro treatment of GCs with LPS perturbs their 
oestradiol production and that GCs express the receptor necessary to detect LPS 
(Herath et al., 2007). Thus, the question arose of whether ovarian cells have an 
innate immune function.
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1.11 Mastitis
In the previous 50 years, dairy conception rates have fallen from around 65% 
to 38%, with a concomitant increase in milk yield (Crowe and Williams, 2012). 
Associated with this increased milk yield is mastitis (infection of the mammary 
gland), which is mainly caused by bacteria. Acute bovine mastitis is caused by Gram 
negative organisms (mainly E. coli) and is associated with clinical signs, such as 
swollen, hard or painful udders. Subclinical bovine mastitis is caused by Gram 
positive organisms, such as Staphylococcus aureus, has no clinical signs and can last 
for several months (Huszenicza et al., 2004, Lavon et al., 2010). Both forms of 
mastitis decrease milk production and increase the concentration of cytokines in milk 
and the circulation (Hansen et al., 2004). In addition to perturbing mammary 
function, around 30% of infected animals also experience endocrine disruption and 
abnormal ovarian steroidogenesis. Animals with subclinical mastitis produce less 
oestradiol and androstenedione and have lower expression of mRNA encoding key 
enzymes (including P450SCc, P450noH and P450arom) for a prolonged period, whereas 
animals with clinical mastitis have lower production of oestradiol and 
androstenedione only during the first oestrous cycle (Lavon et al., 2011a, Lavon et 
al., 2011b). In addition, animals with moderate to severe mastitis have fewer 
secondary and dominant follicles (Rahman et al., 2012). An experimental model of 
acute mastitis, induced through intra-mammary injection of LPS, found that animals 
with induced disease produced less oestradiol, had delayed ovulation and a 
suppressed or delayed LH surge compared to healthy controls (Lavon et al., 2008). It 
is currently unknown whether the ovarian follicular fluid of animals with mastitis 
contains LPS or other pathogen-associated molecular patterns (PAMPs), as occurs in 
animals with uterine disease. The perturbation of ovarian function could thus be 
direct, or through indirect causes, such as the increase in circulating cytokines. What 
is clear, however, is that infections distant to the ovary perturb ovarian function.
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1.12 Immunity
The immune system is an organism’s defence against infection and disease, 
detecting and destroying pathogens, such as bacteria and viruses. Infection is the 
colonisation of a host by a foreign pathogenic species. The immune system consists 
of a number of layers of developing complexity and specificity. Most simply, skin 
acts as a physical barrier to prevent bacteria from entering the body. Once a foreign 
object enters the body it encounters first the innate immune system and then the 
adaptive immune system. The innate immune system is present in all plants and 
animals, but only jawed mammals have developed adaptive immunity (Matsunaga 
and Rahman, 1998). The success of the immune system depends on the ability to 
distinguish self from non-self, through recognition of PAMPs. The immune system 
also needs to identify self-molecules expressed by damaged tissues, such as damage- 
associated molecular patterns (DAMPs).
When a bacterium enters the body, PAMPs activate Toll-like receptors. Most 
PAMPs are conserved structures which can be distinguished by the immune system 
as non-self and are common to many related pathogens (Zhong and Kyriakis, 2007). 
Activation of a TLR triggers an intracellular signalling cascade, resulting in 
expression of inflammatory and immune mediators including cytokines, chemokines 
and prostaglandins (Takeda and Akira, 2005, Kim et al., 2011). Cytokines are small 
peptides below 30kDa involved in many processes including proliferation, 
differentiation, death and survival. These cytokines aid recruitment of immune cells 
to the area of infection and cause inflammation. For the present project, the innate 
immune system and the inflammatory response it elicits in the body was of most 
interest, thus the adaptive immune system will only be briefly described in Table 1.1 
below. Prior to ovulation, ovarian follicles do not contain professional immune cells 
or antigen-presenting cells (Spanel-Borowski et al., 1997, Bromfield and Sheldon,
2011). However, as described above in 1.10, a recent study has described the 
presence of innate immune receptors on GCs and the perturbation of granulosa cell 
function in response to the prototypical PAMP, LPS (Herath et al., 2007). Thus, this 
review will focus on the function of these innate immune receptors, called Toll-like 
receptors.
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Table 1.1 Differences between the innate and adaptive immune responses. The
innate immune response is a non-specific response with receptors that have broad 
specificity. The adaptive immune response occurs later and is specific. For this 
project, the innate immune response is of interest, because ovarian follicles are 
devoid of antibody-producing cells prior to ovulation.
Innate Immune Response Adaptive Immune Response
Pathogen is recognised by receptors 
generated in germline cells
Pathogen is recognised by receptors 
generated through spontaneous mutation
Receptors have broad specificity, i.e. 
recognise many related molecular 
structures ‘PAMPs’
Receptors have narrow specificity, they 
recognise a particular epitope
Receptors are pattern recognition 
receptors
Receptors are B-cell and T-cell receptors 
for antigen
PAMPs are polysaccharides and 
polynucleotides that differ little from 
one pathogen to another but are not 
found in the host
Epitopes are derived from polypeptides 
and reflect the individuality of the 
pathogen
Response is immediate, but with no 
memory of previous exposure
Response takes 3-5 days to develop 
clones of responding cells, but retains 
memory of previous exposure
Occurs in all metazoans Occurs in jawed vertebrates only
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1.12.1 Toll-like Receptors
Toll-like receptors (TLRs) are membrane bound proteins involved in 
recognising pathogens and are expressed by numerous cell types including 
professional immune cells (Kawai and Akira, 2011), endometrial cells (Davies et al., 
2008), ovarian GCs (Herath et al., 2007) and cumulus-oocyte complexes (Shimada et 
al., 2006). They act as pattern recognition receptors (PRRs) to bind molecules 
associated with bacteria, viruses and fungi (PAMPs) or endogenous ligands released 
during cell necrosis (DAMPs). Toll was originally discovered in Drosophila as an 
essential receptor for the establishment of the dorsal-ventral pattern in developing 
embryos (Anderson et al., 1985). Flies with mutant Toll showed increased 
susceptibility to fungal infections, which suggested a roll for Toll in immunity, as 
well as providing an interesting link between two ancient mammalian systems: 
immunity and reproduction (Lemaitre et al., 1996). A mammalian homologue of the 
Drosophila Toll receptor was later shown to induce expression of genes involved in 
inflammation and immunity (Medzhitov et al., 1997). Toll-like receptors are type I 
integral membrane glycoproteins with a horseshoe shaped structure, characterised by 
an extracellular leucine rich domain containing 19-25 tandem leucine rich repeats 
and a cytoplasmic signalling domain, homologous to that of the interleukin-one 
receptor (TIR domain) (Akira et al., 2006). Each leucine (L) rich repeat has the 
structure XLXXLXLXX (X being hydrophilic residues) and consists of an alpha- 
helix and a beta-strand connected by an asparagine ladder (Werling et al., 2009).
To date, eleven different TLRs have been identified in humans (Zhang et al., 
2004), ten TLRs in cow (Menzies and Ingham, 2006, Davies et al., 2008) and 13 in 
mice (Wu et al., 2008). Each TLR binds different PAMPs (Table 1.2) and sensing of 
the PAMP can occur on the cell surface or within endosomes or lysosomes (Akira et 
al., 2006). The location of the TLR is important for correct PAMP recognition and to 
prevent incorrect sensing of self. Toll-like receptor 1, TLR2, TLR4, TLR5, TLR6 
and TLR 10 are expressed on the cell surface, whereas TLR3, TLR7, TLR8 and 
TLR9 are found intracellularly (Barreiro et al., 2009). Of particular interest to this 
thesis are TLR1, TLR2, TLR4, TLR5 and TLR6, as these are extracellular receptors 
that sense bacteria. Studying the recognition of Gram negative and Gram positive 
bacteria is important for these studies, as both types of bacteria are associated with
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endometritis and mastitis. These infections are caused by the Gram negative 
bacterium E. coli, whose LPS binds TLR4 and flagellin (part of flagella used by 
some strains for motility) binds TLR5, and by Gram positive bacteria, such as 
S. aureus, whose lipoproteins are recognised by TLR2 (Bubeck Wardenburg et al., 
2006, Volz et al., 2010, Gilbert et al., 2013). Ultra-purified forms of LPS and 
flagellin will be used in experiments. However, the choice of ligand for TLR2, which 
forms heterodimers with TLR1 and TLR6 to recognise triacylated and diacylated 
lipoproteins, respectively (Schenk et al., 2009), is not so clear cut. Although 
peptidoglycan, a major component of Gram positive bacterial cell walls, was 
considered to be a specific TLR2 agonist, it has recently been shown to activate the 
intracellular pathogen-sensing NOD-like receptors (Girardin et al., 2003, Sorbara 
and Philpott, 2011, Mo et al., 2012). Other TLR2 ligands include lipoteichoic acid 
(LTA) and lipoglycans, which bind TLR2, but seem to also require other TLRs for 
maximal response. Treatment of TLR4 deficient murine macrophages with LTA 
suppressed the response to this PAMP, suggesting that LTA is either also recognised 
by TLR4, or that other contaminating PAMPs, such as LPS, may not have been 
removed during purification (Takeuchi et al., 1999), a recognised problem in 
preparations of endogenous ligands (Tsan and Gao, 2007). Therefore, in order to 
investigate the responses of granulosa cells and oocytes to TLR2 ligands, 
Pam3CSK4, a synthetic triacylated lipoprotein, will be used to ensure greater target 
specificity.
Damage-associated molecular patterns are endogenous molecules released by 
cells after necrosis and are also TLR ligands. A number of DAMPs have been 
described as causing cytokine release through activation of Toll-like receptors, 
including high mobility group box one (HMGB1) and heat shock proteins (HSPs) 
(Andersson et al., 2000, Yang et al., 2005). However, the effects seen in response to 
HMGB1 and HSPs may be due to impurities in the preparations, derived from 
bacterial sources (Tsan and Gao, 2009, Tsan, 2011), thus whether any endogenous 
ligands are true TLR ligands remains controversial. Hyaluronic acid (HA) is a 
glycosaminoglycan, which, in mammals, is synthesised by one of three synthases. 
This produces different length polymers, with high-molecular weight (HMW) HA 
(over 500 kDa) tending to have anti-inflammatory actions and lower molecular 
weight HA being pro-inflammatory.
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Table 1.2 Common pathogen-associated and damage-associated molecular 
patterns that activate specific Toll-like receptors.
Toll-like
Receptor
PAMP ligand DAMP ligand
1 Bacterial lipopeptides 
Soluble lipoproteins
2 Lipoteichoic acid (LTA)
Bacterial lipoproteins and glycolipids
Fungal zymosan
Porins
Heat shock proteins 
HMGB1
3 Double-stranded RNA 
tRNA (fungal)
Polyinosine-polycytidylic acid
mRNA
tRNA (host)
4 Lipopolysaccharide (LPS) Fibrinogen
Hyaluronic acid fragments 
Heat shock proteins 
Defensins 
HMGB1
5 Flagellin
6 Mycoplasma lipopeptides
7 Viruses (single stranded RNA)
8 Viruses (single stranded RNA)
9 Unmethylated CpG motifs in 
bacterial DNA
DNA
HMGB1
10 Unknown
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In this project, HMW HA and ultra-low molecular weight HA (ULMW HA) 
will be used, with molecular weights of over 950 kDa and under 8 kDa, respectively. 
Low-molecular weight hyaluronic acid has been shown to increase production of 
pro-inflammatory cytokines by chondrocytes (Campo et al., 2010), activate TLR4 on 
dendritic cells (Termeer et al., 2002) and bind TLR2 and TLR4 on murine cumulus 
cells (Shimada et al., 2006). This is of interest because hyaluronan is produced by 
cumulus cells within the ovary prior to ovulation (Assidi et al., 2010). During murine 
pregnancy, HA increases to 71% of total cervical glycoaminoglycan and the activity 
of hyaluronidase (the enzyme which breaks down HA) increases during labour 
(Akgul et al., 2012). Thus, post-partum, a large amount of low-molecular weight, 
pro-inflammatory HA may be able to reach the ovary, where, potentially, it could act 
as a DAMP.
Binding of an appropriate ligand to a TLR activates an intracellular signalling 
cascade. The two main pathways are the MyD88-dependent (myeloid differentiation 
primary response gene 88) and the MyD88-independent pathways. The 
MyD88-dependent pathway is used for all TLRs except TLR3 and the 
MyD88-independent pathway is activated by TLR3 and TLR4, thus TLR4 is unique 
in that it can activate signalling via both pathways (Biswas et al., 2007). The best 
characterised TLR signalling pathway is for TLR4, whose prototypical ligand is LPS 
(Beutler, 2002). LPS-binding protein (LBP), a soluble plasma protein, binds LPS and 
the complex then binds CD 14, either soluble CD 14 found in plasma or the cell 
surface form found on cell types including monocytes and ovarian GCs (Herath et 
al., 2007). LPS is then transferred to lymphocyte antigen 96 (LY96), a surface 
protein which interacts with TLR4. Lipid A (the portion of E. coli LPS which binds 
to TLR4) consists of two phosphorylated glucosamines, acetylated by six lipid 
chains, five of which bury inside the LY96 hydrophobic binding pocket and the 
remaining chain interacts with TLR4 (Kawai and Akira, 2010). The two phosphate 
groups of lipid A form a hydrogen bond with negatively charged residues in TLR4 
and LY96, forming a TLR4 dimer connected by LY96, as shown in Fig. 1.8 (Park et 
al., 2009). If this dimerisation is blocked, signalling via TLR4 cannot occur (Youn et 
al., 2008).
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Figure 1.8 TLR4 signalling pathways. LPS binds LBP, which then binds CD 14, 
before being transferred to LY96. This causes TLR4 dimerisation and activation of 
two signalling cascades. The MyD88-dependent pathway is the first and major 
pathway, leading to production of pro-inflammatory cytokines such as IL-8, CCL5, 
IL-6, IL-lp and TNFa. The TLR4-LY96-LPS complex is then endocytosed, 
recruiting TRAM and TRIF, activating the MyD88-independent pathway, which 
leads to production of type one interferons and IFN-inducible genes.
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1.12.2 MyD88-dependent signalling
The various cellular responses triggered by different TLRs (TLR activation 
tends to cause production of either type I interferons or inflammatory cytokines) is 
explained by the presence of Toll-Interleukin Receptor (TIR) domains, found on 
TLRs and on a number of adapter molecules. One such adapter molecular is MyD88, 
which activates mitogen-activated protein kinases (MAPKs) and nuclear factor 
kappa light chain enhancer of B-lymphocytes (NFkB), inducing inflammatory 
cytokines. This pathway depends on the homophilic interaction of the cytoplasmic 
TIR domain of the TLR with the C-terminal TIR domain on MyD88. MyD88 is 
targeted to the plasma membrane where it interacts with TLR4, via TIRAP, which 
contains a PIP2 binding domain. If MyD88 is fused to a PIP2 binding domain TIRAP 
becomes dispensable, thus TIRAP is only necessary for trafficking of MyD88 to the 
membrane (Kagan and Medzhitov, 2006).
Upon stimulation, MyD88 recruits IRAK (interleukin-1 receptor associated 
kinase) through interaction of death domains on both molecules (Neumann et al., 
2008). There are four members of the IRAK family, each of which consists of an 
N-terminal death domain and a central kinase domain (Nguyen et al., 2009). 
However, only IRAKI and IRAK4 are catalytically active (Akira et al., 2006). 
IRAKI7' knockout mice demonstrate a defective LPS response (Gottipati et al., 
2008), whereas IRAK47' knockout mice do not respond to PAMPs which stimulate 
TLR2, TLR3, TLR4, and TLR9 (Suzuki et al., 2002), thus both IRAKs are necessary 
for a complete response to LPS. IRAKI is phosphorylated by IRAK4 (Li et al.,
2002), leading to association with TRAF6 (tumour necrosis factor receptor 
associated factor). The TRAF6 molecule is a member of a group of proteins, each 
consisting of two C-terminal TRAF (tumour necrosis factor associated factor) 
domains, an N-terminal RING finger, involved in protein-protein interactions, and 
zinc finger domains (Bradley and Pober, 2001). Upon TLR stimulation, TRAF6 is 
recruited to the LPS/TLR4/LY96 receptor complex and activated by IRAKI. This 
complex then interacts with TAK1 (TGF-P (transforming growth factor beta) 
activated kinase one), before moving away from the membrane bound receptor to the 
cytoplasm. Then, TAK1 activates MAPKs, which activate a number of transcription 
factors including AP-1. The RING finger domain of TRAF6 acts as a protein ligase
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together with 2 ubiquitin conjugating enzymes to activate IKK (Deng et al., 2000). 
This causes degradation of the inhibitory protein IkB, allowing translocation of 
NFkB to the nucleus. The MyD887' knockout mice do not produce cytokines in 
response to LPS (Kawai et al., 1999) and show no cellular response to peptidoglycan 
(Takeuchi et al., 2000), bacterial DNA (Schnare et al., 2000), flagellin (Hayashi et 
al., 2001) or imidazoquioline (Hemmi et al., 2002). This indicates that MyD88 is 
necessary for signalling through TLR2, TLR4, TLR5, TLR7, TLR9 and TLR 10 
(Hasan et al., 2005). In fact, MyD88 is necessary for signalling through all TLRs 
except TLR3 (Parker et al., 2007).
1.12.3 MyD88-independent signalling
Although MyD887' knockout mice do not produce inflammatory mediators in 
response to TLR activation with LPS (Kawai et al., 1999), LPS induces delayed 
activation of NFkB and JNK in MyD887' mice, inducing interferon-inducible genes 
including IP-10, involved in T-cell recruitment (Kawai et al., 2001). This 
non-classical response to LPS suggested that there may be a MyD88-independent 
pathway via TLR4, resulting in NFkB activation. In addition to the pathway 
explained above, LPS also signals through the MyD88-independent, or TRIF/TRAM 
(TIR domain-containing adaptor inducing IFN/Trif-related adapter molecule) 
pathway. The TRIF/TRAM pathway activates NFkB and MAPK pathways through 
activation of TAK1 by a multiprotein complex recruited by TRIF, in a similar way to 
the MyD88-dependent pathway.
Contrasting to the MyD88-dependent pathway, LPS activation of the 
TRIF/TRAM pathway also leads to activation of IRF-3, a transcription factor which 
induces interferon beta (IFN-p) (Toshchakov et al., 2002). TREF recruits IkB kinases 
(IKK) including TBK1 and IKKi, which induce IRF-3 phosphorylation, inducing 
nuclear translocation of IRF3, where it induces type I interferons. TRIF has been 
shown to be necessary for MyD88-independent signalling via TLR3, as siRNA 
knockdown of TRIF causes impairment of IFN-p expression (Takeda, 2005). 
Although in TRIF7' knockout mice treated with LPS there is little knockdown effect 
in NFkB activation, it appears that the true effect of TRIF7' knockout is masked by 
the early production of NFkB by the MyD88-dependent pathway (Yamamoto et al.,
2003).
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1.12.4 Cytokines and chemokines
Signalling through TLRs activates both NFkB and AP-1, regardless of the 
stimulated receptor, resulting in an inflammatory response characterised by increased 
production of cytokines, including IL-lp, IL-6 and tumour necrosis factor alpha 
(TNFa), and chemokines (CCL5 and IL-8). Signalling through the TRIF/TRAM 
pathway also activates IRF3 and IRF7, resulting in the induction of genes that 
stimulate T cell responses and an antiviral immune response through interferon 
production.
Cytokines are small peptides, which are involved in a number of processes, 
including differentiation, cell survival and immunomodulation. Interleukins 
represent a large family of cytokines, of which IL-6 is classically produced through 
TLR activation. Interleukin 6 has a wide repertoire of actions, including aiding the 
adaptive immune response through induction of B-cell differentiation (Urashima et 
al., 1996) and stimulation of antibody secretion (Dienz et al., 2009). The cytokine is 
also involved in induction of the acute phase response (Wegenka et al., 1993) and 
promotes leukocyte recruitment to the area of infection (Romano et al., 1997). 
Interleukin ip is a potent cytokine which is important for a number of inflammatory 
and immunologic processes (Dinarello, 2011). Tumour necrosis factor alpha is 
another cytokine which is important for the inflammatory response and stimulates 
phagocytosis by macrophages (Collins and Bancroft, 1992).
There are 4 groups of chemokines, categorised according to the spacing of 
their first 2 cysteine residues: CC chemokines have adjacent cysteine residues; CXC 
chemokines have one amino acid between the 2 first cysteines; C chemokines only 
contain 2 cysteine residues in total, and CX3C chemokines have 3 amino acids 
between the first 2 cysteines. Chemokines attract immune cells to the area of 
infection, predominantly neutrophils by IL-8 (Hammond et al., 1995) and T-cell and 
monocyte/macrophage recruitment by CC chemokines such as CCL5 (Murooka et 
al., 2008, Chernova et al., 2009, Chan et al., 2012). In addition to functioning as 
chemoattractants, chemokines also promote immune cell function, for example CC 
chemokines enhance cytotoxicity of natural killer cells (Robertson, 2002).
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1.12.5 Inflammasome activation
In contrast to other cytokines produced through TLR activation, IL-lp is 
synthesised as an inactive pro-peptide in response to TLR activation. In order for 
bioactive IL-ip to be secreted, a second signal must be endocytosed by the cell to 
allow cleavage of the immature protein. This processing is dependent on the NLRP3 
inflammasome, a multiprotein complex consisting of NLRP3 (Nod-like receptor 
pyrin domain containing 3), ASC (apoptosis-associated speck-like protein containing 
a caspase recruitment domain) and caspase 1. Although the mechanisms leading to 
inflammasome activation have not been completely elucidated, it is thought that 
following internalisation of the second signal, reactive oxygen species are released 
which liberate an NLRP3 ligand from its inhibitor (Tschopp and Schroder, 2010). 
This enables NLRP3 to oligomerise and interact with ASC, which recruits 
pro-caspase 1 to the inflammasome. Clustering of pro-caspase 1 on oligomerised 
NLRP3 activates caspase 1, which cleaves pro-IL-lp to its secretable form (Tschopp 
and Schroder, 2010).
1.12.6 Ovulation as an inflammatory process
The acute phase of inflammation is characterised by increased blood flow, 
increased vascular permeability, leukocyte invasion and release of cytokines, 
resulting in tissue repair. These traits are also observed in the process of ovulation, 
during which the ovarian follicle becomes highly vascularised, producing 
prostaglandins and a hyaluronan-rich matrix, similar to that produced during wound 
healing (Richards et al., 2008) (Table 1.3). Leukocytes gather in the theca layer of 
pre-ovulatory follicles (Brannstrom et al., 1993), which release nitric oxide, causing 
vasodilation and secreting IL-ip, a cytokine which increases production of 
collagenases, metalloproteinases and prostaglandins, regulating repair of the ovarian 
surface (Bonello et al., 1996, Gerard et al., 2004). Interleukin-1 alpha also stimulates 
the ovarian surface epithelium to increase expression of IL6 and IL8, which increase 
cellular proliferation, aiding healing of the ovarian surface (Rae et al., 2004, Jabbour 
et al., 2009). The LH surge induces expression of prostaglandin synthase (Joyce et 
al., 2001). Prostaglandins are involved in ovarian follicle rupture (Markosyan and 
Duffy, 2009) and inhibitors of prostaglandin synthesis can block ovulation (Kaur et 
al., 1986).
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Table 1.3 Similarities between inflammation and ovulation (Espey, 1980)
Inflammation Ovulation
Histamine, bradykinin and 
prostaglandins cause hyperaemia, 
vasodilation and oedema
LH surge causes ovarian hyperaemia, 
vasodilation and oedema
Basophils and leukocytes migrate to area 
of inflammation
Basophils and leukocytes accumulate in 
the theca layer prior to ovulation
Proliferating fibroblasts infiltrate areas 
of inflammation, especially during repair
Theca cell layer around follicle contains 
fibroblasts, which proliferate prior to 
follicle rupture
cAMP mediates inflammation and leads 
to production of prostaglandins
LH surge stimulates cAMP in follicle 
cells, leading to steroidogenesis and 
prostaglandin production
Histamine increases vascular function Histamine has significant function
Prostaglandins are important mediators 
of inflammation
LH surge causes synthesis of PGE, 
which suppresses ovulation and PGF, 
which stimulates ovulation
PGE causes vasodilation, increased 
vascular permeability, enhances 
hyperaemia and induces collagenase
PGE causes follicular hyperaemia, leads 
to production of cAMP and stimulates 
production of plasminogen activator
The serine protease collagenase is 
activated
The serine protease plasminogen 
activator is produced in the follicle 
during ovulation
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1.12.7 Ovulation as an innate immune response
It seems clear from the investigations described above that ovulation involves 
a local inflammatory reaction. However, recent studies have focussed on the 
similarities between innate immunity and ovulation and the potential role of innate 
immunity in ovarian physiology, as well as in pathology. The first link between 
innate immunity and inflammation came from the discovery that Toll, which is 
involved in embryo development in Drosophila (Anderson et al., 1985, Halfon et al., 
1995), is also involved in defence against fungal infection (Lemaitre et al., 1996). A 
later study found that 18-wheeler, a Toll-like receptor involved in Drosophila’s 
antibacterial response (Williams et al., 1997), is also involved in follicle cell 
migration and oocyte morphology (Kleve et al., 2006).
In 2006, a murine gene array study discovered a number of genes associated 
with immune function, which were induced in the COCs of mice that had been 
stimulated with gonadotrophins to stimulate growth of pre-ovulatory follicles, 
cumulus expansion and oocyte maturation (Hemandez-Gonzalez et al., 2006). A 
further paper from the same year identified the expression of Toll-like receptors (and 
associated proteins) in murine cumulus oocyte complexes at ovulation, finding that 
the expression of Tlr4, Tlr8, Tlr9, Cdl4 and MyD88 increased at ovulation in vivo 
(Shimada et al., 2006). This paper also investigated the expression of these proteins 
during in vitro maturation and found that Tlr4, Cdl4 and MyD88 expression was 
increased in response to FSH or the EGF-like factor amphiregulin.
Ovulation of a COC depends on formation of the hyaluronan-rich matrix, and 
hyaluronan has been reported to signal through TLR2 and TLR4. A study using 
murine COCs found that treatment of the COC with hyaluronic acid fragments, 
potentially produced through the action of sperm-produced hyaluronidase, increased 
expression of mRNA encoding cytokines and chemokines, including CCL5 and IL-6 
through TLR2 and TLR4, ERK1/2 and p38 MAPK (Shimada et al., 2008), 
supporting the hypothesis of a role for TLRs in fertilisation. Interestingly, 116 mRNA 
expression is increased during ovulation or during IVM, and IL-6 itself can cause 
cumulus expansion without the need for FSH or EGF-like factors (Liu et al., 2009). 
Additionally, this study reported that IL-6 is able to stimulate GVBD of COCs, 
suggesting that DL-6 may play a role in oocyte maturation.
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1.13 Culture Techniques
The above mentioned studies provide some interesting observations. 
However, although experiments using a murine model allow a greater range of 
experiments to be carried out, the results do not necessarily correlate with responses 
in large mammals such as cows or humans (Bilodeau-Goeseels, 2011). As such, it is 
important to investigate the impact of inflammatory mediators on ovarian cells of 
clinically relevant species, and the interactions between the endocrine and immune 
systems in these target animals.
Culture of primary bovine and human cells provides some challenges. The 
first 2 result chapters of this thesis report on work using primary bovine GCs. 
Ideally, GCs are cultured in the absence of serum to prevent luteinisation, maintain 
FSH responsiveness and oestradiol producing capacity (Rouillier et al., 1996). 
Previously, optimum conditions for serum-free culture of GCs were identified 
(Gutierrez et al., 1996). However, GCs do not respond to PAMPs when cultured in 
the absence of serum (at time of experiments, unpublished results from the group; 
subsequently published in (Bromfield and Sheldon, 2011), potentially due to the 
need for soluble factors, such as CD 14, found in serum. Therefore, GCs were 
cultured in the presence of serum for up to 96 hours (although in most experiments 
only for 72) in order to detect cellular responses to TLRs, whilst attempting to 
minimise luteinisation.
The third results chapter reports on findings using primary bovine COCs and 
parthenotes. Although producing embryos would have been more biologically 
relevant, this would have introduced a new variable of sperm to the experiments, 
which are not free from LPS or other bacterial components (Scott and Smith, 1997, 
Okazaki et al., 2010).
In the final results chapter, investigations using a human granulosa cell line 
are described. The COV434 cell line was chosen because it displays many hallmarks 
of healthy GCs, such as responsiveness to FSH and the ability to produce oestradiol 
(Zhang et al., 2000). Although using human primary cells would have been 
interesting, this was not possible due to the poor availability of human ovaries. A 
positive aspect of using a cell line was that it avoided immune cell contamination 
associated with human ovarian follicle aspiration (Fedorcsak et al., 2007).
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Figure 1.9 A summary of our knowledge of endocrine (A) and innate immune 
(B) pathways in bovine GCs prior to the thesis. GC: granulosa cell, COC: 
cumulus-oocyte complex, A4: androstenedione, E2: oestradiol, P4: progesterone, 
EGF: epidermal growth factor, LH: luteinising hormone, FSH: follicle stimulating 
hormone, -R: receptor, TLR4: Toll-like receptor 4, LPS: lipopolysaccharide
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1.14 Conclusions
Bacterial infection in the reproductive tract can cause uterine disease, a 
condition which causes subfertility and pain. Uterine disease is most common in 
humans and cows, with infection after parturition in cattle estimated to cost €1.4 
billion in the EU alone per year (Sheldon et al., 2009) and infertility accounting for a 
third of all bovine culling (Frerking, 1999). The cow provides the only animal 
system where diseases caused by bacterial infections have consistently been linked 
to ovarian dysfunction in vivo. Understanding the impact of bacterial infection on 
ovarian health with the view to designing effective treatment or prevention therefore 
provides an important economical incentive for agricultural and pharmaceutical 
industries. The first bacterium to invade the uterus post partum is E. coli, whose LPS 
collects in follicular fluid. The immune system senses this LPS, and other bacterial 
ligands, such as flagellin, through Toll-like receptors, activating intracellular 
pathways which produce pro-inflammatory cytokines. Prior to the start of this 
project, little was known about the response of GCs or oocytes to PAMPs or 
DAMPs, although the biological function of these cells was better understood 
(Fig. 1.9). The hypothesis tested was that bacterial infections of the bovine 
reproductive tract perturb ovarian granulosa cell function and the health of the 
subsequent embryo. The aims of this thesis were:
To identify whether cells within ovarian follicles express functional 
Toll-like receptors that detect PAMPs associated with bacteria
To investigate the pathways involved in granulosa responses to bacterial 
PAMPs and identify potential therapeutic targets
To explore the interactions between the innate immune system and 
endocrine system within ovarian follicles.
To investigate the impact that follicular fluid LPS contamination may 
have on oocyte maturation and the subsequent embryo
To develop a human granulosa cell model suitable for investigating the 
impact of infections on human ovarian health
41
Chapter 2 
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2.1 General Materials and Methods
The experiments carried out in the thesis used: primary GCs from emerged 
(chapter 3) or dominant (chapter 4) bovine ovarian follicles; bovine cumulus-oocyte 
complexes (COCs) and oocytes (chapter 5), and a human granulosa cell line (chapter 
6). The cells were treated with pathogen-associated molecular patterns (PAMPs) 
associated with bacterial infection and cellular responses evaluated. Cell-free 
supernatants were collected to measure the accumulation of pro-inflammatory 
cytokines and hormones, and protein and RNA were extracted from the cells to 
measure activation of intracellular signals and expression of genes associated with 
innate immunity or physiology. For work using GCs, it was then investigated 
whether it was possible to manipulate this response, using biochemical inhibitors or 
hormones. For experiments using oocytes, egg health was evaluated by examining 
expression of genes associated with oocyte competence and maturation, and through 
microscopy.
2.2 Animals
Ovaries were collected from mixed breeds of heifers (Hereford, Aberdeen 
Angus, Limousin, Charolais, Welsh Black and Belgian Blue breeds; 
aged 2.2 ±0.1 years) or dairy cows (Holstein Fresian breeds, aged 3.1 ± 0.4 years) 
within 15 minutes of killing. The ovaries were transported on ice to the laboratory 
within 90 min in 75 ml sterile Dulbecco’s phosphate-buffered saline (PBS; for 
formulation see appendix 1) with 1% penicillin/streptomycin (both Sigma, 
Gillingham, UK) in 150 ml sterile containers.
2.3 Bovine ovary processing
Ovaries were rinsed in 70% ethanol and sterile PBS before processing for 
mural GCs and cumulus-oocyte complexes (COCs). A sterile 20-gauge needle and 
endotoxin-free syringe (both BD Medical, Oxford, UK) were used to aspirate 
emerged (4 to 7.5 mm diameter) or dominant (>8.5 mm diameter) follicles (Xu et 
al., 1995, Driancourt, 2001) into 30 ml collection medium (0.5% w/v bovine serum 
albumin (BSA), 25 mM HEPES, 0.005% w/v heparin, 1% penicillin/streptomycin 
(all Sigma) in Medium 199) in 90 mm petri dishes (Fisher) warmed to 37°C on a 
slide warmer. The cells were pooled from between 8 and 20 ovaries for each
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experiment. All COCs were collected from the petri dish, using a pulled glass 
Pasteur pipette (Kimble Chase, Vineland, USA), and maintained in collection 
medium without heparin prior to culture. The remaining GCs were centrifuged at 
700 x g for 10 min (Eppendorf 5810R, Cambridge, UK), re-suspended in 30 ml 
culture medium (M l99 with 10% FCS, 1% penicillin/streptomycin, 1% L-glutamine, 
1% ITS; all Sigma) and centrifuged once more at 700 x g for 10 min (Eppendorf 
581 OR). Granulosa cells were counted using a disposable haemocytometer (Immune 
Systems, Devon, UK), adjusted to 1.5 x 106 cells/ml in culture medium (as above), 
which was prewarmed to 37°C. The cells were plated in volumes of 2.5 ml, 1 ml or 
0.5 ml in 6-, 12- or 24-well plates (TPP, Trasadingen, Switzerland), respectively, for 
analysis by PCR, Western blot or ELISA, respectively (Fig. 2.1). All cells were 
cultured at 37°C under 5% CO2 in an incubator used only for primary cells (chapters 
3-5) or cell lines (chapter 6; Binder, Tuttlingen, Germany). Foetal calf serum (FCS; 
Biosera, Ringmer, UK) was batch-tested using LPS and GCs to ensure minimal 
stimulation of pro-inflammatory molecules and the same batch of FCS was used 
throughout the thesis. All medium was filtered through a 0.2 pM filter and stored in 
the base of the 250 ml filter unit (TPP).
2.4 Preparation of peripheral blood mononuclear cells (PBMCs)
Blood was collected into heparinised tubes from the jugular vein of beef 
cows within 15 minutes of killing. After transporting to the laboratory at room 
temperature, the cells and plasma were separated by centrifugation for 10 min at 
500 x g (Eppendorf 581 OR) with the brake off. The buffy coat was carefully 
aspirated using a sterile Pasteur pipette and transferred into a sterile 15 ml centrifuge 
tube. Ten ml of sterile PBS was added to the tube, before centrifugation at 700 x g 
for 10 min with the brake on. The supernatant was discarded and the cell pellet re­
suspended in the residual PBS. Contaminant red blood cells were lysed using 1 ml 
sterile water, mixed by pipetting for 5 sec, before addition of 10 ml sterile PBS. The 
cells were pelleted by centrifugation (as above) and washed in PBS again. The 
PBMCs were then resuspended in 1 ml PBS, counted and adjusted to lxlO6 cells/ml 
in PBS.
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4.0 -  7.5 mm follicles > 8.5 mm follicles
Emerged Dominant
Figure 2.1 Ovaries were processed to extract GCs and cumulus-oocyte 
complexes for culture. Follicles were graded according to size (A; 4-7.5 mm or 
>8.5mm) and aspirated using a sterile 20-gauge needle (B). Follicular fluid was 
examined and only collected if clear (C). The syringe contents were expelled into 
collection medium into separate petri dishes for cells from emerged and dominant 
follicles (D). The COCs and denuded oocytes were removed from each pool of cells 
-  for dominant follicle, these were discarded; for emerged follicles, COCs were 
washed twice in collection medium without heparin (G) and were cultured in organ 
culture dishes (H). Granulosa cells were transferred to sterile 50 ml Falcon tubes (E) 
and washed twice with culture medium, before plating in 12-, 24- or 96-well tissue 
culture dishes (F).
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2.5 Granulosa cells from beef heifers represent a suitable model for dairy cows
Post-pubertal non-pregnant heifers from a slaughterhouse were selected for 
experiments because they do not have gross evidence of disease and are expected to 
be LPS-naive (Santos et al., 2009). As dairy heifers are rarely culled, it was 
important to confirm that GCs from readily available beef heifers responded to 
PAMPs in a similar manner to the dairy cows that are the target for study of uterine 
disease. Thus, GCs were aspirated from dairy (n = -35) and beef (n = -40) heifers 
and cultured as described above. After an initial 48 h establishment period, they were 
treated with control medium or medium containing 10-fold increasing concentrations 
(from 0.001 to 10 pg/ml of ultrapure LPS from Escherichia coli 0111:B4 
(Invivogen); LPS was used because it collects in follicular fluid in cows with metritis 
(Herath et al., 2007) and it stimulates increases in production of IL-6 by murine GCs 
(Gorospe and Spangelo, 1993). After 24 h culture, supernatants were collected and 
the accumulation of inflammatory cytokines IL-6, IL-lp and the chemokine IL-8 
measured by ELISA, as described below (2.19).
Lipopolysaccharide stimulated a dose-dependent increase in accumulation of 
inflammatory mediators by GCs from beef or dairy heifers (Fig. 2.2). Treatment of 
beef GCs with concentrations > 0.01 pg/ml LPS significantly increased the 
accumulation of IL-6, IL-ip and IL-8 (Fig. 2.3 A, C, E; P < 0.001) compared with 
untreated cells. Treatment of GCs from dairy heifers with doses > 0.001 pg/ml LPS 
significantly increased accumulation of IL-6 (Fig. 2.3B; P < 0.05) and doses 
>0.1 pg/ml LPS significantly increased accumulation of IL-ip (Fig. 2.3D; P < 0.05) 
compared to untreated cells. There was a trend for GCs from dairy heifers to exhibit 
a lower response to LPS than GCs from beef heifers, with a significant difference in 
accumulation between populations for IL-ip (P < 0.01) and IL-8 (P < 0.001), but not 
for IL-6 (P = 0.14). However, as GCs from both dairy and beef cattle responded to 
LPS, and IL-6 is the main marker of inflammation used in this work, GCs collected 
from beef breeds represented a suitable model for investigating the effects of 
infection on ovarian health. All further experiments with bovine GCs used post- 
pubertal non-pregnant beef heifers (n = -600 across all experiments). Each 
independent experiment used GCs pooled from 6 -1 0  animals.
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Figure 2.2 Comparison of LPS response by GCs from beef and dairy cows.
Granulosa cells were isolated from beef heifer (A, C, E) or dairy cow (B, D, F) 
emerged ovarian follicles, culture established for 48 h, then treated with control 
medium or medium containing 0.001, 0.01, 0.1, 1 or 10 pg/ml LPS for 24 h. The 
accumulation of IL-6 (A, B), IL-lp (C, D) and IL-8 (E, F) was measured in culture 
supernatants by ELISA. Data are presented as mean + SEM and represent 4 to 5 
independent experiments. Data from beef cattle were analysed by ANOVA with 
Dunnett’s pairwise multiple comparison t test, using square-root normalised data 
(IL-6 and IL-lp) or logio normalised data (IL-8); data from dairy cows was analysed 
using Mann-Whitney U test; values differ from control, * P < 0.05, *** P < 0.001.
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2.6 Determining the optimum duration of treatment for granulosa cell culture
To determine the optimum duration of treatment for examining protein 
responses, GCs were isolated from emerged follicles and treated with control 
medium or medium containing 1 pg/ml LPS for 0, 2, 4, 8, 24 or 30 h. The 
accumulation of IL-6, IL-lp and IL-8 measured in the supernatant by ELISA 
(Fig. 2.3A, C, E). There was a significant increase in IL-6 concentration from 6 h 
and in IL-ip and IL-8 accumulation from 24 h. Thus, 24 h was chosen as the 
appropriate treatment duration for analysis by ELISA.
To determine the optimum treatment duration for RNA analysis, GCs were 
treated with control medium or with medium containing 1 pg/ml LPS for 1, 3 or 5 h 
(Fig. 2.3B, D, F). An increase in expression of IL6, IL8 and IL1B was evident from 
1 h to 5 h, and so 3 h exposure was chosen for future experiments.
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Figure 2.3 Determination of optimum treatment duration. Granulosa cells from 
emerged follicles were equilibrated for 48 h, then treated for 0, 2, 4, 8, 24 or 30 h 
with control medium (‘C’) or medium containing 1 pg/ml LPS. Supernatants were 
collected and the accumulation of IL-6 (A), IL-ip (C) and IL-8 (E) measured by 
ELISA. Data presented as mean + SEM and represent 4 independent experiments. 
The GCs were also treated for 1, 3 or 5 h with control medium or medium containing 
1 pg/ml LPS and expression of IL6 (B), IL1B (D) and IL8 (F) was measured by 
qPCR (normalised to ACTB) and expressed as fold change relative to control. Data 
are presented as mean + SEM and represents 3 independent experiments. Values 
differ from 0 h (A, C, E) or control (B, D, F) by Mann Whitney U test, * P < 0.05
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2.7 Validation of precision of granulosa cell isolation
To ensure that any observations from GCs were not associated with 
contaminating immune cells, the granulosa cell preparations were examined for 
absence of immune cell markers using 2 different methods. First, after isolation and 
prior to any culture, GCs and peripheral blood mononuclear cells (PBMCs) were 
stained for the lymphocyte and antigen-presenting cell marker MHCIL Flow 
cytometry analysis of 10,000 cells (for method see 2.13) showed that 0% cells in the 
population of GCs from emerged and dominant follicles expressed MHCII, 
compared to 33% of cells in the blood cell population (Fig. 2.4A). The expression of 
MHCII and cluster of differentiation 45 (CD45), a marker of leukocytes, neutrophils 
and monocytes (Loken et al., 1990), was then measured in these cells by qPCR (for 
method see 2.20). There was no MHCII or CD45 mRNA detected in RNA from GCs 
isolated from emerged or dominant follicles compared to high expression in the 
mRNA of PBMCs collected from the buffy coat (Fig. 2.4B). Expression of anti- 
Mullerian hormone (AMH), a marker of GCs was also measured, with high 
expression in GCs from emerged follicles, lower expression in GCs from dominant 
follicles and no detectable expression in cells from the buffy coat (Fig. 2.4B).
As follicles emerge during follicle development, they express the FSH 
receptor (FSHR), but only express the LH receptor (LHCGR) on reaching 
dominance. In order to confirm the precision of GC isolation from emerged vs 
dominant follicles, the GC expression of FSHR, LHCGR and CYP19A1 was 
measured by qPCR. The GCs from emerged and dominant follicles both expressed 
FSHR (Fig. 2.4B); GCs from dominant follicles had a greater expression of 
CYP19A1 (Fig. 2.4B), and only GCs from follicles over 8.5 mm in diameter 
expressed LHCGR (Fig. 2.4B), confirming the follicle diameters chosen 
discriminated between emerged and dominant follicles.
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GC MHCII 
negative
GC MHCII 
positive
FITC-A
PBMC MHCII 
negative and 
positive
Gene Emerged Dominant MNC
CD45 0.0 0.0 1.0
MHCII 0.0 0.0 1.9
AMH 5.6 2.2 0.0
FSHR 6.4 6.9 0.0
LHCGR 0.0 3.6 0.0
CYP19A1 0.1 1.9 0.0
Figure 2.4 Granulosa cell preparations were free from immune cells. Granulosa 
cells were isolated and examined immediately for presence of contaminating MHCII 
expressing immune cells. Peripheral blood mononuclear cells were used as a positive 
control. (A) Flow cytometry histograms showing unstained population of GCs or 
blood-derived mononuclear cells in grey and cells positive for MHCII in red. Cell 
purity of each cell type was evaluated by FACS on 5 separate occasions; a 
representative histogram is shown. (B) Mean gene expression relative to ACTB (from 
3-4 experiments) of immune or granulosa cell markers in GCs from emerged or 
dominant follicles or PBMCs.
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2.8 Granulosa cell culture and treatments
Granulosa cells were cultured and treated with PAMPs (LPS, Pam3CSK4 or 
flagellin) or a DAMP (hyaluronic acid), as described for each experiment. Ultrapure 
LPS from Escherichia coli 0111:B4 (Invivogen) was used from 0.001 to 10 pg/ml; 
the synthetic lipopeptide Pam3CSK4 (PAM; Invivogen) was used from 0.001 to 10 
pg/ml, and ultrapure flagellin from Salmonella typhimurium (FLA; Invivogen) was 
used from 0.0001 to 1 pg/ml. Ultra-low molecular weight (ULMW HA) and high 
molecular weight (HMW HA) hyaluronan produced from Streptococcus pyogenes 
(R&D Systems) were used from 0.1 to 1000 pg/ml. Prior to treatment, cells were 
washed in 0.3 ml sterile PBS. Treatments were diluted to the required concentration 
immediately before use in warm culture medium and vortexed before use. Some 
experiments used short-interfering RNA (siRNA; designed and validated for off- 
target effects using Dharmacon siDESIGN centre, Thermo Scientific), as shown in 
Fig 2.5 or small molecule inhibitors (Table 2.1). After treatment, supernatants were 
stored at -20°C in a microcentrifuge tube rack (Alpha Labs, Hampshire, UK) for 
analysis of protein by ELISA. Cells were washed twice in 0.3 ml sterile PBS, before 
harvesting for RNA or protein analysis by PCR or Western blot respectively, or 
estimating cell viability using an MTT assay.
Table 2.1 Small molecule inhibitors used to examine active pathways.
Target Name and code (all Calbiochem) Working
concentration (pM)
NFkB NFkB activation inhibitor Insolution 0.0004 - 40
PKC RO-31-7549 0.001 - 100
p38 MAPK MAPK inhibitor SB230580 0.001 - 100
MEK MEK inhibitor U0126 0.0001 - 10
JNK JNK inhibitor II 0.005 - 500
ERK (chapter 6) ERK activation inhibitor peptide 1 10
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Using antibiotics 
with siRNA causes 
cell death
Allows lipid 
droplets to form
Allows the siRNA to 
enter the lipid droplet, 
forming a micelle
Wash cells twice with 350 pi D-PBS
Mix together and allow to sit for 15 min
Wash cells twice with 350 pi D-PBS and treat as normal
Grow cells as normal in a 24-well plate and establish for 24 h
Add 100 pi siRNA mix to each well 
of cells in a 24-well plate and culture for 24 h
Replace with culture medium without antibiotics 
Culture for 3 h
siRNA 1:100 in Optimem (Gibco) 
Eg. 4 pi siRNA + 400 pi Optimem 
Sit for 5 min
lipofectamine RNA iMAX (Invivogen) 1:33 in Optimem 
Eg. 42 pi lipofectamine+ 1358 pi Optimem 
Sit for 5 min
Target Sense A ntisense
TLR2 GGACAGAAUUAGACACCUAUU UAGGUGUCUAAUUCUGUCCUU
TLR4 GAGUAUAUCUUUAGGAAGUUU ACUUCCUAAAGAUAUACUCUU
Scramble ON-TARGETplus Non-targeting siRNA #1 (Dharmacon)
Figure 2.5 Granulosa cells were treated with siRNA. (A) Flow plan showing 
schedule of experiment. (B) (i) Micelles fuse with the cell’s plasma membrane and 
the siRNA enters the cell by endocytosis. (ii) Argonaute binds the guide strand of the 
siRNA and the other strand is degraded, (iii) The siRNA, argonaute and other 
proteins forms RISC (RNA-induced silencing complex) and binds to the 
complimentary region on the mRNA. (iv) Argonaute catalyses the cleavage of the 
mRNA which is then degraded. (C) Sequences for siRNA used in this project 
(Dharmacon).
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2.9 Cumulus-oocyte complex culture, treatment and staging
The cumulus-oocyte complexes (COCs) were collected from the petri dish 
using a pulled glass Pasteur pipette and washed twice in collection medium without 
heparin, before transferring 15-20 COCs into 1 ml culture medium (0.25 mM sodium 
pyruvate and 1 pg/ml oestradiol in GC culture medium) in round bottom organ 
culture dishes (BD Falcon, Franklin Lakes, USA). For some cultures, medium was 
supplemented with 2.5 pg/ml bovine FSH and 10 pg/ml bovine LH (courtesy of AF 
Parlow, National Hormone and Peptide Program, Torrance, USA). The COCs were 
cultured for 3 or 24 h in control medium or medium containing 1 or 10 pg/ml LPS or 
PAM and supernatant was collected for analysis by ELISA. The COCs were then 
washed once in 300 pi PBS and lysed in buffer RLT (Qiagen, Crawley, UK) for 
analysis by multiplex PCR (see 2.21). The COCs treated for 24 h were examined 
prior to lysis for cumulus expansion, staging from 0 to 4, as shown in Fig. 2.6, using 
previously reported criteria (Vanderhyden et al., 1990).
Figure 2.6 Cumulus-oocyte complexes were staged for cumulus expansion. After 
24 h in-vitro maturation, COCs were staged using a 5-point scale. Stage 0 COCs 
showed no response, with cumulus cells adhered to the plastic (A); stage 1 COCs 
had yet to expand, with the COC still in a firm sphere (B); the outer layer of stage 2 
COCs had started to expand and the cells glistened more (C); stage 3 COCs were 
mostly expanded except the innermost cumulus layer (D); stage 4 COCs were fully 
expanded and spongy both in sight and when handling (E).
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2.10 Parthenote culture
Prior to starting parthenote culture, mineral oil (Sigma) was washed in a 
sterile 500 ml plastic bottle (500 ml oil plus 50 ml GC culture medium) by stirring 
for 48 h, allowing the mixture to separate, and then removing the oil. The oil was 
then washed once again for 48 h, before filtering the separated oil though a 0.2 pM 
sterile filter unit (Nalgene) and storing the oil in the filter base at room temperature 
in the dark.
Cumulus-oocyte complexes were aspirated (as described above) and matured 
in control medium (containing LH and FSH) or medium containing 10 pg/ml LPS or 
PAM for 24 h at 37°C under 5% CO2. On the day of in vitro maturation (IVM), 
embryo culture medium (0.25 mM sodium pyruvate, 8 mg/ml BSA, 
10% L-glutamine, 10% penicillin/streptomycin in medium 199) and mineral oil were 
equilibrated at 37°C in defined atmosphere of 5% CO2, 90% N2 and 5% O2 overnight 
in an incubator used only for parthenote culture (Galaxy 48R; New Brunswick, 
Enfield, USA). The next day, for each treatment, one culture dish was set up with 
three 50 pi wash drops and one 25 pi culture drop (all embryo culture medium) 
completely covered and surrounded with mineral oil. A dish containing 
DMAP (6-dimethylaminopyridine; Sigma) was also made with two 50 pi wash drops 
(both embryo culture medium) and two drops of 2 mM DMAP in embryo culture 
medium (one 50 pi wash drop and one 25 pi culture drop) under mineral oil.
After 24 h IVM, COCs were stripped of their cumulus cells in hyaluronidase 
(Sigma; 300 pg/ml in 1 ml medium -  direct into culture dish) for 4 min at 37°C. In 
order to remove remaining cumulus cells, oocytes were stripped by manual pipetting 
through a pulled glass pipette. The oocytes were then washed 3 times in collection 
medium before treating with 5 pM ionomycin (Calbiochem) in collection medium 
for 4 min. This ionomycin treatment activated calcium oscillations within the egg, 
similar to those observed at fertilisation (Ross et al., 2008). This transient increase in 
calcium leads to the cortical reaction and resumption of meiosis (Raz et al., 1998).
Following ionomycin treatment, the activated oocytes were transferred into 
the DMAP culture dish, washed twice in culture medium, once in DMAP and then 
cultured in DMAP for 4 h. The DMAP treatment inhibited protein phosphorylation,
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downregulating activity of maturation-promoting factor (Ross et al., 2008) and 
inducing mitosis (De La Fuente and King, 1998). After DMAP treatment, oocytes 
were transferred to the culture dish and washed 3 times in culture medium before 
culturing for 42 h. After 42 h culture, parthenotes were examined and the number of 
cells recorded and cells lysed with 75 pi buffer RLT for RNA analysis.
2.11 Culture of a human granulosa cell line
The COV434 cells (a kind gift at passage 28 from Dr P I Schrier, Leiden 
University Medical Centre) were received in our laboratory and used in the present 
work with the first culture denoted as “passage 1”. All experiments used cells from 
passage 3 to 12 and were performed on at least 3 occasions. The COV434 cells were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Paisley, UK), 
supplemented with 10% FCS (Biosera), 1% antibiotic/antimycotic (ABAM; Sigma) 
and 1% L-glutamine (Sigma). Medium was changed every 2 to 3 days, using 4 ml 
2.5% trypsin in EDTA (Sigma) to re-suspend the cells when confluent, before 
splitting 1 flask into 3. When cells were to be treated, 4 ml PBS was used to wash 
the cells. Then, 2 ml Accutase (Gibco), warmed to 37°C was used to detach the cells 
from the flask; cells were counted using a haemocytometer and diluted to the 
required seeding density. An initial experiment tested the response of COV434 cells 
seeded at 1x10s, 2xl05, 5x10s, lxlO6, 2xl06 and 4xl06 cells/ml to 1 pg/ml LPS. 
Subsequent experiments used 5x10s cells/ml, as this was the highest density able to 
be used without medium exhaustion occurring during 48 h culture. The cells were 
seeded into a 12-well or 24-well plate in 1 ml medium/well, for mRNA or protein 
analysis, respectively and equilibrated for 24 h at 37°C under 5% CO2. Medium was 
then aspirated from each well and 1 ml treatment or control medium added.
For some experiments, cells were cultured in the presence of 1 ng/ml or 
100 ng/ml FSH (courtesy of AF Parlow, National Hormone and Peptide Program, 
Torrance, USA) and 2864.1 ng/ml androstenedione (Sigma), concentrations 
previously used in the literature (Zhang et al., 2000). Other treatments including 
PAMPs and small molecule inhibitors are described in detail in chapter 6. After the 
appropriate treatment duration (as described in chapter 6), supernatants were 
removed and stored at -20°C, and the cells were either discarded or stored at -80°C 
in buffer RLT for RNA extraction.
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2.12 Culture of THP-1 human monocytic cell line
The THP-1 cell line was derived from peripheral blood of a patient with 
acute monocytic leukaemia (Tsuchiya et al., 1980). These cells are cultured as 
monocytic cells in suspension but readily differentiate into a macrophage-like cell 
after treatment with phorbol-12-myristate-13-acetate (PMA). In chapter 6, THP-1 
cells were used as a positive control to test human cellular responses to PAMPs. The 
THP-1 cells were obtained from American Type Culture Collection (ATCC, 
Teddington, UK) and were cultured in a THP-1 medium composed of RPMI 1640 
medium (Sigma), supplemented with 10% FCS and 1% ABAM (Sigma) at 37°C 
with 5% CO2 in air. Cells were split 1 flask into 3 flasks of pre-warmed, pre-gassed 
medium twice a week. When cells were to be treated, 10 ml confluent cell 
suspension was diluted with 15 ml normal medium plus 25 pi filter sterilised PMA 
(Sigma) at 5 ng/ml to differentiate the cells into a macrophage phenotype over 24 h, 
in a 12- or 24-well plate with 1 ml/well at a cell density of 2xl05 cells/ml. They were 
then washed in 0.5 ml PBS (Sigma) and incubated for 3 h in control THP-1 medium. 
Medium was then aspirated from each well and 1 ml treatment or control medium 
added. Treatments are described in detail in chapter 6 but included PAMPs and the 
DAMP hyaluronic acid. After treatment, supernatants were removed and stored at 
-20°C and cells were either discarded or stored at -80°C in buffer RLT for mRNA 
analysis.
2.13 Flow cytometry
Flow cytometry is a technique that enables the analysis of many single cells 
simultaneously. Cells in suspension are run through the flow cytometer and 
hydrodynamically focussed through a small nozzle, forcing single cells past the 
laser. As the light from the laser hits the cell, light is reflected in a number of 
directions and is then detected. Forward scatter correlates to the size of the cell and 
side scatter to the complexity of the cell (Kim et al., 2003). Any fluorophores 
associated with the cells are excited by a particular wavelength of light provided by 
the lasers, and emitted light of can be detected using filters for discrete wavelengths. 
Thus through flow cytometry, individual cells can be analysed for size, complexity, 
and the binding of a particular fluorochrome-conjugated antibody.
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Granulosa cells or PBMCs were isolated (as described above) and adjusted to 
4xl05 cells/ml in PBS. They were then centrifuged at 500 x g for 7 min and the 
supernatant removed, prior to incubating in the dark for 30 min in 1 ml PBS 
(unstained) or 1 ml DRAQ5 (a kind gift from Dr Cathy Thornton) at 0.5, 2.0 or 
5.0 pM in PBS; DRAQ5 is a membrane-permeant fluorescent dye that binds DNA 
and can be used in living cells (Martin et al., 2005). Here, it was used prior to 
experiments using flow cytometry as an output, in order to gate for live 
DNA-containing cells. Cells were analysed using FACSAria (BD Biosciences), 
which enables excitation via a blue (488 nm), red (638 nm) or violet (405 nm) laser 
and emission to be detected via various fluorochrome-dependent filter sets.
Cells were first analysed by cell size and complexity. A plot of forward 
scatter versus side scatter was created using the unstained cells, and gates were 
drawn around distinct cell populations (see Fig. 2.8A, B and 2.9A). The cells stained 
with DRAQ5 were then examined, to verify that the gating was around cells with a 
nucleus, rather than cellular debris. At 2.0 pM, DRAQ5 had good discrimination 
from background, so using this histogram, the cells of interest were gated and 
highlighted on the forward scatter versus side scatter plot, allowing a gate to be 
drawn around cells of interest. For future experiments, this gate was used to identify 
the cell populations of interest, with 10,000 events of interest recorded.
To stain for MHCII, untreated cells were washed twice in PBS; then 
incubated for 30 min with mouse anti-ovine MHCII (AbD Serotec, Oxford, UK) 
diluted 1:100 in FACS buffer (0.2% BSA in PBS). Cells were washed twice in 2 ml 
FACS buffer (500 x g for 5 min) and incubated at 4°C for 30 min with Alexa 
Fluor-488 goat anti-mouse (Sigma) diluted 1:500 in FACS buffer. Cells were 
washed twice with 2 ml FACS buffer before analysis by FACSAria.
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Figure 2.7 Peripheral blood mononuclear cells were stained with the nuclear 
stain DRAQ5 to identify the cell population of interest. A plot examining side 
scatter versus forward scatter for unstained PBMCs showed three distinct cell 
populations (A), which were gated as PI, P2 and P3 (B). The unstained cells were 
examined for auto-fluorescence with excitation at 638 nm and emission detected 
using 690 nm long pass filter and 710/40 bandpass filter (C). Cells stained with 
DRAQ5 (D; 0.5, 2.0 or 5.0 pM from left to right) were examined. The three gated 
populations showed different characteristics, with PI (shown in red) showing little 
nuclear staining, a small size and little complexity, thus likely to be debris; P2 
(shown in green) were smaller and less complex than events in the P3 gate (blue), yet 
had a larger amount of nuclear material, suggesting that cells in P2 were 
lymphocytes and cells in P3 were the mononuclear cells of interest.
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Figure 2.8 Granulosa cell populations were stained with DRAQ5 to identify the 
cell population of interest. A plot examining side scatter versus forward scatter for 
unstained GCs showed a number of populations (A). Gates were drawn around 
predicted populations of debris (P4), single cells (PI) and multiple cells (P2). The 
unstained cells auto-fluoresced with excitation at 638 nm and emission detected 
using 690 nm long pass filter and 710/40 bandpass filter (B). However, there was no 
auto-fluorescence off the blue laser (C), so future experiments preferentially used 
FITC-conjugated antibodies. Cells stained with DRAQ5 (D; 0.5, 2.0 or 5.0 pM from 
left to right) were examined and 2.0 pM staining used to gate for the cells of interest. 
These events were shown on the original forward versus side-scatter plot (E; in blue) 
and used to gate around cells of interest for future experiments (F; shown in orange).
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2.14 RNA Extraction
Total RNA was extracted from GCs, COCs, parthenotes or PBMCs using a 
Qiagen RNeasy Mini (GCs and PBMCs) or Micro Kit (COCs and parthenotes; both 
Qiagen, Crawley, UK). Extractions were performed in an RNA-only area of the lab, 
precleaned with RNase Zap wipes (Ambion, Austin, USA), using DNase and RNase- 
free filtered pipette tips (Starlab, Milton Keynes, UK). For treated GCs, cells were 
washed twice at room temperature using 350 pi sterile PBS and then 600 pi buffer 
RLT (Qiagen) was used to lyse the cells in each well of a 6-well tissue culture plate. 
The cells were removed from the plate using a sterile cell scraper (Greiner BioOne, 
Stonehouse, UK). For GCs or PBMCs, when RNA was extracted immediately after 
cell isolation, cells were pelletted through centrifugation, washed in PBS and 600 pi 
buffer RLT used to lyse the cells. Cumulus-oocyte complexes were transferred to a 
0.5 ml tube, washed in 300 pi sterile room temperature PBS and lysed in 75 pi (for 
fewer than 15 COCs) or 350 pi (for more than 15 COCs) buffer RLT.
Lysates were transferred to 1.5 ml tubes (Qiagen) and homogenised by 
passing the suspension through a 21-gauge needle fitted to a sterile syringe 
(BD Biosciences, Oxford, UK) 20 times, or, for cumulus-oocyte complexes, 
centrifuging at 8000 x g for 2 min through a QIAshredder column (Qiagen). One 
volume of 70% molecular grade ethanol (Sigma) was then added to the lysate and 
mixed by pipetting.
2.14.1 RNeasy Mini kit
Up to 700 pi of the sample was transferred to an RNeasy spin column 
(Qiagen) in a 2 ml collection tube, centrifuged (Eppendorf 5415 R, Cambridge, UK) 
for 15 s at 8000 x g and the flow-through discarded. If any sample remained, it was 
centrifuged through the same spin column, after discarding the first flow-through. 
The spin column membrane was washed with 700 pi buffer RW1 (Qiagen) and 
centrifuged for 15 s at 8000 x g and the eluate discarded. Five hundred pi buffer RPE 
(Qiagen) was used to wash the membrane twice, once with centrifugation for 15 s 
and the second time for 2 minutes, both times at 8000 x g, with the flow-through 
discarded after each centrifugation. The spin column was then dried by placing it in 
an empty 2 ml collection tube (Qiagen) and centrifuging for 1 min at 8000 x g.
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The spin column was placed in a new 1.5 ml collection tube and 40 pi RNase-free 
water (Qiagen) pipetted directly onto the membrane. After a final centrifuge for 1 
min at 8000 x g, the tubes containing RNA were placed on ice. The RNA was either 
kept on ice and used immediately or stored at -80°C and discarded if freeze-thawed 
more than twice.
2.14.2 RNeasy Micro kit
Up to 700 pi of the sample was transferred to an RNeasy MinElute spin 
column (Qiagen) in a 2 ml collection tube and centrifuged for 15 s at 8000 x g and 
the flow-through discarded. The spin column membrane was washed with 700 pi 
buffer RW1 (Qiagen) and centrifuged for 15 s at 8000 x g and the eluate discarded. 
The membrane was then washed with 500 pi buffer RPE (Qiagen), centrifuging for 
15 s at 8000 x g, followed by washing with 500 pi 80% molecular grade ethanol for 
2 min, with the flow-through discarded after each centrifugation. The spin column 
was then dried by placing it in an empty 2 ml collection tube (Qiagen), opening the 
spin column lid and centrifuging for 5 min at full speed. The spin column was placed 
in a new 1.5 ml collection tube and 14 pi RNase-free water (Qiagen) pipetted 
directly onto the membrane. After a final centrifuge for 1 min at 8000 x g, the tubes 
containing RNA were placed on ice. RNA was either kept on ice and used 
immediately or stored at -80°C and discarded if freeze-thawed more than twice.
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2.15 RNA quantification
The quantity of RNA was measured using the Nanodrop ND 2.0 
spectrophotometer (Nanodrop products, Wilmington, USA). The spectrophotometer 
was first cleaned using water and a 1 pi sample of water pipetted onto the lower 
optic surface, before initialising the Nanodrop through the instrument’s software. 
The constant for RNA was selected in the computer program and a 1 pi sample of 
water was then used to make a blank measurement, by pipetting it onto the lower 
optic surface, closing the pedestal and clicking on ‘blank’ on the computer program. 
The pedestals were then wiped and 1 pi of each sample in turn loaded onto the 
spectrophotometer and the amount of RNA quantitated by selecting ‘measure.’ The 
optical surfaces on the upper and lower pedestal were wiped with clean lens paper 
after each sample had been read, and the machine cleaned after all samples had been 
read using water. Samples were discarded if they contained under 40 ng/pl RNA or 
if the absorbance ratio at 260/280 was not between 1.8 and 2.2, as pure RNA has an 
absorbance ratio at 260/280 of about 2 with a ratio of greater than 1.8 indicating 
acceptable RNA quality (Thermoscientific, 2011).
2.16 cDNA synthesis
The RNA and DNA were handled in a dedicated laminar flow hood, using 
sterile filter pipette tips (Starlab), autoclaved microfuge tubes and pipettes dedicated 
for this purpose. The hood and items used for PCR were cleaned with 70% ethanol 
prior to use. The QuantiTect Reverse Transcription kit (Qiagen) was used to 
synthesise cDNA. This kit contains gDNA wipeout buffer, reverse transcriptase 
(RT), Quantiscript RT buffer, RT primer mix and RNase-free water. The contents 
were kept at -20°C and defrosted at room temperature, except the RT which was 
defrosted on ice. When defrosted, these solutions were mixed by flicking the tubes 
and centrifuged briefly to collect any residuals on the tube, then kept on ice. 
Genomic DNA was removed using 2 pi of gDNA wipeout buffer per reaction, plus 
up to 1 pg of RNA. The volume was then made up to 14 pi with RNase-free water in 
a thin walled 200 pi tube. This mixture was mixed and incubated for 2 min at 42°C 
using a TC-312 Thermocycler (Techne, Stone, UK) and placed immediately on ice. 
Whilst gDNA elimination occurred, the RT master mix was prepared, consisting of 
1 pi of RT, 4 pi of RT buffer and 1 pi of the RT primer mix per reaction. Six pi of
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this master mix was added to each tube of RNA (after gDNA elimination). The tubes 
were then mixed, pulsed in a microcentrifuge and heated to 42°C for 15 min and 
95°C for 3 min using the thermocycler.
2.17 Polymerase Chain Reaction
Polymerase chain reactions (PCR) were carried out in 0.2 ml thin-walled 
PCR tubes or in a 96-well 0.2 ml PCR plate (Sarstedt, Niimbrecht, Germany). 
Primers had either previously been cited in the literature or were designed using 
NCBI PrimerBlast (conditions: primer length 1 5 - 2 5  bp, GC content 20 - 80%, 
melting temperature 57 - 63°C, PCR product length 70 - 1000 bp) and ordered from 
Sigma Genosys (see Table 2.2). Primers were centrifuged before opening and 
reconstituted in RNase-free water to a concentration of 100 pm before aliquoting and 
storing at -20°C with each aliquot discarded if freeze-thawed more than twice. All 
primer sequences were validated using NCBI BLAST. For non-quantitative PCR, 
Biomix Red (Bioline, London, UK) was used, a premixed 2x solution containing Taq 
polymerase and a red dye allowing direct loading of PCR products onto a gel. Each 
reaction contained 25 pi Biomix red, 0.5 pi each primer, 22.5 pi RNase-free water 
and 1.5 pi cDNA. The reaction mix was vortexed and pulse centrifuged followed by 
PCR using the following cycle: initial denaturation at 95°C for 2 min; 35 cycles of 3- 
step cycling: 30 sec denaturation at 95°C, 30 sec annealing at 60°C, 2 min extension 
at 72°C; final extension 72°C for 5 min, and maintenance at 4°C. To investigate the 
expression of human TLRs in COV434 cells, a commercial primer set was used from 
Invivogen. The reference genes used for each cell-type (ACTB for bovine and human 
granulosa cells; L I9 for COCs and parthenotes) demonstrated invariant gene 
expression across all treatments. The qPCR method described in 2.17.1 was MIQE 
compliant (Bustin et al., 2009).
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2.17.1 Quantitative PCR
Semi-quantitative real-time PCR (qPCR) was carried out using the 
QuantiFast SYBR Green PCR kit (Qiagen), which enables use of primers with 
different melting points. A master mix was made for each gene containing all 
components of the kit (per well: 12.5 pi SYBR green, 10.5 pi water, 0.25 pi each 
primer), except cDNA. Each master mix was vortexed before distributing into wells 
of a 96-well plate (23.5 pl/well) and 1.5 pi of cDNA added in duplicate or triplicate 
(for technical replicates; Fig. 2.10). The plate was sealed (Sarstedt) and centrifuged 
for 3 sec at 3000 x g, before placing in a real-time cycler (BioRad) and using the 
following program: initial denaturation at 95 °C for 5 min followed by 40 cycles of 
2-step cycling: 10 sec denaturation at 95°C, 30 sec combined annealing/extension at 
60°C; denaturation at 95°C for 1 min; annealing at 55°C for 1 min, and 10 s at each 
1°C increase in temperature from 55°C to 95°C to generate a melt curve.
For all plates, a negative control containing the master mix with RNase-free 
water instead of cDNA was used to verify that the primers were binding specifically 
and to check whether primer dimers were forming (where the primers bind to each 
other and this DNA is amplified). The ACTB reference gene was used as an internal 
control for all PCRs using granulosa cell or COV434 cDNA.
In order to determine primer efficiencies, a standard curve was obtained on 
each plate using a series of 10-fold dilutions of positive control cDNA (from neat 
cDNA to lxlO'3 in RNase-free water). If the regression line plotted from the data for 
the serial dilutions had a coefficient of fit (r2) of less than 0.97, the experiment was 
not analysed further (Fig. 2.12). The Ct (Threshold Cycle) values of each set of 
duplicates or triplicates were examined and any reaction more than 0.2 from another 
reaction was not analysed. For all PCR reactions, melt curves were also examined 
(Fig. 2.11). Any samples without a melt curve showing a single smooth peak were 
not analysed. For each sample, the average starting quantity (calculated by the 
iCycler software from the standard curve) of the target gene was divided by the 
average starting quantity of ACTB to adjust the quantity of the target gene to the total 
quantity of cDNA. For some experiments, the fold change in a target gene over a 
control sample was calculated, by dividing the corrected value for the treated sample 
by that for the control.
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1 2 3 4 5 6 7 8 9 10 11 12
A 1 Sample 1 Sample 5 Sample 9
B 0.1 Sample 1 Sample 5 Sample 9
C 0.01 Sample 2 Sample 6 Sample 10
D 0.001 Sample 2 Sample 6 Sample 10
E 1 Sample 3 Sample 7 Sample 11
F 0.1 Sample 3 Sample 7 Sample 11
G 0.01 Sample 4 Sample 8 Negative Control
H 0.001 Sample 4 Sample 8 Negative Control
Figure 2.9 A template PCR plate layout for analysis of 2 genes. Triplicate wells 
contained the reaction for 1 gene shown coloured in purple, and wells containing the 
reaction for the other gene in white. Master-mix containing no cDNA was used as a 
negative control.
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Figure 2.10 Melt curves were examined prior to analysis. A sample melt curve 
showing the standards for IL8 (first peak) and ACTB (second peak). Genes were 
analysed one at a time, standard curve first followed by addition of samples. The 
melt curves were then viewed and any samples without a clean peak were not 
included in analysis. Triplicates were then examined and any more than 0.2 Ct value 
different from the other samples were not analysed.
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Figure 2.11 A sample qPCR trace for a standard curve. Standards were run in 
triplicate with the most concentrated standard containing undiluted mRNA and each 
subsequent dilution being a 1 in 10 dilution of the standard before. A threshold line 
(bright green) situated on the log-phase of the curve gave the threshold cycle (Ct) 
value for each standard, enabling a standard curve to be drawn, plotting Ct values 
against starting concentration of the standards. This resulted in a linear graph with a 
high degree of correlation (in this case 0.999), enabling the unknown starting 
quantity of the samples to be estimated from the curve. In addition, primer 
efficiencies were examined (shown by ‘E ’, in this case 102.2%).
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2.17.2 Multiplex PCR
For cDNA from COCs and parthenotes, multiplex PCR was used to measure 
the expression of target genes. Primers and probes were designed using the Eurofins 
MWG Operon software (conditions: primer length 18-22 bp, GC content 40 - 55%, 
melting temperature 50 - 65°C, PCR product length 100 - 300 bp) and ordered from 
the same company (Ebersberg, Germany); for sequences see Table 2.3. Primers and 
probes were reconstituted to 100 pM in TE buffer (Sigma) and stored at -20°C. For 
each gene, a 20x master mix was made containing 200 pi TE buffer, 20 pi each 
primer (at 100 pM) and 10 pi corresponding probe (at 100 pM) and stored at -20°C. 
For each panel of genes, a mastermix was made containing, for each sample, 10 pi 
multiplex SYBR green (Qiagen), 1 pi each gene mastermix and made up to a total 
volume of 16 pi with water (scaled up when more than 1 sample). Each reaction was 
made in duplicate wells of a 96-well low-profile microplate (BioRad) and contained 
2 pi cDNA and 8 pi of the panel mastermix. The microplate was sealed (Sarstedt), 
vortexed briefly and centrifuged for 3 sec at 3000 x g, before placing in a real-time 
cycler (BioRad) and running the following program: initial denaturation at 95°C for 
5 min followed by 50 cycles of 2-step cycling: 15 sec denaturation at 95°C and 30 
sec combined annealing/extension at 60°C.
Expression of each target gene was determined relative to L I9 using the 
comparative CT method (Livak and Schmittgen, 2001), which compares the CT 
value for the target gene with the CT value for the reference gene (CT value being 
the point where the fluorescence crosses an arbitrary line determined by the cycler). 
To calculate the fold change using the ddCT method, the following equations were 
executed:
1) dCT = CT value for target gene minus CT value for L I9 for each sample
2) ddCT = mean dCT value for control samples minus mean dCT value for target
3) fold change = 2 to the power of ddCT
72
OJ-a
o
u
a . &
3
o  o
c y
PQ
PQ
o
c
<D
a
c y
>n
U
8o
-3
O h
2
oja
E
H
O <
a CN
u
e-h
H
a
c y
s H
U
E-ha PQ
u
u
u
i s
o
c
<D
U
o
o
c y
k
PQ
H
u
H
3
a
’O
U
&
i s
o
3
D
U
U
<
<u
P 4
V i
cd
x
a
H
u
3
c y
3
a
<u
H
<
u S
o < ai
u
U i
O < E-i
s -o
3
x s
O ho
u
<
U
U
- 3
O h
O
u o E -i U |HO
< j 3 U U J 3
H E H U E
£
u
H
&vc/)
• p P
a<
V
Via<ucc
a>
DUs*es
H
aj
ecsCU
U
<UE-i
U<
a
Huu
8<
<HU
OH<
U<
u
uH
<
u
H
U
H
<
U
u
<
<
u
u
u
S3
£
a .
U
3
u
u
3
HU
U
S<
u
u
H
H
U
U
u
u
u
<
o
H
U
<
o
H
U
S
u
s
H
U
U
H
<
U
to
s
u
< u
< <
o
< a
a o
a a
o <
a
a < r
< <
o o
< o
< o
a u
< <
o o
< <
u u
< <
O
o<
u o
a
E-H
E-i
<
u a
u < £
o
< < H
< O
o a
o <
< c <
o
u <
u o< E-i
o a
< <
< a
E-i <
os
* o
I
U
U
<
u
u
H
U
U
U
u
&
u
£
H
U
H
U<
u
u
o<
<
o
<
u
3
£
§
o
<
u<
<
u<
<
a<
u
0  
a
1
a
<
u
a
o
$
u<
o
o
u
H
3
a
a<
o
<
o
<
5<
QP
3
CN
0>
X!
O
Ui
Oh
a
a
v
5/3
+3
3
c
V
C/5
6JD
tH
ea
H
a
sa
Cu
0
aa
i
o
u
H
aa
E-i
a
o
H
<
u
H
a
o
H
<
<
H
E-i
co
s
a
K
PQ
xo
s
<D
3cy
x
w
ffi
aj
i-i
O
x
Oh
O
l-io
3
a
a
H
u<
u
H
U
U
U
U
<
<
u
u
u
u<
H
u
H
<
3
U
u
u
<
u
u
u
E-i
0
U<
u
e
°Q
CNcyx
PQ
x
o
3<D
3cy
’3
<U
P4
5/3
cd
X
<u
E-i
8o
X
O hofc-o
3
0  0  E
u
u
u
0
u
u
E-i
u<
<
u
<
u
<
0
U
<
a<
<
u
u
Q
ss
OQ
cy
PQ
PQ
x
o
3<D
3
cy
«n
U
8
V ,£3 
>  O h
2  oX  t-H
cd O5/3 J3
<  Uh
<D>
O
■8
OS
0  O
U
0<
<
u
H
E-i
U<
U
3
u
u
u
u
E-h
0
u
u
u
u
<
u
<
u<
u<
u
<
u<
u
<
u
<
u
<
OQ
0
cy
X
PQ
a
3
<D
3cy
w
ffi
8o
X
O h
2o
J3
E
E-1aa
E-h
u
<
0
<
0<
u
u
u
u
a  h <  0  
0  E-i
< 9u  <
U  H
t  £  0 0
0
0
0
E-h
0
0
E-i
0
0
3-
r -
t
0<
0
<
0
<
0<
0<
0
0
U
i
0
0
0
0
0<
$
E-i
S
H
CNs
CNcyx
PQ
x
o
303
3
cy
T3<DXVi
cdx
0)
E-i
8o
X
O h
2o
J3
E
u<
u
H
<
3
0
U
U
U
U
P
u
3
u
ci
0
0
H
0
0<
<
0
<
0
H
<
3
E-i
0
0<
0
0
0
<D>
O
■8
cy
PQ
PQ
x
o
3
03
3cy
»n
0
ajI*o
X
O h
2o
3
0)>o
•8
os
0/XoSm
Oh
OHa
<<u
<
a<
a<<
a
o<
o
u  <
a  d<  o
B 3H U
axPQ
x33
33a
xw
ffi
8o
XOhoIhoJ3
E
u
<H
0HU
<
aH
E-i
0H
E-1E-i
0
Uou
t  H
U 0E-i 0P 0
co
a
kPQ
xo3
33
cy
■3
3
&
v>3X3H
CDVho
XOhoWhoJ3
E
aPQPQ
xo333
cy
in
> .
0
3>O
8oX
O ho
E-i
H<
E-i
0
H
8oX
O ho
* 8
Iho < 0 s-O
Vi G 0 0 J3
< E < O E
cy
xPQ
xo30)3
cy
0
E-i<O H
E-i 0
g  g
h  £H 0
<  0E-i E-i
0 < 
E-1 E-i 
0 0 < O 
O E-i E-i 0  0  E-i
E-h
<
CO acy 0
X 0
PQ 0 H
Xo
<
a
a
tc3
3 < PQ3cy
-3
a
E-ia
Xo3
3
3
P*V
3
E-i
O
<
3cy
X
3 < 5
H 0 Oh
3 H 3Ihn 0 VhoX < X
O ho O O hOUiO a t-Ho3 < 3
Ph 0 Oh
c<
g3x/i
a
DDuaH
43
Ga
0
0E-i
0
0E-i
0
0<
0
<
0E-i
3
0
0
3
0
0
0
t
0E-i
<
0
ae-h
0
e
0
a
3
a
£2
oOh
0<
<3
aa
<
a
<
<
o
<
0
a
<
o
o
a
3
3
0<t0
0
0
<
0H
0
0
<
0
E-h
0
<
0
0E-i
<
0
0
E-i
0
0
0
0
0
0E-i
0
0
e
ato
3>O
•8
O s'""HHQ
0
0<
0
H
0<
0<
o
<E-i<
0E-i
0
t
0
0
0
§
a 0
E-i <a <
<
£
o<
E-i
E-i
0
<
0<
< 0
0 a
0 0
<
0<
0 <
0 <oE-i
a a< <
0 0
0
< 0L j
0 P< L _ l
0 P
< 0
0 0< E-i
0 0
< 0
0 &
r__,I P0
0< 0E-h
0 0
< 0
0 0< E-h
os
£
o<
a
<<
o
<
0
a
a
oo
o<
0
1
Q
m VO
m
v ^ m u j m c i  —  i i i a i v ^ i i a i r )  a i i v a  l i i c u i w v a ^
2.17.3 Gel electrophoresis
To visualise PCR products, when required, 2% agarose gels were made by 
dissolving 2 g molecular grade agarose (Melford, Ipswich, UK) in 10 ml of lOx TAE 
buffer (0.4 M Tris-base (Melford) + 0.2 M acetic acid (Fisher) + 0.01 M EDTA 
(Sigma) in H2O) and 90 ml water. This was heated in a conical flask in a microwave 
at 40% power for about 2 min, until the mix boiled and was clear. When cool to 
touch, 8 pi ethidium bromide solution (Sigma) was added to the gel mix, the gel was 
poured into a level mould and a 15-tooth comb was inserted. The gel was cooled at 
room temperature for around half an hour until set. The comb was then removed and 
the gel placed in a tank filled with lx TAE buffer. If BioMix Red was not used, 5 pi 
of loading buffer (Bio-Rad, Hemel Hempstead, UK) was added to each sample and 
mixed by pipetting. Then, 12 pi sample (including loading buffer if necessary) was 
added to each lane on the gel and 5 pi of a 100 base pair ladder (Bio-Rad) loaded at 
each end of the samples. Electrophoresis was started at 120 V for 5 min and then 
continued at a constant 85 V (PowerPac Basic, Biorad). An image of the gel was 
taken using the GelDoc 2000 system (Bio-Rad) and the associated Quantity One 
Software (Bio-Rad).
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2.18 Protein extraction and quantification
Granulosa cells were washed once using room-temperature PBS before being 
lysed using 80 pi Phosphosafe Extraction Reagent (Novagen, Madison, US) per well 
of a 12-well plate (TPP). Adherent cells were removed from each well using a sterile 
cell scraper (Greiner Bio-One) and the lysate transferred to 0.5 ml tubes (Eppendorf). 
These tubes were then centrifuged at 21,000 x g at 4°C for 5 min before 
quantification of protein and storage at -20°C. A detergent compatible (DC) assay 
(Biorad) was used to quantify the protein concentration of each sample according to 
the manufacturer’s instructions. The DC assay is similar to the Lowry assay but 
requires only 15 min incubation time instead of 40 min (Lowry et al., 1951). 
Addition of an alkaline copper solution to the protein enables the protein to reduce 
Folin Reagent by loss of 1 to 3 oxygen atoms, producing a blue colour with a 
maximum absorbance at 750 nm. The development of colour is mainly due to 
oxidation of tyrosine and tryptophan, but also cystine, cysteine and histadine. The 
greater the absorbance at 750 nm, the greater the reduction of Folin Reagent, thus the 
greater the starting quantity of protein.
Briefly, bovine serum albumin (Sigma) was diluted in water to generate 
standards from 0.5 to 2.5 mg/ml. Standards and samples were tested in duplicate, 
made directly in a 96-well plate (TPP) to a total volume of 5 pl/well. Then, 20 pi of 
reagent S (Biorad) was added to each 1 ml of reagent A, an alkaline copper tartrate 
solution (Biorad; forming reagent A’) needed for the assay and mixed by vortexing. 
Twenty-five pi of reagent A’ was added into each well containing sample or 
standard, followed by 200 pi reagent B, a dilute Folin reagent (Biorad). The plate 
was incubated at room temperature for 15 min, before reading absorbance at 750 nm 
using a microplate reader (POLARstar Omega, BMG Labtech, Offenburg, 
Germany). The standards were used to create a linear standard curve by plotting 
absorbance at 750 nm against protein concentration and the concentration of samples 
was determined using this standard curve (y = mx+c).
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2.18.1 SDS-PAGE
For sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE), 10 pg each protein sample was mixed with an equal volume of Laemmli 
buffer (Sigma) in 0.2 ml thin-walled tubes (Eppendorf), vortexed, pulse centrifuged 
and heated for 5 min at 95°C. Mini PROTEAN TGX 12% precast polyacrylamide 
gels were assembled in a mini trans-blot PROTEAN electrophoresis cell (both 
Biorad). The tank was filled with running buffer (25 mM Tris (Melford), 192 mM 
glycine (Melford), 0.1% w/v SDS (Invitrogen) in water) and surrounded with ice. 
Then, 5 pi Precision Plus Protein Kaleidoscope standards (Biorad) was added to the 
first and last well, and samples were added to the remaining wells. Electrophoresis 
was carried out at 200 V for 45 min (PowerPac Basic, Biorad).
2.18.2 Western blot
Polyvinylidene difluoride (PVDF) membrane (GE Healthcare, Chalfont St 
Giles, UK) was immersed in 100% methanol (Fisher) until translucent. Fibre pads 
and blot paper (both Biorad) were equilibrated for 10 min in transfer buffer (20 mM 
Tris, 192 mM glycine, 20% v/v methanol, 0.1% w/v SDS), cooled to 4°C. The 
transfer cassette was assembled as shown in Fig 2.12, surrounded by ice and protein 
was transferred at 400 mA for 1 h at 4°C. The membrane was then removed from the 
cassette and blocked in 5% BSA (Sigma) in transfer buffer overnight at 4°C with 
gentle agitation. The membrane was then incubated with primary antibody (see 
Table. 2.4) at room temperature for 1 h 30, before washing 4 x 5  min with TBS/T 
(20 mM Tris, 125 mM NaCl, 0.1% v/v Tween20 (all Sigma) in water). The 
membrane was incubated for 1 h with secondary antibody at room temperature, 
followed by a further 4 x 5  min washes with TBS/T, before placing the membrane on 
the stage of the ChemiDoc XRS system (Biorad). Then, 1 ml Luminata Forte 
Western HRP substrate solution (Millipore, Billerica, USA) was used to cover the 
membrane and an image was collected, using Quantity-One software (Biorad) before 
saturation occurred (using the highlight saturated pixel function of the program). In 
order to probe for p-actin, the membrane was then incubated in Restore Western Blot 
Stripping Buffer (Thermoscientific, Erembodegem, Belgium) at room temperature 
for 7 min, reblocked and restained with the appropriate primary and secondary 
antibodies.
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Figure 2.12 The transfer cassette for protein transfer from the gel to the 
membrane. PVDF membrane was immersed in 100% methanol until translucent and 
fibre pads and blot paper (all Biorad) were equilibrated for 10 min in transfer buffer 
(20 mM Tris, 192 mM glycine, 20% v/v methanol, 0.1% w/v SDS) pre-cooled to 
4°C. The transfer cassette was assembled surrounded by ice and the protein was 
transferred at 400 mA for 1 h at 4°C.
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Table 2.4 Antibodies used for Western blot analysis.
Target peptide or 
protein
Band
Size
Manufacturer 
and code
Dilution Species raised in 
and clonality
diphosphorylated
ERK1/2
42/44
kDa
Sigma
M8159
1:1000 mouse
monoclonal
p38 MAPK 
(pThr 180/pT yo 182)
39
kDa
Acris Antibodies 
AP05898PU-N
1:1000 rabbit
polyclonal
beta-actin 42
kDa
Abeam
ab8226
1:1000 mouse
monoclonal
mouse IgG-HRP 
linked
N/A Cell Signalling 
7076
1:1000 horse
polyclonal
rabbit IgG-HRP 
linked
N/A Cell Signalling 
7074
1:1000 goat
polyclonal
2.18.3 Quantification of Western blots
Images of Western blots were analysed using the Quantity-One software 
(BioRad), as shown in Fig. 2.13. Firstly, lanes were framed and the bands detected 
by the software. A rolling background was then set to compensate for any changes in 
background intensity. The peak density of each band was measured by the software. 
For p-ERKl/2, the peak density of p-ERKl and p-ERK2 were added together. In 
order to correct for total protein loading, the peak density of bands representing 
either p-p38 MAPK or p-ERKl/2 was divided by the peak density of the band 
representing P-actin. These figures were then divided by the ratio for time 0 to give a 
percentage increase in phosphorylation of p38 MAPK or ERK1/2 over time.
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Figure 2.13 Western blots were analysed using the Quantity One software 
(BioRad). The raw image (A) was cropped to include only the area of interest (B). 
The contrast of the image was then adjusted to optimise the background (C). Using 
the program's software, lanes were framed, so that the centre of each lane bisected 
each set of bands in the middle (D). The angle of each lane was adjusted as 
necessary to run parallel with the blot. The background was then adjusted to allow 
for any changes in background intensity using the rolling background function (E). 
Lastly, bands were detected (F) and the peak density measured.
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2.19 Enzyme-linked immunosorbent assay
The accumulation of inflammatory mediator protein in culture supernatants 
was examined using enzyme-linked immunosorbent assay (ELISA; Table 2.5). 
Samples from human cells were examined using ELISAs specific for human 
inflammatory mediators. Samples from bovine cells were examined using ELISAs 
specific for bovine inflammatory mediators, except for IL-8. The human IL-8 ELISA 
was used for bovine samples as it has previously been shown to cross-react with 
bovine IL-8 (Shuster et al., 1997).
Table 2.5 Assays used to measure accumulation of protein in cell supernatants
Target Name Manufacturer Code
hIL-6 Human IL-6 DuoSet
R&D Systems, 
Abingdon, UK
DY206
hIL-ip Human IL-1 beta/IL-lF2 DuoSet DY201
hIL-8 Human CXCL8/IL-8 DuoSet DY208
hCCL5 Human CCL5/RANTES DuoSet DY278
bTNFa Bovine TNF-alpha DuoSet DY2279
bIL-6 Bovine IL-6 ELISA Reagent Kit
Thermo-Scientific, 
Rockford, USA
ESS0029
bIL-lp Bovine IL-1 beta ELISA 
Reagent Kit ESS0027
bIL-8
(COC)
In-house
E2
(COV434)
In-house (Walker et al., 2002, Atsalis et al., 2004, Lueders et al., 2009, 
Pollock et al., 2010)
E2 Oestradiol ELISA DRG Diagnostics, 
Marburg, Germany
EIA-2693
P4 Progesterone ELISA EIA-1561
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2.19.1 R&D Systems cytokine/chemokine ELISA
Details of reagents and buffers can be found in Tables 2.6 and 2.7. The limit 
of detection, inter- and intra-assay variability can be found in Table 2.9. Capture 
antibody was diluted to working concentration in PBS and used to coat a half-area 
96-well microplate (Greiner Bio-One) and the plate was sealed and incubated at 4°C 
overnight on a shaker. Each well was then aspirated and washed 3 times with wash 
buffer (140 p 1/well). After the final wash, the plate was inverted and blotted against 
clean paper towels. Then, 150 pi of block buffer was added to each well and 
incubated for 1 h on a shaker, followed by a further wash, as described above. The 
most concentrated standard was made in reagent diluent followed by 2-fold serial 
dilutions in reagent diluent. Supernatants were defrosted overnight at 4°C and 
vortexed before use. Then, 50 pi of standard or supernatant was added to each well 
in duplicate and the plate was incubated at room temperature for 2 h. The plate was 
then washed 3 times and 50 pi of detection antibody diluted to working 
concentration in reagent diluent was added to each well, followed by incubation at 
room temperature for 2 h. After a further 3 washes, streptavidin conjugated to 
horseradish peroxidase (streptavidin-HRP; R&D Systems) was diluted in reagent 
diluent (30 pi in 6 ml) and 50 pi was added to each well. The plate was then 
incubated in the dark for 20 minutes at room temperature. A final wash step 
preceded addition of 50 pi substrate solution (1:1 mixture of H2O2 and 
tetramethylbenzidine; BD Biosciences) per well, incubated for 20 minutes at room 
temperature in the dark. Finally, 50 pi of stop solution (2N H2SO4) was added to 
each well and the plate was analysed.
A spectrophotometer (POLARstar Omega) and associated software (MARS 
data analysis vl.2 R2, Omega) was used to determine the concentrations of 
cytokines. The software was used to plot optical density against the concentration of 
the standard (pg/ml). A standard curve was formed using the 4-parameter fit model 
based on the blank corrected raw data and the software calculated the unknown 
concentrations of the samples from this standard curve (for equation see Fig. 2.14). 
Data were analysed only if the coefficient of fit of the curve was greater than 0.990.
83
» 0 0  MOO WOO 3800 4000 4
Figure 2.14 ELISA standards were fitted to a 4-parameter curve. A 4-parameter
D
fit works using the equations y = ((A-D) /  (1 + (x/C) )) + D, where A represents the 
response at 0 pg/ml, B represents the gradient, C represents the inflection point, 
where the curvature changes direction and D represents the response at an infinite 
concentration.
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Table 2.6 Solutions used for each ELISA (all reagents from Sigma unless 
otherwise stated). Wash buffer, block buffer and reagent diluents were made in 
advance and stored for up to 2 weeks at 4°C; substrate solution was made 
immediately before use and stop solution was made in advance and kept at room 
temperature for up to 6 weeks
IL-8 IL-6 IL-ip TNFa
PBS 4 PBS tablets dissolvec in 1 L water
Wash Buffer 0.05% Tween 20 in PBS, pH7.2-7.4
Block Buffer 1% BSA in PBS Same as Reagent Diluent
Reagent Diluent 
(RD)
0.1% BSA, 0.05% 
Tween 20 in TBS 
(20mM Trizma base, 
150 mM NaCl) 
pH 7.2 - 7.4 
0.2 pM filtered
1% BSA in PBS 
pH 7.2 - 7.4 
0.2 pM filtered
5% Tween 20 
in PBS
0.2 pM filtered
Substrate
Solution
1:1 mixture of Colour 
(tetramethylbenzidine)
Reagent A (H2O2) and Colour Reagent B 
(R&D Systems)
Stop solution 2N Sulphuric Acid Solution
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2.19.2 Thermo-Scientific cytokine ELISA
Wash buffer (0.05% Tween20 in PBS), blocking buffer (4% BSA, 
5% sucrose in PBS (all Sigma); 0.2 pM filtered), carbonate-bicarbonate buffer 
(0.2 M made using carbonate-bicarbonate buffer capsules; Sigma) and reagent 
diluent (4% BSA in PBS; 0.2 pM filtered) were made in advance and stored for up to 
2 weeks at 4°C. The limit of detection, inter- and intra-assay variability can be found 
in Table 2.8.
Coating antibody was diluted 1:100 in carbonate-bicarbonate buffer and used 
to coat a half-area 96-well microplate (50 pl/well). The plate was sealed and 
incubated at 4°C overnight on a shaker. Each well was aspirated and 150 pi of block 
buffer was added to each well and incubated for 1 h on a shaker. The plate was then 
washed 3 times using a plate washer (LT-3500, Labtech, Ringmer, UK). The 
provided standard was reconstituted in reagent diluent, and reagent diluent was used 
to prepare 1:2 serial dilutions (highest standard concentration for IL-6 was 5000 
pg/ml; for IL-lp it was 2000 pg/ml). Supernatants were defrosted overnight at 4°C 
and vortexed before use. Then, 50 pi of standard or supernatant was added to each 
well in duplicate and the plate was incubated at room temperature for 1 h. The plate 
was then washed 3 times and 50 pi of detection antibody diluted 1:100 in reagent 
diluent was added to each well, followed by incubation at room temperature for 1 h. 
After a further 3 washes, streptavidin-HRP was diluted 1:400 in reagent diluent and 
50 pi added to each well. The plate was then incubated in the dark for 30 minutes at 
room temperature. A final wash step preceded addition of 50 pi substrate solution 
per well, which was incubated for 20 minutes at room temperature in the dark. 
Finally, 50 pi of stop solution was added to each well and the plate was analysed 
using a microplate spectrophotometer and associated software, as described above.
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2.19.3 IL-8 ELISA for COCs
An ultrasensitive IL-8 ELISA was developed in house, ideal for supernatants 
from a small number of cells, for example COCs. Wash buffer (0.05% Tween20 in 
PBS), carbonate-bicarbonate buffer (0.2 M made using carbonate-bicarbonate buffer 
capsules) and reagent diluent (4% fish-skin gelatine (Sigma) in PBS; 0.2 pM 
filtered) were made in advance and stored for up to 2 weeks at 4°C. The limit of 
detection, inter- and intra-assay variability can be found in Table 2.9.
Coating antibody (mouse anti-sheep IL-8; MCA 1660; AbD Serotec) was 
diluted 1:400 in carbonate-bicarbonate buffer and used to coat a half-area 96-well 
microplate (50 pl/well). The plate was sealed and incubated at room temperature 
overnight on a shaker. Each well was aspirated, washed 3 times using a plate washer 
and 150 pi of reagent diluent was added to each well for 1 h. The plate was then 
washed 3 times using a plate washer and standards (bovine IL-8, RP0023B-025; 
Kingfisher Biotech, St Paul, USA) prepared in reagent diluent using 1:2 serial 
dilutions (highest standard 4000 pg/ml). Supernatants were defrosted overnight at 
4°C and vortexed before use. Then, 50 pi of standard or supernatant was added to 
each well in duplicate and the plate was incubated at room temperature for 90 min. 
The plate was then washed 3 times and 50 pi of detection antibody (rabbit anti-sheep 
IL-8; AHP425; Abd Serotec) diluted 1:700 in reagent diluent was added to each 
well, followed by incubation at room temperature for 2 h. After a further 3 washes, 
the tertiary antibody (HRP-conjugated goat anti-rabbit; P0448; Dako, Glostrup, 
Denmark) was diluted 1:6000 in reagent diluent and 50 pi added to each well and 
incubated for 1 h at room temperature. After a final wash step, 50 pi substrate 
solution (1:1 mixture of H2O2 and tetramethylbenzidine) was added to each well, and 
incubated for 10 minutes at room temperature in the dark. Finally, 50 pi of stop 
solution (2N sulphuric acid) was added to each well and the plate was analysed using 
a microplate spectrophotometer and associated software, as described above.
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2.19.4 Oestradiol ELISA for COV434 cells
This oestradiol ELISA was only used for supernatant from COV434 cells 
(chapter 6). All buffers were made in advance and stored at 4°C for up to 3 weeks 
(for formulations see Table 2.8). The limit of detection, inter- and intra-assay 
variability can be found in Table 2.9. The oestradiol capture antibody was diluted 
1:100 in coating buffer and stored in aliquots at -20°C. Oestradiol-17p-horseradish 
peroxidise (E2-HRP) was diluted 1:500 in EIA buffer and stored at 4°C and used at a 
1:50,000 dilution in EIA buffer. Ethanol was used to dilute 17p-oestradiol (Sigma) to 
a concentration of 10 mg/ml and stored at -20°C. This was then diluted further in 
EIA buffer to give a working stock of 100 ng/ml. Polyclonal anti-oestradiol R4972 
(a kind gift from Jean Routley, University of Liverpool) cross-reacts with 
oestradiol-17p (100%), oestrone (3.3%), androstenedione (1%), progesterone (0.8%) 
and less than 1% with cortisone and dihydrotestosterone (Gudermuth et al., 1998).
The antibody was diluted from stock concentration of 1:100 to a working 
dilution of 1:10,000 using coating buffer (i.e. 50 pi antibody stock in 5 ml coating 
buffer) and used to coat a half-area 96-well microplate. The plate was sealed and 
incubated at 4°C overnight on a shaker. Each well was then aspirated and washed 5 
times with wash buffer (140 p 1/well). After the final wash, the plate was inverted and 
blotted against clean paper towels. Immediately, 50 pi of EIA assay buffer was 
added to each well and incubated for 2 h at room temperature on a shaker. The most 
concentrated standard (25 ng/ml) was made in EIA buffer followed by 2-fold serial 
dilutions in EIA buffer. Supernatants were defrosted overnight at 4°C and vortexed 
before use. Without washing the plate, 20 pi of standard or supernatant and 50 pi of 
E2-HRP was added to each well. The plate was then incubated at room temperature 
for 2 h. The plate was washed 5 times as above. The ABTS substrate was prepared 
immediately before use and 100 pi was added to each well. The plate was incubated 
at room temperature in the dark to allow colour to develop (30-60 min) and the 
optical density determined immediately using a microplate reader set to 405nm.
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Table 2.8 Oestradiol ELISA buffers: all products from Sigma unless otherwise 
stated.
Coating Buffer 
pH 9.6
1.59 g Na2C03 (Anhydrous) 
2.93 g NaHC03 
11 water
EIA buffer 
pH 7.0
Stock A: 27.8 g 0.2 M NaH2P04  in 11 water
Stock B: 28.4 g 0.2 M Na2HP04  in 11 water
195 ml Stock A
305 ml Stock B
8.7 g NaCl
1 g BSA
500 ml water
Wash concentrate 87.66 g NaCl 
5 ml Tween 20 
1 1 water
(dilute 1 in 10 in water for use)
Substrate buffer 9.61 g Citric acid (anhydrous) 
11 water
ABTS 
pH 6.0 
Keep in dark
ABTS: 0.55 g ABTS in 25 ml water
H2O2: 500 pi hydrogen peroxide in 8 ml water
125 pi 40 mM ABTS
125 pi 0.5 M hydrogen peroxide
12.5 ml substrate buffer
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2.19.5 Oestradiol and Progesterone ELISA (DRG Diagnostics)
Due to limitations using the in-house oestradiol ELISA, associated with high 
inter-assay variability and limit of detection, the accumulation of oestradiol and 
progesterone in supernatant from bovine GCs was measured using commercial kits 
(DRG Diagnostics, Marburg, Germany). These commercial kits are based on 
competitive-binding and use ELISA wells pre-coated with an antibody specific to the 
target. All reagents were warmed to room temperature before use and were used 
according to the manufacturer’s instructions.
Briefly, to measure the accumulation of oestradiol, 25 pi of standard 
(0, 25, 100, 250, 500, 1000 or 2000 pg/ml) or sample was pipetted into duplicate 
wells. This was immediately followed by addition of 200 pl/well of enzyme 
conjugate (oestradiol conjugated to horse-radish peroxidase). The contents were 
mixed by repeat pipetting for 10 sec, before incubating for 2 h at room temperature. 
Then, the contents of the wells were expelled, wells were washed 3 times 
(400 pl/well) and residual liquid expelled by forcefully blotting the wells on tissue 
paper. Then, 100 pl/well substrate solution (tetramethylbenzidine) was incubated for 
15 min at room temperature. Finally, 50 pl/well stop solution (0.5 M sulphuric acid) 
was used to prevent further colour development and the plate was read at 450 nm 
(Omega, as above).
To measure the accumulation of progesterone, 25 pi of standard 
(0, 0.3, 1.25, 2.5, 5, 15 or 40 pg/ml) or sample was pipetted into duplicate wells and 
incubated for 5 min. Then 200 pl/well of enzyme conjugate (progesterone 
conjugated to horse-radish peroxidase) was added and mixed by repeat pipetting for 
10 sec, before incubating for 1 h at room temperature. The plates were washed as 
above and 200 pl/well substrate solution (tetramethylbenzidine) was incubated for 
15 min at room temperature. Finally, 50 pl/well stop solution (0.5 M sulphuric acid) 
was used to prevent further colour development and the plate was read at 450 nm 
(Omega, as above).
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Table 2.9 Limit of detection, inter- and intra- assay variability for ELISAs used 
in this project. The inter-assay variability was calculated by dividing the standard 
deviation by the mean of the same sample run on 4 different plates (xlOO). The intra­
assay variability was calculated by dividing the standard deviation by the mean of 
the same sample run on the same plate in multiple wells (xlOO). The limit of 
detection was calculated by adding 3 times the standard deviation of the lowest 
standard (over 4 plates) to the blank.
ELISA Limit of Detection 
pg/ml
Intra-assay
variability
%
Inter-assay
variability
%
hIL-6 8.2 1.2 2.4
hIL-ip 5.1 4.6 7.7
hIL-8 14.3 1.7 5.5
hCCL5 10.6 4.5 4.9
bIL-6 35.6 1.2 3.0
bIL-ip 20.1 4.6 7.7
bTNFa 21.8 3.1 3.8
bIL-8 (in house) 47.3 2.2 2.7
In house E2 333.5 13.0 21.2
E2 (DRG) 10.7 1.1 1.2
P4 (DRG) 40 5.0 3.8
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2.20 MTT assay
Cell survival was estimated using an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide) assay (Mosmann, 1983). A stock solution of 5 mg/ml 
MTT (Sigma) in PBS was used at a working concentration of 0.5 mg/ml in culture 
medium. After removal of the cell supernatants, cells grown in a 24-well plate were 
washed in 350 pi PBS and 250 pi of the MTT at 0.5 mg/ml was added to each well, 
followed by incubation at 37°C for 1 h. The cells were then washed in 350 pi PBS 
and 250 pi of demethyl sulphoxide (DMSO; Sigma) was added to each well to lyse 
the cells. The plate was placed on a rocker for 15 mins and then 50 pi lysed cell 
suspension was pipetted into a 96-well plate (TPP) in duplicate. The plate was 
analysed using a spectrophotometer (POLARstar Omega) at 570 nm and associated 
software (MARS data analysis v l.2  R2, Omega). Results are expressed as a 
percentage of the absorbance for the supernatant from cells cultured in control 
medium.
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Figure 2.15 The MTT estimated cell viability. MTT is yellow in its bromide state 
but the positively charged tetrazolium ring is cleaved by active mitochondrial 
hydrogenases to purple formazan. The cells are then lysed using DMSO, and the 
absorbance measured using a microplate reader.
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2.21 ApoTox Glo assay
To further investigate the effect of treatments on cell health, an ApoTox-Glo 
Triplex Assay was used, according to the manufacturer’s instructions (Fig. 2.16; 
Promega). Prior to starting the assay, the reagents were made and stored at 4°C. To 
make the viability/cytotoxicity reagent, 10 pi of GF-AFC substrate and 10 pi 
bis-AAF-RllO substrate were mixed by vortexing in 2 ml of assay buffer. To make 
the Caspase-Glo 3/7 reagent, the entire Caspase-Glo 3/7 buffer was mixed by 
inversion with the Caspase-Glo 3/7 substrate, in the bottle containing the substrate.
After cells had been treated in duplicate in a 96-well plate, supernatants were 
removed and 100 pi culture medium added to each well. Then, 20 pi 
viability/cytotoxicity reagent was added to each well, mixed by orbital shaking 
(300 rpm for 30 s) and incubated for 30 min at 37°C. Fluorescence was then 
measured with excitation at 400 nm and emission at 505 nm to assess cell viability, 
and 485 nm excitation and 520 nm emission to assess cytotoxicity. Then, 100 pi 
Caspase-Glo 3/7 reagent was added to each well, mixed by orbital shaking (300 rpm 
for 30 s) and incubated for 30 min at room temperature. Luminescence was then 
measured to assess caspase activation, a marker of apoptosis.
Two positive controls were used in this assay: 15 min digitonin (Sigma) 
treatment at 30 pg/ml was used as a positive control for cytotoxicity, and 10 pM 
staurosporine (Sigma) treatment for 4 h was used as a positive control for apoptosis 
and viability.
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LIVE CELL GF-AFC DEAD CELL
is-AAF-RHO /Active live cell
Active dead cell
proteases
Z-DEVD —N
H,N
Z-DEVD- +
COOH
COOH
Luciferase
Figure 2.16 The ApoTox GIo Triplex Assay (Promega) evaluated cell viability, 
toxicity and apoptosis. In step A, 2 proteins are added to the cells; one measures 
cell viability and the other measures cytotoxicity. GF-AFC is cell permeable and is 
cleaved by live cell proteases to AFC, which is fluorogenic with excitation of 400 
nm and emission of 505nm. Dead cells to not have active live cell proteases thus 
AFC is not formed. Bis-AAF-RllO is not cell permeable, thus cannot enter live 
cells. However, dying cells without an intact cell membrane leak dead cell proteases, 
which cleave Bis-AAF-RllO to R110, which fluoresces with excitation of 485 nm 
and emission of 520 nm. In step B, cells are lysed and caspases cleave the substrate 
to produce light through luciferase action.
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2.22 Statistical analyses
Statistical analyses were performed using SPSS version 19 (SPSS Inc) and 
significance ascribed when P < 0.05.
Data were examined for normality by drawing a histogram of the data. For 
normally-distributed data, following square root or log transformation where 
indicated in Results, either Student’s T-test or analysis of variance (ANOVA) was 
used to test for significant differences between groups. For data within 2 groups, 
Student’s T-test was used to compare the two groups. The T-test examines 
differences between the mean of 2 groups of data, comparing the means of each 
group with the variation in each group. For normally-distributed data with more than 
2 groups, ANOVA was used, with Dunnett’s pairwise multiple comparison T-test 
used to compare treatments with control. The post-hoc Dunnett’s T-test function runs 
multiple T-tests comparing treatments against a selected control, but is more 
conservative than running multiple Student’s T-tests, as it references against a 
different table. When the aim was to compare each group with every other group in 
an experiment (rather than compare against control), Fisher’s least significant 
difference post-hoc test was used.
When data were not normally distributed, comparisons between treatment 
and control were made using Mann-Whitney U test, as indicated in Results. For 
discontinuous results, for example the grading of cumulus expansion, groups were 
compared using Fisher’s exact test.
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Chapter 3
Granulosa cells from emerged antral 
follicles of the bovine ovary initiated 
inflammation in response to bacterial 
pathogen-associated molecular patterns 
via Toll-like receptor pathways
3.1 Introduction
Bacterial contamination of the uterus is ubiquitous after parturition in cattle 
(Sheldon et al., 2002) with 40% of animals developing clinical disease (Sheldon et 
al., 2009). In addition to causing distress and suffering to the animal, uterine disease 
causes infertility, not only through endometrial damage, but also by perturbation of 
ovarian function. Cows with uterine disease exhibit slower growth of dominant 
follicles and have lower peripheral plasma oestradiol concentrations than healthy 
animals (Sheldon et al., 2002). However, it is not clear if uterine disease impacts 
emerged ovarian follicles.
In cattle, follicles develop in follicular waves, with a cohort of 6 to 24 
ovarian follicles synchronously emerging in response to a rise in peripheral plasma 
FSH concentrations (Ginther et al., 1996). The concentration of FSH begins to 
decline after a further 2 days and only larger follicles with more FSH receptors are 
able to survive, whilst remaining follicles undergo atresia. As FSH concentrations 
continue to fall, one follicle is selected as the dominant follicle, becoming responsive 
to luteinising hormone (LH). Granulosa cells (GCs) are somatic cells which line 
ovarian follicles and support the growth and development of the oocyte. At follicle 
emergence, GCs begin to express the FSH receptor, and develop the receptor for LH 
when a follicle becomes dominant. Thus, follicles are dependent on GCs to grow and 
develop. This chapter focused on the impact of uterine disease on GCs from emerged 
follicles.
Uterine disease is associated with both Gram negative and Gram positive 
bacteria, including E. coli and T. pyogenes (Williams et al., 2005). Escherichia coli 
is the first bacterium to invade the endometrium of the post-partum cow, paving the 
way for infection by T. pyogenes (Williams et al., 2007). Trueperella pyogenes 
infection is associated with increased severity of uterine lesions and acts 
synergistically with other bacteria to cause tissue damage and severe endometritis 
(Bonnett et al., 1991).
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Escherichia coli is a Gram negative, facultive anaerobic bacterium, part of 
the normal flora of the gastrointestinal tract and widespread in the environment. 
Until recently it had been presumed that the bacteria that colonise the endometrium 
are a random collection of many strains of E. coli from the gastrointestinal tract, 
urinary tract and environment. Interestingly, it now seems that specific strains of 
E. coli are adapted to the uterus and pathogenic in the endometrium, especially 
strains in phylogenetic groups A and B1 (Sheldon et al., 2010). Escherichia coli is 
rod-shaped, has a lipopolysaccharide (LPS) outer layer and some strains use flagella 
for motility (Lane et al., 2007). Thus, the TLRs likely to be important for recognition 
of E. coli include: TLR4, which binds LPS; TL5, which binds a component of 
flagellin, and TLR2, which binds lipoprotein elements of bacterial cell walls, such as 
lipoteichoic acid (Kawai and Akira, 2010).
It has previously been shown that LPS collects in the follicular fluid of cows 
with uterine disease, thus PAMPs are able to be in direct contact with GCs. 
Surprisingly, it was found that bovine GCs have functional responses to LPS, with 
treatment of GCs from emerged follicles with 1 or 10 pg/ml LPS significantly 
decreasing oestradiol production (Herath et al., 2007). In addition, GCs express 
mRNA for TLR4 and associated adapter molecules, including CD14 and LY96 
(Herath et al., 2007), supporting the hypothesis that GCs express functional TLR4. 
However, the expression of other TLRs and functional responses to other PAMPs 
have not yet been examined.
The Pam3CSK4 (PAM) synthetic triacylated lipopeptide binds TLR1/TLR2 
dimers, and this work will use PAM as a TLR2 ligand due to the difficulty in 
obtaining ultrapure forms of other TLR2 ligands, such as bacterial peptidoglycan 
(PGN) and lipoteichoic acid (LTA). Flagellin (FLA) is a component of flagella 
found on gram negative and gram positive bacteria and is recognised by TLR5.
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Ovulation has been likened to inflammation (Espey, 1980) and Toll-like 
receptors may play a role in events leading up to extrusion of the oocyte (Liu et al.,
2008). This indicated that immune and endocrine pathways may interact, an idea 
backed up by the observations that the FSH receptor (FSHR) is necessary for innate 
immune responses in Caenorhabditis elegans (Powell et al., 2009) and that acute LH 
treatment of hen GCs increases expression of RNA for TLR2 and TLR4. Hormones 
have also been linked with innate immune signalling: oestradiol has an inhibitory 
effect on TLR activation in murine uterine epithelial cells (Soboll et al., 2006) and 
suppresses LPS-induced NFkB activation and TNFa expression in human 
macrophages (Murphy et al., 2010) and progesterone decreases interleukin 
production by LPS-stimulated murine macrophages (Jones et al., 2008, Su et al.,
2009). In this chapter, the crosstalk between the innate immune and endocrine 
pathways was further explored.
In addition to binding molecular patterns associated with pathogens, Toll-like 
receptors also bind patterns associated with damage. These may be important in the 
process of ovulation, which causes damage to the follicle, and also in the postpartum 
period, after extensive damage to the endometrium. Of particular interest is 
hyaluronic acid (HA), a major component of extracellular matrix, which is involved 
in wound repair, cell proliferation and migration. Hyaluronan is a major component 
of ovarian follicular fluid, is involved in oocyte maturation through interaction with 
CD44 and may aid capture of the oocyte by the oviduct (Salustri et al., 1999, Yokoo 
et al., 2010). In response to progesterone, the uterine lumen increases concentration 
of HA; this is maintained through early pregnancy (Ashworth et al., 1990). Thus, it 
is possible that HA could also travel to the ovary through the oviduct. During murine 
pregnancy, HA increases to 71% of total cervical glycoaminoglycan and during 
labour, activity of hyaluronidases increases, breaking down the high-molecular form 
of HA (Akgul et al., 2012). Thus, in the post-partum animal, the reproductive system 
contains a large amount of pro-inflammatory low-molecular weight HA, which may 
act as a DAMP in the ovary.
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The hypothesis tested in this chapter was that GCs from emerged follicles 
respond to PAMPs and DAMPs, and that this response is influenced by endocrine 
factors. The aims of this chapter were to investigate the innate immune response of 
GCs from emerged follicles to 3 PAMPs (LPS, PAM and FLA) and 1 DAMP (HA), 
and to explore the interactions between ovarian physiology (the endocrine pathway) 
and pathology (the innate immune response). Firstly, expression and accumulation of 
pro-inflammatory cytokines and chemokines was measured after PAMP or DAMP 
exposure by qPCR and ELISA, respectively. Activation of TLR signalling 
components was identified using Western blot and the effect of blocking the TLR 
pathway was investigated using short interfering RNA (siRNA) and biochemical 
inhibitors. The effect of LPS and PAM on expression of endocrine receptors and 
production of oestradiol and progesterone was then identified, followed by the effect 
of endocrine factors on PAMP-stimulated pro-inflammatory cytokine production.
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3.2 Methods
3.2.1 Granulosa cell culture
To explore the impact of PAMPs and DAMPs, GCs from emerged (4.0 to
7.5 mm) follicles from beef cows were isolated and plated in 12-, 24- or 96-well 
plates at a density of 1.5xl06 cells/ml in culture medium, as described in chapter 2. 
Granulosa cells from beef cattle represent a suitable model for investigating the 
effects of infection and inflammation on dairy GCs (chapter 2). Furthermore, GCs 
from follicles 4.0 to 7.5 mm in diameter represented GCs from emerged follicles, 
with expression of FSHR, low expression of CYP19A1 and no detectable expression 
of LHCGR (chapter 2). The GC cultures were also free from contaminating immune 
cells, thus validating follicle aspiration as a suitable method for GC isolation. Bovine 
PBMCs were isolated from whole blood as described in chapter 2 and used as a 
positive control in some experiments.
After 48 h, the GCs were washed in PBS, then treated with control medium 
or medium containing ultrapure lipopolysaccharide from Escherichia coli 0111:B4 
(LPS; Invivogen), Pam3CSK4 (PAM; Invivogen), flagellin from Salmonella 
typhimurium (FLA; Invivogen) or ultralow (ULMW) or high molecular weight 
(HMW) hyaluronic acid (both R&D). Cellular responses of GCs were tested using 
10-fold increasing concentrations from 0.001 to 10 pg/ml LPS or PAM and 0.0001 
to 1 pg/ml FLA. The response of GCs to HA was tested in the presence or absence of 
1 pg/ml LPS, using 10-fold increasing concentrations from 0.1 to 1000 pg/ml 
ULMW or HMW HA. In subsequent experiments using PAMPs, GCs were 
challenged with 1 pg/ml LPS, 1 pg/ml PAM or 0.1 pg/ml FLA for 3 or 24 h for 
analysis by qPCR or ELISA, respectively; or for up to 5 to 25 min for analysis by 
Western blot.
To investigate the interaction between endocrine and immune pathways, GCs 
were treated with 100 ng/ml FSH (Henderson et al., 1982, McLaughlin et al., 2010), 
4 ng/ml LH (Henderson et al., 1982, Fortune and Hansel, 1985), 500 ng/ml 
oestradiol (E2; Sigma) (Ginther et al., 2001, Beg et al., 2002), 250 ng/ml 
progesterone (P4; Sigma) (Martin et al., 1991, Ginther et al., 2001) or 10 ng/ml
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epidermal-like growth factor (EGF; Calbiochem) (Langhout et al., 1991, Park et al., 
1997) in combination with 1 pg/ml LPS or PAM.
At the end of each experiment, supernatants were collected and stored at 
-20°C prior to protein analysis by ELISA; cells were washed with PBS and an MTT 
test carried out to estimate cell viability, as described in chapter 2. For experiments 
where the method of analysis was qPCR or Western blot, cells were washed twice 
with PBS and then lysed using 350 pi buffer RLT or 80 pi Phosphosafe, 
respectively.
3.2.2 Chemical inhibitors
To explore the role of intracellular signalling pathways in the response of 
GCs to PAMPs, GCs were seeded in a 96-well plate (TPP), equilibrated for 48 h and 
washed with PBS. The GCs were then treated for 30 min with 50 pi of medium 
containing a range of concentrations of inhibitors targeting NFkB (0.0008-80 pM), 
PKC (0.002-200 pM), JNK (0.01-1000 pM), p38 MAPK (0.002-200 pM) or MEK 
(0.002-20 pM; all Calbiochem) or DMSO (1:500). This 30 minute treatment was 
followed by addition of 50 pi control medium, or 50 pi medium containing 2 pg/ml 
LPS or 2 pg/ml PAM. In a further experiment, to limit the impact of inhibitors on 
cell health, inhibitors were also used at their lowest concentration in combination 
with each other using pairs of 25 pi inhibitors targeting NFkB (0.0016 pM), PKC 
(0.004 pM), JNK (0.02 pM), p38 MAPK (0.004 pM) or MEK (0.004 pM) for 
30 min, followed by 50 pi of medium containing LPS or PAM treatment as above.
3.2.3 Short-interfering RNA
To explore the role of TLRs, GCs were transfected with short-interfering 
RNA targeting TLR2 or TLR4 (as described in general methods). After 24 h, cells 
were washed with PBS and lysed using buffer RLT for analysis of TLR expression 
by qPCR, or treated with control medium or medium containing 1 pg/ml LPS or 
PAM for 24 h. Supernatants were collected after 24 h and stored at -20°C for 
analysis by ELISA; cell viability was assessed by MTT assay, as described in 
chapter 2.
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3.2.4 ELISA
Accumulation of IL-6, IL-8, IL-ip and TNFa was measured in the 
supernatant of GCs treated with LPS, PAM or FLA, as described in general methods 
(chapter 2), using kits from R&D Systems for IL-8 and TNFa and kits from Thermo 
Fisher Scientific for IL-6 and IL-1 p. Two technical replicates were used for each 
sample in each ELISA, from at least 3 experiments.
3.2.5 RNA extraction, cDNA synthesis and PCR
Granulosa cells were treated with control medium or medium containing 1 
pg/ml LPS, 1 pg/ml PAM or 0.1 pg/ml FLA for 3 h. Cells were washed twice in 
PBS, lysed using 600 pi buffer RLT and scraped using a cell scraper. Total RNA 
was extracted using the RNeasy Mini kit, as described in general methods. Total 
RNA was quantified using a Nanodrop spectrophotometer and 1 pg total RNA used 
to synthesise cDNA, using the QuantiTect kit, as described in general methods. 
Expression of mRNA encoding genes considered as markers of an innate immune 
response (IL6, IL1B, TNF, IL10, IL8, CCL5) and endocrine receptors (FSHR, EGFR) 
was measured by qPCR, using 3 technical replicates for each sample from 3-4 
experiments.
3.2.6 Western blot
In order to investigate the activation of ERK1/2 and p38 MAPK, GCs were 
plated in a 12-well plate, equilibrated for 24 h, washed twice with PBS and cultured 
in Optimem (low serum medium) for 24 h. They were then treated for 0, 5, 10, 15, 
20 or 25 min with control Optimem medium, or Optimem containing 1 pg/ml LPS or 
1 pg/ml PAM. The medium was discarded before the GCs were washed with PBS 
and 80 pi Phosphosafe Extraction Reagent (Novagen) was used to lyse each well of 
cells. Protein was extracted and quantified using the DC assay (chapter 2), before 
blotting for diphosphorylated ERK1/2 (1:1000; Sigma 8159) or phosphorylated p38 
MAPK (1:1000; Acris Antibodies, San Diego, USA; AP05898PU-N). After imaging 
each blot using the ChemiDoc XRS System, gels were stripped for 7 min in Restore 
Western Blot Stripping Buffer and then re-stained for P-actin (1:1000; Abeam, 
Cambridge, UK; ab8226), as described in general methods.
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Images of each blot were analysed using the ChemiDoc XRS System to 
measure peak density of each band, after adjusting for background, as described in 
chapter 2. Blots from 3 experiments were quantified, with 1 image shown as a 
representative in the results section.
3.2.7 Statistical analyses
Data are presented as mean + SEM, with statistical analyses performed using 
SPSS (version 16, SPSS Inc) and significance ascribed when P < 0.05. Analysis of 
variance was used to examine normally distributed data, following square root or log 
transformation where indicated in Results, as necessary. Dunnett’s pairwise multiple 
comparison T-test was used to compare treatments with control. Data that is not 
significantly different by ANOVA are denoted with the same letter. Where data were 
not normally distributed as indicated in Results, comparisons between treatment and 
control were made using Mann Whitney U Test.
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3.3 Results
3.3.1 Granulosa cells expressed mRNA for TLRs
The GCs from emerged follicles were negative for MHCEI by FACS and did 
not express MHCII or CD45 mRNA (chapter 2), indicating they were not 
contaminated by immune cells. Using these cells, the expression of TLRs was 
analysed by qPCR and the efficiencies of all primers were 100% ± 10%. All 10 
TLRs were expressed by GCs, with higher expression of TLR3 compared to all other 
TLRs (P < 0.001) and lower expression of TLR8 compared to the expression of 
mRNA encoding TLRs 1-7 (Fig. 3.1 A; P < 0.05). Mononuclear cells were used as a 
positive control; the expression of each TLR was not significantly different to any 
other TLR (Fig 3. IB; P > 0.23).
In order to investigate whether treatment of GCs with one PAMP primed the 
cells to respond to another PAMP, TLR expression after the cells were treated with 
LPS or PAM was examined. Treatment of GCs for 3 h with LPS increased 
expression of mRNA encoding TLR2, TLR3 and TLR5 and decreased expression of 
TLR7. Treatment of GCs for 3 h with PAM also increased expression of mRNA 
encoding TLR2 and decreased expression of TLR4, TLR6, TLR7 and TLR10 
(Fig. 3.2A). To examine whether this change in mRNA levels corresponded to a 
functional change at the protein level, GCs were treated for 3 h with control medium 
or medium containing LPS or PAM. They were then washed and cultured for a 
further 24 h with control medium or medium containing LPS or PAM. Pre-treating 
with PAM for 3 h increased accumulation of IL-6 in cells cultured in control medium 
for the subsequent 24 h, but there were no other significant effects of pre-treatment 
(Fig. 3.2B).
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Figure 3.1 Granulosa cells expressed TLRs 1-10. Granulosa cells were isolated 
from emerged follicles (A) and bovine peripheral blood mononuclear cells (B). RNA 
was extracted and expression of TLRs measured by qPCR. Data represented as mean 
+ SEM, normalised to ACTB and represent 3 independent experiments. Primer 
efficiencies were 100% ± 10% for each primer pair. Expression varies from all other 
TLRs by ANOVA and a post-hoc Fisher’s least significant difference test (using 
logio normalised data), * P < 0.05 *** P < 0.001
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TLR1 0.81±0.08 0 77±0 08
TLR2 1.93±0.31 * 2.92±0.47
TLR3 2.43+0.80 * 0.86±0.33
TLR4 1.25±0.19 0.75±0.11 *
TLR5 2.21±0.58 * 0.72±0.31
TLR6 0.97±0.06 0.71±0.12 * *
TLR7 0.41±0.08 ★ * * 0.30±0.04 * * *
TLR8 0.55±0.12 0 51±0.16
TLR9 1.14±0.35 0.71 ±0.11
TLR10 0.83±0.10 0.56±0.09 **
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Figure 3.2 Pre-treatment of GCs with LPS or PAM impacted TLR expression.
(A) Granulosa cells were treated for 3 h with control medium or medium containing 
l pg/ml LPS or PAM. The expression of mRNA encoding TLRs 1-10 was measured 
by qPCR and is expressed as fold change over control, relative to ACTB. Data 
presented as mean + SEM and represent 3 independent experiments. Values differ 
from control by Student’s T-test using logio-normalised data; * P < 0.05, 
** P < 0 .01, *** P < 0.001. In a subsequent experiment, GCs were pre-treated for 
3 h (as above), then further treated for 24 h with control medium ( ‘C ’) or medium 
containing l pg/ml LPS or PAM. Supernatants were collected and the accumulation 
of IL-6 measured by ELISA (B). Data presented as mean + SEM and represent 4 
independent experiments. Values differ from cells pre-treated with control medium 
within subsequent treatment group by ANOVA; P < 0.05.
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3.3.2 Granulosa cells responded to PAMPs
When GCs were treated for 24 h with control medium or medium containing 
10-fold increasing concentrations of LPS, PAM or FLA, supernatants accumulated 
IL-6, IL-lp, IL-8 and TNFa. Treatment with LPS significantly increased 
accumulation of IL-6 and IL-8 at concentrations > 0.01 pg/ml LPS (Fig. 3.3A, D) 
and increased accumulation of IL-lp even from the lowest concentration tested 
(Fig. 3.3B). However there was only a significant increase in the accumulation of 
TNFa at 10 pg/ml LPS treatment (Fig. 3.3C). The GCs exhibited a similar response 
to PAM, with increased accumulation of IL-6, IL-ip and IL-8 at concentrations 
> 0.01 pg/ml PAM (Fig. 3.4A, B, D) and increased accumulation of TNFa at 
10 pg/ml PAM (Fig. 3.4C). Interestingly, although the accumulation of IL-6, TNFa 
and IL-8 was a similar concentration whether cells were treated with LPS or PAM, 
treatment with PAM resulted in a lower concentration of IL-ip than treatment with 
LPS. Treatment with FLA did not increase accumulation of IL-lp, IL-8 or TNFa 
(all below limits of detection). FLA treatment did significantly increase IL-6 at 
>0.1 pg/ml FLA; however, even at 1 pg/ml FLA, accumulation of IL-6 was only 
4 6 + 1 0  pg/ml, compared to 1407 + 267 pg/ml after LPS stimulation and the lowest 
standard on the kit of 78 pg/ml. For future experiments, 1 pg/ml LPS or PAM and 
0.1 pg/ml FLA were used as the standard working concentrations. For FLA this was 
the highest feasible concentration to use (1 pg/ml would have been too costly) and 
the concentration of 0.1 pg/ml stimulated a significant increase in IL-6. For LPS and 
PAM, 1 pg/ml stimulated the greatest accumulation of IL-6, and 1 pg/ml LPS is 
similar to concentrations of LPS previously measured in the follicular fluid of cows 
with severe uterine disease (Herath et al., 2007).
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Figure 3.3 Granulosa cells responded to LPS in a concentration-dependent 
manner. Granulosa cells from emerged follicles were treated for 24 h with control 
medium (‘0’) or medium containing 0.001, 0.01, 0.1, 1 or 10 pg/ml ultrapure LPS 
from E. coli 0111:B4. Supernatants were collected and the accumulation of IL-6 (A), 
EL-lp (B), TNFa (C) and IL-8 (D) measured by ELISA. Data presented as mean + 
SEM and represent at least 3 independent experiments. Values differ from control by 
ANOVA and Dunnett’s pairwise multiple comparison t test (square root normalised 
data for A and B; logio normalised data for (C) or Mann Whitney U test (D) 
* P < 0.05, *** P < 0.001. N/D = below limits of detection.
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Figure 3.4 Granulosa cells responded to PAM in a concentration-dependent 
manner. Granulosa cells from emerged follicles were treated for 24 h with control 
medium (‘0’) or medium containing 0.001, 0.01, 0.1, 1 or 10 pg/ml Pam3CSK4 
(PAM). Supernatants were collected and the accumulation of IL-6 (A), IL-lp (B), 
TNFa (C) and IL-8 (D) measured by ELISA. Data presented as mean + SEM and 
represent 3-5 independent experiments. Values differ from control by Mann Whitney 
U test * P < 0.05. N/D = below limits of detection.
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3.3.3 Granulosa cells did not mount an inflammatory response to HA
When GCs were treated for 24 h with control medium or medium containing 
10-fold increasing concentrations of ULMW or HMW HA in the presence or 
absence of LPS, there was no effect of HA on the accumulation of IL-6. Indeed the 
concentrations of IL-6 were below the limits of detection for control and cells treated 
with ULMW or HMW HA (Fig. 3.5A, B). However, as expected, GCs treated with 
LPS accumulated IL-6 at all concentrations of HA (P < 0.001). When 1 mg/ml 
HMW HA was used in combination with LPS, there was a significant decrease in 
accumulation of IL-6 (P = 0.05; Fig. 3.5B).
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Figure 3.5 Granulosa cells did not mount an inflammatory response to HA.
Granulosa cells from emerged follicles were treated for 24 h with control medium 
(‘0’) or medium containing 10-fold increasing concentrations of ULMW (A) or 
HMW (B) HA in the absence (open bars) or presence of 1 pg/ml LPS (black bars). 
Supernatants were collected and the accumulation of IL-6 measured by ELISA. 
Data represent mean + SEM of at least 3 independent experiments. Values differ 
from 0 pg/ml HA in combination with 1 pg/ml LPS by Mann Whitney, * P < 0.05. 
N/D = below limits of detection.
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3.3.4 Exposure of GCs to PAMPs increased expression of genes associated with 
inflammatory or innate immune pathways
When GCs were treated for 3 h with control medium or medium containing 
LPS (Fig. 3.6A-F), PAM (Fig. 3.7A-F) or FLA (Fig. 3.8A-F), there was increased 
expression of IL6, IL1B, IL10, TNF, IL8 and CCL5. All 6 of these genes associated 
with inflammatory or innate immune pathways had similar fold-increases for each 
replicate (Fig. 3.6 - 3.9 where each line represents one experiment, with the same 
colour points representing the same experiment across figures 3.6-3.9). In general, 
experimental replicates with high expression of one cytokine also had high 
expression of all other cytokines measured. Treatment with LPS increased 
expression of TNF (P < 0.05) and CCL5 (P < 0.001) and tended towards increased 
expression of IL10 (P = 0.051) to a greater extent compared to treatment with FLA, 
and increased expression of CCL5 (P < 0.001) to a greater extent than treatment with 
PAM (Fig. 3.9). Treatment with PAM increased expression of IL1B (P < 0.05), IL10 
(P < 0.01), TNF (P < 0.01) and tended towards increasing expression of IL6 
(P = 0.065) to a greater extent than treatment with FLA and increased expression of 
IL1B and IL8 (P < 0.05) to a greater extent than LPS treatment. Treatment with FLA 
did not stimulate a greater increase in any cytokine measured than treatment with 
LPS or PAM. Therefore, as FLA did not yield protein responses, LPS and PAM 
treatment only were used for further experiments. There was no significant effect of 
LPS (P=0.626) or PAM (P=0.582) on ACTB expression.
3.3.5 Exposure of GCs to PAM, but not LPS, increased expression of genes 
associated with endocrine function
There was no significant effect of LPS (Fig. 3.10A, E) or PAM (Fig. 3.10B, 
F) on expression of FSHR. Treatment with PAM, but not LPS, increased expression 
of EGFR (Fig. 3.10D, F).
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Figure 3.6 Exposure of GCs to LPS increased expression of genes associated 
with inflammation and innate immunity. Granulosa cells from emerged follicles 
were treated for 3 h with control medium ( ‘C ’) or medium containing 1 pg/ml 
ultrapure lipopolysaccharide from E. coli 0111 :B4 (LPS). RNA was extracted, 
cDNA synthesised and the expression of IL6 (A), IL1B (B), 1L10 (C), TNF (D), 
IL8 (E) and CCL5 (F) estimated by qPCR. Each independent experiment is presented 
as one line, with coloured dots representing the same experiment throughout. Mean 
values for LPS treatment differ from control by T-test using log-normalised data, 
* P < 0 .05 , ** P<0.01
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Figure 3.7 Exposure of GCs to PAM increased expression of genes associated 
with inflammation and innate immunity. Granulosa cells from emerged follicles 
were treated for 3 h with control medium (‘C’) or medium containing 
1 pg/ml Pam3CSK4 (PAM). RNA was extracted, cDNA synthesised and the 
expression of IL6 (A), IL1B (B), IL10 (C), TNF (D), IL8 (E) and CCL5 (F) 
estimated by qPCR. Each independent experiment is presented as one line, with 
coloured dots representing the same experiment throughout. Mean values for 
PAM treatment differ from control by T-test using log-normalised data, * P < 0.05, 
** P < 0 .01 , *** P <  0.001
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Figure 3.8 Exposure of GCs to FLA increased expression of genes associated 
with inflammation and innate immunity. Granulosa cells from emerged follicles 
were treated for 3 h with control medium (‘C’) or medium containing 0.1 pg/ml 
ultrapure flagellin (FLA). RNA was extracted, cDNA synthesised and the expression 
of IL6 (A), 1L1B (B), IL10 (C), TNF (D), IL8 (E) and CCL5 (F) estimated by qPCR. 
Each independent experiment is presented as one line, with coloured dots 
representing the same experiment throughout. Mean values for FLA treatment differ 
from control by T-test using log-normalised data, * P < 0.05, ** P < 0.01
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Figure 3.9 Exposure of GCs to LPS, PAM or FLA increased expression of genes 
associated with inflammation and innate immunity. Granulosa cells from 
emerged follicles were treated for 3 h with control medium or medium containing 
1 pg/ml ultrapure lipopolysaccharide from E. coli 0111:B4 (A), 1 pg/ml Pam3CSK4 
(B) or 0.1 pg/ml flagellin (C). RNA was extracted, cDNA synthesised and the 
expression of ACTB, IL6, IL1B, IL10, TNF, IL8 and CCL5 estimated by qPCR. Data 
are presented as mean fold increase in each gene compared to control. Data 
represented as mean + SEM of 3-4 independent experiments. Values differ from 
control by Mann Whitney (A, C) or ANOVA and Dunnett’s post hoc multiple 
comparison T-test (B), * P < 0.05, *** P < 0.001
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Figure 3.10 Exposure of GCs to PAM, but not LPS, increased expression of 
genes encoding endocrine receptors. Granulosa cells from emerged follicles were 
treated for 3 h with control medium ( ‘C’) or medium containing 1 pg/ml 
lipopolysaccharide (A, C, E; LPS) or Pam3CSK4 (B, D, F; PAM). RNA was 
extracted, cDNA synthesised and the expression of FSHR (A, B) and EGFR (C, D) 
estimated by qPCR. Each independent experiment is presented as one line, with each 
colour dot representing the same experiment throughout. (E, F) Data are presented as 
mean fold increase in each gene compared to control. Data presented as mean + 
SEM and represent 4 independent experiments. Values differ from control by Mann 
Whitney U test, * P < 0.05.
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3.3.6 Treatment of GCs with PAMPs activated intracellular signalling pathways
When GCs were treated with control medium or medium containing PAMPs, 
15 min LPS treatment increased phosphorylation of p38 MAPK and ERK1/2 
(Fig. 3.11A-C). After 5 min PAM treatment, there was a trend towards increased 
phosphorylation of p38 MAPK (P < 0.09, Fig. 3.12A, B) and a significant increase in 
phosphorylation of ERK1/2 (Fig. 3.12C), which was maintained for 15 min.
3.3.7 The response of GCs to PAMPs was attenuated using short-interfering 
RNA targeting TLRs
When GCs were treated with lipofectamine vehicle, scrambled siRNA or 
siRNA targeting TLR2 or TLR4 for 24 h, there was no effect of siRNA on cell 
viability as evaluated by MTT test (P > 0.5; Fig. 3.13A). Treatment with each 
targeted siRNA significantly decreased expression of TLR2 or TLR4 mRNA 
(P = 0.05; Fig. 3.13B) and treatment with scrambled siRNA did not significantly 
affect expression of either target gene (P > 0.2). Treatment with PAM significantly 
increased the accumulation of IL-6, but this was attenuated when cells were 
pre-treated with siRNA targeting TLR2 (Fig. 3.13C). Treatment with LPS 
significantly increased the accumulation of IL-6, but this was also attenuated when 
cells were pre-treated with siRNA targeting TLR4 (Fig. 3.13D). There was no effect 
of lipofectamine vehicle, scrambled siRNA or targeted siRNA on accumulation of 
IL-6 by GCs treated with control medium.
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Figure 3.11 LPS induced phosphorylation of ERK1/2 and p38 MAPK in GCs.
Granulosa cells from emerged follicles were treated for 5, 10, 15, 20 or 25 mins with 
control medium (open bars) or medium containing 1 pg/ml LPS (black bars) and 
phosphorylation of ERK1/2 and p38 MAPK analysed by Western blot. (A) A 
representative blot showing LPS treatment with bands corresponding to 
diphosphorylated ERK1/2, phosphorylated p38 MAPK (Thrl80/182) and (3-actin. 
Band densities were quantitated relative to [3-actin and phosphorylation of ERK1/2
(B) and p38 MAPK (C) expressed as a percentage of time 0. Data presented as mean 
+ SEM and represent 3 independent experiments. Values differ from control at each 
time point by t-test (logio normalised data), * P < 0.05, ** P < 0.01
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Figure 3.12 PAM induced phosphorylation of ERK1/2 in GCs. Granulosa cells 
from emerged follicles were treated for 5, 10, 15, 20 or 25 mins with control medium 
(open bars) or medium containing 1 pg/ml PAM (black bars) and phosphorylation of 
ERK1/2 and p38 MAPK analysed by Western blot. (A) A representative blot 
showing PAM treatment with bands corresponding to diphosphorylated ERK1/2, 
phosphorylated p38 MAPK (Thrl80/182) and [3-actin. Band densities were 
quantitated relative to (3-actin and phosphorylation of ERK1/2 (B) and p38 MAPK
(C) expressed as a percentage of time 0. Data presented as mean + SEM and 
represent 3 independent experiments. Values differ from control at each time point 
by t-test (logio normalised data), * P < 0.05, ** P < 0.01
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Figure 3.13 The IL-6 response of GCs to LPS or PAM was attenuated using 
siRNA targeting TLR4 or TLR2, respectively. Granulosa cells from emerged 
follicles were treated for 24 h with lipofectamine (‘vehicle’), scrambled siRNA 
(‘scr’), siRNA targeting TLR2 (‘siTLR2’) or targeting TLR4 ( ‘siTLR4’). After 
washing, the cells were treated for 24 h with control medium (white bars) or medium 
containing 1 pg/ml LPS or 1 pg/ml PAM (black bars). (A) Cell viability was 
examined by MTT test. (B) Expression of TLR2 and TLR4 mRNA was examined by 
qPCR and normalised to the ACTB reference gene. Values differ by Mann Whitney 
U test. Accumulation of IL-6 was measured in the cell supernatants after treatment 
with PAM (C) or LPS (D). Values denoted by the same letter do not differ by Mann 
Whitney U test (P > 0.05). Data presented as mean + SEM and represent 3-5 
independent experiments.
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3.3.8 EGF increased accumulation of IL-6 by GCs
To examine the effect of the endocrine environment, GCs were treated for 
24 h with control medium (Fig. 3.14) or medium containing 1 |ig/ml LPS (Fig. 3.15) 
or PAM (Fig. 3.16) in combination with 100 ng/ml FSH, 4 ng/ml LH, 500 ng/ml E2, 
250 ng/ml P4 or 10 ng/ml EGF. Treatment with EGF significantly increased 
accumulation of DL-6 by GCs treated with control medium or PAM (Fig. 3.14A, 
3.16A; P < 0.05), and there was a trend towards increased accumulation of IL-6 by 
GCs treated with LPS (Fig. 3.15A; P < 0.15). Oestradiol treatment significantly 
decreased IL-6 accumulation by GCs treated with control medium (P < 0.01), but 
had no effect on IL-6 accumulation stimulated by LPS or PAM. There was no 
significant effect of FSH, LH or P4 had on IL-6 accumulation by GCs. There was no 
effect of endocrine treatment on accumulation of IL-lp (Fig. 3.14-16B; P > 0.9) or 
IL-8 (Fig. 3.14-16C; P > 0.9), or on cell viability measured by MTT test (Fig. 3.14D; 
treatments in control medium P > 0.9; Fig 3.15D; treatments in medium containing 
LPS P > 0.7; Fig 3.16D; treatments in medium containing PAM P > 0.3).
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Figure 3.14 EGF increased accumulation of IL-6. Granulosa cells from emerged 
follicles were treated for 24 h with medium containing 100 ng/ml FSH, 4 ng/ml LH, 
500 ng/ml E2, 250 ng/ml P4 or 10 ng/ml EGF. Supernatants were collected and 
accumulation of IL-6 (A), IL-ip (B) and IL-8 (C) measured by ELISA. Data are 
presented as mean + SEM and represent 4 independent experiments. Values differ 
from control by ANOVA and Dunnett’s pairwise multiple comparison t-test 
(logio normalised data), * P < 0.05, ** P < 0.01. (D) Cell viability was assessed by 
MTT test. Data presented as mean + SEM from 3 independent experiments. 
N/D = below limits of detection.
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Figure 3.15 EGF had no significant effect on the accumulation of IL-6 by GCs 
treated with LPS. Granulosa cells from emerged follicles were treated for 24 h with 
medium containing 1 pg/ml LPS in combination with 100 ng/ml FSH, 4 ng/ml LH, 
500 ng/ml E2, 250 ng/ml P4 or 10 ng/ml EGF. Supernatants were collected and 
accumulation of IL-6 (A), IL-ip (B) and IL-8 (C) measured by ELISA. Data are 
presented as mean + SEM and represent 4 independent experiments. D) Cell viability 
was assessed by MTT test. Data presented as mean + SEM from 3 independent 
experiments.
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Figure 3.16 EGF increased accumulation of IL-6 by GCs treated with PAM.
Granulosa cells from emerged follicles were treated for 24 h with medium containing 
1 fxg/ml PAM in combination with 100 ng/ml FSH, 4 ng/ml LH, 500 ng/ml E2, 
250 ng/ml P4 or 10 ng/ml EGF. Supernatants were collected and accumulation of 
EL-6 (A), IL-ip (B) and IL-8 (C) measured by ELISA. Data are presented as mean + 
SEM and represent 4 independent experiments. Values differ from control by 
ANOVA and Dunnett’s pairwise multiple comparison t-test (logio normalised data), 
* P < 0.05. (D) Cell viability was assessed by MTT test. Data presented as 
mean + SEM from 3 independent experiments. N/D = below limits of detection.
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3.3.9 Inhibiting NFkB, p38 MAPK or MEK limited LPS- and PAM-stimulated 
IL-6 accumulation by GCs
Granulosa cells were treated with 10-fold increasing concentrations of 
inhibitors targeting NFkB (range: 0.0008-80 pM), PKC (range: 0.002-200 pM), 
JNK (range: 0.01-1000 pM), p38 MAPK (range: 0.002-200 pM) or MEK (range: 
0.002-20 pM) or DMSO vehicle (1:500) for 30 min, followed by addition of control 
medium or medium containing LPS (Fig. 3.17) or PAM (Fig. 3.18) to a final 
concentration of 1 pg/ml. Each inhibitor significantly limited the anticipated IL-6 
response to LPS or PAM but also significantly decreased cell viability when used at 
higher doses. However, using 0.04 pM NFkB inhibitor, 1 pM MEK inhibitor or 
1 - 1 0  pM p38 MAPK inhibitor significantly decreased LPS-stimulated IL-6 
accumulation without having a significant effect on cell viability (Fig. 3.17 A, D, E). 
Treating GCs with 0.004 -  0.4 pM NFkB inhibitor, or 1 -  10 pM p38 MAPK 
inhibitor significantly limited PAM-stimulated IL-6 accumulation without 
significantly impacting cell viability (Fig. 3.18 A, E). To further test the use of 
inhibitors, inhibitors were also used in pairs at the lowest dose tested previously 
(0.0004 pM NFkB inhibitor, 0.001 pM PKC inhibitor, 0.005 pM JNK inhibitor, 
0.0001 pM MEK inhibitor and 0.001 pM p38 MAPK inhibitor). When using most of 
these combinations of low concentrations of inhibitors, there was no significant 
effect on EL-6 accumulation or cell viability of LPS- and PAM- stimulated cells 
(Fig. 3.17F, 3.18F). However, low-dose MEK and JNK inhibitor combination 
treatment decreased the anticipated IL-6 accumulation in response to LPS without a 
significant effect on cell viability (Fig. 3.17F).
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Figure 3.17 Inhibiting NFkB, MEK or p38 MAPK limited LPS-induced IL-6 
accumulation by GCs. Granulosa cells from emerged follicles were treated for 30 
min with 10-fold increasing concentrations of biochemical inhibitors targeting NFkB 
(A; 0.0004 to 40 pM), PKC (B; 0.001 to 100 pM), JNK (C; 0.005 to 500 pM), 
MEK (D; 0.0001 to 10 pM), p38 MAPK (E; 0.001 to 100 pM) or low dose 
combination treatments using pairs of inhibitors (0.0004 pM NFkB inhibitor, 
0.001 pM PKC inhibitor, 0.005 pM JNK inhibitor, 0.0001 pM MEK inhibitor and 
0.001 pM p38 MAPK inhibitor); followed by addition of LPS to each well making a 
final concentration of 1 pg/ml for 24 h. Supernatants were collected and the 
accumulation of IL-6 measured by ELISA (black bars). Cell viability was assessed 
by MTT assay (red line). Data represent mean + SEM from 3-4 independent 
experiments and are expressed as a percentage of LPS treatment. Values differ from 
LPS treatment by ANOVA and Dunnett’s pairwise multiple comparison t test, 
* P < 0 .05 , ** P < 0 .01 , *** P <  0.001.
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Figure 3.18 Inhibiting NFkB or p38 MAPK limited PAM-induced IL-6 
accumulation by GCs. Granulosa cells from emerged follicles were treated for 30 
min with 10-fold increasing concentrations of biochemical inhibitors targeting NFkB 
(A; 0.0004 to 40 pM), PKC (B; 0.001 to 100 pM), JNK (C; 0.005 to 500 pM), 
MEK (D; 0.0001 to 10 pM), p38 MAPK (E; 0.001 to 100 pM) or low dose 
combination treatments using pairs of inhibitors (0.0004 pM NFkB inhibitor, 
0.001 pM PKC inhibitor, 0.005 pM JNK inhibitor, 0.0001 pM MEK inhibitor and 
0.001 pM p38 MAPK inhibitor); followed by addition of PAM to each well making 
a final concentration of 1 pg/ml for 24 h. Supernatants were collected and the 
accumulation of IL-6 measured by ELISA (black bars). Cell viability was assessed 
by MTT assay (red line). Data represent mean + SEM from 3-4 independent 
experiments and are expressed as a percentage of PAM treatment. Values differ from 
PAM treatment by ANOVA and Dunned’s pairwise multiple comparison t test, 
* P< 0 .05 , ** PcO .O l, *** P <  0.001.
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3.4 Discussion
Bacterial infections of the uterus or mammary gland perturb ovarian 
dominant follicle growth and endocrine function (Sheldon et al., 2002, Lavon et al., 
2011a, Lavon et al., 2011b). Whilst LPS has been found in the follicular fluid from 
dominant follicles of animals with uterine disease (Herath et al., 2007), healthy 
ovarian follicles are devoid of immune cells (Spanel-Borowski et al., 1997, 
Bromfield and Sheldon, 2011). Infections of the bovine female genital tract are 
common and are associated with trauma during parturition (Potter et al., 2010). 
Escherichia coli is the first pathogen to invade the uterus, whose LPS collects inside 
ovarian follicular fluid (Herath et al., 2007). Previously, it was hypothesised that 
TLRs are involved in the physiological process of ovulation in mice through 
interaction of DAMPs, such as hyaluronic acid, with TLRs (Shimada et al., 2008). 
This chapter tested the hypothesis that primary bovine GCs from emerged follicles 
respond to PAMPs and DAMPs, by examining the response of TLRs to pathological 
and physical stimuli. Granulosa cells from emerged follicles expressed TLRs 1-10 
and responded to the PAMPs LPS and PAM at the protein level and to LPS, PAM 
and FLA at the RNA level. However, there was no significant inflammatory 
response to the DAMP HA. Treatment of GCs with LPS or PAM activated 
intracellular signals associated with TLR activation, and the IL-6 response to PAM 
and LPS required TLR2 and TLR4, respectively. When investigating ways to 
manipulate the response, it was shown that EGF may increase the accumulation of 
IL-6 by GCs and it was possible to limit LPS- or PAM- stimulated IL-6 
accumulation using biochemical inhibitors targeting NFkB, MEK or p38 MAPK.
Toll-like receptors are conserved structures expressed mainly by cells of the 
immune system such as macrophages and dendritic cells (Akira et al., 2006, 
Takeuchi and Akira, 2010, Moresco et al., 2011). However, a wider repertoire of 
cells appears to have roles in innate immunity, including the epithelial cells of the 
intestine (Gribar et al., 2008) and endometrium (Cronin et al., 2012). A striking 
feature of healthy ovarian follicles is that they do not contain immune cells within 
the follicle (as shown in chapter 2), so GCs may play a role in innate immunity 
inside ovarian follicles. Previous studies have identified expression of TLR4 in 
bovine GCs (Herath et al., 2007) and TLR2 and TLR4 in murine (Shimada et al.,
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2008) and human (Woods et al., 2011) GCs. In the present study, bovine GCs from 
emerged follicles expressed mRNA encoding all 10 TLRs with high expression of 
TLR3 compared to all other TLRs at time 0 and after 51 h culture. Although changes 
in gene expression may have little bearing on immune function, this high expression 
of TLR3 was notable as viruses such as bovine viral diarrhoea virus infect the ovary 
of cattle and perturb dominant follicle growth (Grooms et al., 1998). Interestingly, 
treatment of GCs with LPS or PAM increased expression of TLR2, suggesting a 
potential priming effect with one PAMP enhancing the sensitivity of the GCs to 
another TLR2 agonist. However, when GCs were pre-treated with LPS or PAM, 
before a further PAM treatment, there was no additional output in IL-6. This could 
be because the increased mRNA expression did not result in an increase in protein, 
or it may be that an output other than IL-6 would have increased. Alternatively, the 
increased TLR2 expression may have occurred to increase responses to non-bacterial 
pathogens, such as herpesvirus virions (Paludan et al., 2011).
Ideally, GCs are cultured in the absence of serum to prevent luteinisation 
(Gutierrez et al., 1997). However, it was previously shown that bovine GCs do not 
increase expression of IL6 mRNA or accumulate IL-6 or IL-8 in response to PAMPs 
in serum-free conditions (Bromfield and Sheldon, 2011). The lack of LPS response 
may be due to the need for soluble CD 14, LY96 or LPS-binding protein. Previously, 
it was demonstrated that CD 14, but not LY96, is required for the response of human 
whole blood to PAM and LPS (Elson et al., 2007) and CD 14 is required for a robust 
response to PAM in many cellular systems (Scott and Smith, 1997, Okazaki et al., 
2010). Thus, as GCs also lacked a response to TLR2 ligands in the absence of serum, 
it seems likely that bovine GCs require soluble CD 14 to produce an inflammatory 
response to PAMPs, despite them expressing CD14 mRNA.
In the previous chapter (Materials and Methods), it was shown that LPS 
increased expression of IL6, IL1B and IL8 from 1 h and this was maintained for at 
least 5 h, and so 3 h was chosen as a suitable time point to examine responses to 
PAMPs at the RNA level. The ligands for TLR2 (PAM), TLR4 (LPS) and TLR5 
(FLA) increased expression of genes encoding inflammatory mediators IL6, 1LIB, 
IL10, TNF, IL8 and CCL5. This response to LPS supports previous observations that 
bovine GCs from emerged follicles increased expression of IL6 after 30 min LPS 
exposure and IL8 after 90 min, with increased expression maintained for at least
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180 min (Bromfield and Sheldon, 2011). A similar response is also exhibited by hen 
GCs with increased expression of IL1B after 4 h LPS treatment (Woods et al., 2009). 
There do not seem to be published observations using PAM or FLA in GCs from any 
species.
The accumulation of pro-inflammatory cytokines (IL-6, IL-lp, TNFa and 
IL-8) increased in a concentration-dependent manner in response to LPS and PAM, 
but not FLA. It is possible that this is because flagellin does not collect inside the 
ovarian follicle, thus there is no need for GCs to respond to flagellin, or it may be 
that although the receptor is expressed at the mRNA level, this is not translated into 
protein. Due to difficulties in sourcing bovine antibody against TLR5, it was not 
possible to examine the localisation of the TLR. The cellular response of bovine GCs 
to LPS and PAM was similar to the response previously observed, showing 
increased accumulation of IL-6 and IL-8 in response to LPS, PAM and to the TLR2 
ligands lipoteichoic acid and peptidoglycan (PGN) (Bromfield and Sheldon, 2011). 
There was a significant increase in inflammatory cytokine production from 
0.01 pg/ml LPS treatment, corresponding to the concentration of LPS measured 
(range 4.5-875 ng/ml) in the follicular fluid of cows with endometritis (Herath et al.,
2007). The present work used the synthetic ligand PAM as a TLR2 agonist to ensure 
greater target specificity than PGN. The importance of this approach was evident 
because preliminary work with PGN induced accumulation of IL-6, an observation 
that could not be replicated when using an ultrapure form of PGN. It is possible that 
the PGN used initially was contaminated with other bacterial components. Also, 
PGN may be an agonist of nucleotide-binding oligomerisation domain-containing 
protein (NOD)-like receptors, rather than binding TLR2 (Inohara et al., 2003, 
Travassos et al., 2004).
From a pathological viewpoint, the increased chemokine production of GCs 
would produce a gradient attracting macrophages and neutrophils towards the ovary, 
helping to clear the oviduct and peritoneal cavity from bacteria prior to ovulation, 
thus protecting the oocyte. However, more interestingly, there may be an effect of 
increased cytokine production on the physiological function of the ovarian follicle. 
Interleukin-6 induces murine cumulus-oocyte complex (COC) expansion and 
improves oocyte competence (Liu et al., 2009). Thus, when a PAMP, such as LPS, is 
present in the follicle and induces GCs to produce IL-6, this may lead to early COC
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expansion. Interleukin-ip decreases production of progesterone receptor and 
steroidogenic acute regulatory protein in equine cumulus cells and also has a 
negative impact on EGF-stimulated oocyte maturation (Caillaud and Gerard, 2009). 
However, during bovine in-vitro maturation (IVM), the addition of IL-ip to the 
culture medium has no effect on cleavage rate or blastocyst development (Al Naib et 
al., 2011). When bovine GCs from small (<5 mm) follicles were treated with IL-lp 
or TNFa, their FSH-stimulated oestradiol production was inhibited (Spicer and 
Alpizar, 1994). Oestrogen is associated with follicle growth and anti-apoptosis in 
GCs (Quirk et al., 2006). Thus by decreasing oestrogen concentration, the follicle 
may prevent an unhealthy oocyte from being ovulated and possibly forming an 
unhealthy embryo.
Hyaluronic acid is a major component of follicular fluid, and has been shown 
to act as a danger signal through TLR2 and TLR4 (Taylor et al., 2004, Scheibner et 
al., 2006). The present work investigated whether bovine GCs exhibit observations 
typical of an innate immune response after treatment with HA and found that there 
was no detectable response to ultra-low (ULMW) or high molecular weight (HMW) 
forms. This is in contrast to observations using HA with murine monocytes 
(Yamawaki et al., 2009), macrophages (Jiang et al., 2005) and COCs (Shimada et al.,
2008). The difference in these responses may be due to purity of the DAMP used -  
in many previous studies E. coli was used as a transfection vector to obtain HA, thus 
it is likely that contaminating LPS may have been present. Supporting the finding in 
this chapter, that HMW HA limited the IL-6 accumulation in response to LPS, HA 
suppresses the LPS-stimulated release of IL-6 by murine macrophages (Muto et al.,
2009). The finding that HA does not stimulate TLRs in the GC model to be used in 
the following chapters is useful, as it means we can be clear that any observations are 
due to treatment with PAMPs, not a response to the damage caused during follicle 
aspiration and GC isolation.
The present work showed that TLRs were expressed by GCs and that GCs 
respond to TLR ligands. In order to link these two observations, siRNA was used to 
target TLR2 or TLR4 (with 79% or 82% efficiency, respectively), and limit the IL-6 
response to PAM or LPS, respectively. Targeting TLR4 has been used previously to 
test the impact of LPS in bovine GCs (Bromfield and Sheldon, 2011) or endometrial 
cells (Cronin et al., 2012). Further confirmation of active TLR pathways in the
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present study was the phosphorylation of p38 MAPK and ERK1/2 following 
treatment of GCs with LPS or PAM. The kinetics of phospho-p38 MAPK and 
phospo-ERKl/2 in GCs in this work was similar to those published in macrophages, 
with rapid phosphorylation of both signals induced by PAMP treatment and 
maintained for at least 20 minutes (Feng et al., 1999, Kong and Ge, 2008). 
Activation of these MAPKs leads to increased expression and secretion of 
pro-inflammatory cytokines. Conversely, inhibiting these pathways decreases the 
IL-6 accumulation in response to LPS or PAM, as shown in this chapter using 
biochemical inhibitors for p38 MAPK and MEK. This work on inhibitors pointed to 
3 pathways worth further investigation: NFkB, p38 MAPK and MEK, which are 
pathways also shown to be interesting in a study using computational modelling to 
investigate anti-inflammatory combinations of small molecule inhibitors aimed at 
decreasing expression of IL1B (Small et al., 2011). Due to the detrimental effects of 
inhibiting key intracellular signals on cell viability, and the increased interest in 
combination therapy, very low concentrations of inhibitors were used in pairs, at 
concentrations which had no detrimental effect on cell viability or IL-6 accumulation 
when used singularly. Interestingly, when using inhibitors targeting MEK and JNK 
in combination, the accumulation of LPS-stimulated IL-6 was decreased. This pair 
points to a possible therapeutic combination which may warrant further investigation 
identifying the optimum concentration of each inhibitor, or trying different inhibitors 
targeting the same pathway.
From above, we can see that the pathological response to PAMPs may affect 
the physiological role of the ovary. However, it is also possible that physiological 
actions may affect the pathological response. The stage of oestrous cycle affects the 
accumulation of IL-6, IL-lp and IL-8 by bovine uterine explants in response to LPS 
(Borges et al., 2012), suggesting that hormones may crosstalk with innate immune 
responses. In this chapter, it was reported that EGF, which helps to coordinate 
LH-mediated events including oocyte maturation and COC expansion (Conti et al., 
2006), increased accumulation of IL-6, but not IL-8 or IL-ip by GCs treated with 
control medium or medium containing PAM. This is consistent with results using 
ovarian epithelial cancer cell lines, which showed increased IL6 expression after 
EGF treatment through STAT3 and JAK2 (Colomiere et al., 2008) and increased 
expression after treatment with an EGFR ligand through NFkB (Alberti et al., 2011).
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It is unsurprising that LH had no effect on cytokine accumulation by GCs from 
emerged follicles, because GCs only express the LH receptor after a follicle reaches 
dominance. Treatment of GCs with PAM increased expression of EGFR within 3 h. 
Previously, it was shown that TNFa up-regulated EGFR expression in human 
colonic myofibroblasts (Yoo et al., 2012). However, in the present thesis, both PAM 
and LPS lead to increased TNFa accumulation only at 10 pg/ml, and LPS did not 
affect EGFR expression, thus it seems unlikely that this is the mechanism which 
causes increased EGFR expression in response to PAM. In epithelial cells, agonists 
of TLR2 increase activation of EGFR, although expression of EGFR was not 
examined in this study (Shaykhiev et al., 2008). The EGF receptor negatively 
regulated bacteria-induced TLR2 expression in HeLa cells (Mikami et al., 2005). It 
seems possible that if EGFR negatively regulates TLR2 signalling, increased TLR2 
signalling (through PAM) may cause an increase in EGFR expression as a negative 
feedback loop to control the response.
A previous study found that FSH treatment increased accumulation of IL-8 
by GCs from emerged follicles after 24 h or 48 h and increased IL-6 accumulation 
after 48 h (Bromfield and Sheldon, 2011). In contrast, the present study found no 
significant effect of FSH on accumulation of LPS-stimulated cytokine production. 
These contrasting results are likely due to the different concentration of FSH used 
(although the concentration of FSH used in this project was supraphysiological at 
100 ng/ml, it was lower than the concentration used in the 2011 study of 2.5 ng/ml). 
Follicle-stimulating hormone (at 31-2000 ng/ml) also increased IL-6 accumulation 
by rat GCs at the 48 h time point (Gorospe and Spangelo, 1993), suggesting that it 
may be interesting to extend the present work to study a wider range of temporal 
responses.
In the present work, there was no significant effect of oestradiol or 
progesterone on LPS- or PAM-stimulated IL-6 accumulation, although oestradiol 
significantly decreased IL-6 accumulation by cells in control medium. This is in 
contrast to the effect of progesterone on foetoplacental arteries (Shields et al., 2005) 
and the observation that human peripheral blood monocytes isolated during the luteal 
phase (when progesterone concentrations are higher) produced less IL-6 (Schwarz et 
al., 2000). Similarly, oestrogen decreased accumulation of IL-6 by peripheral blood 
mononuclear cells (Rachon et al., 2002) and down-regulated the DL-6 promoter in the
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HeLa cell line (Delrieu et al., 2000). Although these results support the findings in 
this chapter, it seems strange that increased oestradiol (as seen just prior to 
ovulation) decreases IL-6 accumulation, which seems to play a role in oocyte 
maturation and cumulus expansion, which needs to occur prior to ovulation. 
Potentially, the increased oestradiol acts as a brake in oocyte maturation by 
regulating the concentration of IL-6 in the follicle.
In conclusion, GCs from emerged follicles expressed TLRs and produced a 
cellular response characteristic of a TLR2 and TLR4 innate immune response. 
Treatment with PAM or LPS increased accumulation of inflammatory mediators 
IL-6, IL-lp, TNFa and IL-8, and increased phosphorylation of p38 MAPK and 
ERK1/2. The increased accumulation of IL-6 in response to PAMPs was decreased 
using biochemical inhibitors targeting p38 MAPK, NFkB or MEK, highlighting the 
importance of these signals in the TLR cascade. Surprisingly, the DAMP HA had no 
significant effect on GCs, although modulated the IL-6 response to LPS, with a high 
concentration of the HMW form limiting the IL-6 accumulation. The expression of 
EGFR and FSHR was not affected by PAMP treatment, but EGF significantly 
increased accumulation of IL-6, providing evidence for crosstalk between immune 
and endocrine pathways. Overall, GCs from emerged follicles may have roles in 
innate immunity, at least against pathogens.
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Chapter 4
Pathogen-associated molecular patterns 
initiated inflammation and perturbed 
the endocrine function of granulosa 
cells from dominant follicles via TLR2 
and TLR4 pathways
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4.1 Introduction
In the previous chapter, the interactions between pathogen-associated 
molecular patterns (PAMPs) and granulosa cells (GCs) from emerged ovarian 
follicles were investigated. Emerged follicles are a homogeneous population, most of 
which will become atretic, with usually only a single follicle progressing to 
dominance. In this chapter, GCs from dominant follicles will be used, which differ 
from those in emerged follicles, as these will mainly come from follicles which have 
the potential to ovulate. In vivo observations show that uterine disease has the 
greatest impact on dominant follicles, with reduced growth rate and steroidogenesis 
(Sheldon et al., 2002, Williams et al., 2007). Thus, although the in vivo observations 
may be due to the effect of infection on growing emerged follicles, investigating the 
impact of infection on dominant follicles may be more biologically relevant than 
experiments using smaller follicles.
In cattle, a single dominant follicle is usually selected from a cohort of 
smaller emerged follicles that develop in waves in response to an increased 
concentration of FSH in peripheral plasma (Adams et al., 1992). Uniquely amongst 
ovarian follicles, the dominant follicle may go on to ovulate, rather than undergoing 
atresia. Interestingly, any viable emerged follicle is capable of becoming dominant, 
as cows can be super-ovulated with FSH (Adams et al., 1993, Ireland et al., 2007); 
one randomly selected 5 mm follicle can be directed to become dominant if all other 
follicles of a similar size are destroyed (Gibbons et al., 1997), and the subordinate 
follicle will become dominant if the dominant follicle is ablated prior to day 15 of 
the oestrous cycle (Dean and Dailey, 2011).
The future dominant follicle emerges 7 h earlier than the largest subordinate 
follicle, probably because it has a small developmental advantage over the other 
follicles, such as being closer to the ovarian vasculature or having more cells (Kulick 
et al., 1999). Prior to deviation, all follicles grow at the same rate (Ginther et al., 
1997). However, because the future dominant follicle emerged first, it is larger and 
thus maintains its advantage over the other follicles in the cohort, because the rate of 
growth of the surface area of a spherical object is greater for the sphere with the 
larger radius. Thus, the larger follicle increases its surface area at a greater rate, 
reflected by more GCs within the follicle and a greater number of FSH receptors. As
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FSH concentrations decline, the larger follicle is still able to grow due to its 
increased number of FSH receptors. The greater response to FSH in the larger 
follicle also increases the production of insulin-like growth factor (IGF) binding 
protein (IGFBP) proteases (Rivera and Fortune, 2001), which cleave IGFBPs, 
increasing the concentration of bio-available IGF-1 within the follicle (Rivera and 
Fortune, 2003). The bio-available IGF-1 acts synergistically with FSH to increase 
the production of oestradiol by the dominant follicle (Adashi, 1998), which then 
suppresses FSH thus starving the smaller follicles of their gonadotrophin drive 
(Burke et al., 1996, Ginther et al., 2000). It has also been hypothesised that other 
substances produced by the dominant follicle may suppress FSH including inhibin 
(Lussier et al., 1993, Kaneko et al., 1997), which may be synthesised by the 
dominant follicle in response to falling concentrations of FSH, thus further 
suppressing the subordinate follicles (Mihm et al., 1997).
During follicle selection, the GCs within the dominant follicle start to express 
mRNA encoding the LH receptor (Xu et al., 1995, Nogueira et al., 2007). This 
enables the follicle to grow independently of FSH, thus as FSH concentrations 
decline, subordinate follicles without LH receptors are unable to grow or develop 
and undergo atresia, whilst the dominant follicle continues to grow under the 
influence of LH. If LH pulse frequency remains low, the dominant follicle undergoes 
atresia, FSH is no longer suppressed and a new wave begins (Roche, 1996). If LH 
pulse frequency increases and circulating concentrations of progesterone are low, the 
dominant follicle persists until ovulation. After ovulation, the GCs begin to luteinise 
and increase production of progesterone, forming the corpus luteum. A number of 
processes require LH including GC luteinisation, cumulus expansion and oocyte 
maturation (Yamashita and Shimada, 2012, Sayasith et al., 2013). However, LH 
receptors are mainly expressed on GCs and not on cumulus cells or oocytes (Peng et 
al., 1991). It is thus hypothesised that LH signals are propagated through the follicle 
by EGF-like factors, such as epiregulin and amphiregulin (Park et al., 2004, 
Ashkenazi et al., 2005, Jamnongjit et al., 2005). A recent paper supporting this 
theory reported that cows treated with gonadotrophin increase granulosa expression 
of epiregulin and amphiregulin and bovine GCs treated with EGF increase 
expression of mRNA encoding genes related to ovulation (Sayasith et al., 2013).
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The characteristics of GCs within the dominant follicle include increased 
expression of CYP19A1, increased conversion of androstenedione to oestradiol, and 
expression of luteinising hormone receptors (LHCGR) in addition to their existent 
FSH receptors (FSHR) (Fortune et al., 2001). Granulosa cell function not only 
regulates dominant follicle growth and function, but also directs ovulation of the 
oocyte, with ovulation triggered by LH but mediated by EGF that induces a cascade 
of events resembling inflammation (Matzuk et al., 2002, Park et al., 2004).
In vivo, the impact of uterine infection on ovarian function is only detectable 
on dominant ovarian follicles, with decreased follicle growth rate and reduced 
oestradiol production (Sheldon et al., 2002, Williams et al., 2007). In addition, LPS 
was measured in the follicular fluid from dominant, not emerged, ovarian follicles 
(Herath et al., 2007). Previous studies have focussed on GCs from emerged follicles, 
hypothesising that the damage to the follicles only becomes apparent after attaining 
dominance, but that the damage was caused whilst follicles were smaller (Bromfield 
and Sheldon, 2011). Although this is not improbable, it seems likely that uterine 
infection may also impact dominant follicle health directly.
The hypothesis for this chapter was that GCs from dominant follicles respond 
to pathogen-associated molecular patterns and that this response is influenced by 
endocrine factors.
The aims of this chapter were to investigate the innate immune response of 
GCs from dominant follicles to three PAMPs (LPS, PAM and FLA), and to explore 
the interactions between ovarian physiology (the endocrine pathway) and pathology 
(the innate immune response). Firstly, expression and accumulation of 
pro-inflammatory cytokines and chemokines was measured after PAMP exposure by 
qPCR and ELISA, respectively. Activation of TLR signalling components was 
identified using Western blot and the effect of blocking the TLR pathway was 
investigated using short interfering RNA (siRNA) and biochemical inhibitors. The 
effect of LPS and PAM on expression of endocrine receptors and production of 
oestradiol and progesterone was then identified, followed by the effect of endocrine 
factors on PAMP-stimulated pro-inflammatory cytokine production.
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4.2 Methods
4.2.1 Granulosa cell culture
To explore the impact of PAMPs, GCs from dominant (>8.5 mm) follicles 
from beef cows were isolated and plated in 12-, 24- or 96-well plates at a density of 
1.5xl06 cells/ml in culture medium, as described in chapter 2. Granulosa cells from 
beef cattle represent a suitable model for investigating the effects of infection and 
inflammation on dairy GCs (chapter 2). Furthermore, GCs from follicles >8.5 mm 
in diameter represented GCs from dominant follicles, with expression of FSHR and 
LHCGR and high expression of CYP19A1 (chapter 2). The GC cultures were also 
free from contaminating immune cells, thus validating follicle aspiration as a suitable 
method for GC isolation (chapter 2).
After 48 h, the GCs were washed in PBS, then treated with control medium 
or medium containing ultrapure lipopolysaccharide from Escherichia coli 0111:B4 
(LPS; Invivogen), Pam3CSK4 (PAM; Invivogen) or flagellin from Salmonella 
typhimurium (FLA; Invivogen). Cellular responses of GCs were tested using 10-fold 
increasing concentrations from 0.001 to 10 pg/ml LPS or PAM and 0.0001 to 1 pg/ml 
FLA. In subsequent experiments using PAMPs, GCs were challenged with 1 pg/ml 
LPS, 1 pg/ml PAM or 0.1 pg/ml FLA for 3 or 24 h for analysis by qPCR or ELISA, 
respectively; or for up to 5 to 25 min for analysis by Western blot.
To investigate the interaction between endocrine and immune pathways, GCs 
were treated with 100 ng/ml FSH (Henderson et al., 1982, McLaughlin et al., 2010), 
4 ng/ml LH (Henderson et al., 1982, Fortune and Hansel, 1985), 500 ng/ml 
oestradiol (E2) (Ginther et al., 2001, Beg et al., 2002), 250 ng/ml progesterone (P4) 
(Martin et al., 1991, Ginther et al., 2001) or 10 ng/ml epidermal-like growth factor 
(EGF) (Langhout et al., 1991, Park et al., 1997) in combination with 1 pg/ml LPS or 
PAM. At the end of each experiment, supernatants were collected and stored at 
-20°C prior to protein analysis by ELISA; cells were washed with PBS and an MTT 
test carried out to estimate cell viability, as described in chapter 2. For experiments 
where the method of analysis was qPCR or Western blot, cells were washed twice 
with PBS and then lysed using 350 pi buffer RLT or 80 pi Phosphosafe, 
respectively.
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4.2.2 Chemical inhibitors
To explore the role of intracellular signalling pathways in the response of 
GCs to PAMPs, GCs were seeded in a 96-well plate (TPP), equilibrated for 48 h and 
washed with PBS. The GCs were then treated for 30 min with 50 pi of medium 
containing a range of concentrations of inhibitors targeting NFkB (0.0008-80 pM), 
PKC (0.002-200 pM), JNK (0.01-1000 pM), p38 MAPK (0.002-200 pM) or 
MEK (0.002-20 pM; all Calbiochem) or DMSO (1:500). This 30 minute treatment 
was followed by addition of 50 pi control medium, or 50pl medium containing 
2 pg/ml LPS or 2 pg/ml PAM. In a further experiment, to limit the impact of 
inhibitors on cell health, inhibitors were also used at their lowest concentration in 
combination with each other using pairs of 25 pi inhibitors targeting 
NFkB (0.0016 pM), PKC (0.004 pM), JNK (0.02 pM), p38 MAPK (0.004 pM) or 
MEK (0.004 pM) for 30 min, followed by 50 pi of medium containing LPS or PAM 
treatment as above.
4.2.3 Short-interfering RNA
To explore the role of TLRs, GCs were transfected with short-interfering 
RNA targeting TLR2 or TLR4 (as described in chapter 2). After 24 h, cells were 
washed with PBS and lysed using buffer RLT for analysis of TLR expression by 
qPCR, or treated with control medium or medium containing 1 pg/ml LPS or PAM 
for 24 h. Supernatants were collected after 24 h and stored at -20°C for analysis by 
ELISA; cell viability was assessed by MTT assay, as described in chapter 2.
4.2.4 ELISA
Accumulation of IL-6, IL-8, IL-ip and TNFa was measured in the 
supernatant of GCs treated with LPS, PAM or FLA, as described in general methods 
(chapter 2), using kits from R&D Systems for IL-8 and TNFa and kits from Thermo 
Fisher Scientific for IL-6 and IL-lp. Accumulation of oestradiol and progesterone 
was measured in the supernatant of GCs using ELISA kits from DRG Diagnostics, 
as described in chapter 2. Two technical replicates were used for each sample in each 
ELISA, from at least 3 experiments.
142
11 U l  I I U V M I I I I l C U i l  J U I I I C I ^ V ^
4.2.5 RNA extraction, cDNA synthesis and PCR
Granulosa cells were treated with control medium or medium containing 
1 |ig/ml LPS, 1 fig/ml PAM or 0.1 ng/ml FLA for 3 h. Cells were washed twice in 
PBS, lysed using 600 nl buffer RLT and scraped using a cell scraper. Total RNA 
was extracted using the RNeasy Mini kit, as described in general methods. Total 
RNA was quantified using a Nanodrop spectrophotometer and 1 ng total RNA used 
to synthesise cDNA, using the QuantiTect kit, as described in general methods. 
Expression of mRNA encoding genes considered as markers of an innate immune 
response (IL6, IL1B, TNF, IL10, IL8, CXCL5) and genes involved in the endocrine 
function of GCs (FSHR, LHCGR, EGFR, CYP19A1) was measured by qPCR, using 
3 technical replicates for each sample from 3-4 experiments.
4.2.6 Western blot
In order to investigate the activation of ERK1/2 and p38 MAPK, GCs were 
plated in a 12-well plate, equilibrated for 24 h, washed twice with PBS and cultured 
in Optimem (low serum medium) for 24 h. They were then treated for 0, 5, 10, 15, 
20 or 25 min with control Optimem medium, or Optimem containing 1 pg/ml LPS or 
1 pg/ml PAM. The medium was discarded before the GCs were washed with PBS 
and 80 pi Phosphosafe Extraction Reagent (Novagen) used to lyse each well of cells. 
Protein was extracted and quantified using the DC assay (chapter 2), before blotting 
for diphosphorylated ERK1/2 (1:1000; Sigma 8159) or phosphorylated p38 MAPK 
(1:1000; Acris Antibodies AP05898PU-N). After imaging each blot using the 
ChemiDoc XRS System, gels were stripped for 7 min in Restore Western Blot 
Stripping Buffer and then re-stained for P-actin (1:1000; Abeam ab8226), as 
described in general methods.
Images of each blot were analysed using the ChemiDoc XRS System to 
measure peak density of each band, after adjusting for background, as described in 
chapter 2. Blots from 3 experiments were quantified, with 1 image shown as a 
representative in the results section.
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4.2.7 Statistical analyses
Data are presented as mean + SEM, with statistical analyses performed using 
SPSS (version 16, SPSS Inc) and significance ascribed when P < 0.05. Analysis of 
variance was used to examine normally distributed data, following square root or log 
transformation where indicated in Results, as necessary. Dunnett’s pairwise multiple 
comparison T-test was used to compare treatments with control. Data that is not 
significantly different by ANOVA are denoted with the same letter. Where data were 
not normally distributed as indicated in Results, comparisons between treatment and 
control were made using Mann Whitney U Test.
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4.3 Results
4.3.1 Granulosa cells expressed mRNA for TLRs
The GCs from dominant follicles were negative for MHCII by FACS 
(chapter 2), indicating they were not contaminated by immune cells. Using these 
cells, the expression of TLRs was analysed by qPCR and the efficiencies of all 
primers were 100% ± 10%. All 10 TLRs were expressed by GCs, with higher 
expression of TLR1, TLR3, TLR5 and TLR6 and lower expression of TLR8 compared 
to the other TLRs (P < 0.01; Fig 4.1 A). Mononuclear cells were used as a positive 
control; the expression of each TLR was not significantly different to any other TLR 
(Fig 4 .IB; P >  0.23).
In order to investigate whether treatment of GCs with one PAMP primed the 
cell to respond to another PAMP, we examined TLR mRNA expression after the 
cells were treated with LPS or PAM. Treatment of GCs for 3 h with LPS increased 
expression of mRNA encoding TLR2 and decreased expression of TLR4, TLR6, 
TLR7 and TLR8. Treatment of GCs for 3h with PAM also increased expression of 
mRNA encoding TLR2 and decreased expression of TLR6, TLR7, TLR8 and TLR9 
(Fig. 4.2A). To examine whether this change in mRNA levels corresponded to a 
functional change at the protein level, GCs were treated for 3 h with control medium 
or medium containing LPS or PAM. They were then washed twice with PBS, before 
culturing for a further 24 h with control medium or medium containing LPS or PAM. 
Interestingly, pre-treating with LPS or PAM increased accumulation of IL-6 by GCs 
subsequently treated with PAM for 24 h, mirroring the 3-fold increase in TLR2 
expression (Fig. 4.2B).
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Figure 4.1 Granulosa cells expressed TLRs 1-10. Granulosa cells were isolated 
from dominant follicles (A) and bovine peripheral blood mononuclear cells (B). 
RNA was extracted and expression of TLRs measured by qPCR. Data represented as 
mean + SEM, normalised to ACTB and represent 3 independent experiments. Primer 
efficiencies were 100% ± 10% for each primer pair. Data that is not significantly 
different by ANOVA and post-hoc Fisher’s least significant difference test (using 
logio normalised data) are denoted with the same letter.
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Figure 4.2 Pre-treatment of GCs with LPS or PAM impacted TLR expression.
(A) Granulosa cells were treated for 3 h with control medium or medium containing 
1 pg/ml LPS or PAM. The expression of mRNA encoding TLRs 1-10 was measured 
by qPCR and is expressed as fold change over control, relative to ACTB. 
Data presented as mean + SEM and represent 3 independent experiments. 
Values differ from control by Student’s T-test using logio-normalised data; 
* P < 0.05, ** P < 0.01, *** P < 0.001. In a subsequent experiment, GCs were 
pre-treated for 3 h (as above), then further treated for 24 h with control medium ( ‘C ’) 
or medium containing 1 pg/ml LPS or PAM. Supernatants were collected and the 
accumulation of IL-6 measured by ELISA (B). Data presented as mean + SEM and 
represent 4 independent experiments. Values differ from cells pre-treated with 
control medium within subsequent treatment group by ANOVA; P < 0.05.
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4.3.2 Granulosa cells responded to PAMPs
When GCs were treated for 24 h with control medium or medium containing 
10-fold increasing concentrations of LPS or PAM, supernatants accumulated IL-6, 
IL-ip, IL-8 and TNFa. Treatment with LPS significantly increased accumulation of 
IL-6 at concentrations > 0.01 pg/ml (Fig. 4.3A) and increased accumulation of IL-8 
and IL-lp even from the lowest concentration tested (Fig. 4.3B, D). The GCs 
exhibited a similar response to PAM, with increased accumulation of IL-6 from 
1 pg/ml (Fig. 4.4A) and increased accumulation of IL-8 at concentrations 
> 0.01 pg/ml (Fig. 4.4D). Interestingly, although the accumulation of IL-6 was a 
similar concentration whether cells were treated with LPS or PAM, treatment with 
PAM resulted in a lower concentration of IL-ip and a higher concentration of IL-8 
than treatment with LPS.
Treatment with FLA did not increase accumulation of IL-6, IL-lp or IL-8 (all 
below limits of detection). No treatment increased accumulation of TNFa. For future 
experiments, 1 pg/ml LPS or PAM were used as the standard working concentrations 
because 1 pg/ml stimulated the greatest accumulation of IL-6, and 1 pg/ml LPS is 
similar to concentrations of LPS previously measured in the follicular fluid of cows 
with severe uterine disease (Herath et al., 2007).
148
0.8-
0.6-
N/D
0.4-
0.2-
0.0-
0 0.001 0.01 0.1 1 10
o. 40-
LPS (ng/ml)
0 0.001 0.01 0.1 1 10 
LPS (jj.g/ml)
Figure 4.3 Granulosa cells responded to LPS in a concentration-dependent 
manner. Granulosa cells from dominant follicles were treated for 24 h with control 
medium (‘0’) or medium containing 0.001, 0.01, 0.1, 1 or 10 pg/ml ultrapure LPS. 
Supernatants were collected and the accumulation of IL-6 (A), IL-ip (B), TNFa (C) 
and IL-8 (D) measured by ELISA. Data presented as mean + SEM and represent at 
least 4 independent experiments. Values differ from control by ANOVA and 
Dunnett’s pairwise multiple comparison t test (square root normalised data) 
* P < 0.05, ** P < 0.01, *** P < 0.001. N/D = below limits of detection.
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Figure 4.4 Granulosa cells responded to PAM in a concentration-dependent 
manner. Granulosa cells from dominant follicles were treated for 24 h with control 
medium (‘0’) or medium containing 0.001, 0.01, 0.1, 1 or 10 pg/ml Pam3CSK4 
(PAM). Supernatants were collected and the accumulation of IL-6 (A), IL-ip (B), 
TNFa (C) and IL-8 (D) measured by ELISA. Data presented as mean + SEM and 
represent at least 4 independent experiments. Values differ from control by ANOVA 
and Dunnett’s pairwise multiple comparison t test (square root normalised data) 
* P < 0.05, ** P < 0.01, *** P < 0.001. N/D = below limits of detection.
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4.3.3 Exposure of GCs to PAMPs increased expression of genes associated with 
inflammatory or innate immune pathways
When GCs were treated for 3 h with control medium or medium containing 
LPS (Fig. 4.5A-F) or PAM (Fig. 4.6A-F), they increased expression of IL6, IL1B, 
IL10, TNF, IL8 and CCL5. All 6 of these genes associated with inflammatory or 
innate immune pathways had similar fold-increase for each replicate (Fig. 4.5, 4.6; 
each line represents one experiment, with the same colour points representing the 
same experiment across figures 4.5-4.6). In general, experimental replicates with 
high expression of one cytokine also had high expression of all other cytokines 
measured. Treatment with PAM increased expression of IL1B (P < 0.05), 
TNF (P < 0.05) and IL8 (P < 0.001) to a greater extent than LPS treatment (Fig. 4.7). 
There was no significant effect of LPS (P = 0.958) or PAM (P = 0.362) on ACTB 
expression.
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Figure 4.5 Exposure of GCs to LPS increased expression of genes associated 
with inflammation and innate immunity. Granulosa cells from dominant follicles 
were treated for 3 h with control medium (‘C’) or medium containing 1 pg/ml 
ultrapure lipopolysaccharide from E. coli 0111 :B4 (LPS). RNA was extracted, 
cDNA synthesised and the expression of IL6 (A), IL1B (B), 1L10 (C), TNF (D), 
IL8 (E) and CCL5 (F) estimated by qPCR. Each independent experiment is presented 
as one line, with coloured dots representing the same experiment throughout. Mean 
values for LPS treatment differ from control by T-test using log-normalised data, 
* P < 0.05, ** P < 0.01, *** P < 0.001
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Figure 4.6 Exposure of GCs to PAM increased expression of genes associated 
with inflammation and innate immunity. Granulosa cells from dominant follicles 
were treated for 3 h with control medium (‘C’) or medium containing 
1 pg/ml Pam3CSK4 (PAM). RNA was extracted, cDNA synthesised and the 
expression of IL6 (A), IL1B (B), 1L10 (C), TNF (D), IL8 (E) and CCL5 (F) 
estimated by qPCR. Each independent experiment is presented as one line, 
with coloured dots representing the same experiment throughout. Mean values for 
PAM treatment differ from control by T-test using log-normalised data, * P < 0.05, 
** P < 0.01, *** P < 0.001
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Figure 4.7 Exposure of GCs to LPS or PAM increased expression of genes 
associated with inflammation and innate immunity. Granulosa cells from 
dominant follicles were treated for 3 h with control medium or medium containing 
1 pg/ml LPS (A) or 1 pg/ml PAM (B). RNA was extracted, cDNA synthesised and 
the expression of ACTB, IL6, 1L1B, IL10, TNF, IL8 and CCL5 estimated by qPCR. 
Data are presented as mean fold increase in each gene compared to control. Data 
represented as mean + SEM of 3-4 independent experiments. Values differ from 
control by ANOVA and Dunnett’s post hoc multiple comparison T-test (using logio 
normalised data), *** P < 0.001
154
v _ . u a | _ n u i  “  —  i i u n i  u u i i j u j u j u
4.3.4 Treatment of GCs with PAMPs activated intracellular signalling pathways
When GCs were treated with control medium or medium containing PAMPs, 
15 min LPS treatment increased phosphorylation of p38 MAPK and ERK1/2 
(Fig. 4.8A-C). After 20 min PAM treatment, there was an increase in 
phosphorylation of p38 MAPK (P < 0.01, Fig. 4.9A, B) and after 10 minutes, a 
significant increase in phosphorylation of ERK1/2 (Fig. 4.9C), which was 
maintained for 15 min.
4.3.5 The response of GCs to PAMPs was attenuated using short-interfering 
RNA targeting TLRs
When GCs were treated with lipofectamine vehicle, scrambled siRNA, or 
siRNA targeting TLR2 or TLR4 for 24 h, there was no effect of siRNA on cell 
viability as evaluated by MTT test (P > 0.5; Fig. 4.10A). Treatment with each 
targeted siRNA significantly decreased expression of TLR2 or TLR4 mRNA 
(P < 0.05; Fig. 4.10B) and treatment with scrambled siRNA did not significantly 
affect expression of either target gene (P > 0.9). Treatment with PAM significantly 
increased the accumulation of IL-6, but this was attenuated when cells were pre­
treated with siRNA targeting TLR2 (P < 0.01; Fig. 4 .10C). Treatment with LPS 
significantly increased the accumulation of IL-6, but this was also attenuated when 
cells were pre-treated with siRNA targeting TLR4 (P < 0.05; Fig. 4.10D). There was 
no significant effect of lipofectamine vehicle, scrambled siRNA or targeted siRNA 
on accumulation of IL-6 by GCs treated with control medium.
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Figure 4.8 LPS induced phosphorylation of ERK1/2 and p38 MAPK in GCs.
Granulosa cells from dominant follicles were treated for 5, 10, 15, 20 or 25 mins 
with control medium (open bars) or medium containing 1 pg/ml LPS (black bars) 
and phosphorylation of ERK1/2 and p38 MAPK analysed by Western blot. (A) A 
representative blot showing LPS treatment with bands corresponding to 
diphosphorylated ERK1/2, phosphorylated p38 MAPK (Thrl80/182) and (3-actin. 
Band densities were quantitated relative to p-actin and phosphorylation of ERK1/2 
(B) and p38 MAPK (C) expressed as a percentage of time 0. Data presented as mean 
+ SEM and represent 3 independent experiments. Values differ from control at each 
time point by t-test (logio normalised data), * P < 0.05, ** P < 0.01
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Figure 4.9 PAM induced phosphorylation of ERK1/2 and p38 MAPK in GCs.
Granulosa cells from dominant follicles were treated for 5, 10, 15, 20 or 25 mins 
with control medium (open bars) or medium containing 1 pg/ml PAM (black bars) 
and phosphorylation of ERK1/2 and p38 MAPK analysed by Western blot. (A) A 
representative blot showing PAM treatment with bands corresponding to 
diphosphorylated ERK1/2, phosphorylated p38 MAPK (Thrl80/182) and p-actin. 
Band densities were quantitated relative to P-actin and phosphorylation of ERK1/2 
(B) and p38 MAPK (C) expressed as a percentage of time 0. Data presented as mean 
+ SEM and represent 3 independent experiments. Values differ from control at each 
time point by t-test (logio normalised data), * P < 0.05, ** P < 0.01
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Figure 4.10 The IL-6 response of GCs to LPS or PAM was attenuated using 
siRNA targeting TLR4 or TLR2, respectively. Granulosa cells from dominant 
follicles were treated for 24 h with lipofectamine (white bars), non-specific 
scramble-siRNA (grey bars) or specific siRNA (black bars) targeting TLR2 or TLR4. 
The viability of the cells was assessed by MTT test (A) and expression of TLR2 or 
TLR4 estimated by qPCR (B). Data is expressed relative to ACTB and is presented as 
mean + SEM, representing 3 independent experiments. Following 24 h treatment 
with lipofectamine (‘vehicle’), scramble-siRNA (‘scr’) or siRNA targeting TLR2 
( ‘siTLR2’) or TLR4 ( ‘siTLR4’), GCs were treated for a further 24 h with control 
medium (white bars) or medium containing 1 pg/ml PAM (C) or 1 pg/ml LPS (D) 
and the accumulation of IL-6 measured by ELISA. Data presented as mean + SEM, 
expressed as percentage of PAM (C) or LPS (D) vehicle treatment and represent 4-5 
independent experiments. Data that is not significantly different by ANOVA (logio 
normalised for qPCR data; square-root normalised for ELISA data) are denoted with 
the same letter.
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4.3.6 Inhibiting NFkB, p38 MAPK or MEK limited LPS- and PAM-stimulated 
IL-6 accumulation by GCs
To explore which intracellular signalling pathways are important for the 
inflammatory response to LPS and PAM, GCs were pre-treated with chemical 
inhibitors that target NFkB or specific MAPK. There was a reduction in the 
accumulation of IL-6 in culture supernatants in response to LPS, without a 
significant impact on cell survival, when cells were pre-treated with 0.04 -  4 pM 
NFkB inhibitor (Fig. 4.11 A), 5 pM JNK inhibitor (Fig. 4.11C), 1 - 1 0  pM MEK 
inhibitor (Fig. 4.1 ID) or 0.001 -  10 pM p38 MAPK inhibitor (Fig. 4.1 IE). Similarly, 
there was a reduction in the accumulation of IL-6 in culture supernatants in response 
to PAM, without a significant impact on cell survival, when cells were pre-treated 
with 0.4 pM NFkB inhibitor (Fig. 4.12A), 50 pM JNK inhibitor (Fig. 4.12C), 
1 - 1 0  pM MEK inhibitor (Fig. 4.12D) or 1 -  10 pM p38 MAPK inhibitor 
(Fig. 4.12E). There was no reduction in IL-6 accumulation without a corresponding 
effect on cell health when a PKC inhibitor was used (Fig. 4.1 IB, 4.12B).
Toward a therapeutic approach, pairs of inhibitors were also tested using the 
lowest concentration of each inhibitor in order to minimise the impact on granulosa 
cell health. The combination of inhibitors targeting p38 MAPK (0.001 pM) and 
MEK (0.0001 pM) limited the accumulation of IL-6 in response to LPS (Fig. 4.1 IF). 
However, there was no significant effect of the pairs of inhibitors on the response to 
PAM (Fig. 4.12F).
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Figure 4.11 Inhibiting NFkB, MEK or p38 MAPK limited LPS-induced IL-6 
accumulation by GCs. Granulosa cells were treated for 30 min with 10-fold 
increasing concentrations of biochemical inhibitors targeting NFkB (A; 0.0004 to 
40 pM), PKC (B; 0.001 to 100 pM), JNK (C; 0.005 to 500 pM), MEK (D; 0.0001 to 
10 pM), p38 MAPK (E; 0.001 to 100 pM) or low dose combination treatments using 
pairs of inhibitors (0.0004 pM NFkB inhibitor, 0.001 pM PKC inhibitor, 0.005 pM 
JNK inhibitor, 0.0001 pM MEK inhibitor and 0.001 pM p38 MAPK inhibitor); 
followed by addition of 1 pg/ml LPS (final concentration) to each well for 24 h. 
Supernatants were collected and the accumulation of IL-6 measured by ELISA 
(black bars). Cell viability was assessed by MTT assay (red line). Data presented as 
mean + SEM from 3-4 independent experiments and are expressed as a percentage of 
LPS treatment. Values differ from LPS treatment by ANOVA and Dunnett’s 
pairwise multiple comparison t test, * P < 0.05, ** P < 0.01, *** P < 0.001.
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Figure 4.12 Inhibiting NFkB, MEK or p38 MAPK limited PAM-induced IL-6 
accumulation by GCs. Granulosa cells were treated for 30 min with 10-fold 
increasing concentrations of biochemical inhibitors targeting NFkB (A; 0.0004 to 
40 pM), PKC (B; 0.001 to 100 pM), JNK (C; 0.005 to 500 pM), MEK (D; 0.0001 to 
10 pM), p38 MAPK (E; 0.001 to 100 pM) or low dose combination treatments using 
pairs of inhibitors (0.0004 pM NFkB inhibitor, 0.001 pM PKC inhibitor, 0.005 pM 
JNK inhibitor, 0.0001 pM MEK inhibitor and 0.001 pM p38 MAPK inhibitor); 
followed by addition of 1 pg/ml PAM (final concentration) to each well for 24 h. 
Supernatants were collected and the accumulation of IL-6 measured by ELISA 
(black bars). Cell viability was assessed by MTT assay (red line). Data presented as 
mean + SEM from 3-4 independent experiments and are expressed as a percentage of 
PAM treatment. Values differ from PAM treatment by ANOVA and Dunnett’s 
pairwise multiple comparison t test, * P < 0.05, ** P < 0.01, *** P < 0.001.
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4.3.7 Exposure of GCs to LPS or PAM impacted endocrine function
To investigate the effect of PAMPs on endocrine function, GCs were 
collected after 3 h treatment with LPS or PAM to examine mRNA expression. 
Treatment of cells with LPS reduced the expression of mRNA encoding EGFR and 
CYP19A1 but not FSHR or LHCGR (Fig. 4.13, 4.14). Treatment of GCs with PAM 
decreased the mRNA expression of LHCGR and CYP19A1 and tended towards 
decreasing expression of EGFR (0.86 ± 0.06 fold change; P < 0.1) but did not affect 
FSHR expression (Fig. 4.13, 4.14).
To investigate the effect of PAMPs on hormone production, GCs were 
treated with FSH and androstenedione. Cell supernatants accumulated oestradiol and 
progesterone in a time-dependent manner with significant increases in oestradiol 
from 2 h and significant increases in progesterone from 24 h. Exposure to LPS or 
PAM for 24 h reduced the accumulation of oestradiol (Fig.4.15B-D) and 
progesterone (Fig.4.16B-D) in culture supernatants.
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Figure 4.13 Exposure of GCs to LPS or PAM decreased expression of genes 
associated with reproductive function. Granulosa cells from dominant follicles 
were treated for 3 h with control medium ( ‘C’) or medium containing 1 pg/ml LPS 
(A, C, E, G) or PAM (B, D, F, H). RNA was extracted, cDNA synthesised and the 
expression of FSHR (A, B), LHCGR (C, D), EGFR (E, F) and CYP19A1 (G, H) 
estimated by qPCR. Each independent experiment is presented as one line, with 
coloured dots representing the same experiment throughout. Mean values for LPS or 
PAM treatment differ from control by T-test using log-normalised data, * P < 0.05.
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Figure 4.14 Exposure of GCs to LPS or PAM decreased expression of genes 
associated with reproductive function. Granulosa cells from dominant follicles 
were treated for 3 h with control medium or medium containing 1 jig/ml LPS (A) or 
1 |4,g/ml PAM (B). RNA was extracted, cDNA synthesised and the expression of 
ACTB, FSHR, LHCGR, EGFR and CYP19A1 estimated by qPCR. Data are presented 
as mean fold increase in each gene compared to control. Data represented as 
mean + SEM of 3-4 independent experiments. Values differ from control by 
ANOVA and Dunnett’s post hoc multiple comparison T-test (using logio normalised 
data), * P < 0.05.
164
O  C
+FSH+A41500-
E
g 1000-
CN
LU
500-
0 2 64 24 30
Tim e (h)
E1 1°J:
CMLU
C PAM
C LPS
150—i
J: 100-
CNLU
2145 pg/m l
Figure 4.15 Exposure of GCs to LPS or PAM decreased production of 
oestradiol. (A) Granulosa cells from dominant follicles were treated for 0, 2, 4, 6, 24 
or 30 h with control medium (red open bars) or medium containing 1 ng/ml FSH and 
107 M androstenedione (black bars). Supernatants were collected and the 
accumulation of oestradiol measured by ELISA. Data presented as mean + SEM and 
differ from time 0 within treatment group by ANOVA and Dunned’s post hoc 
multiple comparison T-test (logio normalised data), ** P < 0.01, *** P < 0.001. 
Granulosa cells were then treated for 24 h with control medium containing 1 ng/ml 
FSH and 107 M androstenedione (‘C’) or control medium also containing 1 pg/ml 
LPS (B) or 1 pg/ml PAM (C). Supernatants were collected and the accumulation of 
oestradiol measured by ELISA. Each independent experiment is presented as one 
line, with coloured dots representing the same experiment throughout. (D) Data 
presented as mean + SEM, expressed as a percentage of control oestradiol 
accumulation and represent 3 independent experiments; values differ from control by 
Mann-Whitney U test; * P < 0.05.
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Figure 4.16 Exposure of GCs to LPS or PAM decreased production of 
progesterone. (A) Granulosa cells from dominant follicles were treated for 0, 2, 4, 6, 
24 or 30 h with medium containing 1 ng/ml FSH and 107 M androstenedione. 
Supernatants were collected and the accumulation of progesterone measured by 
ELISA. Data presented as mean + SEM and differ from time 0 by ANOVA and 
Dunnett’s post hoc multiple comparison T-test (square root normalised data), 
** P < 0.01. Granulosa cells were then treated for 24 h with control medium 
containing 1 ng/ml FSH and 10 7 M androstenedione (‘C’) or control medium also 
containing 1 pg/ml LPS (B) or 1 pg/ml PAM (C). Supernatants were collected and 
the accumulation of progesterone measured by ELISA. Each independent experiment 
is presented as one line, with coloured dots representing the same experiment 
throughout. (D) Data presented as mean + SEM, expressed as a percentage of control 
progesterone accumulation and represent 3 independent experiments; values differ 
from control by Mann-Whitney U test; * P < 0.05.
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4.3.8 EGF increased accumulation of IL-6 by GCs
Previously, it was shown that treatment with PAMPs impacts the hormonal 
output of GCs (Fig. 4.16). It was also of interest whether the endocrine environment 
affected the inflammatory output of the GCs from dominant follicles. Thus, GCs 
were treated for 24 h with control medium (Fig. 4.17) or medium containing LPS 
(Fig. 4.18) or PAM (Fig. 4.19) in combination with 100 ng/ml FSH, 4 ng/ml LH, 
500 ng/ml E2, 250 ng/ml P4 or 10 ng/ml EGF. Treatment with LH or EGF 
significantly increased accumulation of IL-6 by GCs treated in control medium 
(Fig. 4.17A). Treatment with EGF also significantly increased accumulation of IL-6 
by GCs treated in LPS or PAM medium (Fig. 4.18A, 4.19A). Oestradiol treatment 
significantly decreased EL-6 accumulation by GCs stimulated by LPS or PAM but 
had no effect on GCs treated in control medium (P >0.6). FSH, LH and P4 had no 
significant effect on IL-6 accumulation by GCs. There was no effect of endocrine 
treatment on accumulation of IL-lp or IL-8, or on cell viability measured by MTT 
test (P > 0.9).
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Figure 4.17 LH or EGF increased accumulation of IL-6 by GCs from dominant 
follicles. Granulosa cells from dominant follicles were treated for 24 h with control 
medium (‘C’) or medium containing 100 ng/ml FSH, 4 ng/ml LH, 500 ng/ml E2, 
250 ng/ml P4 or 10 ng/ml EGF. Supernatants were collected and accumulation of 
IL-6 (A), IL-lp (B) and IL-8 (C) measured by ELISA. Data are presented as 
mean + SEM and represent at least 4 independent experiments. For IL-6 values, data 
are expressed as a percentage of control. Values differ from control by ANOVA and 
Dunnett’s pairwise multiple comparison t-test (logio normalised data), * P < 0.05, 
*** P < 0.001. (D) Cell viability was assessed by MTT test. Data presented as 
mean + SEM from 3 independent experiments. N/D = below limits of detection.
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Figure 4.18 EGF increased accumulation of IL-6 by GCs from dominant 
follicles treated with LPS; oestradiol decreased IL-6 accumulation. Granulosa 
cells from dominant follicles were treated for 24 h with medium containing 1 pg/ml 
LPS or medium containing 1 ng/ml LPS plus 100 ng/ml FSH, 4 ng/ml LH, 
500 ng/ml E2, 250 ng/ml P4 or 10 ng/ml EGF. Supernatants were collected and 
accumulation of IL-6 (A), IL-lp (B) and IL-8 (C) measured by ELISA. Data are 
presented as mean + SEM and represent at least 4 independent experiments. For IL-6 
values, data are expressed as a percentage of LPS treatment alone. Values differ 
from control by ANOVA and Dunnett’s pairwise multiple comparison t-test 
(logio normalised data), * P < 0.05. (D) Cell viability was assessed by MTT test. 
Data presented as mean + SEM from 3 independent experiments.
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Figure 4.19 EGF increased accumulation of IL-6 by GCs from dominant 
follicles treated with PAM; oestradiol decreased IL-6 accumulation. Granulosa 
cells from dominant follicles were treated for 24 h with medium containing 1 pg/ml 
PAM or medium containing 1 ng/ml PAM plus 100 ng/ml FSH, 4 ng/ml LH, 
500 ng/ml E2, 250 ng/ml P4 or 10 ng/ml EGF. Supernatants were collected and 
accumulation of IL-6 (A), IL-ip (B) and IL-8 (C) measured by ELISA. Data are 
presented as mean + SEM and represent at least 4 independent experiments. For IL-6 
values, data are expressed as a percentage of PAM treatment alone. Values differ 
from control by ANOVA and Dunnett’s pairwise multiple comparison t-test 
(logio normalised data), * P < 0.05, ** P < 0.01. (D) Cell viability was assessed by 
MTT test. Data presented as mean + SEM from 3 independent experiments. 
N/D = below limits of detection.
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4.4 Discussion
Bacterial infections of the uterus or mammary gland perturb ovarian 
dominant follicle growth and endocrine function (Sheldon et al., 2002, Lavon et al., 
201 la, Lavon et al., 2011b). Whilst LPS has been found in the follicular fluid from 
dominant follicles of animals with uterine disease (Herath et al., 2007), healthy 
ovarian follicles are devoid of immune cells (Spanel-Borowski et al., 1997, 
Bromfield and Sheldon, 2011). So, the present study considered whether the GCs 
inside dominant follicles may have roles in innate immunity. Primary GCs collected 
from dominant follicles expressed mRNA for all ten TLRs, and produced IL-lp, 
IL-6 and IL-8 in response to PAM and LPS via the TLR2 and TLR4 pathways, 
respectively. However, the cells did not accumulate cytokines in response to the 
TLR5 ligand, flagellin. The GCs had rapid responses to PAM or LPS, with increased 
abundance of IL6, IL1B, IL10, TNF, IL8 and CCL5 mRNA, and increased 
phosphorylation of p38 MAPK and ERK1/2. Furthermore, treating GCs with 
inhibitors targeting MAPK or NFkB reduced the cellular response to these PAMPs. 
Treatment with LPS or PAM also reduced the accumulation of oestradiol and 
progesterone, and the expression of genes important for granulosa cell endocrine 
function. The inflammatory responses to PAMPs via TLR2 and TLR4 pathways by 
GCs provides a molecular explanation of how bacterial infections distant to the 
ovary may perturb ovarian dominant follicle function.
In the present study, FACS and PCR analysis were used to confirm that the 
preparations of GCs isolated from dominant follicles were free from immune cell 
contamination, as determined by lack of CD45 and MHCII expression, because such 
contaminations might have confounded the investigations (chapter 2). The bovine 
GCs from dominant follicles expressed mRNA encoding all ten TLRs and the gene 
expression was maintained during cell culture. Although levels of TLR gene 
expression may have little bearing on immune function, the high expression of TLR3 
was notable. This is interesting because viruses such as bovine viral diarrhoea virus 
infect the ovary of cattle and perturb dominant follicle growth (Grooms et al., 1998). 
The high expression of TLR1 and TLR6 was also noticeable, as these receptors 
dimerise with TLR2 to recognise bacterial lipoproteins (Kawai and Akira, 2011). 
However, the granulosa cell expression of TLR2 and TLR4 was of immediate
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relevance as these receptors are required to detect the purified PAMPs used in the 
present study. Pre-treatment of GCs with LPS or PAM increased both expression of 
TLR2 and, in contrast to GCs from emerged follicles, the cellular response to further 
PAM treatment, suggesting that PAMPs have the ability to prime GCs from 
dominant follicles to respond to other TLR ligands. Supporting this hypothesis that 
LPS primes cells to respond to TLR2 ligands, LPS pre-treatment also increases IL-6 
accumulation by murine bone-marrow derived macrophages subsequently treated 
with the TLR2/TLR6 agonist FSL-1 (Schroder et al., 2012), and pre-treatment of 
dendritic cells with LPS increases IL-6 production by cells subsequently challenged 
with PAM (Geisel et al., 2007).
The cellular response of GCs isolated from dominant follicles to PAMPs was 
similar to that of GCs isolated from emerged follicles. Supernatants of GCs from 
dominant follicles treated with LPS or PAM for 24 h accumulated the cytokines 
IL-lp and IL-6, and the chemokine IL-8. In addition to protein accumulation, the 
GCs mounted acute responses after 3h treatment with LPS and PAM, characterised 
by increased expression of gene transcripts for the cytokines IL6, IL1B, IL10 and 
TNF and the chemokines IL8 and CCL5. The changes in inflammatory mediators 
found in the present study are typical of those associated with an innate immune 
response to LPS or PAM in immune cells such as macrophages and dendritic cells 
(Akira et al., 2006, Takeuchi and Akira, 2010, Moresco et al., 2011). Interestingly, 
many of the inflammatory mediators associated with innate immunity also have 
physiological functions in the ovary. For example, IL-6 induces murine cumulus- 
oocyte-complex expansion (Liu et al., 2009) and IL-lp decreases progesterone 
production by FSH-treated murine GCs (Santana et al., 1996). Chemokines also play 
a role, with IL-8 involved in follicle development, ovulation and corpus luteum 
formation (Goto et al., 2002). The absence of TNFa protein in the present study 
might be considered surprising for some tissues and immune cells; however, changes 
in protein are less often detected than changes in TNF gene expression in cells of the 
bovine reproductive tract (Swangchan-Uthai et al., 2012). The requirement for TLR2 
and TLR4 in bovine GCs to produce IL-6 in response to PAM and LPS was 
confirmed using siRNA targeting TLR4 or TLR2, respectively. Although TLR2 has 
not been investigated, bovine GCs from emerged follicles before dominance 
similarly required TLR4 to respond to LPS (Bromfield and Sheldon, 2011).
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In immune cells, binding of bacterial PAMPs to TLRs activates NFkB and 
MAPK pathways, leading to production of inflammatory mediators (Akira et al., 
2006). In the present study, treatment of GCs from dominant follicles with LPS or 
PAM increased the abundance of phosphorylated ERK1/2 and p38 MAPK within 
20 min. These observations are similar to those in bovine GCs collected from 
follicles before dominance and treated with LPS (Bromfield and Sheldon, 2011). 
However, to extend these observations, the present study also explored the effect of 
chemical inhibitors that target NFkB, JNK, MEK or p38 MAPK on the accumulation 
of LPS or PAM-stimulated IL-6. Indeed, concentrations of the inhibitors targeting 
NFkB, JNK, MEK or p38 MAPK were identified that reduced the TLR4- or 
TLR2-mediated inflammatory response, without significantly reducing granulosa 
cell survival. An approach to limiting the risk of chemical cytotoxicity when 
designing therapeutics is to use combinations of inhibitors at minimal concentrations 
(Small et al., 2011). In the present study, this approach identified a combination of 
inhibitors targeting p38 MAPK and MEK that limited the accumulation of 
LPS-stimulated IL-6, with no significant effect on granulosa cell viability. Although 
beyond the scope of the present work, to move toward therapeutics it would also be 
important to explore whether these chemical inhibitors modulated granulosa cell 
steroidogenesis. Previously, it was shown that GCs from bovine dominant follicles 
have greater abundance of phosphorylated ERK1/2 than GCs from smaller follicles 
(Ryan et al., 2007). As ERK1/2 may be involved in follicular development, and 
treatment of GCs with PAMPs increased phosphorylation of ERK1/2, it is possible 
that PAMP treatment may increase the rate of follicular development, although not 
from primordial follicles, whose rate of follicular atresia increases (Bromfield and 
Sheldon, 2013).
Cows with uterine disease or mastitis have lower peripheral oestradiol 
concentrations and delayed ovulation in vivo (Sheldon et al., 2009, Lavon et al., 
2011b). The accumulation of oestradiol and progesterone is decreased when GCs 
from dominant follicles are treated with 1 pg/ml LPS (Herath et al., 2007). Similarly, 
in the present study, there was a -50% decrease in oestradiol accumulation and 
qPCR was used to measure a -30% decrease in CYP19A1 expression by GCs from 
dominant follicles after treatment with LPS or PAM. It is likely that these changes
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would have a detrimental impact on ovarian follicle growth and the likelihood of 
ovulation.
Progesterone accumulation was also impacted with LPS treatment, an effect 
also observed after in vivo infusion of LPS into bovine mammary gland (Lavon et 
al., 2011b). This lower progesterone concentration further decreases the chance of 
successful conception, as the endometrium will be affected. Progesterone tends to 
have an anti-inflammatory effect; for example, macrophages treated with 
progesterone produce significantly less IL-6 when stimulated with LPS compared to 
macrophages treated with either oestradiol or control medium (Su et al., 2009). Thus, 
lower progesterone would favour a pro-inflammatory response. This could be useful 
to the animal to help clear the infection. However, inappropriate inflammation 
increases tissue damage and decreases the likelihood of conception. In contrast to the 
effect of LPS on progesterone accumulation, the statistically significant decrease in 
progesterone accumulation caused by PAM is less likely to be of biological 
significance.
In the present study, LPS also decreased expression of EGFR and treatment 
with PAM decreased expression of LHCGR, which might further perturb ovarian 
function. Links between LPS and the EGF system have been observed previously: 
LPS increases expression of EGFR ligands amphiregulin and epiregulin (Brandi et 
al., 2010). Activation of EGFR leads to endocytosis of the receptor, followed by 
either degradation or recycling (Madshus and Stang, 2009). Thus, a negative 
feedback loop may down-regulate EGFR gene expression following receptor 
internalisation. Further links between the EGF system and infection were 
demonstrated in this study, as treatment of GCs with EGF increased IL-6 
accumulation and increased LPS- or PAM- stimulated IL-6 accumulation. This 
pro-inflammatory effect of EGF is consistent with previous studies using 
mesenchymal stem cells (Kerpedjieva et al., 2012) and ovarian cancer cells 
(Colomiere et al., 2008). Treatment of murine COCs with the EGF-like factor 
amphiregulin increases expression of Myd88 and other TLR-associated genes 
(Shimada et al., 2006), which in turn could increase the response of COCs to 
PAMPs. However, in the same study, amphiregulin did not increase the expression 
of Myd88 or TLR4 in murine GCs (Shimada et al., 2006). It would be interesting in 
future work to examine the effect of EGF, hormones and gonadotrophins on TLR
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expression in bovine GCs and the effect of PAMPs on production of amphiregulin 
and epiregulin.
Oestradiol decreased PAMP stimulated IL-6 accumulation, but not IL-6 
accumulation by GCs in control medium. These results are not surprising, as it is 
unlikely that basal IL-6 accumulation would be reduced and oestradiol has many 
anti-inflammatory actions on a variety of cell types including bone cells 
(Kurebayashi et al., 1997) and in the brain (Vegeto et al., 2002). Supporting the 
findings of the present study, treatment of murine macrophages with oestradiol 
down-regulates LPS-induced 116 and Tnf expression (Deshpande et al., 1997) and 
dampens the LPS-stimulated production of the chemokine MCP-1 by murine 
macrophages (Frazier-Jessen and Kovacs, 1995). A potential mechanism for this 
dampening is the suppression of NFkB activation, perhaps through influencing 
translocation of the p65 subunit to the nucleus (Ghisletti et al., 2005) or by 
increasing expression of a micro-RNA inhibitor of NFkB (Murphy et al., 2010).
Interestingly, LH increased IL-6 accumulation when GCs were not treated 
with a PAMP, but LH did not increase LPS- or PAM- stimulated IL-6 accumulation. 
Published results supporting this finding that LH increases IL-6 accumulation 
include a study which examined the response of ovarian epithelial and cancer 
cell-lines to treatment with gonadotrophins and noted increased IL6 mRNA and 
protein (Syed et al., 2002). A more recent study mimicked the LH surge using cAMP 
and found this increased 116 mRNA expression in murine GCs (Mack et al., 2012). 
Signalling cascades induced by LH lead to increased production of EGFR ligands 
(Liu et al., 2008). Thus, the increased production of IL-6 by LH could be purely 
because an EGF-like factor is produced. Potentially, the lack of an increased IL-6 
response when GCs are treated with LH in addition to a PAMP compared to PAMP 
treatment alone could be through interference of the PAMP in the cAMP and PKC 
LH signalling pathway, thus preventing the EGFR ligand being produced 
(Freimann et al., 2004).
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In conclusion, bovine GCs from dominant follicles expressed functional 
TLR4 and TLR2, but not TLR5. Granulosa cells produced cellular responses to LPS 
and PAM, with increased expression and accumulation of inflammatory cytokines 
and chemokines, activation of MAPK pathways, and perturbation of steroidogenesis. 
There is potential for the development of therapeutic approaches as the inflammatory 
responses to bacterial PAMPs were blunted using biochemical inhibitors targeting 
NFkB and MAPK. The present study supports the hypothesis that GCs from 
dominant follicles play a role in innate immunity in the ovary.
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Chapter 5 
The impact of bacterial infections 
the oocyte and embryo
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5.1 Introduction
In the previous chapters, the effects of PAMPs on GCs from both emerged 
and dominant follicles were investigated. Lipopolysaccharide collects in the 
follicular fluid of cows with uterine disease (Herath et al., 2007) and GCs respond to 
this LPS, producing IL-6 (chapters 3 and 4). This means that the oocyte is bathed in 
a cocktail of LPS (it is not currently known if other PAMPs collect in follicular 
fluid) and inflammatory mediators. Although the effect of LPS and IL-6 on murine 
oocytes has been investigated (Shimada et al., 2006, Liu et al., 2009), less is known 
about the effect of PAMPs on the bovine oocyte and developing embryo. Thus, it 
was of interest whether PAMPs have a direct effect on the cumulus-oocyte complex 
(COC), or only an effect through perturbed mural granulosa cytokine production.
Ovulation is the process by which an oocyte is released by the dominant 
follicle in response to a surge in LH, released from the pituitary gland. The ovarian 
surface epithelium ruptures, releasing the oocyte surrounded by cumulus cells. The 
remaining mural GCs of the follicle become luteinised and the remainder of the 
primary follicle forms a highly vascularised corpus luteum, which produces 
progesterone. The LH surge induces expression of EGF-like factors by GCs (Park et 
al., 2004), which propagate the LH signal across the follicle to the COC, leading to 
resumption of meiosis in the oocyte and formation of a hyaluronan-rich extracellular 
matrix, necessary for cumulus expansion (Fulop et al., 2003). The LH surge also 
stimulates plasminogen activator, producing bioactive plasmin (LeMaire, 1989), 
which then activates collagenase (Woessner Jr et al., 1989), digesting the follicular 
tissue to form a hole in the follicle wall, through which the COC can ovulate.
Ovulation is similar to an inflammatory response on a number of levels. At 
the gross anatomical level, the site of ovulation appears swollen and red and the 
process damages the ovarian surface epithelium and vasculature, triggering the 
coagulation cascade and remodelling tissue in a similar way to wound repair. At the 
biochemical level, a number of inflammatory mediators, including pro-inflammatory 
cytokines and prostaglandins, are involved in both ovulation and more classical 
inflammation. The cytokine IL-1 induces prostaglandin synthesis (Gerard et al., 
2004) and PGE increases protein levels of plasminogen activator in GCs, which acts 
proteolytically to aid ovulation (Markosyan and Duffy, 2009). Supporting the theory
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that prostaglandins commonly associated with inflammation play a role in follicle 
rupture, inhibitors of prostaglandin synthesis block ovulation (Kaur et al., 1986). 
Prostaglandin E2 (PGE2) also acts in combination with EGF factors to trigger 
cumulus expansion. The chemokine IL-8 is a potent attractant of neutrophils and 
may be involved in follicle rupture and angiogenesis during ovulation (Runesson et 
al., 2000).
A number of studies have identified molecular similarities between ovulation 
and immunity or inflammation. In GCs, LH increases production of EGF factors 
through p38 MAPK and PKA (Yamashita et al., 2009). These then act through the 
EGFR and ERK1/2 pathways to increase expression of mRNA encoding PTGS2 
(also known as COX2), which converts arachidonic acid to prostaglandins 
(Yamashita et al., 2009, Sayasith et al., 2013). These pathways (p38 MAPK and 
ERK1/2) were identified in chapters 3 and 4 as key signals in the response of GCs to 
LPS and PAM. Luteinising hormone also induces genes involved with production of 
hyaluronan rich matrix, such as hyaluronan synthase 2 (HAS2) (Richards, 2005). 
This matrix, which is made during cumulus expansion and which surrounds the 
oocyte, is similar to the matrix generated at sites of tissue injury (Richards et al.,
2008). Cumulus expansion is also dependent on PTGS2 and PTX3, which stabilises 
the hyaluronan matrix (Richards et al., 2008) and, interestingly, also facilitates 
macrophage pathogen recognition through Toll-like receptors (Bottazzi et al., 2006).
An important paper related to the present study was published by Liu et al in 
2009 and examined the effect of IL-6 on murine COCs (Liu et al., 2009). This paper 
reported that expression of 116 is up-regulated just before ovulation and, in vitro, can 
be induced by FSH, EGF-like amphiregulin or PGE2. This in vitro up-regulation was 
blocked using inhibitors for p38 MAPK, MEK or PKA. However, perhaps more 
interesting was the finding that IL-6 is capable of inducing murine COC expansion, 
also increasing expression of Ptgs2, Has2 and Ptx3. In previous chapters, it was 
reported that IL-6 is produced by GCs in response to challenge with bacterial 
PAMPs, which suggests PAMPs could cause inappropriate expansion of the COC 
and oocyte activation. This hypothesis was tested in a recent paper, which treated 
COCs with LPS during in vitro maturation and found that LPS increased expansion 
of COCs and perturbed oocyte meiosis (Bromfield and Sheldon, 2011).
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Previous investigations into the effect of PAMPs on oocyte health have 
focussed on the COC. However, of greater interest is how exposure to PAMPs or 
cytokines within the ovarian follicle during maturation may affect the subsequent 
embryo. Due to difficulties in forming an embryo, and not wanting to introduce LPS 
in semen to the investigations (Teankum et al., 2007, Fujita et al., 2011), the current 
work used parthenotes as a model for embryos. During parthenogenesis, an oocyte is 
activated by inducing calcium oscillations and inhibiting cytosolic protein synthesis. 
The activated oocyte acts as if it has been fertilised, with resumption of meiosis, 
pro-nuclear formation, DNA synthesis and, in cattle, division up to the blastocyst 
stage (Soloy et al., 1997). However, some differences in gene expression have been 
identified with altered expression of genes related to pregnancy (including PLAC8, 
CDX2 and GAB1) and metabolism (including PTGS2) between buffalo embryos 
created through parthenogenesis and embryos created through IVF (Abdoon et al., 
2012). A recent paper examined the effects of IL-6 on porcine parthenogenesis and 
identified a pro-survival effect, with increased expression of the anti-apoptotic 
BIRC5 (also known as SURVIVIN) and decreased expression of BCL2 and CASP3 
(Shen et al., 2012). Other genes found to be affected by IL-6 treatment included 
STAT3, which is involved in IL-6 signalling and is essential for early embryo 
development; POU5F1, which is involved in pluripotency, is necessary for embryo 
development and interacts with the STAT3 negative regulator Sox2, and IL6ST, 
whose protein product forms part of the IL-6 receptor. As it was previously shown 
that GCs produce IL-6 in response to LPS or PAM (chapters 3 and 4), these genes 
were of interest in the current study.
The hypothesis for this chapter was that the presence of PAMPs during IVM 
perturbs COC expansion and parthenogenesis. The aims of this chapter were to 
investigate whether COCs exhibit an innate immune response to PAMP treatment 
during IVM and whether PAMP treatment affects cumulus expansion, oocyte 
maturation or early embryo development. Firstly, COCs were exposed to PAMPs 
during IVM and scored for expansion. The accumulation of pro-inflammatory 
cytokines and chemokines was measured by ELISA and expression of appropriate 
genes estimated by multiplex PCR. After IVM in the presence of LPS or PAM, 
oocytes were activated and cleavage noted over 42 h. After this, expression of key 
genes involved in early embryogenesis was estimated by multiplex PCR.
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5.2 Methods
5.2.1 Cumulus-oocyte complex in  vitro maturation
Cumulus-oocyte complexes (COCs) were pooled from 12 to 25 ovaries and 
washed twice in collection medium without heparin, as described in general methods 
(chapter 2). Healthy COCs with at least 3 layers of cumulus cells were cultured for 
3 h or 24 h in one of 6 treatment groups: i) control IVM medium, ii) IVM medium 
containing 1 pg/ml LPS, iii) IVM medium containing 1 pg/ml PAM, iv) IVM 
medium containing 2.5 pg/ml FSH and 10 pg/ml LH, v) IVM medium containing
2.5 pg/ml FSH, 10 pg/ml LH and 1 pg/ml LPS or vi) IVM medium containing
2.5 pg/ml FSH, 10 pg/ml LH and 1 pg/ml PAM. After 3 h, COCs were lysed with 
buffer RLT for analysis by multiplex PCR. After 24 h, COCs were scored for 
expansion, supernatants were collected and COCs were lysed with buffer RLT for 
analysis of gene expression.
5.2.2 Parthenogenesis and culture of parthenotes
After 24 h IVM, oocytes were stripped of their cumulus cells using 
hyaluronidase and manual pipetting. After 3 washes, the oocytes were activated 
using ionomycin and mitosis induced using DMAP. After a further 3 washes, 
oocytes were cultured for 42 h, before being lysed in 75 pi buffer RLT for analysis 
of gene expression by multiplex PCR. Cell number was recorded at 22 h and 42 h; 
these time points were chosen because they are similar to those used in previous 
investigations into oocyte cleavage and bovine parthenotes activated with the same 
protocol as used in the present work show no difference in cleavage between 42 h 
and 48 h (Susko-Parrish et al., 1994, Ross et al., 2008, Somfai et al., 2010, Liang et 
al., 2011).
5.2.3 ELISA
Accumulation of IL-6 and 1L-8 was measured in the supernatant of COCs 
treated with LPS or PAM, as described in general methods (chapter 2), using a kit 
from Thermo Fisher Scientific (IL-6) and the in-house sensitive IL-8 kit. Two 
technical replicates were used for each sample in each ELISA, from least 4 
experiments.
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5.2.4 RNA extraction, cDNA synthesis and PCR
The COCs were treated with control medium or medium containing 1 pg/ml 
LPS or 1 pg/ml PAM for 3 h or 24 h. Cells were washed once in PBS and lysed 
using 75 pi (for < 1 2  COCs) or 350 pi (for > 1 3  COCs) buffer RLT. Parthenotes 
were collected after 42 h culture and lysed using 75 pi buffer RLT. The cells were 
homogenised using a Qiashredder spin column and RNA was extracted using the 
RNeasy Micro kit, as described in general methods. Total RNA was quantified using 
a Nanodrop spectrophotometer and 1 pg total RNA used to synthesis cDNA, using 
the QuantiTect kit, as described in general methods. For COCs, expression of mRNA 
encoding genes considered as markers of cumulus expansion (HAS2, PTX3) or 
oocyte competence (NLRP5, ZAR1, GDF9) was measured by multiplex PCR, using 
2 technical replicates for each sample from at least 4 experiments. For parthenotes, 
expression of mRNA encoding genes associated with apoptosis (BIRC5, BCL2, 
CASP3), the placenta (GAB1, CDX2, PLAC8), IL-6 (STAT3, POU5F1, I16ST), 
DNMT1, H19 or DUSP1 was measured by multiplex PCR, using 2 technical 
replicates for each sample from at least 4 experiments. Data was normalised to L I9 
for both COCs and parthenotes.
5.2.5 Statistical Analyses
Data are presented as mean + SEM, with statistical analyses performed using 
SPSS (version 16, SPSS Inc) and significance ascribed when P < 0.05. Categorised 
data (COC expansion and parthenote cleavage) were examined using Fisher’s Exact 
Test. Data examining protein accumulation by ELISA were not normally distributed 
thus comparisons were made between treatment and control by Mann Whitney U 
test. Multiplex data were analysed using the ddCT method described in chapter 2 and 
error estimated as previously described (Livak and Schmittgen, 2001). Error was 
estimated by calculating the standard error of CT values for samples and standards 
and adding this error to the mean dCT values to calculate an upper and lower limit 
for ddCT and fold increase. The error of the fold increases was then estimated by 
dividing the difference between the upper and lower limit by the Z value 3.92. Data 
were then analysed using the ANOVA function in GraphPad Prism.
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5.3 Results
5.3.1 Exposure of COCs to PAMPs perturbed in  vitro maturation
Previously, it was reported that exposure of COCs to IL-6 or LPS increased 
cumulus expansion and perturbed oocyte meiosis during in vitro maturation (Liu et 
al., 2009, Bromfield and Sheldon, 2011). Therefore, the present study examined the 
effects of LPS and PAM on cumulus expansion and gene expression. The COCs 
were cultured for 24 h in control medium or medium containing LPS or PAM, in the 
presence or absence of gonadotrophins.
As expected, treatment of COCs with gonadotrophins increased the 
percentage of COCs at stage 3 or 4 and decreased the percentage of COCs at stage 0 
or 1 (with gonadotrophin: 76% at stage 3 or 4; 8% at stage 0 or 1 vs 7% at stage 3 or 
4; 73% at stage 0 or 1 without gonadotrophin; P < 0.001), showing that the COCs 
used were healthy and responded appropriately to gonadotrophin treatment. 
Challenging the COCs with 10 pg/ml LPS in the presence of gonadotrophins 
increased COC expansion to stage 4 (72% vs 45% P < 0.001), but also increased the 
number which were dead or had no response (Fig 5.1, 5.3; 12% vs 3%; P < 0.05). 
However, LPS had no significant effect on expansion when COCs were cultured in 
gonadotrophin-free medium (Fig 5.1, 5.3; P > 0.1). Treatment of COCs with 1 pg/ml 
PAM in the presence of gonadotrophins decreased COC expansion to stage 4 
(Fig 5.2-5.3; 26% vs 45%; P < 0.05). However, there was no effect of 10 pg/ml 
PAM treatment on COC expansion (P < 0.6). Treatment of COCs with 10 pg/ml 
PAM increased the number which were dead or had no response (Fig 5.2-5.3; 
P < 0.05).
5.3.2 Treatment of COCs with PAM during IVM increased accumulation of 
inflammatory mediators
After 24 h IVM, there was no significant effect of LPS on COC accumulation 
of IL-6 or IL-8 (Fig 5.4A, C). In contrast, supernatants collected from COCs treated 
with PAM increased accumulation of IL-6 (Fig 5.4B) and tended towards increased 
accumulation of IL-8 (Fig 5.4D).
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Figure 5.1 Treatment with LPS increased bovine cumulus expansion. Bovine 
COCs were isolated from emerged follicles and matured in vitro in control medium 
(‘C’) or medium containing 1 (‘L I’) or 10 pg/ml LPS (‘L10’) in the absence 
(open bars) or presence (black bars) of 2.5 pg/ml FSH and 10 pg/ml LH. After 24 h, 
cumulus expansion was scored from 0 (A) to 4 (E), with 4 being most expanded. 
Data presented as percentage of COCs at each stage of expansion, based on data 
from at least 6 experiments and expressed as a percentage of the total COCs treated. 
Data differing by Fisher’s Exact Test are denoted with different letters.
184
\ _ u u p i c i  j  ci  i i u  c n i u i  j  v
80-1
60-
o©at
(9 40-m
20-
ac
80'
60
CM0)at
« 40 co
20-
0-
80
60
©at«  40 <o
20
0-
a annn
a a ai i i—
C P1 P10
80-i
60-
© o>
« 40- co
20-
0
80-i
60-o 
© at 2 40^  <o
20H
B a a
I—I b abi , i - T.„. r-p
C P1 P10
c ciii
a  -LH-FSH 
■ I  +LH+FSH
C P1 P10 
Treatment
C P1 P10
Treatment
Figure 5.2 Treatment with PAM decreased bovine cumulus expansion. Bovine 
COCs were isolated from emerged follicles and matured in vitro in control medium 
(‘C’) or medium containing 1 (‘P I ’) or 10 ng/ml PAM (‘P10’) in the absence 
(open bars) or presence (black bars) of 2.5 pg/ml FSH and 10 pg/ml LH. After 24 h, 
cumulus expansion was scored from 0 (A) to 4 (E), with 4 being most expanded. 
Data presented as percentage of COCs at each stage of expansion, based on data 
from at least 5 experiments and expressed as a percentage of the total COCs treated. 
Data differing by Fisher’s Exact Test are denoted with different letters.
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Figure 5.3 The presence of PAMPs during IVM affected cumulus expansion.
Bovine COCs were isolated from emerged follicles and matured in vitro in control 
medium (*C‘) or medium containing 1 or 10 pg/ml LPS or PAM in the absence (A) 
or presence (B) of 2.5 pg/ml FSH and 10 pg/ml LH. After 24 h, cumulus expansion 
was scored from 0 to 4 (with 4 being most expanded). Data presented as percentage 
of COCs at each stage of expansion, based on data from at least 5 experiments and 
expressed as a percentage of the total COCs treated in each group. The number of 
COCs in each treatment group is indicated above each bar. Representative images of 
each stage are shown below the key.
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Figure 5.4 Treatment of COCs with PAM during IVM increased accumulation
of IL-6. Bovine COCs were isolated from emerged follicles and matured in vitro in 
control medium (‘C’) or medium containing 1 or 10 (ig/ml LPS (‘L I’ or ‘L10’) or 
PAM (‘P I’ or ‘P10’) in the absence (open bars) or presence (closed bars) of
2.5 pg/ml FSH and 10 pg/ml LH. After 24 h, supernatants were collected and the 
accumulation of IL-6 (A, B) and IL-8 (C, D) measured by ELISA. Data expressed as 
pg/ml cytokine production per COC and are presented as mean + SEM from at least 
3 replicates. Values differ from control within gonadotrophin group by Mann 
Whitney, P < 0.05. N/D = below limits of detection.
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5.3.3 Exposure of COCs to PAMPs perturbed expression of genes associated 
with cumulus expansion and oocyte quality
As shown in Fig 5.4, treatment of COCs with PAM increased accumulation 
of IL-6. As IL-6 increases murine expression of Has2 and Ptx3 (Liu et al., 2009), the 
present study aimed to address whether treatment of COCs with PAMPs perturbs the 
expression of these genes associated with cumulus expansion or the expression of 
maternal effect genes associated with oocyte quality.
Treatment of COCs with LPS for 3 h decreased expression of PTX3 and 
HAS2, when cells were treated with or without gonadotrophins (Fig 5.5A, B). 
Conversely, treatment of COCs with 10 pg/ml PAM for 3 h increased expression of 
PTX3 and HAS2 (Fig 5.5C, D). Treatment with either LPS (Fig 5.6) or PAM 
(Fig 5.7) for 3 h decreased expression of NLRP5, ZAR1 and GDF9.
After 24 h treatment with PAMPs during IVM, COCs increased expression 
of PTX3 in response to 10 pg/ml LPS (Fig 5.8A) and decreased expression of HAS2 
(Fig 5.8B) in response to either 1 or 10 pg/ml LPS. Treatment of COCs in 
gonadotrophin-free medium containing PAM increased expression of PTX3 and 
HAS2 (Fig 5.8C, D). However, in medium containing gonadotrophin, 1 pg/ml PAM 
decreased expression of HAS2 (Fig 5.8D). After 24 h treatment with LPS, COCs 
decreased accumulation of NLRP5 (Fig 5.9A), ZAR1 (Fig 5.9B) and GDF9 
(Fig 5.9C). In contrast, PAM treatment increased expression of all 3 maternal effect 
genes (Fig 5.10).
188
v _  1 1 u p i v ^ i  y  i c i i i v j  y \ j
<*) 4n
Q.
0) 3-D) c  (0
o 2H 
2  
£
<*>
1-
4n
a.
<D 3-O)c(0
o 2- 
2  
£
® 1-J > 11
s  ©
***
H AI * T I
C L1 L10
i i
P1 P10
□  -LH-FSH 
■  +LH+FSH
L1 L10
CM 4-| 
CO
5
© 3-O)c  (0
o 2-\ 
2  
£
® H
J3 ©
B
CM 4-] <0
2
© 3- o> c  ©
0 2H 
2  
£
1  -I.
JS ©
P1 P10
** ** an
L1 L10
V ‘ " - "'I'
P1 P10
C L1 L10
C P1 P10
Figure 5.5 Treatment of COCs for 3 h with LPS decreased expression of genes 
involved with cumulus expansion; PAM treatment increased expression of these 
genes. Bovine COCs were isolated from emerged follicles and matured in vitro in 
control medium (‘C’) or medium containing 1 or 10 pg/ml LPS (‘L I’ or ‘L10’) or 
PAM (‘P I’ or ‘P10’) in the absence (open bars) or presence (closed bars) of
2.5 pg/ml FSH and 10 pg/ml LH. After 3 h culture, COCs were lysed, RNA 
extracted and the expression of PTX3 (A, C) and HAS2 (B, D) estimated by 
multiplex PCR. Data represented as mean plus estimated error, relative to control, 
from at least 4 independent experiments and differ from control within group 
by ANOVA, followed by Dunnett’s multiple comparison post-hoc T-test, 
* P < 0.05, ** P < 0.01, *** P < 0.001
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Figure 5.6 Treatment of COCs for 3 h with LPS decreased expression of 
maternal effect genes associated with oocyte quality. Bovine COCs were isolated 
from emerged follicles and matured in vitro in control medium (‘C’) or medium 
containing 1 or 10 pg/ml LPS (‘L I’ or ‘L10’) in the absence (open bars) or presence 
(closed bars) of 2.5 pg/ml FSH and 10 pg/ml LH. After 3 h culture, COCs were 
lysed, RNA extracted and the expression of NLRP5 (A), ZAR1 (B) and GDF9 (C) 
estimated by multiplex PCR. Data represented as mean plus estimated error, relative 
to control, from at least 4 independent experiments and differ from control within 
group by ANOVA, followed by Dunnett’s multiple comparison post-hoc T-test, 
** P<0.01, *** P <  0.001
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Figure 5.7 Treatment of COCs for 3 h with PAM decreased expression of 
maternal effect genes associated with oocyte quality. Bovine COCs were isolated 
from emerged follicles and matured in vitro in control medium (‘C’) or medium 
containing 1 or 10 pg/ml PAM (‘P I’ or ‘P10’) in the absence (open bars) or presence 
(closed bars) of 2.5 pg/ml FSH and 10 pg/ml LH. After 3 h culture, COCs were 
lysed, RNA extracted and the expression of NLRP5 (A), ZAR1 (B) and GDF9 (C) 
estimated by multiplex PCR. Data represented as mean plus estimated error, relative 
to control, from at least 5 independent experiments and differ from control within 
group by ANOVA, followed by Dunnett’s multiple comparison post-hoc T-test, 
** P < 0.01, ***P <  0.001
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Figure 5.8 Treatment of COCs for 24 h with LPS or PAM impacted expression 
of genes involved with cumulus expansion. Bovine COCs were isolated from 
emerged follicles and matured in vitro in control medium (‘C’) or medium 
containing 1 or 10 pg/ml LPS (‘L I’ or ‘L10’) or PAM (‘P I’ or ‘P10’) in the absence 
(open bars) or presence (closed bars) of 2.5 pg/ml FSH and 10 pg/ml LH. After 24 h 
culture, COCs were lysed, RNA extracted and the expression of PTX3 (A, C) and 
HAS2 (B, D) estimated by multiplex PCR. Data represented as mean plus estimated 
error, relative to control, from at least 4 independent experiments and differ from 
control within group by ANOVA, followed by Dunnett’s multiple comparison 
post-hoc T-test, * P < 0.05, ** P < 0.01, *** P < 0.001
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Figure 5.9 Treatment of COCs for 24 h with LPS decreased expression of 
maternal effect genes associated with oocyte quality. Bovine COCs were isolated 
from emerged follicles and matured in vitro in control medium (‘C’) or medium 
containing 1 or 10 ng/ml LPS (‘L I’ or ‘L10’) in the absence (open bars) or presence 
(closed bars) of 2.5 |xg/ml FSH and 10 pg/ml LH. After 24 h culture, COCs were 
lysed, RNA extracted and the expression of NLRP5 (A), ZAR1 (B) and GDF9 (C) 
estimated by multiplex PCR. Data represented as mean plus estimated error, relative 
to control, from at least 4 independent experiments and differ from control within 
group by ANOVA, followed by Dunnett’s multiple comparison post-hoc T-test, 
* P < 0.05, ** P < 0.01, *** P < 0.001
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Figure 5.10 Treatment of COCs for 24 h with PAM increased expression of 
maternal effect genes associated with oocyte quality. Bovine COCs were isolated 
from emerged follicles and matured in vitro in control medium (‘C’) or medium 
containing 1 or 10 pg/ml PAM (‘P I’ or ‘P10’) in the absence (open bars) or presence 
(closed bars) of 2.5 pg/ml FSH and 10 pg/ml LH. After 24 h culture, COCs were 
lysed, RNA extracted and the expression of NLRP5 (A), ZAR1 (B) and GDF9 (C) 
estimated by multiplex PCR. Data represented as mean plus estimated error, relative 
to control, from at least 4 independent experiments and differ from control within 
group by ANOVA, followed by Dunnett’s multiple comparison post-hoc T-test, 
** P < 0.01, * * * P <  0.001
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5.3.4 Exposure of COCs to PAMPs during IVM increased parthenote cleavage 
rate
In the present study, the effect of bacterial infection on ovarian health prior to 
ovulation was of interest. Therefore, COCs were matured in vitro in control medium 
or medium containing LPS or PAM before activating with ionomycin and DMAP. 
The oocytes which had undergone IVM in the presence of LPS tended towards 
increased cleavage rate after 22 h (Fig 5.11 A; 20% vs 12%; P < 0.06). After 42 h, 
IVM with either LPS or PAM increased cleavage rate (Fig 5.12B; P < 0.01).
5.3.5 Exposure of COCs to PAMPs during IVM perturbed expression of genes 
necessary for normal embryo development
Cumulus-oocyte complexes were treated with PAMPs during IVM, activated, 
cultured for 42 h and the expression of genes necessary for normal embryo 
development measured by multiplex PCR. The expression of ZAR1 (Fig 5.13A) and 
GDF9 (Fig 5.13B) was increased by treatment with PAM. Treatment with LPS 
tended towards increased expression of GDF9 (Fig 5.13B; P < 0.06).
Treatment with PAM decreased expression of CASP3 (Fig 5.14A) but there 
was no significant effect of LPS or PAM treatment on expression of DUSP1 
(Fig 5.14B) or GAB1 (Fig 5.14C). Although primers for NLRP5, BCL2, BIRC5, 
CDX2, PLAC8, STAT3, POU5F1, H19 and DNMT1 worked with positive control 
cDNA, expression of these genes in COC samples could not be detected except 
STAT3, BIRC5 and H I9 could be detected in 3 out of 5 samples treated with PAM.
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Figure 5.11 The presence of PAMPs during IVM increased cleavage of 
activated oocytes during parthenogenesis. Bovine COCs were isolated from 
emerged follicles and matured in vitro in medium containing 2.5 pg/ml FSH and 
10 pg/ml LH (‘C’) or 10 pg/ml LPS or PAM in gonadotrophin-containing medium. 
After 24 h, COCs were stripped with hyaluronidase and activated using ionomycin 
and DMAP. After 22 h (A) and 42 h (B) culture in embryo culture medium, the 
number of cells in each parthenote were counted. Data presented as percentage of 
parthenotes with 1, 2, 3 or > 4 cells, based on data from at least 5 experiments. The 
number of parthenotes in each treatment group is indicated above each bar.
1 9 6
LPS PAM LPS PAM
Figure 5.12 In  vitro  maturation of COCs in the presence of PAMPs increased 
parthenote expression of maternal effect genes associated with oocyte quality.
Bovine COCs were isolated from emerged follicles and matured in vitro in medium 
containing 2.5 pg/ml FSH and 10 pg/ml LH (‘C’) or 10 pg/ml LPS or PAM in 
gonadotrophin-containing medium. After 24 h, COCs were stripped with 
hyaluronidase and activated using ionomycin and DMAP. After a further 42 h 
culture in embryo culture medium, RNA was extracted and the expression of ZAR1 
(A) and GDF9 (B) estimated by multiplex PCR. Data represented as mean plus 
estimated error, relative to control, from 5 independent experiments and differ from 
control within group by ANOVA, followed by Dunnett’s multiple comparison 
post-hoc T-test, * P < 0.05, ** P < 0.01
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Figure 5.13 In  vitro  maturation of COCs in the presence of PAMPs had little 
effect on parthenote expression of genes associated with apoptosis or placenta 
development. Bovine COCs were isolated from emerged follicles and matured in 
vitro in medium containing 2.5 pg/ml FSH and 10 pg/ml LH (‘C’) or 10 pg/ml LPS 
or PAM in gonadotrophin-containing medium. After 24 h, COCs were stripped with 
hyaluronidase and activated using ionomycin and DMAP. After a further 42 h 
culture in embryo culture medium, RNA was extracted and the expression of 
CASP3 (A) DUSP1 (B) and GAB1 (C) estimated by multiplex PCR. Data 
represented as mean plus estimated error, relative to control, from 5 independent 
experiments and differ from control within group by ANOVA, followed by 
Dunnett’s multiple comparison post-hoc T-test, * P < 0.05, ** P < 0.01
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5.4 Discussion
Bacterial infections of the uterus or mammary gland perturb ovarian follicle 
growth, endocrine function and ovulation (Sheldon et al., 2002, Lavon et al., 2011a, 
Lavon et al., 2011b). Lipopolysaccharide has been found in the follicular fluid from 
follicles of cows with uterine disease (Herath et al., 2007) and bovine GCs respond 
to LPS, producing IL-6 (Bromfield and Sheldon, 2011). Interleukin-6 causes murine 
cumulus expansion and increases expression of genes involved in this cumulus 
expansion and oocyte maturation (Liu et al., 2009). So, the present study considered 
whether the bovine oocyte and subsequent embryo are affected by the presence of 
PAMPs in follicular fluid. The presence of LPS or PAM during IVM perturbed 
cumulus expansion and increased production of inflammatory mediators by the 
COCs. The expression of genes involved in maturation including HAS2 and PTX3 
was perturbed after 3 h or 24 h treatment with either PAMP. The expression of 
maternal effect genes associated with oocyte quality (NLRP5, ZAR1, GDF9) was 
decreased after 3 h or 24 h treatment with LPS or PAM. Interestingly, the presence 
of PAMPs during IVM increased cleavage rate and increased expression of ZAR1 
and GDF9 in the subsequent parthenote. However, there was little effect of PAMPs 
on expression of genes involved in apoptosis or placental development, except for 
expression of GDF9, which was increased after 24 h PAM treatment. The 
perturbation of oocyte maturation and early embryogenesis by PAMPs provides the 
basis for understanding how infections distal to the ovary may affect oocyte health 
and why a healthy embryo may not develop despite ovulation occurring.
To the best of the author’s knowledge, this is the first study examining the 
effects of pathogen-associated molecular patterns on oocyte gene expression and 
development. A recent paper investigated the effects of LPS exposure during IVM 
on bovine oocyte cumulus expansion and maturation and found that LPS increased 
accumulation of IL-6 by COCs, increased rates of cumulus expansion in the absence 
of FSH and increased rates of meiotic failure (Bromfield and Sheldon, 2011). In 
contrast, the present study reported that LPS had a significant effect on cumulus 
expansion in the presence, but not the absence of gonadotrophin. In the 2011 study, 
around 90% of COCs expanded in the presence of gonadotrophin. In contrast, in the 
present study, only 50% of COCs expanded in the presence of gonadotrophin and
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absence of LPS. Regardless, both studies showed that LPS perturbed cumulus 
expansion. However, further experiments are necessary to determine the magnitude 
of the effect of LPS. Potentially, it is an interaction between LH and LPS which 
increases COC expansion, decreasing the role of FSH. Supporting the theory of 
crosstalk between innate immune signalling pathways and the FSH-receptor 
pathway, FSHR is required for innate immunity in Caenorhabditis elegans and it 
was previously hypothesised that the FSH-receptor may play a role in granulosa 
pathogen response (Powell et al., 2009). Is it possible that LPS may signal through 
the FSH receptor, perhaps binding in concert with LH? Supporting this theory, 
ovulatory concentrations of LH can activate FSHR in fish, although this is less 
common in mammals (Andersson et al., 2009). Potentially, LPS increases the 
affinity of the FSHR for LH. An alternative theory is that LPS increases 
accumulation of IL-6 which then causes COC expansion, as it has previously been 
shown to do in mouse (Liu et al., 2009). However, in the present study, PAM rather 
than LPS increased accumulation of IL-6, but did not increase cumulus expansion.
The present study reported that LPS decreased and PAM increased 
expression of HAS2 and PTX3 necessary for cumulus expansion when COCs were 
treated for 3 h. After 24 h, expression of PTX3 was increased by either LPS or PAM 
treatment. However, the effect of 24 h PAMP treatment on expression of Has2 
varied depending on whether COCs were cultured with or without gonadotrophin, 
with LPS decreasing HAS2 expression stimulated by gonadotrophin and PAM 
increasing HAS2 expression of COCs in gonadotrophin-free medium but decreasing 
HAS2 expression when using gonadotrophin-containing medium. These results were 
unexpected because LPS increased expansion but mostly decreased expression of 
genes associated with expansion, suggesting that LPS may trigger expansion through 
atypical pathways. A link between hyaluronan (synthesised via Has2) and TLRs was 
previously identified when it was reported that hyaluronan binds TLR2 and TLR4 
and induces expression of 116 in murine COCs (Shimada et al., 2008). However, 
these results should be explored with caution because of the difficulty in obtaining 
ultrapure hyaluronan free from contaminating PAMPs. It was interesting that LPS 
and PAM increased expression of PTX3 because PTX3 facilitates recognition of 
pathogens by macrophages (Mantovani et al., 2003) and is induced by LPS treatment 
of human neutrophils or macrophages (Imamura et al., 2007). Thus, potentially
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PTX3 could also aid in sensing of pathogens by cumulus-oocytes complexes. This is 
an interesting hypothesis as Toll was originally discovered in Drosophila as an 
essential receptor for the establishment of the dorsal-ventral pattern in developing 
embryos (Anderson et al., 1985) and was later found to play a role in innate 
immunity (Lemaitre et al., 1996).
Another interesting link between innate immunity and embryo development 
is the Nod-like receptor family, of which NLRP5 is a member, which are involved 
with intracellular sensing of PAMPs. During bovine oocyte development, NLPR5 is 
first detected in oocytes from primary follicles and accumulates during oocyte 
growth, before depletion after fertilisation with 5-8 cell embryos only having 10% of 
the initial expression levels (Pennetier et al., 2006). Although embryos from Zarl'1' 
knockout mice mostly arrest prior to cleavage (Wu et al., 2003), bovine ZAR1 is 
expressed in the oocyte and embryo until blastocyst formation, with upregulation at 
the 4-cell stage, suggesting that the embryo also expresses ZAR1 (Brevini et al., 
2004). Similarly to the other two maternal effect genes, GDF9 is expressed 
throughout oocyte development and embryo growth, with levels falling until 
blastocyst formation, when there is no detectible expression (Pennetier et al., 2004). 
In the present study, treatment of COCs with LPS or PAM during IVM generally 
decreased COC expression of NLRP5, ZAR1 or GDF9, although it was interesting 
that 24 h PAM treatment increased expression of GDF9 in both COCs and 
subsequent parthenotes. Experiments using rats show that GDF9 is anti-apoptotic 
during follicular growth (Orisaka et al., 2006). Thus this increased expression of 
GDF9 may be associated with cell survival. Supporting this theory, PAM decreased 
expression of pro-apoptotic CASP3. Depletion of NLRP5 suppresses embryogenesis 
(Wu, 2009), thus the decrease in expression of the maternal effect genes by PAMPs 
may be a protective mechanism to prevent embryo development in an infected 
environment. However, it seems more likely that decreased NLRP5, ZAR1 and 
GDF9 expression is a carryover effect from the increased rate of maturation 
stimulated by PAMP treatment and could thus perturb synchronisation between 
embryo and uterus, and could therefore impact on establishment of pregnancy.
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The present study investigated the effects of LPS and PAM on the bovine 
oocyte and early embryo. The presence of PAMPs during IVM is a biologically 
relevant problem, as cows with uterine disease collect LPS in the follicular fluid of 
ovarian dominant follicles (Herath et al., 2007). It was found that treatment of COCs 
with LPS or PAM increased cumulus expansion and accelerated oocyte 
development, with a knock-on effect on subsequent parthenotes developed from 
treated COCs, which had increased cleavage rates. Although the results published 
here are mainly observational, rather than mechanistic, this appears to be the first 
study investigating the effects of infection on expression of key genes in oocyte 
development. Further investigations, with a greater number of replicates, will 
hopefully elucidate some of the findings of this study and determine whether 
exposure to PAMPs during cumulus expansion and oocyte maturation affects 
blastocyst formation or successful embryo genesis.
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Chapter 6 
Toward a model for 
human ovarian cells
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6.1 Introduction
The previous chapters report data about the impact of PAMPs on GCs, 
cumulus-oocyte complexes and early development of the embryo in cattle. So, the 
next question was whether these observations in cattle apply to other species. In 
trout, LPS administration has no effect on ovarian steroid production or oocyte 
maturation (MacKenzie et al., 2006), but leads to a significant increase in TNF 
expression in the whole ovary (Crespo et al., 2010). Avian GCs express functional 
TLRs and treatment with LPS has effects on their steroidogenesis (Woods et al.,
2009) and expression of genes associated with inflammation, including IL6 and IL1B 
(Abdelsalam et al., 2011). Lipopolysaccharide induces expression of Cxcll and 
Cxcl2 chemokines in murine GCs (Son and Roby, 2006), significantly decreases 
accumulation of oestradiol by LH-stimulated rat GCs (Taylor and Terranova, 1996) 
and increases production of IL-6 by murine GCs (Gorospe and Spangelo, 1993). The 
presence of LPS in culture medium during human in-vitro fertilisation significantly 
decreases incidence of pregnancy (Fishel et al., 1988) and treatment of human GCs 
with LPS increases expression and secretion of TNFa (Sancho-Tello et al., 1992). 
Pelvic inflammatory disease leads to infertility in 100,000 American women each 
year (N.I.A.I.D, 2009), thus it was important to investigate the effects of infection on 
human ovarian cell health. The most evident responses in previous chapters were by 
the GCs (chapters 3 & 4) rather than embryos in cattle; and working with human 
oocytes and embryos was not practical or ethical in the present thesis, so a human 
granulosa cell line was used in this chapter.
The cell line COV434 was established from a primary human granulosa cell 
tumour (van den Berg-Bakker et al., 1993). The COV434 cell line has several 
features considered essential for normal granulosa cell function, including the 
production and secretion of oestradiol after treatment with FSH and androstenedione; 
stimulation of cell growth by FSH, and communication between COV434 cells and 
cumulus oophorus cells containing a viable oocyte (Zhang et al., 2000). The use of a 
granulosa cell line to study responses to PAMPs avoids the common confounder of a 
mixed population of cells, including immune cells, associated with human ovarian 
follicle aspiration (Fedorcsak et al., 2007). However, using a cell line is less 
physiologically relevant as the cells are not primary cells; for example, some
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apoptosis-related genes are expressed by primary GCs but not by COV434 cells 
(Zhang et al., 2000). It was thus necessary to validate whether the COV434 cell line 
was suitable for investigating the effects of infection and inflammation, in particular 
whether the cell line expresses pattern recognition receptors, and whether the 
function of the COV434 cells is perturbed by treatment with PAMPs.
Macrophages are professional immune cells and express TLRs and respond 
to PAMPs (Fu Qiu et al., 2011). Therefore, a human monocytic cell line was used as 
a positive control to verify that the techniques used were suitable. The THP-1 cell 
line was derived from peripheral blood of a patient with acute monocytic leukaemia 
(Tsuchiya et al., 1980). These cells are cultured as monocytic cells in suspension but 
readily differentiate into a macrophage-like cell after treatment with phorbol-12- 
myristate-13-acetate (PMA).
The hypothesis tested in this chapter was that the human granulosa cell line 
COV434 expresses TLRs and can mount an inflammatory response to pathogen 
associated molecules. The aim of this chapter was to investigate whether the 
COV434 cell line expressed TLRs at the mRNA level. Functionality of the receptors 
was then tested by challenging the COV434 cells with PAMPs and measuring the 
inflammatory response of the cells after acute exposure, at the RNA level, and also 
after 24 h, at the protein level. This work concentrated on two prototypical cytokines 
(IL-6 and IL-ip) and two prototypical chemokines (IL-8 and CCL5). The effect of 
PAMPs on the physiological health of the cells was also studied by examining the 
effect of PAMPs on oestradiol production by COV434 cells treated with FSH and 
androstendione. Initial work determined suitable cell culture conditions for PAMP 
treatment, and then the response of COV434 and THP-1 cells to PAMPs was 
measured at the RNA and protein level.
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6.2 Methods
6.2.1 Culture of a human granulosa cell-line
The COV434 cells were cultured as described in chapter 2. After seeding 
cells and allowing them to equilibrate for 24 h, medium was aspirated from each 
well and 1 ml treatment or control medium added. After the period of time stated 
below, supernatants were removed and stored at -20°C, and the cells were either 
discarded or stored at -80°C in buffer RLT for RNA extraction. For some 
experiments, cells were cultured in the presence of 1 ng/ml or 100 ng/ml bovine 
FSH, which activates human FSH receptors (Aizen et al., 2012) and is 80% similar 
to human FSH (Gharib et al., 1989), and 2864.1 ng/ml androstenedione (Sigma); 
concentrations used previously (Zhang et al., 2000).
6.2.2 Culture of THP-1 human monocytic cell-line
The THP-1 cells were cultured as described in chapter 2. After differentiating 
into a macrophage phenotype using 5 ng/ml PM A, cells were washed in 0.5 ml PBS 
and incubated for 3 h in control THP-1 medium. Medium was aspirated from each 
well and 1 ml treatment or control medium added. After treatment, supernatants were 
removed and stored at -20°C and cells were either discarded or stored at -80°C in 
buffer RLT (Qiagen) for RNA analysis.
6.2.3 Treatments
The COV434 cells were first seeded at 1x10s cells/ml to 4xl06 cells/ml 
(1x10s, 2xl05, 5x10s, lxlO6, 2xl06, 4xl06 cells/ml) and challenged for 24 h with 
1 pg/ml ultrapure LPS from E. coli 0111:B4 (Invivogen, San Diego, USA) or 
control medium, to identify the most appropriate cell density. Subsequent 
experiments were carried out using a cell density of 5xl05 cells/ml. To explore 
accumulation of inflammatory mediators, the COV434 cells were treated for 0, 2, 4, 
8, 24, 30 or 48 h with control media or LPS; although PAMP treatments were 
applied for 24 h in all subsequent experiments. Thus, for analysis of inflammatory 
mediator responses by mRNA or protein, the COV434 and THP-1 cells were treated 
for 3 or 24 h, respectively, with control medium or medium containing 1 pg/ml 
ultrapure LPS from E. coli 0111:B4 (Invivogen), 1 pg/ml lipoteichoic acid (LTA; 
purified from S. Aureus\ Invivogen), 1 pg/ml peptidoglycan (PGN; from Bacillus
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subtilis; Invivogen), 1 pg/ml bacterial DNA (DNA; from E. coli K12\ Invivogen), 
0.1 ng/ml recombinant flagellin (FLA; Invivogen), 10 ng/ml hyaluronic acid 
(HA; Calbiochem, San Diego, USA) or 20 ng/ml human TNFa (Miltenyi Biotech, 
Cologne, Germany); the latter was used as a positive control because TNFa affects 
granulosa cell steroidogenesis and IL-6 production (Spangelo et al., 1995). In some 
experiments, COV434 cells were also treated with inhibitors of the TLR pathway for 
24 h: 4 pM NFkB activation inhibitor Insolution, 10 pM p38 MAPK inhibitor 
(SB230580), 1 pM MEK inhibitor (U0126), 10 pM ERK activation inhibitor peptide 
1 or 50 pM JNK inhibitor II (all Calbiochem).
6.2.4 Storage of cell lines
The COV434 cells were washed in PBS (Sigma), detached from the culture 
flask using 1.8 ml Accutase (Gibco) and re-suspended in 2 ml normal medium 
supplemented with 10% DMSO (Sigma). To freeze THP-1 cells, the suspension was 
centrifuged (Eppendorf 5810R, Cambridge, UK) at 1800 x g for 5 min and the 
supernatant discarded. The cells were then resuspended in 4 ml freezing medium 
(21 ml normal medium plus 3 ml DMSO (Sigma) plus 6 ml FCS (Biosera). Cell 
suspensions were transferred into cryovials (Elkay, Basingstoke, UK) and placed in a 
-l°C/min propranol-based cell freezing container (Nalgene, Roskilde, DK) for 24 h 
and then into a liquid nitrogen freezer.
6.2.5 Effect of treatments on cell viability, apoptosis and cytotoxicity
The COV434 cells were plated at 2xl04 cells/well in 100 pi medium in an 
opaque-walled, clear-bottomed 96-well plate (Greiner Bio One). After 24 h culture, 
they were treated for a further 24 h with control medium or medium containing FSH 
(1 or 100 ng/ml), LPS, PGN, LTA (1 pg/ml), FLA (0.1 ng/ml), TNFa (20 ng/ml), 
NFkB inhibitor (0.004-40 pM), p38 MAPK, ERK1/2 inhibitor (0.01-100 pM), 
MEK inhibitor (0.001 -  10 pM) or JNK inhibitor (0.05-500 pM). Staurosporine 
(10 pM for 4 h) and digitonin (30 pg/ml for 15 min) were used as positive controls. 
An ApoTox-Glo Triplex assay (Promega, Madison, USA) was used to assess the 
effect of each treatment on cell viability, apoptosis and necrosis, as described in 
chapter 2.
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6.2.6 RNA extraction, cDNA synthesis and PCR
Expression of mRNA for TLR1-10 was identified using the TLR RT-Primer 
Set (Invivogen), GoTaq Flexi DNA Polymerase kit (Promega) and dNTPs 
(Promega). PCR conditions were as described in the primer set instructions 
(Invivogen; 95 °C for 2 min, followed by 35 cycles (95°C for 30 s, 60°C for 30 s, 
72°C for 2 min), followed by 72°C for 2 min and hold at 16°C). Following 
amplification, products were assessed on a 2% agarose gel (containing 0.8% 
ethidium bromide) by electrophoresis, as described in chapter 2. Images were 
collected using the GelDoc 2000 system and associated software (Biorad, Hemel 
Hempstead, UK).
Real-time quantification of IL8, IL6 and IL1B relative to the reference gene 
ACTB were performed using the QuantiFast SYBR green kit (Qiagen) and the 
iCycler iQ thermal cycler (Biorad). PCR conditions and primer sequences are 
described in chapter 2.
6.2.7 ELISA
The accumulation of IL-6, IL-ip, IL-8 and CCL5 were measured in the 
supernatant of COV434 and THP-1 cells, using kits from R&D Systems, as 
described chapter 2.
Accumulation of oestradiol was measured in the supernatants of COV434 
cells using an ELISA method kindly detailed by Jane Brown, Sue Walker and Karen 
Steinman at the Conservation and Research Centre, Smithsonian’s National 
Zoological Park, Viriginia, USA and is a similar method to that used in the literature 
(Walker et al., 2002, Atsalis et al., 2004, Lueders et al., 2009, Pollock et al., 2010). 
The method for this ELISA is described in chapter 2.
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6.2.8 Statistical analyses
Due to variation in the accumulation of cytokines in COV434 supernatants 
between passages, all data on COV434 cells is represented as percentage of control. 
For time and cell density experiments, data is shown as percentage control at the 
highest time or density for each culture because at 0 h or low cell density, 
accumulation of cytokine was sometimes below the limit of detection for the test. 
Significance was ascribed when P < 0.05 except when the Mann-Whitney U test was 
used, when P < 0.05 was regarded as significant. For experiments when a trend was 
expected (experiments using increasing cell density or culture time), the Jonckheere- 
Terpstra test was used, which is similar to Mann Whitney U test but for greater than 
2 samples and used when a trend is expected (Bewick et al., 2004). Further details of 
statistical tests used are in figure legends.
209
—  1 1 U 1 1 1 C 4 I 1  ^ l U J J U I U O U  v v l J  J J I l v
6.3 Results
6.3.1 Determining the optimum cell density at which to culture COV434 cells
There does not seem to be a published consensus on the optimum cell density 
to grow COV434 cells, particularly with regards to measuring cytokine output. To 
determine this, COV434 cells were cultured at 4xl06, 2xl06, lxlO6, 5x10s, 2.5x105 
or 1.25xl05 cells/ml for 24 h in a 24-well plate, either in control medium or medium 
containing 1 pg/ml ultrapure LPS. There was no detectable accumulation of IL-6 or 
IL-ip in the supernatants of the COV434 cells, as measured by ELISA. 
Accumulation of CCL5 was mostly below the limit of detection for the assay, 
although there was some accumulation of CCL5 at the higher cell densities. 
Increasing cell density increased accumulation of IL-8 by cells in control medium 
(Fig. 6.1 A). Treatment with medium containing 1 pg/ml LPS had no effect on IL-8 
accumulation (P = 0.968). Subsequent experiments used 5x10s cells/ml because this 
was the highest density at which the cells could be plated without medium becoming 
exhausted during 48 h culture. Interestingly, COV434 cells constitutively produced 
IL-8, although this decreased with passage number (Fig. 6.IB).
6.3.2 Determining the optimum duration for COV434 cell culture
COV434 cells were plated at 5x10s cells/ml in a 24-well plate for 0, 2, 4, 8, 
24, 30 or 48 h and treated with control medium or medium containing 1 pg/ml 
ultrapure LPS or 20 ng/ml TNFa. The accumulation of IL-8 increased over time for 
all treatment groups (Fig. 6.1C). There was no treatment effect for LPS (P = 0.821). 
However, there was a significant effect of TNFa treatment at 48 h 
(P < 0.05; Fig. 6. ID). For subsequent experiments, COV434 cells were cultured for 
24 h because the concentration of IL-8 in the supernatants of the cells cultured for 
24 h is above the limit of detection for the ELISA, yet still allows for a stimulated 
increase in IL-8 accumulation to be detected.
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Figure 6.1 COV434 cells constitutively produced IL-8. (A) COV434 cells were 
cultured at 1.25xl05, 2.5xl05, 5x10s, lxlO6, 2xl06 or 4xl06 cells/ml for 24 h in 
control medium; supernatants were collected and the concentration of IL-8 
determined by ELISA. Data are presented as mean + SEM of 3 independent 
experiments relative to 4xl06 cells/ml. Values differ from 1.25x10s cells/ml by 
Mann-Whitney U test, * P < 0.05. (B) Supernatants from untreated COV434 cells 
were collected at passages 3, 4, 6 and 7 and the concentration of IL-8 determined by 
ELISA. Data are presented as mean + SEM from duplicate wells from 1 experiment. 
(C) COV434 cells were cultured for 0, 2, 4, 8, 24, 30 or 48 h in control medium; 
supernatants were collected and the concentration of IL-8 determined by ELISA. 
Data are presented as mean + SEM of 3 independent experiments expressed as 
percentage of value at 48 h. Values differ from 0 h by Mann-Whitney U test, 
* P < 0.05, ** P < 0.01. (D) COV434 cells were treated for 0, 2, 4, 8, 24, 30 or 48 h 
in control medium (□) or with 20 ng/ml TNFa (■); supernatants were collected and 
the concentration of IL-8 determined by ELISA. Data are presented as mean + SEM 
of 3 independent experiments relative to the control treatment at 48 h. Values differ 
between treatments by Mann-Whitney U test, * P < 0.05.
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6.3.3 COV434 cells expressed T L R s 4-10
Analysis by qPCR showed that COV434 cells expressed mRNA for 
TLR4-10, but not TLR1-3. As expected, the THP-1 cells expressed mRNA for 
TLR1-10 (Fig. 6.2).
6.3.4 Initial PAMP panel
In an initial experiment, COV434 and THP-1 cells were treated for 3 or 24 h 
with LPS, LTA, PGN, DNA, FLA, HA or TNFa in order to decide which treatments 
to carry on to further experiments. Accumulation of IL-8, IL-6, IL-ip and CCL5 was 
measured by ELISA and expression of IL6, IL8 and IL1B was measured by qPCR. 
At the mRNA level, LPS, LTA, PGN and DNA increased expression of IL1B by 
COV434 cells (Fig. 6.3B) and LTA, PGN, FLA and HA increased expression of IL6, 
IL1B and IL8 by THP-1 cells (Fig. 6.3D-F). At the protein level, only the positive 
control TNFa stimulated a response in COV434 cells (Fig. 6.4A-D), whereas LPS, 
LTA, PGN, HA and TNFa caused increased accumulation of pro-inflammatory 
cytokines in THP-1 cells (Fig. 6.5A-D). From this initial treatment panel, LPS, LTA, 
PGN, FLA and TNFa were taken forward as treatments for subsequent experiments.
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Figure 6.2 COV434 cells expressed TLR4-10. Photographs of representative 
electrophoresis gels of qPCR products visualised using ethidium bromide. 
Expression of TLR4-10 was evident in untreated COV434 cells and expression of 
TLR1-10 in untreated THP-1 cells. Double-stranded DNA, provided with the 
Inviogen primers was used as a positive control and water was used as a negative 
control (-ve). Images are representative of results obtained from RNA extracted on 3 
separate occasions. A 100 bp DNA ladder (Promega) is shown on the left and right 
hand side of each gel.
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Figure 6.3 mRNA responses by COV434 and THP-1 cells to an initial PAMP 
panel. COV434 (A-C) and THP-1 cells (D-F) were treated with control medium 
(‘C’) or medium containing LPS, LTA, PGN, DNA (all 1 jig/ml), 0.1 pg/ml FLA or 
10 pg/ml HA for 3 h. Expression of IL8 (A, D), IL6 (B, E) and IL1B (C, F) mRNA 
was measured by real-time PCR. Data is presented as mean of duplicate wells from 
one initial experiment, relative to control. N/D = below limits of detection.
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Figure 6.4 Protein responses of COV434 cells to an initial PAMP panel.
COV434 cells were treated for 24 h with control medium (‘C’) or medium 
containing LPS, LTA, PGN, DNA (all 1 ng/ml), 0.1 (ig/ml FLA, 10 pg/ml HA or 
20 ng/ml TNFa. Accumulation of IL-6 (A), IL-lp (B), IL-8 (C) and CCL5 (D) was 
measured in the supernatants by ELISA. Data is presented as mean of duplicate wells 
from one initial experiment. N/D = below limits of detection.
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Figure 6.5 Protein responses of THP-1 cells to an initial PAMP panel. THP-1 
cells were treated for 24 h with control medium (‘C’) or medium containing LPS, 
LTA, PGN, DNA (all 1 pg/ml), 0.1 pg/ml FLA, 10 pg/ml HA or 20 ng/ml TNFa. 
Accumulation of EL-6 (A), IL-ip (B), IL-8 (C) and CCL5 (D) was measured in the 
supernatants by ELISA. Data is presented as mean of duplicate wells from one initial 
experiment.
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6.3.5 Response of COV434 cells to PAMPs
In an initial experiment, none of the treatments had an effect on cell viability, 
cytotoxicity or apoptosis as measured using the ApoTox Glo Triplex Assay 
(Fig. 6.6A-C). In subsequent experiments, an MTT test was used to assess 
cell viability; PAMP treatment did not significantly affect cell viability 
(Fig. 6.7D; P > 0.2). Treatment of COV434 cells with PAMPs for 3 h significantly 
increased IL1B expression (all treatments P < 0.05; Fig. 6.7A), but expression of IL8 
was highly variable (Fig. 6.7B). COV434 cells did not express detectable IL6 
mRNA. Treatment of COV434 cells with PAMPs for 24 h did not significantly 
increase IL-8 accumulation, although treatment with TNFa increased IL-8 
production (Fig. 6.7C; P < 0.001). None of the treatments increased the 
accumulation of IL-lp, IL-6 or CCL5 above the limits of detection of the assay, 
except that treatment with TNFa increased CCL5 accumulation (control < 2 pg/ml; 
all PAMPs < 2 pg/ml; TNFa 40 + 6 pg/ml; P < 0.05).
6.3.6 Response of THP-1 cells to PAMPs
Treatment of THP-1 cells with LTA or PGN for 3 h increased expression of 
IL6, IL1B and IL8 mRNA (Fig 6.8A-C). Treatment of THP-1 cells for 24 h with 
LPS, LTA, PGN or TNFa increased the accumulation of IL-6, IL-lp, IL-8 and CCL5 
in cell supernatants (Fig. 6.9A-D; P < 0.05). Although the accumulation of these 
cytokines and chemokines following treatment with FLA was not significantly 
greater than control, 3 h treatment with FLA increased IL1B mRNA expression 9.86 
+ 2.66 fold compared with control (Fig. 6.8B; P < 0.05).
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Figure 6.6 Treatment of COV434 cells with PAMPs for 24 h had no significant 
effect on viability, cytotoxicity or apoptosis. COV434 cells were treated with 
control medium (‘C’) or medium containing LPS, LTA, PGN, DNA (all 1 pg/ml), 
0.1 pg/ml FLA or 20 ng/ml TNFa for 24 h. Staurosporine (10 pM for 4 h; ‘S’) and 
digitonin (30 pg/ml for 15 min; ‘D’) were used as positive controls. The 
ApoTox-Glo Triplex assay (Promega, Madison, USA) was used to evaluate the 
effect of treatments on cell viability (A), cytotoxicity (B) and apoptosis (C). Data 
presented as mean of duplicate wells from one experiment.
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Figure 6.7 COV434 ceils responded to PAMPs at the RNA level but did not 
accumulate protein. COV434 cells were treated for 3 h with control medium (‘C’) 
or medium containing PAMPs (LPS, LTA, PGN all 1 pg/ml; FLA 0.1 pg/ml) and the 
expression of IL1B (A) and IL8 (B) mRNA determined by qPCR (normalised to 
ACTB). Data are presented as mean + SEM for fold change relative to control of 3 
independent experiments. Data were analysed using the Mann-Whitney U test; 
values differ from the control, *P < 0.05. COV434 cells were treated for 24 h with 
control medium (‘C’) or medium containing PAMPs (LPS, LTA, PGN all 1 pg/ml; 
FLA 0.1 pg/ml) or 20 ng/ml TNFa and accumulation of IL-8 (C) measured in the 
supernatant. The number of cells at the end of 24 h treatment was evaluated by MTT 
assay (D). Data are presented as mean + SEM, expressed as a percentage of control 
IL-8 accumulation (C) or control absorbance (D) and represent 4 independent 
experiments. Data were analysed using ANOVA, with Dunnett’s pairwise multiple 
comparison t-test; values differ from control, *** P < 0.001.
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Figure 6.8 THP-1 cells increased expression of mRNA encoding pro- 
inflammatory cytokines in response to PAMPs. THP-1 cells were treated for 3 h 
with control medium (‘C’) or medium containing LPS, LTA, PGN (all 1 pg/ml) 
or 0.1 pg/ml FLA. RNA was extracted and expression of IL-8, IL-6 and 
IL-ip (E-G) mRNA measured by qPCR. Data presented as mean + SEM for fold 
change relative to control from 3 independent experiments. Values differ from 
control using ANOVA, with Dunnett’s pairwise multiple comparison t-test, 
* P < 0.05, ** P < 0.01, *** P < 0.001.
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Figure 6.9 THP-1 cells increased accumulation of pro-inflammatory cytokines 
in response to PAMPs. THP-1 cells were treated for 24 h with control medium 
(‘C’) or medium containing LPS, LTA, PGN (all 1 ng/ml), 0.1 pg/ml FLA or 
20 ng/ml TNFa and accumulation of IL-8, IL-6, IL-lp and CCL5 (A-D) measured 
in the supernatants by ELISA. Data are presented as mean + SEM and represent 4 
independent experiments. Data were analysed using the Mann-Whitney U test 
(IL-8, EL-6, CCL5) or ANOVA, with Dunnett’s pairwise multiple comparison t-test 
(IL-1P); values differ from control, * P < 0.05, *** P < 0.001. N/D = below limits of 
detection.
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6.3.7 Effect of FSH on the response of COV434 cells to PAMPs
The effect of FSH on COV434 cells was explored because FSH modulates 
TLR4 in murine cells (Shimada et al., 2006). There was no effect of FSH treatment 
on IL-8 accumulation by COV434 cells in control medium (Fig. 6.10A; P > 0.8). 
Treatment of COV434 cells with 1 ng/ml or 100 ng/ml FSH at the time of PAMP or 
TNFa treatment, or with 100 ng/ml FSH for 24 h before and during PAMP or TNFa 
treatment, did not significantly increase the accumulation of IL-8 (Fig. 6.10B-D; 
all P > 0.6). As expected, when COV434 cells were treated for 0 - 48 h, there was a 
significant effect of treatment on the accumulation of oestradiol (Fig. 6.11 A; 
P < 0.001). There was no effect of PAMP treatment on oestradiol accumulation 
when COV434 cells were treated for 24 h with LPS, PGN or TNFa in addition to 
100 ng/ml FSH and 2.9 pg/ml androstenedione (Fig. 6.1 IB; all P > 0.5).
6.3.8 Using chemical inhibitors decreased the constitutive accumulation of IL-8
The ApoTox-Glo kit was used to determine the most appropriate dose for 
each inhibitor: a concentration that the COV434 cells could tolerate without a 
decrease in cell viability or an increase in cytotoxicity or apoptosis, whilst also 
causing a decrease in IL-8 (Fig. 6.12). The following concentrations were used in 
further experiments, and were similar to those used in the literature: 4 pM NFkB 
inhibitor (Abke et al., 2006), 10 pM p38 MAPK inhibitor (Meini et al., 2011), 
50 pM JNK inhibitor (Schiavone et al., 2009), 10 pM ERK1/2 inhibitor, 1 pM MEK 
inhibitor (Scherle et al., 1998). After 24 h treatment of COV434 cells with inhibitors 
targeting NFkB, p38 MAPK or JNK, there was a significant decrease in IL-8 
accumulation (P < 0.05; Fig. 6.13A), but inhibiting NFkB or JNK also decreased cell 
number, as measured by MTT (both P < 0.05; Fig 6.13B). After adjusting for cell 
viability, the inhibitors targeting p38 MAPK, JNK or MEK caused a significant 
decrease in IL-8 accumulation (all P = 0.05).
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Figure 6.10 FSH did not affect the responsiveness of COV434 cells to PAMPs.
(A) COV434 cells were treated for 24 h with control medium (‘C’) or medium 
containing 1 ng/ml FSH (FSH 1), 100 ng/ml FSH (FSH 100) or 100 ng/ml FSH after 
24 h pre-treatment with 100 ng/ml FSH (‘PRE’). Supernatants were collected and the 
accumulation of IL-8 measured by ELISA. Values are presented as mean + SEM of 
3-4 independent experiments and do not significantly differ from control by 
ANOVA. COV434 cells were treated for 24 h with control medium (‘C’) or medium 
containing LPS, LTA, PGN (all 1 pg/ml), 0.1 pg/ml FLA or 20 ng/ml TNFa in the 
presence of 1 ng/ml FSH (B), or 100 ng/ml FSH (C), or 100 ng/ml FSH after 24 h 
pre-treatment with 100 ng/ml FSH (FSH pre-treatment) (D). Values are presented as 
mean + SEM of 3-4 independent experiments relative to control treatment. Values 
differ from control by ANOVA, using the Dunnett’s pairwise multiple comparison 
t-test to compare treatments with control, ** P < 0.01, *** P < 0.001.
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Figure 6.11 COV434 cells produced oestradiol when stimulated with FSH and 
A4 but this was not perturbed by PAMPs. (A) COV434 cells were treated for 
0 - 48 h with control medium or medium containing 100 ng/ml FSH and 2.9 pg/ml 
A4. Data are presented as mean + SEM of 3 independent experiments, and analysed 
by ANOVA, using Dunnett’s pairwise multiple comparison T-test to compare each 
time point with time 0, within treatments. (B) COV434 cells were treated for 24 h 
with control medium (‘C’) or medium containing 100 ng/ml FSH and 2.9 pg/ml 
androstenedione (A4) and 1 pg/ml ultrapure LPS, 1 pg/ml PGN or 20 ng/ml TNFa. 
Data are presented as mean + SEM of 3 independent experiments and analysed using 
the Mann-Whitney U test, * P < 0.05, ** P < 0.01
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Figure 6.12 Impact of chemical inhibitors on COV434 cells. COV434 cells were 
treated for 24 h with inhibitors of NFkB (A; 0.004 to 40 pM), p38 MAPK 
(B; 0.01 to 100 pM), MEK (C; 0.001 to 10 pM), ERK1/2 (D; 0.01 to 100 pM) or 
JNK (E; 0.05 to 500 pM). Cell viability (blue line), cytotoxicity (red line) and 
apoptosis (black line) was assessed using the ApoTox Glo Triplex Assay (Promega) 
and supernatants were collected and the accumulation of IL-8 measured by ELISA 
(black bars). Data are presented as mean from duplicate wells of 1 experiment.
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Figure 6.13 Chemical inhibitors of the MAPK pathway decreased the 
constitutive production of IL-8 by COV434 cells. COV434 cells were treated for 
24 h with control medium (‘C’) or medium containing inhibitors targeting NFkB 
(4 pM), p38 MAPK (10 pM), JNK (50 pM), ERK1/2 (10 pM) or MEK (1 pM). 
Supernatants were collected and the concentration of IL-8 measured by ELISA (A). 
The number of cells at the end of 24 h treatment was evaluated by MTT assay (B). 
Data are presented as mean + SEM of 3 independent experiments, relative to control 
and were analysed by ANOVA, using Dunnett’s pairwise multiple comparison t-test 
to compare treatments with control, * P < 0.05, ** P < 0.01.
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6.4 Discussion
The present study tested the hypothesis that the human granulosa cell line 
COV434 expresses TLRs and can mount an inflammatory response to pathogen 
associated molecules. The COV434 cells were selected because they have 
physiological responses similar to primary GCs (Zhang et al., 2000). Primary GCs 
would be interesting to study but obtaining pure populations of cells without immune 
cell contamination that may affect the study was not practical (Fedorcsak et al., 
2007). The COV434 cells expressed TLR4-10 and functional responses to PAMPs 
were evident at the mRNA level. However, treatment of COV434 cells with PAMPs 
did not produce inflammatory responses evident at the protein level, although 
PAMPs were effective with a THP-1 monocytic cell line. Of note, the COV434 cells 
produced IL-8 constitutively, probably via MAPK activation.
The presence of mRNA encoding TLRs in COV434 cells was in agreement 
with expression of receptors in ovarian GCs from hens (Woods et al., 2009), cattle 
(Herath et al., 2007) and mice (Shimada et al., 2006). The expression of TLR4 by 
COV434 cells agrees with a recent report using the same cells (Woods et al., 2011), 
which was published after these experiments were completed. The absence of 
TLR1-3 in our COV434 cells was interesting: the genes encoding for these TLRs are 
on chromosome 4 with TLR2 and TLR3 close together (4q32 and 4q35 respectively; 
HUGO), although TLR1 and TLR4 are both on 4pl4. The published karyotype for 
COV434 cells shows structural rearrangement only of 22q and trisomy 5 (van den 
Berg-Bakker et al., 1993), so any mutation is likely to be small scale (at least for 
TLR1), and may possibly just be in the region where the PCR primers bind, rather 
than a deletion of the whole gene. The lack of expression of TLR2 found in the 
present COV434 cell work with commercial primers is in contrast to recently 
published work showing expression of TLR2 (Woods et al., 2011), although the latter 
study used 40 rather than the present study’s 35 cycles for PCR.
The present study examined two prototypical cytokines (IL-6 and IL-ip) and 
two prototypical chemokines (IL-8 and CCL5). These cytokines are involved in a 
variety of immune processes, including neutrophil, T-cell and leukocyte 
chemoattraction (CCL5 and IL-8) and the acute-phase protein response (IL-6). 
However, cytokines also play a role in ovarian physiology and pathology.
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Cumulus-oocyte-complex expansion and improved oocyte competence can be 
induced by IL-6 (Liu et al., 2009). Interleukin ip decreases progesterone production 
by FSH-treated GCs (Santana et al., 1996) and may be involved in follicle rupture 
(Adashi, 1997). CCL5 causes chemotaxis of sperm in vitro (Isobe et al., 2002), and 
may be involved in eosinophil recruitment during granulosa cell luteinisation (Aust 
et al., 2000). The physiological roles of IL-8 include follicle development and 
ovulation (Goto et al., 1997, Ujioka et al., 1998, Goto et al., 2002). Cytokines and 
chemokines are also involved in ovarian pathologies, including cancer, premature 
ovarian failure, endometriosis, salpingitis and endometritis (Kitaya and Yamada, 
2011). For example, high levels of IL8 expression correlate with the severity of 
ovarian carcinoma, and blocking IL8 using siRNA decreases tumour growth (Merritt 
et al., 2008).
Treatment of COV434 cells with PAMPs for 3 h increased expression of 
IL1B compared with control. The significant increases in IL1B expression in 
COV434 cells treated with PGN probably reflects the ability of PGN to signal 
through NLR pathways as well as TLR2 (Inohara et al., 2003, Elinav et al., 2011). A 
recent report also indicates that COV434 cells show nuclear translocation of NFkB 
following treatment with LPS (Woods et al., 2011). Treatment of COV434 cells with 
PAMPs for 24 h had no significant effect on cytokine or chemokine protein 
accumulation, although COV434 cells consitutively produced IL-8. The COV434 
cells did not express or accumulate IL-6, which is in contrast to the supernatants of 
cultured GCs from healthy women, which contain IL-6 but not IL-8 (Carlberg et al., 
2000), and in rats where LPS stimulates a dose-dependent increase in IL-6 
accumulation at 48 h (Gorospe and Spangelo, 1993). The lack of CCL5 from 
COV434 cells in the present study agrees with a report of only faint expression of 
CCL5 in COV434 cells (Aust et al., 2000). In bovine GCs, treatment with LPS or 
TLR2 ligands (PGN, lipoteichoic acid or the synthetic ligand Pam3CSK4) increased 
accumulation and expression of IL-8 and IL-6 (Bromfield and Sheldon, 2011). The 
lack of accumulation of IL-ip despite significant increases in IL1B expression in 
COV434 cells treated with PAMPs, is likely to be due to inactivation of the 
inflammasome. For IL-lp to be released, cells must receive two signals. The first 
results in synthesis of pro-IL-ip and components of the inflammasome; the second 
signal leads to activation of the inflammasome and cleavage of pro-IL-ip to
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secretable IL-ip (Guarda and So, 2010, Latz, 2010). A recent study showed that 
internalised bacterial, adenoviral or mammalian host DNA activated the 
inflammasome (Muruve et al., 2008). In the present study, COV434 cells received a 
single ‘hit’ from a PAMP, which was not transfected and thus was not internalised 
by the cell. It is likely that the inflammasome was not activated and thus IL-ip was 
not secreted. On the other hand, THP-1 cells did release mature IL-lp because they 
were first stimulated with PMA, which causes production of endogenous ATP, 
providing the second signal to activate the inflammasome (Netea et al., 2009). It is 
possible that the lack of response to PAMPs is due to the upregulation of nuclear 
receptor related 1 protein (NURR1) in COV434 cells (Alexiadis et al., 2011), 
because NURR1 protects from LPS-induced inflammation in dopamingeric neurons 
(Saijo et al., 2009) and macrophages (Bonta et al., 2006).
The COV434 cells express functional FSH receptors, and produce oestradiol 
in response to FSH and androstenedione treatment (Zhang et al., 2000). Treatment 
with FSH increases the accumulation of IL-6 in murine GCs (Gorospe and Spangelo, 
1993) and FSH can induce Tlr4 mRNA in mice (Shimada et al., 2006). Treatment of 
FSH and androstenedione treated bovine GCs with LPS (Herath et al., 2007) or 
TNFa (Williams et al., 2008) inhibits oestradiol production. However, in the present 
study, treatment with FSH had no effect on the responsiveness of COV434 cells to 
PAMPs, and PAMPs or TNFa did not impact oestradiol accumulation. The present 
study treated COV434 cells with either 1 ng/ml or 100 ng/ml FSH for 24 h. These 
doses were chosen because 1 ng/ml has been shown to be optimum for granulosa cell 
culture (Gutierrez et al., 1997) and 100 ng/ml is the concentration previously used in 
COV434 cells (Zhang et al., 2000). In the previously mentioned studies, FSH was 
used at concentrations between 30 and 2000 ng/ml for 48 h (Gorospe and Spangelo, 
1993) or 100 ng/ml for 16 h (Shimada et al., 2006). It is not possible to directly 
compare this literarture with the present study because COV434 cells do not express 
or produce IL-6. However, it suggests that the difference in response is either due to 
the difference between using a cell line and using primary cells or a species 
difference, and not a difference in FSH treatment.
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Accumulation of IL-8 in the supernatants of cultured COV434 cells in 
control medium decreased with increased passage number. This phenonomem has 
also been reported in BEAS-2B bronchial epithelial cell line (Sanders et al., 1998). It 
is possible that IL-8 is produced by cells at early passage number in response to the 
temperature change involved in defrosting stored cell-lines and that the IL-8 
accumulation decreases during normal culture. If this is the case, it does not change 
the findings of this study, as COV434 cells did not respond to PAMPs at any passage 
number. Accumulation of IL-8 by untreated COV434 cells suggested that COV434 
cells produce IL-8 constitutively. This is a common feature of tumour cells, and has 
been reported in melanoma cells (Schadendorf et al., 1993), tumour-associated brain 
endothelial cells (Charalambous et al., 2005) and pancreatic carcinoma cells (Hidaka 
et al., 2002). Treatment with inhibitors of p38 MAPK, JNK and MEK reduced the 
accumulation of IL-8, even when taking the effects of the chemical inhibitors on cell 
survival into account. Of note, these signalling molecules are all upstream of the 
transcription factor activator protein 1 (AP-1), which induces IL-8 mRNA and 
protein (Wolf et al., 2001, Hoffmann et al., 2002, Kim et al., 2006, Khalaf et al., 
2010). Interestingly, AP-1 is constitutively active in COV434 cells (Chu et al., 
2004). The COV434 cell line is thought to be developed from a juvenile granulosa 
cell tumor (Pisarska et al., 2011). Thirty per cent of JGCT have a mutated gsp 
oncogene, leading to constitutive activation of the Gs alpha subunit (Kalfa et al., 
2009). This leads to increased cyclic AMP (Buchfelder et al., 1999), which in turn 
can cause increased activation of AP-1 (Kontny et al., 1992). This mutation has not 
been reported in COV434 cells, but is a possible mechanism for the constitutive 
activation of AP-1 and accumulation of IL-8. Other possible mechanisms include the 
Mothers against decapentaplegic homolog (SMAD) 2/3 pathway, which is associated 
with Fosb, part of AP-1 (Fei et al., 2010). Supporting evidence for this mechanism 
includes: activity of the SMAD2/3 pathway in JGCT (Middlebrook et al., 2009); 
activity of SMAD2 in COV434 cells (Stenvers et al., 2009), and the regulation of 
gonadal tumorogenesis by SMAD3 (Geisel et al., 2007). Inhibiting the SMAD2 
pathway or identifying the presence of of the gsp oncogene could clarify the role of 
these pathways in the constitutive activation of AP-1.
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In conclusion, the COV434 cell line expressed mRNA for TLR4-10 and 
responded to PAMPs at the RNA level, but were unable to mount a protein 
inflammatory response. Although the COV434 cells produced oestradiol, production 
of this steroid was not perturbed by PAMP treatment. The COV434 cell line 
constitutively produced IL-8 but did not produce IL-6 in contrast to observations in 
primary human GCs. So the COV434 human granulosa cell line may be less useful 
for investigating immunity than for studies of physiology or cancer.
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Chapter 7 
General Discussion
Bacterial contamination of the bovine uterus is ubiquitous after parturition 
and is associated with infertility and perturbed ovarian function. Previously, it was 
reported that LPS from E. coli collects in the follicular fluid of animals with uterine 
disease, and that the GCs lining ovarian follicles express the molecular machinery 
necessary to sense this LPS. The present thesis examined the response of cells from 
within ovarian follicles to bacterial PAMPs. It was reported that GCs from emerged 
and dominant follicles responded to PAMPs but, although exposure to PAMPs 
during maturation affected the oocyte, the developing embryo seems to be somewhat 
protected. We also examined the response of a human granulosa cell line to bacterial 
PAMPs, but discovered many limitations in using a cancerous cell line as a model 
for investigating the innate immune function of GCs. Whilst the impact on cattle is 
clear, the effect of PAMPs in humans remains an open question.
Previous investigations have tended to focus on the responses of GCs from 
the growing pool of emerged follicles to LPS (Bromfield and Sheldon, 2011). 
However, in vivo, perturbation of ovarian function is only detectable when follicles 
reach dominance, with decreased follicle growth rate and delayed ovulation (Sheldon 
et al., 2002, Williams et al., 2007). It is possible that only dominant follicles are 
perturbed by bacterial contamination of the uterus. An alternative, and more likely, 
hypothesis is that bacterial infections perturb ovarian function at all stages of follicle 
growth, but that these effects are only detectable in the whole animal once follicles 
grow larger. The results published in the present thesis support this latter hypothesis, 
with GCs from both emerged and dominant follicles responding to the bacterial 
PAMPs, LPS and PAM. Although there were many similarities between the 
responses of GCs from emerged and dominant follicles, some differences also 
emerged (Table 7.1). Granulosa cells from both cell populations expressed all 10 
TLRs, although the expression pattern of these receptors differed between emerged 
and dominant follicles. It was particularly interesting that both cell populations 
expressed a high level of TLR3, thus the response of GCs to viruses or viral PAMPs, 
whilst beyond the scope of this project, would be interesting to investigate. In 
particular, the effect of bovine herpesviruses and bovine diarrhoea virus would be 
interesting to study, as these infections are also associated with ovarian dysfunction 
and endometritis or mastitis (Grooms et al., 1998, Donofrio et al., 2009).
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Table 7.1 The responses of GCs isolated from emerged and dominant follicles to 
PAMPs.
Emerged Dominant
Expressed TLR1-10; high TLR3; low TLR8
LPS -» \TLR2, TLR3, TLR5; [TLR7 
PAM -> t TLR2\ ITLR4, TLR6, TLR7, 
TRL10
No priming effect
LPS or PAM -> fIL-6, IL-10, TNF-a, IL-8 
FLA—► tIL-6
1 pg/ml LPS —► 1696 pg/ml IL-6 
1 pg/ml PAM —* 1401 pg/ml IL-6 
1 pg/ml FLA —► 46 pg/ml IL-6
LPS, PAM or FLA -> \1L6, IL1B, IL10, 
TNF, IL8, CCL5
PAM -* t EGFR
LPS or PAM tp-ERKl/2, p-p38
Expressed TLR1-10; high TLR1, 
TLR3, TLR5, TLR6; low TLRS
LPS -> t TLR2\ [TLR4, TLR6, TLR7, 
TLR8, TLR10 
PAM -► ]TLR2\ [TLR6, TLR7,
TLR8, TLR9
LPS or PAM TIL-6 response to 
subsequent PAM treatment
LPS or PAM -*  TIL-6, IL-ip, IL-8 
FLA —► no effect
1 pg/ml LPS —► 843 pg/ml IL-6 
1 pg/ml PAM —► 1200 pg/ml EL-6 
1 pg/ml FLA —► N/D IL-6
LPS or PAM -»  TIL6, IL1B, IL10, 
TNF, IL8, CCL5 
FLA —* not tested
LPS -> [EGFR, CYP19A1 
PAM ILHCGR, CYP19A1
LPS or PAM -*> Tp-ERKl/2, p-p38
E2 -► |IL-6; EGF -♦ |IL-6 
EGF+PAM —> fIL-6 (compared to PAM 
alone)
Inhibiting NFkB, MEK, p38 or MEK+JNK 
|IL-6 LPS response 
Inhibiting NFkB or p38|IL-6 PAM 
response
Effect of PAMPs on E2 and P4 not tested
EGF or LH -> |IL6 
E2+LPS -»> |IL-6 ; EGF+LPS 
TIL-6 (compared to LPS alone) 
E2+PAM -> |EL-6 ; EGF+PAM -> 
TIL-6 (compared to PAM alone)
Inhibiting NFkB, MEK, p38, JNK or 
p38+MEK jIL-6 LPS response 
Inhibiting NFkB, MEK or p38 |IL-6 
PAM response
LPS or PAM |E 2 
LPS |P 4
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One interesting observation was that GCs isolated from emerged follicles 
tended to have a greater response to bacterial PAMPs than those isolated from 
dominant follicles, with increased cytokine production in response to LPS, PAM or 
FLA. This observation supports the theory that bacterial infections affect emerged 
follicle health, with the impact only detectable once the follicles reach dominance, in 
addition to bacterial infections impacting dominant follicle function directly.
Prior to the investigations presented in the current thesis, a working model 
summarising current knowledge of endocrine and innate immune function within 
ovarian follicles was described (Fig 1.9). The present work produced observations 
which develop these basic models, and provides further links between these two 
ancient systems (Fig 7.1 and 7.2). Of particular note was the interplay between 
PAMPs, IL-6 and the LH-EGF pathway, especially in GCs isolated from dominant 
follicles, where EGF is likely to play a greater role in promoting maturation of the 
oocyte. Treatment of GCs isolated from dominant follicles with LPS or PAM 
decreased expression of EGFR and LHCGR, respectively. Supposing that these 
reductions in mRNA translate to reduced protein, these reductions in receptor 
expression may delay maturation of the oocyte. Potentially, this is a protective 
mechanism against ovulation occurring in a ‘dirty’ environment. Increased LH 
enhances EGFR activation (Panigone et al., 2008), potentially through increased 
production of EGF, thus it was unsurprising that treatment of GCs with LH or EGF 
enhanced constitutive accumulation of IL-6 (potential mechanisms have been 
previously discussed in chapters 3 and 4). However, it was surprising that treatment 
of GCs with LH in tandem with LPS or PAM did not enhance PAMP-stimulated 
IL-6 accumulation, even though EGF co-treatment augmented PAMP-stimulated 
IL-6 accumulation by around 50%. This suggests that PAMPs may interfere with the 
LH-stimulated production of EGF. Previously, this pathway was described in mouse 
and pig as involving cAMP, PKA, p38 and ERK1/2 (Yamashita et al., 2009, Hsieh et 
al., 2011) and, interestingly, p38 and ERK1/2 were both involved in the response of 
GCs to LPS and PAM in the present thesis. Thus, it would be of interest for further 
investigations to focus on the interactions between PAMPs and EGF, in particular, 
the effect of PAMPs on the accumulation of EGF-like factors.
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Figure 7.1 A summary of the interactions between innate immune and 
endocrine pathways in GCs isolated from emerged follicles. Granulosa cells 
isolated from emerged follicles expressed FSHR and EGFR. They also expressed all 
10 TLRs. PAM and LPS bound TLR2 and TLR4, respectively, inducing an 
intracellular cascade resulting in increased expression and accumulation of cytokines 
and chemokines. Granulosa cells also produced IL-6 constitutively. Treatment of 
GCs with LPS impacted on expression of some TLRs, of particular note increasing 
expression of TLR2. Treatment of GCs with PAM decreased expression of TLRs 
including TLR4 and increased expression of TLR2. PAM treatment also increased 
expression of EGFR. Oestradiol treatment decreased the constitutive accumulation of 
IL-6, which was enhanced by EGF treatment. Red lines represent a decrease in 
production or expression, whereas green lines represent an increase.
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Figure 7.2 A summary of the interactions between innate immune and 
endocrine pathways in GCs isolated from dominant follicles. Granulosa cells 
isolated from dominant follicles expressed FSHR, LHCGR, EGFR and CYP19A1. 
They also expressed all 10 TLRs. PAM and LPS bound TLR2 and TLR4, 
respectively, inducing an intracellular cascade resulting in increased expression and 
accumulation of cytokines and chemokines. Granulosa cells also produced IL-6 
constitutively. Treatment of GCs with LPS decreased expression of TLRs, including 
TLR4, and increased expression of TLR2. Treatment of GCs with PAM decreased 
expression of some TLRs and increased expression of TLR2. PAM treatment also 
decreased expression of LHCGR, whereas LPS treatment decreased expression of 
EGFR. Treatment with LPS or PAM decreased expression of CYP19A1 and 
accumulation of oestradiol or progesterone. Oestradiol treatment decreased the LPS- 
or PAM-stimulated accumulation of IL-6, which was enhanced by EGF treatment. 
Treatment of GCs with LH or EGF increased constitutive IL-6 accumulation. Red 
lines represent a decrease in production or expression, whereas green lines represent 
an increase.
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Arguably the most novel aspect of this research was the impact of bacterial 
contamination during oocyte maturation on subsequent embryo health. Although it 
may have been interesting to investigate the impact of PAMPs during embryo 
development, it was more relevant to concentrate on the effects of bacterial 
contamination during oocyte maturation on the subsequent embryo. In vivo, LPS can 
be isolated from the follicular fluid of previously infected cows even after the visible 
uterine contamination has been cleared (Herath et al., 2007). Therefore, if ovulation 
and fertilisation occurs, the embryo may develop in a ‘clean’ environment, yet the 
oocyte may have matured whilst bathed in LPS. The results in chapter 5 demonstrate 
that both LPS and PAM not only impact directly on cumulus expansion and 
expression of key genes involved in early embryo development, but that this 
enhanced maturation translates into changes in the subsequent embryo with 
increased cleavage rates in parthenogenetically activated oocytes. It seems that this 
early maturation continues through into early first and subsequent cleavages. It 
would have been fascinating to continue development of these parthenotes into the 
blastocyst stage. However, this was not possible due to time and technical 
limitations. There was little impact of LPS or PAM exposure during IVM on 
parthenote gene expression after 42 h culture, thus it would have been interesting to 
discover whether the accelerated growth continued through early embryogenesis, and 
whether it led to increased rates of embryo death. It would be interesting to extend 
these in vitro studies into the live animal, maturing bovine oocytes in vitro in the 
presence of PAMPs and then returning to the cow, to test whether there is any impact 
on implantation or embryo health.
The work presented in this thesis highlights the importance of using a valid 
model for investigations. Primary bovine GCs responded to LPS and PAM and 
constitutively produced few inflammatory mediators. Although the model was not 
perfect, in that the culture of the GCs without serum was not possible, the GCs 
continued to function physiologically, producing oestradiol in response to FSH and 
COCs expanding in response to gonadotrophin stimulus. In contrast, the COV434 
cells constitutively produced high concentrations of IL-8 and did not respond at the 
protein level to PAMPs. Although cell-lines have a purpose and are often offer the 
best option for human work, it is important to recognise the difficulties with using 
abnormal cancerous cells.
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One important question remaining to be answered is how LPS collects inside 
the follicle. It seems likely that endotoxin from invading E. coli in the uterus passes 
into the local vasculature which then runs to the ovary. Perhaps the LPS simply 
diffuses into the follicular fluid, but then why does it not diffuse out again once the 
concentration of LPS in the blood is lower than in the follicular fluid? The 
blood-follicle barrier was previously estimated to be 100 kDa (Clarke et al., 2006) 
somewhat larger than the size of LPS monomers of 10 kDa (Petsch and Anspach, 
2000). However, LPS also forms large aggregates, up to 1000 kDa in size (Petsch 
and Anspach, 2000). Maybe LPS aggregates once inside the follicle but does not 
aggregate in the blood due to circulatory movement and pressure? Another possible 
explanation is that LPS binds to a component of follicular fluid. In the present work, 
it was shown that HMW HA dampens the inflammatory effect of LPS. Potentially, 
HA could bind LPS, thus decreasing the affinity of LPS to TLR4. We know that HA 
is physically sticky, but perhaps it is also chemically sticky? Investigations could 
simply start with preparing a mix of LPS and hyaluronan, allowing time for binding 
to occur, soaking isolated follicles in the soup and then measuring LPS in aspirated 
follicular fluid, to test whether a greater concentration of LPS is present in follicles 
soaked in LPS alone rather than LPS+HA. However, it is unlikely that this simple 
approach ex vivo would yield meaningful results. A more complex but physiological 
method could include the use of knock-out mice to disrupt formation of the follicular 
fluid and test how LPS accumulated after uterine infusion. This could prove 
challenging as the HasZ1' knockout mouse dies close to birth, thus conditional 
knockout mice would have to be used, silencing similar genes only in ovarian GCs 
(Roughley et al., 2011)
The results presented in this thesis, in concert with those published in recent 
papers (Bromfield and Sheldon, 2011, Bromfield and Sheldon, 2013), have provided 
greater understanding of the impact of bacterial infections on ovarian health at 
different stages of follicular development and embryo genesis. It seems that ovarian 
follicles are sensitive to LPS at the early stages of development, before becoming 
less sensitive whilst secondary follicles. However, as the antral stage is reached, the 
follicles are once again perturbed by PAMPs (Fig 7.3). Oocyte maturation is also 
perturbed by LPS and PAM, but the early embryo seems to be somewhat protected 
from bacterial infections.
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Figure 7.3 The bacterial PAMPs LPS and PAM impact ovarian follicle health at 
most stages of development. Recent ex vivo experiments have shown that LPS 
decreases the primordial pool of bovine follicles, showing an impact of infection at 
even this early stage of follicular development, although secondary follicles seem to 
be somewhat protected from endotoxin exposure (Bromfield and Sheldon, 2013). 
Once follicles emerge, in vitro results show a perturbation of granulosa function with 
increased cytokine production (chapter 3) and decreased hormone production 
(Herath et al., 2007). At the follicle grows, perturbation becomes detectable in vivo 
and granulosa cell function is further perturbed (chapter 4). Oocyte maturation in the 
presence of LPS or PAM increases cumulus expansion, cytokine production, meiotic 
failure (Bromfield and Sheldon, 2011) and impacts on the expression of maternal 
effect genes (chapter 5). The early oocyte initially develops earlier after maturation 
in the presence of PAMPs, but there seems to be little effect on the subsequent 
embryo (chapter 5).
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Advancing our knowledge of how infection impacts fertility could help to 
address a number of problems humanity faces. From an economic point of view, 
much of the developed world is in the midst of a period of uncertainty, as developing 
nations learn the skills the Western World previously exclusively offered, but can 
provide at lower prices. With bovine uterine disease estimated to cost the EU alone 
1.4 billion Euros per year (Sheldon et al., 2009), the potential to reduce the portion 
of costs attributable to reduced fecundity and decreased milk yield is an attractive 
proposition for farmers and government alike.
Developing tools to improve fertility is also of economic interest to the 
pharmaceutical industry. In the previous years, the number of blockbuster drugs 
launched has decreased whilst the number of patents expiring has increased, 
resulting in declining profits for many companies and a burgeoning business for 
generic drugs (Harrison, 2013). The treatment of infertility is an emerging market 
able to target animal and human health. The current trend for professional women to 
delay motherhood, combined with increased incidence of bacterial sexually- 
transmitted infections, such as Chlamydia, provides an affluent potential therapeutic 
group (Vickers and Osgood, 2010).
Alternatively, we can look at infertility from a human standpoint. With the 
human population ever expanding, our need for fuel is exponentially rising. Cattle 
provide a means of converting grass, which is indigestible to humans, to milk or 
beef, providing a source of protein and fat. Thus, by increasing bovine fertility, there 
is less wastage in the farming system and food supply is increased. However, this is 
incredibly energy-inefficient and, in the author’s opinion, will not solve any 
problems with food shortage. As a general rule in nature, when the food supply to a 
species increases, the numbers of that species expand. Humans are unlikely to be an 
exception. Thus, a greater understanding of the mechanisms underlying fertility 
could be used to control population expansion, allowing sustainable development. 
As a therapeutic this could be used as a prophylactic treatment to decrease fertility.
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Infections of the female genital tract are common in humans and cattle and 
impact the environment, global food security, animal welfare and the economy. In 
addition to impacting the uterus, mammary gland and brain of infected animals, 
these infections also perturb ovarian function. Cattle with endometritis or mastitis 
have decreased dominant follicle growth rate and lower peripheral concentrations of 
oestradiol. The present thesis investigated the role of bacterial pathogen-associated 
molecular patterns on the GCs and oocytes within bovine ovarian follicles. Previous 
investigations had focussed on the effect of the prototypical PAMP LPS on GCs 
isolated from emerged follicles. The present work extended these findings, exploring 
the impact of the TLR2 agonist PAM and TLR5 agonist FLA on GCs from both 
emerged and dominant follicles. In addition to further dissecting the inflammatory 
pathways activated in these cells through the use of siRNA, Western blots and 
biochemical inhibitors, the crosstalk between endocrine and innate immune 
pathways was examined, identifying an interesting link between EGF and IL-6. The 
natural progression of follicle development was followed after dominance, to focus 
on the impact of bacterial PAMPs in the follicle on the oocyte and subsequent 
embryo, demonstrating a striking perturbation of early events during oocyte 
maturation and embryogenesis. Lastly, a human granulosa cell line was investigated. 
Although these cells were found to express TLRs, the abnormality of these cells was 
demonstrated and will hopefully act as a caution for others using cell-lines to 
investigate physiology and non-cancerous pathology.
The findings presented in the current thesis provide a greater understanding 
of ovarian physiology and pathology. With this insight, potential therapeutics to treat 
ovarian dysfunction and infertility caused by bacterial infection can start to be 
explored, in addition to the creation of prophylactics which could intentionally limit 
fertility.
242
Appendix 1
Dulbecco’s Phosphate Buffered Saline Components (Sigma) Concentration (mg/L)
Potassium Chloride 200
Potassium Phosphate (anhydrous) 200
Sodium Chloride 8000
Disodium Phosphate (anhydrous) 1150
RPMI1640 Components (Sigma) Concentration (mg/L)
Amino Acids Glycine 10
L-Arginine hydrochloride 200
L-Asparagine 50
L-Aspartic acid 20
L-Cystine 65.2
L-Glutamic Acid 20
L-Glutamine 300
L-Histidine 15
L-Hydroxyproline 20
L-Isoleucine 50
L-Leucine 50
L-Lysine hydrochloride 40
L-Methionine 15
L-Phenylalanine 15
L-Proline 20
L-Serine 30
L-Threonine 20
L-Tryptophan 5
L-Tyrosine 28.83
L-Valine 20
Vitamins Biotin 0.2
Choline chloride 3
D-Calcium pantothenate 0.25
Folic Acid 1
Niacinamide 1
Para-Aminobenzoic Acid 1
Pyridoxine hydrochloride 1
Riboflavin 0.2
Thiamine hydrochloride 1
Vitamin B 12 0.005
i-Inositol 35
Inorganic Salts Calcium nitrate 100
Magnesium Sulfate 48.84
Potassium Chloride 400
Sodium Bicarbonate 2000
Sodium Chloride 6000
Sodium Phosphate dibasic anhydrous 800
Other D-Glucose 2000
Glutathione (reduced) 1
Phenol Red 5.3
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Medium 199 (M199) Components (Gibco) Concentration (mg/L)
Amino Acids Glycine 50
L-Alanine /hydrochloride 25/70
L-Aspartic acid 30
L-Cysteine hydrochloride-H20 0.1
L-Cystine 2HC1 26
L-Glutamic Acid 66.8
L-Glutamine 100
L-Histidine hydrochloride-H20 21.88
L-Hydroxyproline 10
L-Isoleucine 40
L-Leucine 60
L-Lysine hydrochloride 70
L-Methionine 15
L-Phenylalanine 25
L-Proline 40
L-Serine 25
L-Threonine 30
L-Tryptophan 10
L-Tyrosine disodium salt dihydrate 58
L-Valine 25
Alpha-tocopherol Phosphate 0.01
Vitamins Ascorbic Acid 0.05
Biotin 0.01
Choline chloride 0.5
D-Calcium pantothenate 0.01
Folic Acid 0.01
Menadione (Vitamin K3) 0.01
Niacinamide 0.025
Nicotinic acid (Niacin) 0.025
Para-Aminobenzoic Acid 0.05
Pyridoxal hydrochloride 0.025
Pyridoxine hydrochloride 0.025
Riboflavin 0.01
Thiamine hydrochloride 0.01
Vitamin A / D2 0.1 /0.1
i-Inositol 0.05
Calcium Chloride 264
Ferric nitrate 0.7
Inorganic Salts Magnesium Sulfate 200
Potassium Chloride 400
Sodium Bicarbonate 2200
Sodium Chloride 6800
Sodium Phosphate monobasic 158
2-deoxy-D-ribose 0.5
Adenine sulfate 10
Other Adenosine 5'-phosphate 0.2
Adenosine 5'-triphosphate 1
Cholesterol 0.2
D-Glucose 1000
Glutathione 0.05
Guanine hydrochloride 0.3
Hypoxanthine 0.3
Phenol Red 20
Ribose 0.5
Sodium acetate-3H20 83
Thymine 0.3
Tween 80 20
Uracil 0.3
Xanthine 0.344
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Dulbecco’s Modified Eagle’s Medium Components (Gibco) Concentration (mg/L)
Amino Acids Glycine 30
L-Alanyl-Glutamine 862
L-Arginine hydrochloride 84
L-Cystine 48
L-Histidine hydrochloride-H20 42
L-Isoleucine 105
L-Leucine 105
L-Lysine hydrochloride 146
L-Methionine 30
L-Phenylalanine 66
L-Serine 42
L-Threonine 95
L-Tryptophan 16
L-Tyrosine 72
L-Valine 94
Vitamins Choline chloride 4
D-Calcium pantothenate 4
Folic Acid 4
Niacinamide 4
Pyridoxine hydrochloride 4
Riboflavin 0.4
Thiamine hydrochloride 4
i-Inositol 7.2
Inorganic Salts Calcium Chloride 264
Ferric Nitrate 0.1
M agnesium Sulfate 200
Potassium Chloride 400
Sodium Bicarbonate 3700
Sodium Chloride 6400
Sodium Phosphate monobasic 141
Other D-Glucose (Dextrose) 1000
Phenol Red 15
Sodium Pyruvate 110
245
References
Abdelsalam M, Isobe N & Yoshimura Y (2011). Effects of lipopolysaccharide on 
the expression of proinflammatory cytokines and chemokines and influx of 
leukocytes in the hen ovary. Poultry Science, 90; 2054-2062.
Abdoon AS, Ghanem N, Kandil OM, Gad A, Schellander K & Tesfaye D (2012). 
cDNA microarray analysis of gene expression in parthenotes and in vitro produced 
buffalo embryos. Theriogenology, 77; 1240-1251.
Abke S, Neumeier M, Weigert J, Wehrwein G, Eggenhofer E, Schaffler A, 
Maier K, Aslanidis C, Scholmerich J & Buechler C (2006). Adiponectin-induced 
secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) 
and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I 
diabetes. Cardiovascular Diabetology, 5; 17.
Acosta TJ (2007). Studies of follicular vascularity associated with follicle selection 
and ovulation in cattle. Journal o f Reproduction and Development, 53; 39-44.
Adams GP, Kot K, Smith CA & Ginther OJ (1993). Selection of a dominant 
follicle and suppression of follicular growth in heifers. Animal Reproduction 
Science, 30; 259-271.
Adams GP, Matteri RL, Kastelic JP, Ko JCH & Ginther OJ (1992). Association 
between surges of follicle-stimulating hormone and the emergence of follicular 
waves in heifers. Journal o f Reproduction and Fertility, 94; 177-188.
Adashi EY (1997). The potential role of IL-1 in the ovulatory process: an evolving 
hypothesis. Journal o f Reproductive Immunology, 35; 1-9.
Adashi EY (1998). The IGF family and folliculogenesis. Journal o f Reproductive 
Immunology, 39; 13-19.
Aizen J, Kowalsman N, Kobayashi M, Hollander L, Sohn YC, Yoshizaki G, Niv 
MY & Levavi-Sivan B (2012). Experimental and computational study of inter- and 
intra- species specificity of gonadotropins for various gonadotropin receptors. 
Molecular and Cellular Endocrinology, 364; 89-100.
Akgul Y, Holt R, Mummert M, Word A & Mahendroo M (2012). Dynamic 
changes in cervical glycosaminoglycan composition during normal pregnancy and 
preterm birth. Endocrinology, 153; 3493-3503.
Akira S, Uematsu S & Takeuchi O (2006). Pathogen recognition and innate 
immunity. Cell, 124; 783-801.
246
Aktas H, Wheeler MB, Rosenkrans CF, First NL & Leibfried-Rutledge ML
(1995). Maintenance of bovine oocytes in prophase of meiosis I by high [cAMP]i. 
Journal o f Reproduction and Fertility, 105; 227-235.
Al Naib A, Mamo S, O’gorman GM, Lonergan P, Swales A & Fair T (2011). 
Regulation of non-classical major histocompatability complex class I mRNA 
expression in bovine embryos. Journal o f Reproductive Immunology, 91; 31-40.
Alberti C, Pinciroli P, Valeri B, Ferri R, Ditto A, Umezawa K, Sensi M, 
Canevari S & Tomassetti A (2011). Ligand-dependent EGFR activation induces 
the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage 
epithelial ovarian cancer. Oncogene, 31; 4139-4149.
Albertini D, Combelles C, Benecchi E & Carabatsos MJ (2001). Cellular basis 
for paracrine regulation of ovarian follicle development. Reproduction, 121; 647-
653.
Alexiadis M, Eriksson N, Jamieson S, Davis M, Drummond AE, Chu S, Clyne 
CD, Muscat GE & Fuller PJ (2011). Nuclear receptor profiling of ovarian 
granulosa cell tumors. Hormones and Cancer, 2; 157-169.
Allrich RD (1994). Endocrine and neural control of estrus in dairy cows. Journal o f 
Dairy Science, 77; 2738-2744.
Allworth AE & Albertini DF (1993). Meiotic maturation in cultured bovine 
oocytes is accompanied by remodeling of the cumulus cell cytoskeleton. 
Developmental Biology, 158; 101-112.
Anderson KV, Jurgens G & Niisslein-Volhard C (1985). Establishment of dorsal- 
ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll 
gene product. Cell, 42; 779-789.
Andersson E, Nijenhuis W, Male R, Swanson P, Bogerd J, Taranger GL & 
Schulz RW (2009). Pharmacological characterization, localization and
quantification of expression of gonadotropin receptors in Atlantic salmon (Salmo 
salar L.) ovaries. General and Comparative Endocrinology, 163; 329-339.
Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson- 
Harris H, Janson A, Kokkola R, Zhang M, Yang H & Tracey KJ (2000). High 
mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in 
human monocytes. Journal o f Experimental Medicine, 192; 565-570.
247
Antczak M & Van Blerkom J (1997). Oocyte influences on early development: the 
regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and 
differentially distributed within the cells of the preimplantation stage embryo. 
Molecular Human Reproduction, 3; 1067-1086.
Ashkenazi H, Cao X, Motola S, Popliker M, Conti M & Tsafriri A (2005). 
Epidermal growth factor family members: endogenous mediators of the ovulatory 
response. Endocrinology, 146; 77-84.
Ashworth CJ, Fliss MFV & Bazer FW (1990). Evidence for steroid control of a 
putative angiogenic factor in the porcine uterus. Journal o f Endocrinology, 125; 15- 
19.
Assidi M, Dieleman SJ & Sirard M-A (2010). Cumulus cell gene expression 
following the LH surge in bovine preovulatory follicles: potential early markers of 
oocyte competence. Reproduction, 140; 835-852.
Assidi M, Dufort I, Ali A, Hamel M, Algriany O, Dielemann S & Sirard M-A
(2008). Identification of potential markers of oocyte competence expressed in bovine 
cumulus cells matured with follicle-stimulating hormone and/or phorbol myristate 
acetate in vitro. Biology o f Reproduction, 79; 209-222.
Atsalis S, Margulis SW, Bellem A & Wielebnowski N (2004). Sexual behavior 
and hormonal estrus cycles in captive aged lowland gorillas (Gorilla gorilla). 
American Journal o f Primatology, 62; 123-132.
Auersperg N, Wong AST, Choi K-C, Kang SK & Leung PCK (2001). Ovarian 
surface epithelium: biology, endocrinology, and pathology. Endocrine Reviews, 22; 
255-288.
Aust G, Simchen C, Heider U, Hmeidan FA, Blumenauer V & Spanel-Borowski
K (2000). Eosinophils in the human corpus luteum: the role of RANTES and eotaxin 
in eosinophil attraction into periovulatory structures. Molecular Human 
Reproduction, 6; 1085-1091.
Ball P & Peters AR (2004). Reproduction in Cattle, Blackwell Publishing Ltd.
Barreiro LB, Ben-Ali M, Quach HLN, Laval G, Patin E, Pickrell JK, Bouchier 
C, Tichit M, Neyrolles O, Gicquel B, Kidd JR, Kidd KK, Alcaa"S A, 
Ragimbeau J, Pellegrini S, Abel L, Casanova J-L & Quintana-Murci L (2009). 
Evolutionary dynamics of human Toll-like receptors and their different contributions 
to host defense. Public Library o f Science Genetics, 5; el000562.
248
Battaglia DF, Beaver AB, Harris TG, Tanhehco E, Viguie C & Karsch FJ
(1999). Endotoxin disrupts the estradiol-induced luteinizing hormone surge: 
interference with estradiol signal reading, not surge release. Endocrinology, 140; 
2471-2479.
Battaglia DF, Krasa HB, Padmanabhan V, Viguie C & Karsch FJ (2000). 
Endocrine alterations that underlie endotoxin-induced disruption of the follicular 
phase in ewes. Biology o f Reproduction, 62; 45-53.
Bazer F, Thatcher W, Hansen P, Mirando M, Ott T & Plante C (1991). 
Physiological mechanisms of pregnancy recognition in ruminants. Journal o f 
Reproduction and Fertility Supplement, 43; 39-47.
Bazer FW, Spencer TE, Johnson GA, Burghardt RC & Wu G (2009). 
Comparative aspects of implantation. Reproduction, 138; 195-209.
Beg MA, Bergfelt DR, Kot K & Ginther OJ (2002). Follicle selection in cattle: 
dynamics of follicular fluid factors during development of follicle dominance. 
Biology of Reproduction, 66; 120-126.
Beutin L, Wang Q, Naumann D, Han W, Krause G, Leomil L, Wang L & Feng
L (2007). Relationship between O-antigen subtypes, bacterial surface structures and 
O-antigen gene clusters in Escherichia coli 0123 strains carrying genes for Shiga 
toxins and intimin. Journal o f Medical Microbiology, 56; 177-184.
Beutler B (2002). TLR4 as the mammalian endotoxin sensor. Current Topics in 
Microbiology Immunology, 270; 109-120.
Bewick V, Cheek L & Ball J (2004). Statistics review 10: further nonparametric 
methods. Critical Care, 8; 196 - 199.
Bilodeau-Goeseels S (2011). Cows are not mice: the role of cyclic AMP, 
phosphodiesterases, and adenosine monophosphate-activated protein kinase in the 
maintenance of meiotic arrest in bovine oocytes. Molecular Reproduction and 
Development, 78; 734-743.
Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, Yamamoto M, Lopez- 
Collazo E, Akira S & Tergaonkar V (2007). Role for MyD88-independent, TRIF 
pathway in Lipid A/TLR4-induced endotoxin tolerance. The Journal o f Immunology, 
179; 4083-4092.
Bonello N, Mckie K, Jasper M, Andrew L, Ross N, Braybon E, Brannstrom M 
& Norman RJ (1996). Inhibition of nitric oxide: effects on interleukin-1 beta-
249
enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at 
ovulation in the rat. Biology o f Reproduction, 54; 436-445.
Bonnett BN, Martin SW, Gannon VP, Miller RB & Etherington WG (1991). 
Endometrial biopsy in Holstein-Friesian dairy cows. III. Bacteriological analysis and 
correlations with histological findings. Canandian Journal ofVetinary Research, 55; 
168-173.
Bonta PI, Van Tiel CM, Vos M, Pols TWH, Van Thienen JV, Ferreira V, 
Arkenbout EK, Seppen J, Spek CA, Van Der Poll T, Pannekoek H & De Vries
CJM (2006). Nuclear receptors Nur77, Nurrl, and NOR-1 expressed in 
atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. 
Arteriosclerosis Thrombosis and Vascular Biology, 26; 2288-2294.
Borges AM, Healey GD & Sheldon IM (2012). Explants of intact endometrium to 
model bovine innate immunity and inflammation ex vivo. American Journal o f 
Reproductive Immunology, 67; 526-539.
Bottazzi B, Bastone A, Doni A, Garlanda C, Valentino S, Deban L, Maina V, 
Cotena A, Moalli F, Vago L, Salustri A, Romani L & Mantovani A (2006). The 
long pentraxin PTX3 as a link among innate immunity, inflammation, and female 
fertility. Journal o f Leukocyte Biology, 79; 909-912.
Bradley J  & Pober J  (2001). Tumour necrosis factor receptor-associated factors 
(TRAFs). Oncogene, 20; 6482-6491.
Brandi K, Sun L, Neppl C, Siggs OM, Gall SML, Tomisato W, Li X, Du X, 
Maennel DN, Blobel CP & Beutler B (2010). MyD88 signaling in 
nonhematopoietic cells protects mice against induced colitis by regulating specific 
EGF receptor ligands. Proceedings o f the National Academy o f Sciences, 107; 
19967-19972.
Brannstrom M, Mayrhofer G & Robertson SA (1993). Localization of leukocyte 
subsets in the rat ovary during the periovulatory period. Biology o f Reproduction, 
48; 277-286.
Braw-Tal R (2002). The initiation of follicle growth: the oocyte or the somatic 
cells? Molecular and Cellular Endocrinology, 187; 11-18.
Brevini TaL, Cillo F, Colleoni S, Lazzari G, Galli C & Gandolfi F (2004). 
Expression pattern of the maternal factor zygote arrest 1 (Zarl) in bovine tissues, 
oocytes, and embryos. Molecular Reproduction and Development, 69; 375-380.
250
Brinster RL (1974). Embryo development. Journal o f Animal Science, 38; 1003- 
1012.
Bromfield JJ & Sheldon IM (2011). Lipopolysaccharide initiates inflammation in 
bovine granulosa cells via the TLR4 pathway and perturbs oocyte meiotic 
progression in vitro. Endocrinology, 152; 5029-5040.
Bromfield JJ & Sheldon IM (2013). Lipopolysaccharide reduces the primordial 
follicle pool in the bovine ovarian cortex ex vivo and in the murine ovary in vivo. 
Biology o f Reproduction, 88; 98.
Bubeck Wardenburg J, Williams WA & Missiakas D (2006). Host defenses 
against Staphylococcus aureus infection require recognition of bacterial lipoproteins. 
Proceedings o f the National Academy of Sciences, 103; 13831-13836.
Buchfelder M, Fahlbusch R, Merz T, Symowski H & Adams EF (1999). Clinical 
correlates in acromegalic patients with pituitary tumours expressing GSP oncogenes. 
Pituitary, 1; 181-185.
Bullock J, Boyle J & Wang M (2001). Physiology, Lippincott, Williams and 
Wilkins.
Burke CR, Macmillan KL & Boland MP (1996). Oestradiol potentiates a 
prolonged progesterone-induced suppression of LH release in ovariectomised cows. 
Animal Reproduction Science, 45; 13-28.
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, 
Nolan T, Pfaffi MW, Shipley GL, Vandesompele J & Wittwer CT (2009). The 
MIQE Guidelines: minimum information for publication of quantitative real-time 
PCR experiments. Clinical Chemistry, 55; 611-622.
Caillaud M & Gerard N (2009). In vivo and in vitro effects of interleukin-lp on 
equine oocyte maturation and on steroidogenesis and prostaglandin synthesis in 
granulosa and cumulus cells. Reproduction, Fertility and Development, 21; 265-273.
Calder MD, Caveney AN, Smith LC & Watson AJ (2003). Responsiveness of 
bovine cumulus-oocyte-complexes (COC) to porcine and recombinant human FSH, 
and the effect of COC quality on gonadotropin receptor and Cx43 marker gene 
mRNAs during maturation in vitro. Reproductive Biology and Endocrinology, 1; 14.
Campo GM, Avenoso A, Campo S, D’ascola A, Nastasi G & Calatroni A (2010). 
Small hyaluronan oligosaccharides induce inflammation by engaging both Toll-like- 
4 and CD44 receptors in human chondrocytes. Biochemical Pharmacology, 80; 480- 
490.
251
Carabatsos MJ, Elvin J, Matzuk MM & Albertini DF (1998). Characterization of 
oocyte and follicle development in growth differentiation factor-9-deficient mice. 
Developmental Biology, 204; 373-384.
Carlberg M, Nejaty J, Froysa B, Guan Y, Soder O & Bergqvist A (2000). 
Elevated expression of tumour necrosis factor a in cultured granulosa cells from 
women with endometriosis. Human Reproduction, 15; 1250-1255.
Chan O, Burke JD, Gao DF & Fish EN (2012). The chemokine CCL5 regulates 
glucose uptake and AMP kinase signaling in activated T cells to facilitate 
chemotaxis. Journal o f Biological Chemistry, 287; 29406-29416.
Chapwanya A, Meade KG, Doherty ML, Callanan JJ, Mee JF & O’farrelly C
(2009). Histopathological and molecular evaluation of Holstein-Friesian cows 
postpartum: toward an improved understanding of uterine innate immunity. 
Theriogenology, 71; 1396-1407.
Charalambous C, Pen LB, Su YS, Milan J, Chen TC & Hofman FM (2005). 
Interleukin-8 differentially regulates migration of tumor-associated and normal 
human brain endothelial cells. Cancer Research, 65; 10347-10354.
Chernova I, Lai JP, Li H, Schwartz L, Tuluc F, Korchak HM, Douglas SD & 
Kilpatrick LE (2009). Substance P (SP) enhances CCL5-induced chemotaxis and 
intracellular signaling in human monocytes, which express the truncated neurokinin- 
1 receptor (NK1R). Journal o f Leukocyte Biology, 85; 154-164.
Chu S, Nishi Y, Yanase T, Nawata H & Fuller PJ (2004). Transrepression of 
estrogen receptor p signaling by nuclear factor-KB in ovarian granulosa cells. 
Molecular Endocrinology, 18; 1919-1928.
Clarke HG, Hope SA, Byers S & Rodgers RJ (2006). Formation of ovarian 
follicular fluid may be due to the osmotic potential of large glycosaminoglycans and 
proteoglycans. Reproduction, 132; 119-131.
Collins HL & Bancroft GJ (1992). Cytokine enhancement of complement- 
dependent phagocytosis by macrophages: synergy of tumor necrosis factor-a and 
granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus 
neoformans. European Journal o f Immunology, 22; 1447-1454.
Colomiere M, Ward AC, Riley C, Trenerry MK, Cameron-Smith D, Findlay J, 
Ackland L & Ahmed N (2008). Cross talk of signals between EGFR and IL-6R 
through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian 
carcinomas. British Journal o f Cancer, 100; 134-144.
252
Conti M, Hsieh M, Park J-Y & Su Y-Q (2006). Role of the epidermal growth 
factor network in ovarian follicles. Molecular Endocrinology, 20; 715-723.
Coussens PM & Nobis W (2002). Bioinformatics and high throughput approach to 
create genomic resources for the study of bovine immunobiology. Veterinary 
Immunology and Immunopathology, 86; 229-244.
Crespo D, Bonnet E, Roher N, Mackenzie SA, Krasnov A, Goetz FW, Bobe J & 
Planas JV (2010). Cellular and molecular evidence for a role of tumor necrosis 
factor alpha in the ovulatory mechanism of trout. Reproductive Biology and 
Endocrinology, 8; 34.
Cronin JG, Turner ML, Goetze L, Bryant CE & Sheldon IM (2012). Toll-like 
receptor 4 and MyD88-dependent signaling mechanisms of the innate immune 
system are essential for the response to lipopolysaccharide by epithelial and stromal 
cells of the bovine endometrium. Biology o f Reproduction, 86; 51, 51-59.
Crowe MA, Kelly P, Driancourt MA, Boland MP & Roche JF (2001). Effects of 
follicle-stimulating hormone with and without luteinizing hormone on serum 
hormone concentrations, follicle growth, and intrafollicular estradiol and aromatase 
activity in gonadotropin-releasing hormone-immunized heifers. Biology of 
Reproduction, 64; 368-374.
Crowe MA & Williams EJ (2012). Triennial Lactation Symposium: effects of 
stress on postpartum reproduction in dairy cows. Journal o f Animal Science, 90; 
1722-1727.
Davidson V & Sittman D (1999). Biochemistry, Lippincott, Williams and Wilkins.
Davies D, Meade K, Herath S, Eckersall PD, Gonzalez D, White J, Conlan RS, 
O'farrelly C & Sheldon IM (2008). Toll-like receptor and antimicrobial peptide 
expression in the bovine endometrium. Reproductive Biology and Endocrinology, 6; 
53.
De La Fuente R & King WA (1998). Developmental consequences of karyokinesis 
without cytokinesis during the first mitotic cell cycle of bovine parthenotes. Biology 
of Reproduction, 58; 952-962.
Dean M & Dailey RA (2011). The ability of subordinate follicles of the second 
follicular wave to become dominant is lost by day 15 of the estrous cycle in cattle. 
Animal Reproduction Science, 126; 162-167.
253
Delrieu I, Chinestra P, Delassus F, Bayard F, Prats H & Faye (2000). IL-6 
promoter is modulated by the 24 kDa FGF-2 isoform fused to the hormone binding 
domain of the oestrogen receptor. Cytokine, 12; 1110-1114.
Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C 
& Chen ZJ (2000). Activation of the I[kappa]B kinase complex by TRAF6 requires 
a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. 
Cell, 103; 351-361.
Deshpande R, Khalili H, Pergolizzi RG, Michael SD & Chang MD (1997). 
Estradiol down-regulates LPS-induced cytokine production and NFkB activation in 
murine macrophages. American Journal o f Reproductive Immunology, 38; 46-54.
Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D, Noubade R, Briso EM, 
Charland C, Leonard WJ, Ciliberto G, Teuscher C, Haynes L & Rincon M
(2009). The induction of antibody production by IL-6 is indirectly mediated by IL-21 
produced by CD4+ T cells. The Journal o f Experimental Medicine, 206; 69-78.
Dinarello CA (2011). A clinical perspective of IL-lp as the gatekeeper of 
inflammation. European Journal o f Immunology, 41; 1203-1217.
Dohmen MJW, Joop K, Sturk A, Bols PEJ & Lohuis JaCM (2000). Relationship 
between intra-uterine bacterial contamination, endotoxin levels and the development 
of endometritis in postpartum cows with dystocia or retained placenta. 
Theriogenology, 54; 1019-1032.
Donofrio G, Franceschi V, Capocefalo A, Cavirani S & Sheldon IM (2009). 
Isolation and characterization of bovine herpesvirus 4 (BoHV-4) from a cow affected 
by post partum metritis and cloning of the genome as a bacterial artificial 
chromosome. Reproductive Biology and Endocrinology, 7; 83.
Driancourt MA (2001). Regulation of ovarian follicular dynamics in farm animals. 
Implications for manipulation of reproduction. Theriogenology, 55; 1211-1239.
Drillich M, Beetz O, Pfutzner A, Sabin M, Sabin H-J, Kutzer P, Nattermann H 
& Heuwieser W (2001). Evaluation of a systemic antibiotic treatment of toxic 
puerperal metritis in dairy cows. Journal o f Dairy Science, 84; 2010-2017.
Drillich M, Voigt D, Forderung D & Heuwieser W (2007). Treatment of acute 
puerperal metritis with flunixin meglumine in addition to antibiotic treatment. 
Journal o f Dairy Science, 90; 3758-3763.
254
Dubuc J, Duffield TF, Leslie KE, Walton JS & Leblanc SJ (2010). Risk factors 
for postpartum uterine diseases in dairy cows. Journal o f Dairy Science, 93; 5764- 
5771.
Elinav E, Strowig T, Henao-Mejia J & Flavell RA (2011). Regulation of the 
antimicrobial response by NLR proteins. Immunity, 34; 665-679.
Elson G, Dunn-Siegrist I, Daubeuf B & Pugin J (2007). Contribution of Toll-like 
receptors to the innate immune response to Gram-negative and Gram-positive 
bacteria. Blood, 109; 1574-1583.
Eppig JJ, O'brien M & Wigglesworth K (1996). Mammalian oocyte growth and 
development in vitro. Molecular Reproduction and Development, 44; 260-273.
Erickson BH (1966). Development and senescence of the postnatal bovine ovary. 
Journal o f Animal Science, 25; 800-805.
Espey L (1980). Ovulation as an inflammatory reaction - a hypothesis. Biology of 
Reproduction, 22; 73-106.
Evans ACO, Adams GP & Rawlings NC (1994). Endocrine and ovarian follicular 
changes leading up to the first ovulation in prepubertal heifers. Journal o f 
Reproduction and Fertility, 100; 187-194.
Fedorcsak P, Raki M & Storeng R (2007). Characterization and depletion of 
leukocytes from cells isolated from the pre-ovulatory ovarian follicle. Human 
Reproduction, 22; 989-994.
Fei T, Xia K, Li Z, Zhou B, Zhu S, Chen H, Zhang J, Chen Z, Xiao H, Han J-DJ 
& Chen Y-G (2010). Genome-wide mapping of SMAD target genes reveals the role 
of BMP signaling in embryonic stem cell fate determination. Genome Research, 20; 
36-44.
Feng G-J, Goodridge HS, Harnett MM, Wei X-Q, Nikolaev AV, Higson AP & 
Liew F-Y (1999). Extracellular signal-related kinase (ERK) and p38 mitogen- 
activated protein (MAP) kinases differentially regulate the lipopolysaccharide- 
mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: 
Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK 
MAP kinase. The Journal o f Immunology, 163; 6403-6412.
Ferreira EM, Vireque AA, Adona PR, Meirelles FV, Ferriani RA & Navarro
PA (2009). Cytoplasmic maturation of bovine oocytes: structural and biochemical 
modifications and acquisition of developmental competence. Theriogenology, 71; 
836-848.
255
Fishel S, Jackson P, Webster J & Faratian B (1988). Endotoxins in culture 
medium for human in vitro fertilization. Fertility and Sterility, 49; 108-111.
Fissore RA, Pinto-Correia C & Robl JM  (1995). Inositol trisphosphate-induced 
calcium release in the generation of calcium oscillations in bovine eggs. Biology of 
Reproduction, 53; 766-774.
Fortune JE & Hansel W (1985). Concentrations of steroids and gonadotropins in 
follicular fluid from normal heifers and heifers primed for superovulation. Biology of 
Reproduction, 32; 1069-1079.
Fortune JE, Rivera GM, Evans ACO & Turzillo AM (2001). Differentiation of 
dominant versus subordinate follicles in cattle. Biology o f Reproduction, 65; 648-
654.
Fortune JE, Willis EL, Bridges PJ & Yang CS (2009). The periovulatory period 
in cattle: progesterone, prostaglandins, oxytocin and ADAMTS proteases. Animal 
Reproduction Science, 6; 60-71.
Fraser HM (2006). Regulation of the ovarian follicular vasculature. Reproductive 
Biology and Endocrinology, 4; 18.
Frazier-Jessen MR & Kovacs EJ (1995). Estrogen modulation of JE/monocyte 
chemoattractant protein-1 mRNA expression in murine macrophages. The Journal o f 
Immunology, 154; 1838-1845.
Freimann S, Ben-Ami I, Hirsh L, Dantes A, Halperin R & Amsterdam A (2004). 
Drug development for ovarian hyper-stimulation and anti-cancer treatment: blocking 
of gonadotropin signaling for epiregulin and amphiregulin biosynthesis. Biochemical 
Pharmacology, 68; 989-996.
Frerking H (1999). Causes of abolition of milk yield controlled cows in the district 
of the agricultural Chamber of Hannover from 1958 to 1997 (Abgangsursachen von 
ganzjaehrig milchleistungsgeprueften Kuehen im Bereich der 
Landwirtschaftskammer Hannover von 1958 bis 1997). Praktische Tierarzt, 80; 607- 
612.
Fu Qiu, Maniar A, Quevedo Diaz M, Chapoval AI & Medvedev AE (2011). 
Activation of cytokine-producing and antitumor activities of natural killer cells and 
macrophages by engagement of Toll-like and NOD-like receptors. Innate Immunity, 
17; 375-387.
256
Fujita Y, Mihara T, Okazaki T, Shitanaka M, Kushino R, Ikeda C, Negishi H, 
Liu Z, Richards JS & Shimada M (2011). Toll-like receptors (TLR) 2 and 4 on 
human sperm recognize bacterial endotoxins and mediate apoptosis. Human 
Reproduction, 26; 2799-2806.
Fulop C, Szanto S, Mukhopadhyay D, Bardos T, Kamath RV, Rugg MS, Day 
AJ, Salustri A, Hascall YC, Giant TT & Mikecz K (2003). Impaired cumulus 
mucification and female sterility in tumor necrosis factor-induced protein-6 deficient 
mice. Development, 130; 2253-2261.
Geisel J, Kahl F, Muller M, Wagner H, Kirschning CJ, Autenrieth IB & Frick
J-S (2007). IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist 
tolerance and cross-tolerance in dendritic cells. The Journal o f Immunology, 179; 
5811-5818.
Gerard N, Caillaud M, Martoriati A, Goudet G & Lalmanach A (2004). The 
interleukin-1 system and female reproduction. Journal o f Endocrinology, 180; 203- 
212.
Gershon E, Plaks V & Dekel N (2008). Gap junctions in the ovary: expression, 
localization and function. Molecular and Cellular Endocrinology, 282; 18-25.
Gharib SD, Roy A, Wierman ME & Chin WW (1989). Isolation and 
characterization of the gene encoding the beta-subunit of rat follicle-stimulating 
hormone. DNA, 8; 339-349.
Ghisletti S, Meda C, Maggi A & Vegeto E (2005). 17P-Estradiol inhibits 
inflammatory gene expression by controlling NF-kB intracellular localization. 
Molecular and Cellular Biology, 25; 2957-2968.
Gibbons JR, Wiltbank MC & Ginther OJ (1997). Functional interrelationships 
between follicles greater than 4 mm and the follicle-stimulating hormone surge in 
heifers. Biology of Reproduction, 57; 1066-1073.
Gilbert FB, Cunha P, Jensen K, Glass EJ, Foucras G, Robert-Granie C, Rupp 
R & Rainard P (2013). Differential response of bovine mammary epithelial cells to 
Staphylococcus aureus or Escherichia coli agonists of the innate immune system. 
Vetinary Research, 44; 40.
Gilbert S (2000). Developmental Biology, Sinauer Associates.
Ginther O, Bergfelt D, Beg M & Kot K (2001). Effect of LH on circulating 
oestradiol and follicular fluid factor concentrations during follicle deviation in cattle. 
Reproduction, 122; 103-110.
257
Ginther OJ, Bergfelt DR, Kulick LJ & Kot K (2000). Selection of the dominant 
follicle in cattle: role of estradiol. Biology o f Reproduction, 63; 383-389.
Ginther OJ, Kot K, Kulick LJ & Wiltbank MC (1997). Emergence and deviation 
of follicles during the development of follicular waves in cattle. Theriogenology, 48; 
75-87.
Ginther OJ, Wiltbank MC, Fricke PM, Gibbons JR & Kot K (1996). Selection 
of the dominant follicle in cattle. Biology o f Reproduction, 55; 1187-1194.
Giordano JO, Edwards JL, Di Croce FA, Roper D, Rohrbach NR, Saxton AM, 
Schuenemann GM, Prado TM & Schrick FN (2013). Ovulatory follicle 
dysfunction in lactating dairy cows after treatment with Folltropin-V at the onset of 
luteolysis. Theriogenology, 79; 1210-1217.
Girardin SE, Travassos LH, Herve M, Blanot D, Boneca IG, Philpott DJ, 
Sansonetti PJ & Mengin-Lecreulx D (2003). Peptidoglycan molecular 
requirements allowing detection by Nodi and Nod2. Journal o f Biological 
Chemistry, 278; 41702-41708.
Gong JG, Campbell BK, Bramley TA, Gutierrez CG, Peters AR & Webb R
(1996). Suppression in the secretion of follicle-stimulating hormone and luteinizing 
hormone, and ovarian follicle development in heifers continuously infused with a 
gonadotropin-releasing hormone agonist. Biology o f Reproduction, 55; 68-74.
Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL & Richards JS
(2000). Follicle-stimulating hormone (FSH) stimulates phosphorylation and 
activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced 
kinase (Sgk): evidence for a kinase-independent signaling by FSH in granulosa cells. 
Molecular Endocrinology, 14; 1283-1300.
Gorospe WC & Spangelo BL (1993). Interleukin-6 production by rat granulosa 
cells in vitro: effects of cytokines, follicle-stimulating hormone, and cyclic 3',5'- 
adenosine monophosphate. Biology o f Reproduction, 48; 538-543.
Goto J, Kanayama N, Asahina T, Okada Y, Kobayashi T & Terao T (1997). 
Induction of follicular growth by exogenous interleukin-8. Human Reproduction, 12; 
2729-2734.
Goto J, Suganuma N, Takata K, Kitamura K, Asahina T, Kobayashi H, 
Muranaka Y, Furuhashi M & Kanayama N (2002). Morphological analyses of 
interleukin-8 effects on rat ovarian follicles at ovulation and luteinization in vivo. 
Cytokine, 20; 168-173.
258
Gottipati S, Rao NL & Fung-Leung W-P (2008). IRAKI: A critical signaling 
mediator of innate immunity. Cellular Signalling, 20; 269-276.
Green MP, Ledgard AM, Beaumont SE, Berg MC, Mcnatty KP, Peterson AJ & 
Back PJ (2011). Long-term alteration of follicular steroid concentrations in relation 
to subclinical endometritis in postpartum dairy cows. Journal o f Animal Science, 89; 
3551-3560.
Gribar SC, Anand RJ, Sodhi CP & Hackam DJ (2008). The role of epithelial 
Toll-like receptor signaling in the pathogenesis of intestinal inflammation. Journal o f 
Leukocyte Biology, 83; 493-498.
Grooms DL, Brock KV, Pate JL & Day ML (1998). Changes in ovarian follicles 
following acute infection with bovine viral diarrhea virus. Theriogenology, 49; 595- 
605.
Guarda G & So A (2010). Regulation of inflammasome activity. Immunology, 130; 
329-336.
Gudermuth DF, Concannon PW, Daels PF & Lasley BL (1998). Pregnancy- 
specific elevations in fecal concentrations of estradiol, testosterone and progesterone 
in the domestic dog (Canis familiaris). Theriogenology, 50; 237-248.
Gutierrez C, Campbell B & Webb R (1996). Development of a long term bovine 
granulosa cell culture system: Induction and maintenance of estradiol production, 
response to follicle-stimulationg hormone and morphological characteristics. Biology 
of Reproduction, 56; 608-616.
Gutierrez CG, Campbell BK & Webb R (1997). Development of a long-term 
bovine granulosa cell culture system: induction and maintenance of estradiol 
production, response to follicle-stimulating hormone, and morphological 
characteristics. Biology o f Reproduction, 56; 608-616.
Gutierrez CG, Ralph JH, Telfer EE, Wilmut I & Webb R (2000). Growth and 
antrum formation of bovine preantral follicles in long-term culture in vitro. Biology 
of Reproduction, 62; 1322-1328.
Half on MS, Hashimoto C & Keshishian H (1995). The Drosophila Toll gene 
functions zygotically and is necessary for proper motoneuron and muscle 
development. Developmental Biology, 169; 151-167.
Hammond ME, Lapointe GR, Feucht PH, Hilt S, Gallegos CA, Gordon CA, 
Giedlin MA, Mullenbach G & Tekamp-Olson P (1995). IL-8 induces neutrophil
259
chemotaxis predominantly via type I IL-8 receptors. The Journal o f Immunology, 
155; 1428-1433.
Hansen PJ, Soto P & Natzke RP (2004). Mastitis and fertility in cattle -  possible 
involvement of inflammation or immune activation in embryonic mortality. 
American Journal o f Reproductive Immunology, 51; 294-301.
Harrison C (2013). Patent watch. Nature Reviews Drug Discovery, 12; 336-337.
Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S, Guiet C, 
Briere F, Vlach J, Lebecque S, Trinchieri G & Bates EEM (2005). Human 
TLR 10 is a functional receptor, expressed by B cells and plasmacytoid dendritic 
cells, which activates gene transcription through MyD88. The Journal o f 
Immunology, 174; 2942-2950.
Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, 
Akira S, Underhill DM & Aderem A (2001). The innate immune response to 
bacterial flagellin is mediated by Toll-like receptor 5. Nature, 410; 1099-1103.
Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, 
Tomizawa H, Takeda K & Akira S (2002). Small antiviral compounds activate 
immune cells via TLR7 MyD88-dependent signalling pathway. Nature Immunology, 
3; 196-200.
Henderson KM, Mcneilly AS & Swanston IA (1982). Gonadotrophin and steroid 
concentrations in bovine follicular fluid and their relationship to follicle size. Journal 
of Reproduction and Fertility, 65; 467-473.
Herath S, Fischer DP, Werling D, Williams EJ, Lilly ST, Dobson H, Bryant CE 
& Sheldon IM (2006). Expression and function of Toll-like receptor 4 in the 
endometrial cells of the uterus. Endocrinology, 147; 562-570.
Herath S, Lilly S, Fischer D, Williams E, Dobson H, Bryant C & Sheldon M
(2009a). Bacterial lipopolysaccharide induces an endocrine switch from 
prostaglandin F2a to prostaglandin E2 in bovine endometrium. Endocrinology; 
1912-1920.
Herath S, Lilly ST, Santos NR, Gilbert RO, Goetze L, Bryant CE, White JO, 
Cronin J & Sheldon IM (2009b). Expression of genes associated with immunity in 
the endometrium of cattle with disparate postpartum uterine disease and fertility. 
Reproductive Biology and Endocrinology, 7; 55.
260
Herath S, Williams EJ, Lilly ST, Gilbert RO, Dobson H, Bryant CE & Sheldon
IM (2007). Ovarian follicular cells have innate immune capabilities that modulate 
their endocrine function. Reproduction, 134; 683-693.
Hernandez-Gonzalez I, Gonzalez-Robayna I, Shimada M, Wayne CM, Ochsner 
SA, White L & Richards JS (2006). Gene expression profiles of cumulus cell 
oocyte complexes during ovulation reveal cumulus cells express neuronal and 
immune-related genes: does this expand their role in the ovulation process? 
Molecular Endocrinology, 20; 1300-1321.
Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, Ikeda 
O, Mita S, Setoguchi T & Ogawa M (2002). Curcumin inhibits interleukin 8 
production and enhances interleukin 8 receptor expression on the cell surface. 
Cancer, 95; 1206-1214.
Hirsbrunner G, Knutti B, Kupfer U, Burkhardt H & Steiner A (2003). Effect of 
prostaglandin E2, DL-cloprostenol, and prostaglandin E2 in combination with D- 
cloprostenol on uterine motility during diestrus in experimental cows. Animal 
Reproduction Science, 79; 17-32.
Hoffmann E, Dittrich-Breiholz O, Holtmann H & Kracht M (2002). Multiple 
control of interleukin-8 gene expression. Journal of Leukocyte Biology, 72; 847-855.
Hosoda K & Terada T (2007). Bovine follicular fluid contains antagonist activity 
for cumulus expansion promoting effect by epidermal growth factor. Reproduction 
in Domestic Animals, 42; 225-229.
Hosoe M, Kaneyama K, Ushizawa K, Hayashi KG & Takahashi T (2011). 
Quantitative analysis of bone morphogenetic protein 15 (BMP 15) and growth 
differentiation factor 9 (GDF9) gene expression in calf and adult bovine ovaries. 
Reproductive Biology and Endocrinology, 9; 33.
Hsieh M, Thao K & Conti M (2011). Genetic dissection of epidermal growth factor 
receptor signaling during luteinizing hormone-induced oocyte maturation. Public 
Libary of Science ONE, 6; e21574.
Huszenicza G, Janosi S, Gaspardy A & Kulcsar M (2004). Endocrine aspects in 
pathogenesis of mastitis in postpartum dairy cows. Animal Reproduction Science, 
82-83; 389-400.
Imamura M, Kawasaki T, Savchenko AS, Ohashi R, Jiang S, Miyamoto K, Ito 
Y, Iwanari H, Sagara M, Tanaka T, Hamakubo T, Kodama T, Uchiyama M & 
Naito M (2007). Lipopolysaccharide induced expression of pentraxin 3 in human 
neutrophils and monocyte-derived macrophages. Cellular Immunology, 248; 86-94.
261
Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K,
| Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna 
| JL & Nunez G (2003). Host recognition of bacterial muramyl dipeptide mediated 
through NOD2. Journal of Biological Chemistry, 278; 5509-5512.
Ireland J, Ward F, Jimenez-Krassel F, Ireland JLH, Smith GW, Lonergan P & 
Evans ACO (2007). Follicle numbers are highly repeatable within individual 
animals but are inversely correlated with FSH concentrations and the proportion of 
I good-quality embryos after ovarian stimulation in cattle. Human Reproduction, 22; 
1687-1695.
Isobe T, Minoura H, Tanaka K, Shibahara T, Hayashi N & Toyoda N (2002). 
The effect of RANTES on human sperm chemotaxis. Human Reproduction, 17; 
1441-1446.
Jabbour HN, Sales KJ, Catalano RD & Norman JE (2009). Inflammatory 
pathways in female reproductive health and disease. Reproduction, 138; 903-919.
Jamnongjit M, Gill A & Hammes SR (2005). Epidermal growth factor receptor 
signaling is required for normal ovarian steroidogenesis and oocyte maturation. 
Proceedings of the National Academy of Sciences of the United States of America, 
j  102; 16257-16262.
Jana B, Kucharski J & Ziecik AJ (2004). Effect of intrauterine infusion of 
Escherichia coli on hormonal patterns in gilts during the oestrous cycle. 
Reproduction, Nutrition, Development, 44; 37-48.
Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas 
MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, 
Medzhitov R & Noble PW (2005). Regulation of lung injury and repair by Toll-like 
receptors and hyaluronan. Nature Medicine, 11; 1173-1179.
Jones LA, Anthony J-P, Henriquez FL, Lyons RE, Nickdel MB, Carter KC, 
Alexander J & Roberts CW (2008). Toll-like receptor-4-mediated macrophage 
activation is differentially regulated by progesterone via the glucocorticoid and 
progesterone receptors. Immunology, 125; 59-69.
Joyce IM, Pendola FL, O’brien M & Eppig JJ (2001). Regulation of 
prostaglandin-endoperoxide synthase 2 messenger ribonucleic acid expression in 
mouse granulosa cells during ovulation. Endocrinology, 142; 3187-3197.
Kagan J & Medzhitov R (2006). Phosphoinositide-mediated adaptor recruitment 
controls Toll-like receptor signaling. Cell, 125; 943-955.
Kaim M, Bloch A, Wolfenson D, Braw-Tal R, Rosenberg M, Voet H & Folman
Y (2003). Effects of GnRH administered to cows at the onset of estrus on timing of 
ovulation, endocrine responses, and conception. Journal of Dairy Science, 86; 2012- 
2021 .
Kaiser UB, Jakubowiak A, Steinberger A & Chin WW (1997). Differential 
effects of gonadotropin-releasing hormone (GnRH) pulse frequency on gonadotropin 
subunit and GnRH receptor messenger ribonucleic acid levels in vitro. 
Endocrinology, 138; 1224-1231.
Kalfa N, Veitia R, Benayoun B, Boizet-Bonhoure B & Sultan C (2009). The new 
molecular biology of granulosa cell tumors of the ovary. Genome Medicine, 1; 81.
Kaneko H, Taya K, Watanabe G, Noguchi J, Kikuchi K, Shimada A & 
Hasegawa Y (1997). Inhibin is involved in the suppression of FSH secretion in the 
growth phase of the dominant follicle during the early luteal phase in cows. 
Domestic Animal Endocrinology, 14; 263-271.
Kaneko H, Terada T, Taya K, Watanabe G, Sasamoto S, Hasegawa Y & 
Igarashi M (1991). Ovarian follicular dynamics and concentrations of oestradiol-17 
beta, progesterone, luteinizing hormone and follicle stimulating hormone during the 
periovulatory phase of the oestrous cycle in the cow. Reproduction, Fertility and 
Development, 3; 529-535.
Kaur G, Chhina GS, Mohan Kumar V & Singh B (1986). Blockade of ovulation 
by prostaglandins synthesis inhibitor in medial preoptic area. Physiology and 
Behavior, 38; 747-749.
Kawai T, Adachi O, Ogawa T, Takeda K & Akira S (1999). Unresponsiveness of 
MyD88-deficient mice to endotoxin. Immunity, 11; 115-122.
Kawai T & Akira S (2010). The role of pattem-recognition receptors in innate 
immunity: update on Toll-like receptors. Nature Immunology, 11; 373-384.
Kawai T & Akira S (2011). Toll-like receptors and their crosstalk with other innate 
receptors in infection and immunity. Immunity, 34; 637-650.
Kawai T, Takeuchi O, Fujita T, Inoue J-I, Muhlradt PF, Sato S, Hoshino K & 
Akira S (2001). Lipopolysaccharide stimulates the MyD88-independent pathway 
and results in activation of IFN-regulatory factor 3 and the expression of a subset of 
lipopolysaccharide-inducible genes. The Journal of Immunology, 167; 5887-5894.
263
Kerpedjieva SS, Kim DS, Barbeau DJ & Tamama K (2012). EGFR ligands drive 
multipotential stromal cells to produce multiple growth factors and cytokines via 
early growth response-1. Stem Cells and Development, 21; 2541-2551.
Khalaf H, Jass J & Olsson P-E (2010). Differential cytokine regulation by NF- 
kappaB and AP-1 in Jurkat T-cells. BMC Immunology, 11; 26.
Kim EY, Zeng QT, Kuo FC, Rawn J & Mentzer SJ (2003). Visual representation 
of cell subpopulation from flow cytometry data. American Medical Informatics 
Association Annual Symposium Proceedings; 893.
Kim S-H, Serezani CH, Okunishi K, Zaslona Z, Aronoff DM & Peters-Golden
M (2011). Distinct protein kinase A anchoring proteins direct prostaglandin E2 
modulation of Toll-like receptor signaling in alveolar macrophages. Journal of 
Biological Chemistry, 286; 8875-8883.
Kim Y-M, Reed W, Wu W, Bromberg PA, Graves LM & Samet JM (2006). 
Zn2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human 
airway epithelial cells. American Journal of Physiology - Lung Cellular and 
Molecular Physiology, 290; L1028-L1035.
Kitaya K & Yamada H (2011). Pathophysiological roles of chemokines in human 
reproduction: an overview. American Journal of Reproductive Immunology, 65; 449- 
459.
Kleve CD, Siler DA, Syed SK & Eldon ED (2006). Expression of 18-wheeler in 
the follicle cell epithelium affects cell migration and egg morphology in Drosophila. 
Developmental Dynamics, 235; 1953-1961.
Kong L & Ge B-X (2008). MyD88-independent activation of a novel actin- 
Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell 
Research, 18; 745-755.
Kontny E, Kvanta A & Fredholm BB (1992). Activation of protein kinase C and 
elevation of cAMP interact synergistically to raise c-Fos and AP-1 activity in Jurkat 
cells. European Journal o f Pharmacology: Molecular Pharmacology, 227; 333-338.
Kulick LJ, Kot K, Wiltbank MC & Ginther OJ (1999). Follicular and hormonal 
dynamics during the first follicular wave in heifers. Theriogenology, 52; 913-921.
Kurebayashi S, Miyashita Y, Hirose T, Kasayama S, Akira S & Kishimoto T
(1997). Characterization of mechanisms of interleukin-6 gene repression by estrogen 
receptor. The Journal of Steroid Biochemistry and Molecular Biology, 60; 11-17.
264
Lane MC, Alteri CJ, Smith SN & Mobley HLT (2007). Expression of flagella is 
coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. 
Proceedings of the National Academy of Sciences, 104; 16669-16674.
Langhout DJ, Spicer LJ & Geisert RD (1991). Development of a culture system 
for bovine granulosa cells: effects of growth hormone, estradiol, and gonadotropins 
on cell proliferation, steroidogenesis, and protein synthesis. Journal of Animal 
Science, 69; 3321-3334.
i
i
Larsen W, Tung H & Polking C (1981). Response of granulosa cell gap junctions 
to human chorionic gonadotropin (hCG) at ovulation. Biology of Reproduction, 25; 
1119-1134.
Latz E (2010). The inflammasomes: mechanisms of activation and function. Current 
Opinion in Immunology, 22; 28-33.
Lavon Y, Leitner G, Goshen T, Braw-Tal R, Jacoby S & Wolfenson D (2008). 
Exposure to endotoxin during estrus alters the timing of ovulation and hormonal 
concentrations in cows. Theriogenology, 70; 956-967.
| Lavon Y, Leitner G, Klipper E, Moallem U, Meidan R & Wolfenson D (201 la). 
Subclinical, chronic intramammary infection lowers steroid concentrations and gene 
expression in bovine preovulatory follicles. Domestic Animal Endocrinology, 40; 98- 
109.
Lavon Y, Leitner G, Moallem U, Klipper E, Voet H, Jacoby S, Glick G, Meidan 
R & Wolfenson D (2011b). Immediate and carryover effects of Gram-negative and 
Gram-positive toxin-induced mastitis on follicular function in dairy cows. 
Theriogenology, 76; 942-953.
Lavon Y, Leitner G, Yoet H & Wolfenson D (2010). Naturally occurring mastitis 
effects on timing of ovulation, steroid and gonadotrophic hormone concentrations, 
and follicular and luteal growth in cows. Journal of Dairy Science, 93; 911-921.
Lemaire WJ (1989). Mechanism of mammalian ovulation. Steroids, 54; 455-469.
Lemaitre B, Nicolas E, Michaut L, Reichhart J & Hoffmann J (1996). The 
dorsoventral regulatory gene cassette spaetzle/Toll/cactus controls the potent 
antifungal response in Drosophila adults. Cell, 86; 973-983.
Lewis G (2004). Steroidal regulation of uterine immune defenses. Animal 
Reproduction Science, 82-83; 281-294.
Li S, Strelow A, Fontana EJ & Wesche H (2002). IRAK-4: A novel member of the 
IRAK family with the properties of an IRAK-kinase. Proceedings of the National 
Academy of Sciences of the United States of America, 99; 5567-5572.
Liang SL, Zhao QJ, Li XC, Jin YP, Wang YP, Su XH, Guan WJ & Ma YH
(2011). Dynamic analysis of Ca(2)+ level during bovine oocytes maturation and 
early embryonic development. Journal ofVetinary Science, 12; 133-142.
Liu Z, Matos DGD, Fan H-Y, Shimada M, Palmer S & Richards JS (2009). 
Interleukin-6: an autocrine regulator of the mouse cumulus cell-oocyte complex 
expansion process. Endocrinology, 150; 3360-3368.
Liu Z, Shimada M & Richards J (2008). The involvement of the Toll-like receptor 
family in ovulation. Journal o f Assisted Reproductive Genetics, 25; 223-228.
Livak KJ & Schmittgen TD (2001). Analysis of relative gene expression data using 
real-time quantitative PCR and the 2-AACT method. Methods, 25; 402-408.
Loken MR, Brosnan JM, Bach BA & Ault KA (1990). Establishing optimal 
lymphocyte gates for immunophenotyping by flow cytometry. Cytometry, 11; 453- 
459.
Lonergan P, Carolan C, Van Langendonckt A, Donnay I, Khatir H & 
Mermillod P (1996). Role of epidermal growth factor in bovine oocyte maturation 
and preimplantation embryo development in vitro. Biology of Reproduction, 54; 
1420-1429.
Lorenzo PL, Illera MJ, Illera JC & Illera M (1994). Enhancement of cumulus 
expansion and nuclear maturation during bovine oocyte maturation in vitro by the 
addition of epidermal growth factor and insulin-like growth factor I. Journal of 
Reproduction and Fertility, 101; 697-701.
Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951). Protein measurement 
with the folin phenol reagent. Journal o f Biological Chemistry, 193; 265-275.
Lueders I, Hildebrandt TB, Pootoolal J, Rich P, Gray CS & Niemuller CA
(2009). Ovarian ultrasonography correlated with fecal progestins and estradiol 
during the estrous cycle and early pregnancy in giraffes (Giraffa Camelopardalis 
rothschildi). Biology of Reproduction, 81; 989-995.
Lussier JG, Carruthers TD & Murphy BD (1993). Effects of bovine follicular 
fluid and partially purified bovine inhibin on FSH and LH release by bovine pituitary 
cells in culture. Reproduction Nutrition Development, 33; 109-119.
266
Mack EM, Smith JE, Kurz SG & Wood JR (2012). cAMP-dependent regulation 
of ovulatory response genes is amplified by IGF1 due to synergistic effects on Akt 
I phosphorylation and NF-kB transcription factors. Reproduction, 144; 595-602.
! Mackenzie S, Montserrat N, Mas M, Acerete L, Tort L, Krasnov A, Goetz FW 
| & Planas JV (2006). Bacterial lipopolysaccharide induces apoptosis in the trout
! ovary. Reproductive Biology and Endocrinology, 4; 46.
iI
iI
| Madshus IH & Stang E (2009). Internalization and intracellular sorting of the EGF 
I receptor: a model for understanding the mechanisms of receptor trafficking. Journal 
! of Cell Science, 122; 3433-3439.
Makabe S, Naguro T & Stallone T (2006). Oocyte-follicle cell interactions during 
ovarian follicle development, as seen by high resolution scanning and transmission 
electron microscopy in humans. Microscopy Research and Technique, 69; 436-449.
Malhi PS, Adams GP & Singh J (2005). Bovine model for the study of 
reproductive aging in women: follicular, luteal, and endocrine characteristics. 
Biology of Reproduction, 73; 45-53.
| Mantovani A, Garlanda C & Bottazzi B (2003). Pentraxin 3, a non-redundant 
soluble pattern recognition receptor involved in innate immunity. Vaccine, 21, 
Supplement 2; S43-S47.
Markosyan N & Duffy DM (2009). Prostaglandin E2 acts via multiple receptors to 
regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. 
Endocrinology, 150; 435-444.
Martin RM, Leonhardt H & Cardoso MC (2005). DNA labeling in living cells. 
Cytometry Part A, 67A; 45-52.
Martin TL, Fogwell RL & Ireland JJ (1991). Concentrations of inhibins and 
steroids in follicular fluid during development of dominant follicules in heifers. 
Biology of Reproduction, 44; 693-700.
Matsuda F, Inoue N, Manabe N & Ohkura S (2012). Follicular growth and atresia 
in mammalian ovaries: regulation by survival and death of granulosa cells. Journal 
of Reproduction and Development, 58; 44-50.
Matsunaga T & Rahman A (1998). What brought the adaptive immune system to 
vertebrates? - The jaw hypothesis and the seahorse. Immunological Reviews, 166; 
177-186.
267
Matzuk MM, Burns KH, Viveiros MM & Eppig JJ (2002). Intercellular 
communication in the mammalian ovary: oocytes carry the conversation. Science, 
296; 2178-2180.
Mclaughlin M, Bromfield JJ, Albertini DF & Telfer EE (2010). Activin promotes 
follicular integrity and oogenesis in cultured pre-antral bovine follicles. Molecular 
Human Reproduction, 16; 644-653.
Medzhitov R, Preston-Hurlburt P & Janeway C (1997). A human homologue of 
the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388; 
394-397.
Meini S, Cucchi P, Catalani C, Bellucci F, Giuliani S & Maggi CA (2011). 
Bradykinin and B2 receptor antagonism in rat and human articular chondrocytes. 
British Journal of Pharmacology, 162; 611-622.
Menzies M & Ingham A (2006). Identification and expression of Toll-like receptors 
1-10 in selected bovine and ovine tissues. Veterinary Immunology and 
Immunopathology, 109; 23-30.
Merritt WM, Lin YG, Spannuth WA, Fletcher MS, Kamat AA, Han LY, 
Landen CN, Jennings N, De Geest K, Langley RR, Villares G, Sanguino A, 
Lutgendorf SK, Lopez-Berestein G, Bar-Eli MM & Sood AK (2008). Effect of 
interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on 
ovarian cancer cell growth. Journal of the National Cancer Institute, 100; 359-372.
Middlebrook BS, Eldin K, Li X, Shivasankaran S & Pangas SA (2009). Smadl- 
Smad5 ovarian conditional knockout mice develop a disease profile similar to the 
juvenile form of human granulosa cell tumors. Endocrinology, 150; 5208-5217.
Mihm M, Good TE, Ireland JL, Ireland JJ, Knight PG & Roche JF (1997). 
Decline in serum follicle-stimulating hormone concentrations alters key 
intrafollicular growth factors involved in selection of the dominant follicle in heifers. 
Biology of Reproduction, 57; 1328-1337.
Mikami F, Gu H, Jono H, Andalibi A, Kai H & Li J-D (2005). Epidermal growth 
factor receptor acts as a negative regulator for bacterium Nontypeable Haemophilus 
influenzae-induced Toll-like receptor 2 expression via a Src-dependent p38 mitogen- 
activated protein kinase signaling pathway. Journal of Biological Chemistry, 280; 
36185-36194.
Miller A, Williams E, Sibley K, Herath S, Lane E, Fishwick J, Nash D, Rycroft 
A, Dobson H, Bryant C & Sheldon M (2007). The effects of A.pyogenes on 
endometrial function in vitro and on uterine and ovarian function in vivo. 
Theriogenology, 68; 972-980.
268
Mo J, Boyle JP, Howard CB, Monie TP, Davis BK & Duncan JA (2012). 
Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 
2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. Journal of 
Biological Chemistry, 287; 23057-23067.
Moges N & Jebar A (2012). Prevalence of subclinical endometritis and its effect on 
pregnancy in crossbred dairy cows in Gondar. Journal of Reproduction and 
Infertility, 3; 26-31.
Moresco EMY, Lavine D & Beutler B (2011). Toll-like receptors. Current 
Biology, 21; R488-R493.
Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: 
application to proliferation and cytotoxicity assays. Journal of Immunological 
Methods, 65; 55-63.
Murooka TT, Rahbar R, Platanias LC & Fish EN (2008). CCL5-mediated T-cell 
chemotaxis involves the initiation of mRNA translation through mTOR/4E-BPl. 
Blood, 111; 4892-4901.
Murphy AJ, Guyre PM & Pioli PA (2010). Estradiol suppresses NF-kB activation 
through coordinated regulation of let-7a and miR-125b in primary human 
macrophages. The Journal of Immunology, 184; 5029-5037.
Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ & 
Tschopp J (2008). The inflammasome recognizes cytosolic microbial and host DNA 
and triggers an innate immune response. Nature, 452; 103-107.
Muto J, Yamasaki K, Taylor KR & Gallo RL (2009). Engagement of CD44 by 
hyaluronan suppresses TLR4 signaling and the septic response to LPS. Molecular 
Immunology, 47; 449-456.
N.I.A.I.D. 2009. Pelvic Inflammatory Disease [Online]. National Institute of Allergy 
and Infectious Diseases. Available:
http://www.niaid.nih.gov/topics/pelvicinflammatorydisease/Pages/default.aspx 
[Accessed 26th May 2013].
Netea MG, Nold-Petry CA, Nold MF, Joosten LaB, Opitz B, Van Der Meer 
JHM, Van De Veerdonk FL, Ferwerda G, Heinhuis B, Devesa I, Funk CJ, 
Mason RJ, Kullberg BJ, Rubartelli A, Van Der Meer JWM & Dinarello CA
(2009). Differential requirement for the activation of the inflammasome for 
processing and release of IL-ip in monocytes and macrophages. Blood, 113; 2324- 
2335.
269
Neumann D, Kollewe C, Pich A, Cao P, Resch K & Martin MU (2008). 
Threonine 66 in the death domain of IRAK-1 is critical for interaction with signaling 
molecules but is not a target site for autophosphorylation. Journal of Leukocyte 
Biology, 84; 807-813.
Nguyen T, De Nardo D, Masendycz P, Hamilton JA & Scholz GM (2009). 
i Regulation of IRAK-1 activation by its C-terminal domain. Cellular Signalling, 21;
| 719-726.
| Nogueira MFG, Buratini J, Price CA, Castilho ACS, Pinto MGL & Barros CM
(2007). Expression of LH receptor mRNA splice variants in bovine granulosa cells: 
changes with follicle size and regulation by FSH in vitro. Molecular Reproduction 
and Development, 74; 680-686.
Okamura F & Nishiyama H (1978). Penetration of spermatozoon into the ovum 
and transformation of the sperm nucleus into the male pronucleus in the domestic 
fowl, Gallus gallus. Cell and Tissue Research, 190; 89-98.
| Okazaki T, Mihara T, Fujita Y, Yoshida S, Teshima H & Shimada M (2010).
| Polymyxin B neutralizes bacteria-released endotoxin and improves the quality of 
| boar sperm during liquid storage and cryopreservation. Theriogenology, 74; 1691- 
| 1700.
Opsomer G, Grohn YT, Hertl J, Coryn M, Deluyker H & De Kruif A (2000). 
Risk factors for post partum ovarian dysfunction in high producing dairy cows in 
Belgium: afield study. Theriogenology, 53; 841-857.
Orisaka M, Orisaka S, Jiang J-Y, Craig J, Wang Y, Kotsuji F & Tsang BK
I (2006). Growth differentiation factor 9 is antiapoptotic during follicular development 
from preantral to early antral stage. Molecular Endocrinology, 20; 2456-2468.
Paludan SR, Bowie AG, Horan KA & Fitzgerald KA (2011). Recognition of 
herpesviruses by the innate immune system. Nature Reviews Immunology, 11; 143-
154.
Panigone S, Hsieh M, Fu M, Persani L & Conti M (2008). Luteinizing hormone 
signaling in preovulatory follicles involves early activation of the epidermal growth 
factor receptor pathway. Molecular Endocrinology, 22; 924-936.
Park BS, Song DH, Kim HM, Choi B-S, Lee H & Lee J-O (2009). The structural 
basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature, 458; 
1191-1195.
270
Park J-Y, Su Y-Q, Ariga M, Law E, Jin S-LC & Conti M (2004). EGF-like 
growth factors as mediators of LH action in the ovulatory follicle. Science, 303; 682- 
684.
Park KW, Iga K & Niwa K (1997). Exposure of bovine oocytes to EGF during 
maturation allows them to develop to blastocysts in a chemically-defined medium. 
Theriogenology, 48; 1127-1135.
Parker LC, Prince LR & Sabroe I (2007). Translational mini-review series on 
Toll-like receptors: networks regulated by Toll-like receptors mediate innate and 
adaptive immunity. Clinical and Experimental Immunology, 147; 199-207.
Peng X-R, Hsueh AJW, Lapolt PS, Bjersing L & Ny T (1991). Localization of 
luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell 
types during follicle development and ovulation. Endocrinology, 129; 3200-3207.
| Pennetier S, Perreau C, Uzbekova S, Thelie A, Delaleu B, Mermillod P &
| Dalbies-Tran R (2006). MATER protein expression and intracellular localization 
| throughout folliculogenesis and preimplantation embryo development in the bovine, 
j BioMed Central Developmental Biology, 6; 26.
Pennetier S, Uzbekova S, Perreau C, Papillier P, Mermillod P & Dalbies-Tran
R (2004). Spatio-temporal expression of the germ cell marker genes MATER, ZAR1, 
GDF9, BMP 15 and VASA in adult bovine tissues, oocytes, and preimplantation 
embryos. Biology of Reproduction, 71; 1359-1366.
Perry GA, Smith MF, Roberts AJ, Macneil MD & Geary TW (2007). 
Relationship between size of the ovulatory follicle and pregnancy success in beef 
heifers. Journal of Animal Science, 85; 684-689.
Peter AT, Bosu WT & Dedecker RJ (1989). Suppression of preovulatory 
luteinizing hormone surges in heifers after intrauterine infusions of Escherichia coli 
endotoxin. American Journal ofVetinary Research, 50; 368-373.
Petsch D & Anspach FB (2000). Endotoxin removal from protein solutions. 
Journal of Biotechnology, 76; 97-119.
Pisarska MD, Barlow G & Kuo F-T (2011). Minireview: roles of the forkhead 
transcription factor FOXL2 in granulosa cell biology and pathology. Endocrinology, 
152; 1199-1208.
Pollock K, Booth R, Wilson R, Keeley T, Grogan K, Kennerley P & Johnston
SD (2010). Oestrus in the Julia Creek dunnart (Sminthopsis douglasi) is associated
271
with wheel running behaviour but not necessarily changes in body weight, food 
consumption or pouch morphology. Animal Reproduction Science, 117; 135-146.
| Portela VM, Zamberlam G, Goncalves PB, De Oliveira JF & Price CA (2011).
S Role of angiotensin II in the periovulatory epidermal growth factor-like cascade in 
| bovine granulosa cells in vitro. Biology of Reproduction, 85; 1167-1174.
| Potter TJ, Guitian J, Fishwick J, Gordon PJ & Sheldon IM (2010). Risk factors
; for clinical endometritis in postpartum dairy cattle. Theriogenology, 74; 127-134.
|
Powell JR, Kim DH & Ausubel FM (2009). The G protein-coupled receptor 
FSHR-1 is required for the Caenorhabditis elegans innate immune response. 
Proceedings of the National Academy of Sciences, 106; 2782-2787.
Quirk SM, Cowan RG & Harman RM (2006). The susceptibility of granulosa 
cells to apoptosis is influenced by oestradiol and the cell cycle. Journal of 
Endocrinology, 189; 441-453.
I Rachon D, Mysliwska J, Suchecka-Rachon K, Wieckiewicz J & Mysliwski A
(2002). Effects of oestrogen deprivation on interleukin-6 production by peripheral 
blood mononuclear cells of postmenopausal women. Journal of Endocrinology, 172; 
387-395.
Rae MT, Niven D, Ross A, Forster T, Lathe R, Critchley HOD, Ghazal P & 
Hillier SG (2004). Steroid signalling in human ovarian surface epithelial cells: the 
response to interleukin-la determined by microarray analysis. Journal of 
Endocrinology, 183; 19-28.
Rahman MM, Mazzilli M, Pennarossa G, Brevini TaL, Zecconi A & Gandolfi F
(2012). Chronic mastitis is associated with altered ovarian follicle development in 
dairy cattle. Journal of Dairy Science, 95; 1885-1893.
Raz T, Ben-Yosef D & Shalgi R (1998). Segregation of the pathways leading to 
cortical reaction and cell cycle activation in the rat egg. Biology of Reproduction, 58; 
94-102.
Richards JS (2005). Ovulation: new factors that prepare the oocyte for fertilization. 
Molecular and Cellular Endocrinology, 234; 75-79.
Richards JS, Liu Z & Shimada M (2008). Immune-like mechanisms in ovulation. 
Trends in Endocrinology & Metabolism, 19; 191-196.
Rico C, Medigue C, Fabre S, Jarrier P, Bontoux M, Clement F & Monniaux D
(2011). Regulation of anti-Mullerian hormone production in the cow: a multiscale
272
study at endocrine, ovarian, follicular, and granulosa cell levels. Biology of 
Reproduction, 84; 560-571.
Rivera GM & Fortune JE (2001). Development of codominant follicles in cattle is 
associated with a follicle-stimulating hormone-dependent insulin-like growth factor 
binding protein-4 protease. Biology of Reproduction, 65; 112-118.
Rivera GM & Fortune JE (2003). Proteolysis of insulin-like growth factor binding 
proteins -4 and -5 in bovine follicular fluid: implications for ovarian follicular 
; selection and dominance. Endocrinology, 144; 2977-2987.
t
j Robertson MJ (2002). Role of chemokines in the biology of natural killer cells.
| Journal of Leukocyte Biology, 71; 173-183.
I
i
j
j Roche JF (1996). Control and regulation of folliculogenesis - a symposium in 
perspective. Reviews of Reproduction, 1; 19-27.
Rodgers RJ & Irving-Rodgers HF (2010). Formation of the ovarian follicular 
antrum and follicular fluid. Biology of Reproduction, 82; 1021-1029.
Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, 
Faggioni R, Luini W, Van Hinsbergh V, Sozzani S, Bussolino F, Poli V, 
Ciliberto G & Mantovani A (1997). Role of IL-6 and its soluble receptor in 
induction of chemokines and leukocyte recruitment. Immunity, 6; 315-325.
Ross PJ, Beyhan Z, lager AE, Yoon SY, Malcuit C, Schellander K, Fissore RA 
& Cibelli JB (2008). Parthenogenetic activation of bovine oocytes using bovine and 
murine phospholipase C zeta. BioMed Central Developmental Biology, 8; 16.
Roughley PJ, Lamplugh L, Lee ER, Matsumoto K & Yamaguchi Y (2011). The 
role of hyaluronan produced by Has2 gene expression in development of the spine. 
Spine, 36; E914-E920.
Rouillier P, Matton P, Sirard MA & Guilbault LA (1996). Follicle-stimulating 
hormone-induced estradiol and progesterone production by bovine antral and mural 
granulosa cells cultured in vitro in a completely defined medium. Journal of Animal 
Science, 74; 3012-3019.
Rowson LEA, Lawson RaS, Moor RM & Baker AA (1972). Egg transfer in the 
cow: synchronisation requirements. Journal o f Reproduction and Fertility, 28; 427- 
431.
Runesson E, Ivarsson K, Olof Janson P & Brannstrom M (2000). Gonadotropin- 
and cytokine-regulated expression of the chemokine interleukin 8 in the human
273
preovulatory follicle of the menstrual cycle. Journal of Clinical Endocrinology & 
Metabolism, 85; 4387-4395.
Ryan KE, Casey SM, Canty MJ, Crowe MA, Martin F & Evans ACO (2007). 
Akt and Erk signal transduction pathways are early markers of differentiation in 
dominant and subordinate ovarian follicles in cattle. Reproduction, 133; 617-626.
Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH 
| & Glass CK (2009). A Nurrl/CoREST pathway in microglia and astrocytes protects 
dopaminergic neurons from inflammation-induced death. Cell, 137; 47-59.
|
Salasel B, Mokhtari A & Taktaz T (2010). Prevalence, risk factors for and impact 
of subclinical endometritis in repeat breeder dairy cows. Theriogenology, 74; 1271- 
1278.
j Salustri A, Camaioni A, Di Giacomo M, Fulop C & Hascall V (1999). 
Hyaluronan and proteoglycans in ovarian follicles. Human Reproduction Update, 5; 
293-301.
I
i!
I Sancho-Tello M, Chen T-Y, Clinton TK, Lyles R, Moreno RF, Tilzer L, 
j Imakawa K & Terranova PF (1992). Evidence for lipopolysaccharide binding in 
human granulosa-luteal cells. Journal of Endocrinology, 135; 571-578.
Sanders SP, Siekierski ES, Porter JD, Richards SM & Proud D (1998). Nitric 
oxide inhibits rhinovirus-induced cytokine production and viral replication in a 
human respiratory epithelial cell line. Journal of Virology, 72; 934-942.
Santana P, Llanes L, Hernandez I, Gonzalez-Robayna I, Tabraue C, Gonzalez- 
Reyes J, Quintana J, Estevez F, Ruiz De Galarreta CM & Fanjul LF (1996). 
Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: 
evidence for a regulatory role of ceramide on progesterone and prostaglandin 
biosynthesis. Endocrinology, 137; 2480-2489.
Santos NR, Lamb GC, Brown DR & Gilbert RO (2009). Postpartum endometrial 
cytology in beef cows. Theriogenology, 71; 739-745.
Sayasith K, Lussier J, Dore M & Sirois J (2013). Human chorionic gonadotropin- 
dependent up-regulation of epiregulin and amphiregulin in equine and bovine 
follicles during the ovulatory process. General and Comparative Endocrinology, 
180; 39-47.
Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M & 
Czarnetzki BM (1993). IL-8 produced by human malignant melanoma cells in vitro 
is an essential autocrine growth factor. Journal of Immunology, 151; 2667-2675.
274
Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD & Horton MR
(2006). Hyaluronan fragments act as an endogenous danger signal by engaging 
TLR2. The Journal of Immunology, 111; 1272-1281.
Schenk M, Belisle JT & Modlin RL (2009). TLR2 looks at lipoproteins. Immunity, 
31; 847-849.
Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, Nurnberg SA, 
Magolda RL & Trzaskos JM (1998). Inhibition of MAP kinase kinase prevents 
cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated 
monocytes. The Journal of Immunology, 161; 5681-5686.
Schiavone D, Dewilde S, Vallania F, Turkson J, Di cunto F & Poli V (2009). The 
RhoUAVrchl Rho GTPase gene is a common transcriptional target of both the 
gpl30/STAT3 and Wnt-1 pathways. Biochemical Journal, 421; 283-292.
I
Schier AF (2007). The maternal-zygotic transition: death and birth of RNAs.
I Science, 316; 406-407.
t
I
i Schnare M, Holt AC, Takeda K, Akira S & Medzhitov R (2000). Recognition of 
CpG DNA is mediated by signaling pathways dependent on the adaptor protein 
MyD88. Current Biology, 10; 1139-1142.
Schroder K, Irvine KM, Taylor MS, Bokil NJ, Le Cao K-A, Masterman K-A, 
Labzin LI, Semple CA, Kapetanovic R, Fairbairn L, Akalin A, Faulkner GJ, 
Baillie JK, Gongora M, Daub CO, Kawaji H, Mclachlan GJ, Goldman N, 
Grimmond SM, Carninci P, Suzuki H, Hayashizaki Y, Lenhard B, Hume DA & 
Sweet MJ (2012). Conservation and divergence in Toll-like receptor 4-regulated 
gene expression in primary human versus mouse macrophages. Proceedings of the 
National Academy of Sciences, 109; E944-E953.
Schwarz E, Schafer C, Bode JC & Bode C (2000). Influence of the menstrual 
cycle on the LPS-induced cytokine response of monocytes. Cytokine, 12; 413-416.
Scott L & Smith S (1997). Mouse in vitro fertilization, embryo development and 
viability, and human sperm motility in substances used for human sperm preparation 
for assisted reproduction. Fertility and Sterility, 67; 372-381.
Sharma SC & Richards JS (2000). Regulation of API (Jun/Fos) factor expression 
and activation in ovarian granulosa cells. Journal of Biological Chemistry, 275; 
33718-33728.
275
Shaykhiev R, Behr J & Bals R (2008). Microbial patterns signaling via Toll-Like 
receptors 2 and 5 contribute to epithelial repair, growth and survival. Public Library 
of Science ONE, 3; el 393.
Sheldon IM 2007. Endometritis in cattle: pathogenesis, consequences for fertility, 
diagnosis and therapeutic recommendations. Intervet: Reproduction Management 
Bulletin.
Sheldon IM, Cronin JG, Goetze L, Donofrio G & Schuberth H-J (2009).
Defining postpartum uterine disease and the mechanisms of infection and immunity
in the female reproductive tract in cattle. Biology of Reproduction, 81; 1025-1032.
|
I Sheldon IM, Noakes DE, Rycroft AN, Pfeiffer DU & Dobson H (2002). Influence 
I of uterine bacterial contamination after parturition on ovarian dominant follicle 
I selection and follicle growth and function in cattle. Reproduction, 123; 837-845.
i|
I Sheldon IM, Rycroft AN, Dogan B, Craven M, Bromfield JJ, Chandler A,
I Roberts MH, Price SB, Gilbert RO & Simpson KW (2010). Specific strains of
: Escherichia coli are pathogenic for the endometrium of cattle and cause pelvic 
inflammatory disease in cattle and mice. Public Libary of Science ONE, 5; e9192.
Shen X-H, Cui X-S, Lee S-H & Kim N-H (2012). Interleukin-6 enhances porcine 
parthenote development in vitro, through the IL-6/Stat3 signaling pathway. Journal 
of Reproduction and Development, 58; 453-460.
Shields AD, Wright J, Paonessa DJ, Gotkin J, Howard BC, Hoeldtke NJ & 
Napolitano PG (2005). Progesterone modulation of inflammatory cytokine 
production in a fetoplacental artery explant model. American Journal o f Obstetrics 
and Gynecology, 193; 1144-1148.
Shimada M, Hernandez-Gonzalez I, Gonzalez-Robanya I & Richards JS (2006). 
Induced expression of pattern recognition receptors in cumulus oocyte complexes: 
novel evidence for innate immune-like functions during ovulation. Molecular 
Endocrinology, 20; 3228-3239.
Shimada M, Yanai Y, Okazaki T, Noma N, Kawashima I, Mori T & Richards
JS (2008). Hyaluron fragments generated by sperm-secreted hyaluronidase stimulate 
cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of 
ovulated COCs, which may enhance fertilization. Development, 135; 2001-2011.
Shuster DE, Kehrli ME, Rainard P & Paape M (1997). Complement fragment 
C5a and inflammatory cytokines in neutrophil recruitment during intramammary 
infection with Escherichia coli. Infection and Immunity, 65; 3286-3292.
276
j Simoni M, Gromoll J & Nieschlag E (1997). The follicle-stimulating hormone 
receptor: biochemistry, molecular biology, physiology, and pathophysiology. 
Endocrine Reviews, 18; 739-773.
Small BG, Mccoll BW, Allmendinger R, Pahle J, Lopez-Castejon G, Rothwell 
NJ, Knowles J, Mendes P, Brough D & Kell DB (2011). Efficient discovery of 
anti-inflammatory small-molecule combinations using evolutionary computing. 
Nature Chemical Biology, 7; 902-908.
Smitz J & Cortvrindt R (2002). The earliest stages of folliculogenesis in vitro. 
Reproduction, 123; 185-202.
Soboll G, Crane-Godreau MA, Lyimo MA & Wira CR (2006). Effect of 
oestradiol on PAMP-mediated CCL20/MIP-3a production by mouse uterine 
epithelial cells in culture. Immunology, 118; 185-194.
Soloy E, Kanka J, Viuff D, Smith SD, Callesen H & Greve T (1997). Time course 
of pronuclear deoxyribonucleic acid synthesis in parthenogenetically activated 
bovine oocytes. Biology of Reproduction, 57; 27-35.
Somfai T, Aacute, Inaba Y, Aikawa Y, Ohtake M, Kobayashi S, Konishi K & 
Imai K (2010). Relationship between the length of cell cycles, cleavage pattern and 
developmental competence in bovine embryos generated by in vitro fertilization or 
parthenogenesis. Journal of Reproduction and Development, 56; 200-207.
Son D-S & Roby KF (2006). Interleukin-la-induced chemokines in mouse 
granulosa cells: impact on keratinocyte chemoattractant chemokine, a CXC 
subfamily. Molecular Endocrinology, 20; 2999-3013.
Sorbara MT & Philpott DJ (2011). Peptidoglycan: a critical activator of the 
mammalian immune system during infection and homeostasis. Immunological 
Reviews, 243; 40-60.
Spanel-Borowski K, Rahner P & Ricken AM (1997). Immunolocalization of 
CD 18-positive cells in the bovine ovary. Journal o f Reproduction and Fertility, 111; 
197-205.
Spangelo BL, Judd AM, Call GB, Zumwalt J & Gorospe WC (1995). Role of the 
cytokines in the hypothalamic-pituitary-adrenal and gonadal axes. 
Neuroimmunomodulation, 2; 299-312.
Spencer TE, Sandra O & Wolf E (2008). Genes involved in conceptus-endometrial 
interactions in ruminants: insights from reductionism and thoughts on holistic 
approaches. Reproduction, 135; 165-179.
277
Spicer LJ & Alpizar E (1994). Effects of cytokines on FSH-induced estradiol 
production by bovine granulosa cells in vitro: dependence on size of follicle. 
Domestic Animal Endocrinology, 11; 25-34.
Stabenfeldt G, Ewing L & Mcdonald L (1969). Peripheral plasma progesterone 
levels during the bovine oestrous cycle. Journal of Reproduction and Fertility, 19; 
433-442.j
| Stenvers K, Bilandzic M, Wang Y & Findlay J (2009). Betaglycan as a 
determinant of TGF-beta superfamily action in human granulosa tumor cells. 81; 
546.
Su L, Sun Y, Ma F, Lii P, Huang H & Zhou J (2009). Progesterone inhibits Toll­
like receptor 4-mediated innate immune response in macrophages by suppressing 
NF-kB activation and enhancing SOCS1 expression. Immunology Letters, 125; 151-
155.
Susko-Parrish JL, Leibfried-Rutledge ML, Northey DL, Schutzkus V & First
NL (1994). Inhibition of protein kinases after an induced calcium transient causes 
| transition of bovine oocytes to embryonic cycles without meiotic completion. 
! Developmental Biology, 166; 729-739.
Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, 
Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW &
Yeh W-C (2002). Severe impairment of interleukin-1 and Toll-like receptor 
signalling in mice lacking IRAK-4. Nature, 416; 750-756.
Swangchan-Uthai T, Lavender CRM, Cheng Z, Fouladi-Nashta AA & Wathes
DC (2012). Time course of defense mechanisms in bovine endometrium in response 
to lipopolysaccharide. Biology o f Reproduction, 87; 135, 131-113.
Syed V, Ulinski G, Mok SC & Ho SM (2002). Reproductive hormone-induced, 
STAT3-mediated interleukin 6 action in normal and malignant human ovarian 
surface epithelial cells. Journal of the National Cancer Institute, 94; 617-629.
Tadros W & Lipshitz HD (2009). The matemal-to-zygotic transition: a play in two 
acts. Development, 136; 3033-3042.
Takeda K (2005). Toll-like receptors and their adaptors in innate immunity. Current 
Medicinal Chemistry, 4; 3-11.
Takeda K & Akira S (2005). Toll-like receptors in innate immunity. International 
Immunology, 17; 1-14.
Takeuchi O & Akira S (2010). Pattern recognition receptors and inflammation. 
Cell, 140; 805-820.
Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K & 
Akira S (1999). Differential roles of TLR2 and TLR4 in recognition of Gram- 
negative and Gram-positive bacterial cell wall components. Immunity, 11; 443-451.
Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T & Akira S (2000). 
Cellular responses to bacterial cell wall components are mediated through MyD88- 
dependent signaling cascades. International Immunology, 12; 113-117.
I Taylor CC & Terranova PF (1996). Lipopolysaccharide inhibits in vitro 
luteinizing hormone-stimulated rat ovarian granulosa cell estradiol but not 
progesterone secretion. Biology of Reproduction, 54; 1390-1396.
Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC & Gallo RL
| (2004). Hyaluronan fragments stimulate endothelial recognition of injury through 
I TLR4. Journal of Biological Chemistry, 279; 17079-17084.
: Teankum K, Pospischil A, Janett F, Brugnera E, Hoelzle LE, Hoelzle K, 
Weilenmann R, Zimmermann DR, Gerber A, Polkinghorne A & Borel N
(2007). Prevalence of chlamydiae in semen and genital tracts of bulls, rams and 
bucks. Theriogenology, 67; 303-310.
Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, 
Freudenberg M, Galanos C & Simon JC (2002). Oligosaccharides of hyaluronan 
activate dendritic cells via Toll-like receptor 4. Journal of Experimental Medicine, 
195; 99-111.
Thermoscientific. 2011. Technical bulletin T042 NanoDrop spectrophotometers: 
assessment of nucleic acid purity [Online]. Available: 
http://www.nanodrop.com/Library/T042-NanoDrop-Spectrophotometers-Nucleic- 
Acid-Purity-Ratios.pdf [Accessed July 8th 2013].
Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, Dean J & Nelson
LM (2000). Mater, a maternal effect gene required for early embryonic development 
in mice. Nature Genetics, 26; 267-268.
Toshchakov V, Jones BW, Perera P-Y, Thomas K, Cody MJ, Zhang S, Williams 
BRG, Major J, Hamilton TA, Fenton MJ & Vogel SN (2002). TLR4, but not 
TLR2, mediates IFN—induced STAT1/-dependent gene expression in macrophages. 
Nature Immunology, 3; 392-398.
279
Travassos LH, Girardin SE, Philpott DJ, Blanot D, Nahori M-A, Werts C & 
Boneca IG (2004). Toll-like receptor 2-dependent bacterial sensing does not occur 
via peptidoglycan recognition. European Molecular Biology Organisation Reports,
\ 5; 1000-1006.
| Tsan M-F & Gao B (2007). Review: pathogen-associated molecular pattern 
| contamination as putative endogenous ligands of Toll-like receptors. Journal of 
Endotoxin Research, 13; 6-14.
I
i Tsan M & Gao B (2009). Heat shock proteins and immune system. Journal of 
Leukocyte Biology, 85; 905-910.
Tsan MF (2011). Heat shock proteins and high mobility group box 1 protein lack 
cytokine function. Journal of Leukocyte Biology, 89; 847-853.
Tschopp J & Schroder K (2010). NLRP3 inflammasome activation: the 
convergence of multiple signalling pathways on ROS production? Nature Reviews 
Immunology, 10; 210-215.
| Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T & Tada K
| (1980). Establishment and characterization of a human acute monocytic leukemia 
I cell line (THP-1). International Journal of Cancer, 26; 171-175.
j
Ujioka T, Matsukawa A, Tanaka N, Matsuura K, Yoshinaga M & Okamura H
(1998). Interleukin-8 as an essential factor in the human chorionic gonadotropin- 
induced rabbit ovulatory process: interleukin-8 induces neutrophil accumulation and 
activation in ovulation. Biology of Reproduction, 58; 526-530.
I Urashima M, Chauhan D, Hatziyanni M, Ogata A, Hollenbaugh D, Aruffo A & 
Anderson KC (1996). CD40 ligand triggers interleukin-6 mediated B cell 
differentiation. Leukemia Research, 20; 507-515.
Van Den Berg-Bakker CaM, Hagemeijer A, Franken-Postma EM, Smit 
VTHBM, Kuppen PJK, Claasen HHVR, Cornelisse CJ & Schrier PI (1993). 
Establishment and characterization of 7 ovarian carcinoma cell lines and one 
granulosa tumor cell line: growth features and cytogenetics. International Journal of 
Cancer, 53; 613-620.
Van Den Hurk R & Zhao J (2005). Formation of mammalian oocytes and their 
growth, differentiation and maturation within ovarian follicles. Theriogenology, 63; 
1717-1751.
Vanderhyden BC, Caron PJ, Buccione R & Eppig JJ (1990). Developmental 
pattern of the secretion of cumulus expansion-enabling factor by mouse oocytes and
280
the role of oocytes in promoting granulosa cell differentiation. Developmental 
Biology, 140; 307-317.
Vegeto E, Ciana P & Maggi A (2002). Estrogen and inflammation: hormone 
generous action spreads to the brain. Molecular Psychiatry, 7; 236-238.
Vickers DM & Osgood ND (2010). Current crisis or artifact of surveillance: 
insights into rebound chlamydia rates from dynamic modelling. BioMed Central 
i Infectious Diseases, 10; 70.
Volz T, Nega M, Buschmann J, Kaesler S, Guenova E, Peschel A, Rocken M, 
Gotz F & Biedermann T (2010). Natural Staphylococcus aureus-derived 
peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate 
immune system exclusively in the presence of TLR signals. The Journal of the 
Federation o f American Societies for Experimental Biology, 24; 4089-4102.
W.H.O. 2011. Sexually transmitted infections [Online]. Available: 
http://www.who.int/mediacentre/factsheets/fsllO/en/ [Accessed 09/05/2013 2013].
i!
[ Walker SL, Waddell WT & Goodrowe KL (2002). Reproductive endocrine 
[ patterns in captive female and male red wolves (Canis rufus) assessed by fecal and 
! serum hormone analysis. Zoo Biology, 21; 321-335.
Wandji SA, Srsen V, Voss AK, Eppig JJ & Fortune JE (1996). Initiation in vitro 
of growth of bovine primordial follicles. Biology of Reproduction, 55; 942-948.
Wegenka UM, Buschmann J, Liitticken C, Heinrich PC & Horn F (1993).
| Acute-phase response factor, a nuclear factor binding to acute-phase response 
elements, is rapidly activated by interleukin-6 at the posttranslational level.
! Molecular and Cellular Biology, 13; 276-288.
Werling D, Jann O, Offord V, Glass E & Coffey T (2009). Variation matters: 
TLR structure and species-specific pathogen recognition. Trends in Immunology, 30; 
124-130.
Whitfield C & Roberts IS (1999). Structure, assembly and regulation of expression 
of capsules in Escherichia coli. Molecular Microbiology, 31; 1307-1319.
Whitworth DJ (1998). XX germ cells: the difference between an ovary and a testis. 
Trends in Endocrinology and Metabolism, 9; 2-6.
Wildt L, Haeusler A, Marshall G, Hutchison JS, Plant TM, Belchetz PE & 
Knobil E (1981). Frequency and amplitude of gonadotropin-releasing hormone
281
stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology, 109;
! 376-385.t
t
i
j
Williams EJ, Fischer DP, Noakes DE, England GCW, Rycroft A, Dobson H & 
Sheldon IM (2007). The relationship between uterine pathogen growth density and 
ovarian function in the postpartum dairy cow. Theriogenology, 68; 549-559.
Williams EJ, Fischer DP, Pfeiffer DU, England GCW, Noakes DE, Dobson H &
| Sheldon IM (2005). Clinical evaluation of postpartum vaginal mucus reflects uterine 
j  bacterial infection and the immune response in cattle. Theriogenology, 63; 102-117.
|
| Williams EJ, Sibley K, Miller AN, Lane EA, Fishwick J, Nash DM, Herath S,
| England GCW, Dobson H & Sheldon IM (2008). The effect of Escherichia coli 
| lipopolysaccharide and tumour necrosis factor alpha on ovarian function. American 
| Journal of Reproductive Immunology, 60; 462-473.
iI
| Williams MJ, Rodriguez A, Kimbrell DA & Eldon ED (1997). The 18-wheeler 
| mutation reveals complex antibacterial gene regulation in Drosophila host defense, 
j European Molecular Biology Organisation Journal, 16; 6120-6130.
j Woessner Jr JF, Morioka N, Zhu C, Mukaida T, Butler T & Lemaire WJ
; (1989). Connective tissue breakdown in ovulation. Steroids, 54; 491-499.
j
Wolf JS, Chen Z, Dong G, Sun woo JB, Bancroft CC, Capo DE, Yeh NT, 
Mukaida N & Waes CV (2001). IL (Interleukin)-la promotes nuclear factor-KB 
and AP-1 -induced IL-8 expression, cell survival, and proliferation in head and neck 
squamous cell carcinomas. Clinical Cancer Research, 7; 1812-1820.
Woods DC, Schorey JS & Johnson AL (2009). Toll-like receptor signaling in hen 
ovarian granulosa cells is dependent on stage of follicle maturation. Reproduction, 
137; 987-996.
Woods DC, White YaR, Dau C & Johnson AL (2011). TLR4 activates NF- 
[kappa]B in human ovarian granulosa tumor cells. Biochemical and Biophysical 
Research Communications, 409; 675-680.
Wrobel KH & Suss F (1998). Identification and temporospatial distribution of 
bovine primordial germ cells prior to gonadal sexual differentiation. Anatomy and 
Embryology, 197; 451 -467.
Wu B, Ignotz G, Currie WB & Yang X (1997). Dynamics of maturation- 
promoting factor and its constituent proteins during in vitro maturation of bovine 
oocytes. Biology of Reproduction, 56; 253-259.
282
Wu H, Wang H, Xiong W, Chen S, Tang H & Han D (2008). Expression patterns 
and functions of Toll-like receptors in mouse Sertoli cells. Endocrinology, 149; 
4402-4412.
Wu X (2009). Maternal depletion of NLRP5 blocks early embryogenesis in rhesus 
macaque monkeys (Macaca mulatto). Human Reproduction, 24; 415-424.
Wu X, Viveiros MM, Eppig JJ, Bai Y, Fitzpatrick SL & Matzuk MM (2003). 
Zygote arrest 1 (Z arl) is a novel matemal-effect gene critical for the oocyte-to- 
, embryo transition. Nature Genetics, 33; 187-191.
Xu Z, Garverick HA, Smith GW, Smith MF, Hamilton SA & Youngquist RS
(1995). Expression of follicle-stimulating hormone and luteinizing hormone receptor 
messenger ribonucleic acids in bovine follicles during the first follicular wave. 
Biology of Reproduction, 53; 951-957.
Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O,
; Sugiyama M, Okabe M, Takeda K & Akira S (2003). Role of adaptor TRIF in the 
i MyD88-independent Toll-like receptor signaling pathway. Science, 301; 640-643.
IIl
! Yamashita Y, Hishinuma M & Shimada M (2009). Activation of PKA, p38 
MAPK and ERK1/2 by gonadotropins in cumulus cells is critical for induction of 
EGF-like factor and TACE/ADAM17 gene expression during in vitro maturation of 
porcine COCs. Journal of Ovarian Research, 2; 20.
I
Yamashita Y & Shimada M (2012). The release of EGF domain from EGF-like 
factors by a specific cleavage enzyme activates the EGFR-MAPK3/1 pathway in 
both granulosa cells and cumulus cells during the ovulation process. Journal of 
Reproduction and Development, 58; 510-514.
Yamawaki H, Hirohata S, Miyoshi T, Takahashi K, Ogawa H, Shinohata R, 
Demircan K, Kusachi S, Yamamoto K & Ninomiya Y (2009). Hyaluronan 
receptors involved in cytokine induction in monocytes. Glycobiology, 19; 83-92.
Yang H, Wang H, Czura CJ & Tracey KJ (2005). The cytokine activity of 
HMGB1. Journal of Leukocyte Biology, 78; 1-8.
Yokoo M, Kimura N & Sato E (2010). Induction of oocyte maturation by 
hyaluronan-CD44 interaction in pigs. The Journal of Reproduction and 
Development, 56; 15-19.
Yoo J, Perez CER, Nie W, Edwards RA, Sinnett-Smith J & Rozengurt E (2012). 
TNF-a induces upregulation of EGFR expression and signaling in human colonic
283
myofibroblasts. American Journal of Physiology - Gastrointestinal and Liver 
Physiology, 302; G805-G814.
Youn H-S, Lim HJ, Lee HJ, Hwang D, Yang M, Jeon R & Ryu J-H (2008). 
Garlic (Allium sativum) extract inhibits lipopolysaccharide-induced Toll-Like 
receptor 4 dimerization. Bioscience, Biotechnology, and Biochemistry, 72; 368-375.
Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA & 
Ghosh S (2004). A Toll-like receptor that prevents infection by uropathogenic 
j bacteria. Science, 303; 1522-1526.
I
I
j Zhang H, Vollmer M, De Geyter M, Litzistorf Y, Ladewig A, Durrenberger M, 
j Guggenheim R, Miny P, Holzgreve W & De Geyter C (2000). Characterization of 
| an immortalized human granulosa cell line (COV434). Molecular Human 
j Reproduction, 6; 146-153.
i
| Zhong J & Kyriakis JM (2007). Dissection of a signaling pathway by which 
pathogen-associated molecular patterns recruit the JNK and p38 MAPKs and trigger 
cytokine release. Journal of Biological Chemistry, 282; 24246-24254.
284
